Sentence,class,file
http://dx.doi.org/10.1093/mollus/eyl025 .,Non-OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
http://dx.doi.org/10.1371/ journal.pone.0053704 .,Non-OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
http://dx.doi.org/10.1371/journal.pone.0095003 .,Non-OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
http://dx.doi.org/10.1371/journal.pone.0007866 .,Non-OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
"http://dx.doi.org/10.1371/journal.pone.0029987 .Maas, A.E., Blanco-Bercial, L., Lawson, G.L., 2013.",Non-OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
http://dx.doi.org/10.1371/ journal.pone.0053889 .,Non-OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
http://dx.doi.org/10.1371/ journal.pone.0028655 .,Non-OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
"PLoS ONE 5 (4), e10278.http://dx.doi.org/10.1371/journal.pone.0010278 .",Non-OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
http://dx.doi.org/10.1111/j.1463-6409.2007.00289 .,Non-OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
http://dx.doi.org/10.1111/j.1463-6409.2007.00312 .,Non-OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
http://dx.doi.org/10.1371/journal.pone.0034506 .,Non-OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
http://dx.doi.org/10.1111/j.1755- 0998.2009.02576.x .,Non-OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
http://dx.doi.org/10.3390/d2040450 .,Non-OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
"29 (3), 263–276.http://dx.doi.org/10.1016/j.devcel.2014.04.001 .",OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
http://dx.doi.org/10.3391/ai.2012.7.3.002 .,Non-OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
http://dx.doi.org/10.1371/ journal.pone.0006300 .,Non-OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
http://dx.doi.org/10.1371/ journal.pone.0013991 .,Non-OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
"100, 107–142.http://dx.doi.org/10.1016/B978-0-12-387786-4.00011-7 .",Non-OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
http://dx.doi.org/10.2478/dna-2014-0003 .,OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
http://dx.doi.org/10.1111/ j.1755-0998.2009.02826.x .,Non-OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
http://dx.doi.org/10.1371/journal.pone.0039345 .,Non-OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
http://dx.doi.org/ 10.1007/s11802-013-2052-9 .,Non-OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
http://dx.doi.org/10.1155/ 2011/978253 .,Non-OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
"9 (1), 237– 242. http://dx.doi.org/10.1111/j.1755-0998.2009.02649.x .",Non-OADS,/arxiv_data1/oa_pdf/c6/cc/main.PMC4778524.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d9/a1/main.PMC4778525.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2016) 23, 237 –242 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.02.013 1319-562X ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/d9/a1/main.PMC4778525.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d9/a1/main.PMC4778525.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d2/95/main.PMC4778538.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2016) 23, 243 –247 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.03.006 1319-562X ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/d2/95/main.PMC4778538.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d2/95/main.PMC4778538.pdf
"Soybean ClpB/Hsp101 mRNA sequence(Glyma05g00 540; GenBank accession number NM_ 001251193.1; Lee et al., 1994 ) was used as query to search for the soybean genomes for homologs using BLASTN func-tion of the Phytozome database ( http://www.phytozome.net ).",OADS,/arxiv_data1/oa_pdf/d2/95/main.PMC4778538.pdf
ClpB/Hsp100 conserved domains were identiﬁed in NCBI con- served domain database ( http://www.ncbi.nlm.nih.gov/ Structure/cdd/cdd.shtml ) and SMART database ( http:// smart.embl-heidelberg.de/ ).,OADS,/arxiv_data1/oa_pdf/d2/95/main.PMC4778538.pdf
WoLF PSORT ( http://www.gen- script.com/psort/wolf_psort.html ) software was used for pre- diction of sub-cellular localization.,OADS,/arxiv_data1/oa_pdf/d2/95/main.PMC4778538.pdf
"37, 1737, < http://dx.doi.org/10.1007/s11738-014-1737-z >.",Non-OADS,/arxiv_data1/oa_pdf/d2/95/main.PMC4778538.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/15/44/iev145.PMC4778571.pdf
"NOAA/NCDC Paleoclimatology Program,Boulder CO, USA (http://www.bugscep.com).",Non-OADS,/arxiv_data1/oa_pdf/15/44/iev145.PMC4778571.pdf
"Table 1 : numbers of threatened species by major groups of organisms (1996–2014) (http://cmsdocs.s3.amazonaws.com/summaryJournal of Insect Science , 2016, Vol.",Non-OADS,/arxiv_data1/oa_pdf/15/44/iev145.PMC4778571.pdf
(http://radon.uio.no/WDD/Login.aspx?,Non-OADS,/arxiv_data1/oa_pdf/15/44/iev145.PMC4778571.pdf
[in Swedish] (http://www.artfakta.se/GetSpecies.aspx?SearchType ¼Advanced) (accessed 20 February 2015).,Non-OADS,/arxiv_data1/oa_pdf/15/44/iev145.PMC4778571.pdf
[in Norwegian] (http://www.nhm.uio.no/fakta/zoologi/insekter/norcol/regioner_lang.html) (accessed 16 January 2015).,Non-OADS,/arxiv_data1/oa_pdf/15/44/iev145.PMC4778571.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2b/8c/main.PMC4778577.pdf
"Raw data for this project were de-posited at SRA database with the accession numbers SRX1389337 (http://www.ncbi.nlm.nih.gov/sra/SRX1389337 ) for day 0 control, SRX1389392 ( http://www.ncbi.nlm.nih.gov/sra/SRX1389392 )f o rd a y3 longevity experiment, and SRX1389395 ( http://www.ncbi.nlm.nih.gov/ sra/SRX1389395 ) for day 3 chitin-treatment experiment.",Non-OADS,/arxiv_data1/oa_pdf/2b/8c/main.PMC4778577.pdf
"Speci ﬁcations Subject area Biology, Plant Molecular Biology Type of data Transcriptome sequencesOrganism/Cell line/tissueNepenthes × ventrata (Pitcher) Sequencer type Illumina HiSeq ™2500 Data format Raw and processed Experimental factors Experimental plot, control and treatments of pitchers Experimental features RNA-seq dataset for gene discovery in a pitcher plantSample source location MalaysiaData accessibility SRA database accession SRX1389337(http://www.ncbi.nlm.nih.gov/sra/SRX1389337) SRX1389392(http://www.ncbi.nlm.nih.gov/sra/SRX1389392) SRX1389395(http://www.ncbi.nlm.nih.gov/sra/SRX1389395) http://dx.doi.org/10.1016/j.gdata.2015.11.0072213-5960/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/2b/8c/main.PMC4778577.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2b/8c/main.PMC4778577.pdf
"Stan-dard Trinotate (v2.0.0) annotation pipeline ( https://trinotate.github.io/) was carried out to annotate the assembled unique transcripts against Swissprot [4],P f a m [5], eggNOG [6], Gene Ontology [7], SignalP [8], and Rnammer [9].",OADS,/arxiv_data1/oa_pdf/2b/8c/main.PMC4778577.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2016) 23, 282 –287 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.11.004 1319-562X /C2112015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/20/b2/main.PMC4778578.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/20/b2/main.PMC4778578.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/20/b2/main.PMC4778578.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2016) 23, 293 –299 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.06.017 1319-562X ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/a7/1d/main.PMC4778579.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a7/1d/main.PMC4778579.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a7/1d/main.PMC4778579.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0a/ee/main.PMC4778580.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2016) 23, 268 –271 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.06.020 1319-562X ª2015 Production and hosting by Elsevier B.V. on behalf of King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/0a/ee/main.PMC4778580.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0a/ee/main.PMC4778580.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8b/17/main.PMC4778581.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2016) 23, 205 –210 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.11.006 1319-562X /C2112015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/8b/17/main.PMC4778581.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8b/17/main.PMC4778581.pdf
< http://www.fao.org/ﬁ/statist/FISOFT/FISHPLUS.,Non-OADS,/arxiv_data1/oa_pdf/8b/17/main.PMC4778581.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5f/03/main.PMC4778582.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2016) 23, 189 –197 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.10.008 1319-562X /C2112015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/5f/03/main.PMC4778582.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5f/03/main.PMC4778582.pdf
These results suggest that CS information can be regarded as important parameters in the prediction of protein folds.Chemical shift values corresponding to the protein backbone atoms were obtained from the BMRB ( http://www.bmrb.,OADS,/arxiv_data1/oa_pdf/5f/03/main.PMC4778582.pdf
The online web server PSIPRED ( http://bioinf.cs.ucl.ac.uk/psipred/ ) was used to obtain the predicted secondary structure of each protein sequence in the 76-protein fold class dataset.,OADS,/arxiv_data1/oa_pdf/5f/03/main.PMC4778582.pdf
The online web server PSIPRED ( http://bioinf.cs.ucl.ac.uk/psipred/ ) was used to obtain the predicted secondary struc- ture of each protein sequence.,OADS,/arxiv_data1/oa_pdf/5f/03/main.PMC4778582.pdf
The Random Forests algorithm was applied using R-2.15.1software ( http://www.r-project.org/ ) and the Random Forest program package.,OADS,/arxiv_data1/oa_pdf/5f/03/main.PMC4778582.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/92/b9/main.PMC4778583.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2016) 23, 311 –317 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.09.027 1319-562X /C2112015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/92/b9/main.PMC4778583.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/92/b9/main.PMC4778583.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/81/be/main.PMC4778584.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2016) 23, 288 –292 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.04.007 1319-562X ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/81/be/main.PMC4778584.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/81/be/main.PMC4778584.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/aa/50/main.PMC4778585.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2016) 23, 198 –204 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.10.007 1319-562X /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/aa/50/main.PMC4778585.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/aa/50/main.PMC4778585.pdf
"94 (3), 388–403.http://dx.doi.org/10.1002/jsfa.6371 .",Non-OADS,/arxiv_data1/oa_pdf/aa/50/main.PMC4778585.pdf
http://dx.doi.org/10.1155/2014/831989 .,Non-OADS,/arxiv_data1/oa_pdf/aa/50/main.PMC4778585.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Astaxanthin supplementationDose-dependentHippocampal genesHousekeeping gene, RT-PCR 1.",Non-OADS,/arxiv_data1/oa_pdf/d8/d0/main.PMC4778586.pdf
Direct link to deposited data Deposited data can be found here: http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?targ=self&form= html&view=brief&acc=GSE621972.,OADS,/arxiv_data1/oa_pdf/d8/d0/main.PMC4778586.pdf
http://dx.doi.org/10.1016/j.gdata.2015.11.001 2213-5960/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d8/d0/main.PMC4778586.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d8/d0/main.PMC4778586.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: ApomicticGenome sequencing Genome survey Illumina sequencingMangosteen Speci ﬁcation Subject area Biology, plant molecular biologyType of data Genomic DNA sequencesOrganism/Cell line/tissue Garcina mangostana (leaf) Sequencer type Illumina HiSeq ™2000 Data format Raw sequences (Fastq)Experimental factors Experimental plotExperimental features DNA-seq dataset for mangosteen genome surveySample source location MalaysiaData accessibility SRA database accession SRX1426419 (http://www.ncbi.nlm.nih.gov/sra/SRX1426419 ) 1.",Non-OADS,/arxiv_data1/oa_pdf/4e/33/main.PMC4778587.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/sra/SRX1426419 .,OADS,/arxiv_data1/oa_pdf/4e/33/main.PMC4778587.pdf
Raw data forthis project were deposited at SRA database with the accession number SRX1426419 ( http://www.ncbi.nlm.nih.gov/sra/SRX1426419 ).,OADS,/arxiv_data1/oa_pdf/4e/33/main.PMC4778587.pdf
http://dx.doi.org/10.1016/j.gdata.2015.11.018 2213-5960/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/4e/33/main.PMC4778587.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4e/33/main.PMC4778587.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c1/2b/main.PMC4778588.pdf
"Speci ﬁcations Subject area Biology, Plant Molecular Biology Type of data Transcriptome sequencesOrganism/Cell line/tissuePolygonum minus (leaf and root) Sequencer type Illumina HiSeq ™2000 (leaf), Roche 454 GS-FLX (root) Data format Raw and processedExperimental factorsControlled growth chamber (leaf), experimental plot (root) Experimental featuresRNA-seq dataset for gene discovery in plant Sample source locationMalaysia Data accessibility GenBank accession SRX669305 ( http://www.ncbi.nlm.nih.gov/sra/SRX669305 ) and SRX313492(http://www.ncbi.nlm.nih.gov/sra/SRX313492 ) 1.",OADS,/arxiv_data1/oa_pdf/c1/2b/main.PMC4778588.pdf
The raw data and assembly project have been deposited atGenBank under the accessions SRX313492 ( http://www.ncbi.nlm.nih.,OADS,/arxiv_data1/oa_pdf/c1/2b/main.PMC4778588.pdf
gov/sra/SRX313492 ) and SRX669305 ( http://www.ncbi.nlm.nih.gov/ sra/SRX669305 ) for the root and leaf tissues respectively.,Non-OADS,/arxiv_data1/oa_pdf/c1/2b/main.PMC4778588.pdf
http://dx.doi.org/10.1016/j.gdata.2015.11.003 2213-5960/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c1/2b/main.PMC4778588.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c1/2b/main.PMC4778588.pdf
Root 454 reads were clipped to pseudo reads equivalent to that of leaf Illumina short reads of 90 bp with 5 bp overlap using an in-house PHP script ( http://gitlab.inbiosis.ws/open-source/rnaseq-utils ).,OADS,/arxiv_data1/oa_pdf/c1/2b/main.PMC4778588.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: PhytophthoraP.,Non-OADS,/arxiv_data1/oa_pdf/25/00/main.PMC4778589.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/assembly/GCA_001314425.1 http://www.ncbi.nlm.nih.gov/assembly/GCA_001314365.1 http://www.ncbi.nlm.nih.gov/assembly/GCA_001314455.1 http://www.ncbi.nlm.nih.gov/assembly/GCA_001314345.1 http://www.ncbi.nlm.nih.gov/assembly/GCA_001314355.1 http://www.ncbi.nlm.nih.gov/assembly/GCA_001314375.1 http://www.ncbi.nlm.nih.gov/assembly/GCA_001314925.1 http://www.ncbi.nlm.nih.gov/assembly/GCA_001314505.1 http://www.ncbi.nlm.nih.gov/assembly/GCA_001314445.1http://www.ncbi.nlm.nih.gov/assembly/GCA_001314435.1http://www.ncbi.nlm.nih.gov/assembly/GCA_000785725.1 http://www.ncbi.nlm.nih.gov/assembly/GCA_000785735.1 2.,Non-OADS,/arxiv_data1/oa_pdf/25/00/main.PMC4778589.pdf
http://dx.doi.org/10.1016/j.gdata.2015.11.015 2213-5960/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/25/00/main.PMC4778589.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/25/00/main.PMC4778589.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/c7/main.PMC4778590.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2016) 23, 272 –281 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.11.002 1319-562X /C2112015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/00/c7/main.PMC4778590.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/c7/main.PMC4778590.pdf
http://dx.doi.org/10.1155/ 2012/936950 .280 A. Hashem et al.,OADS,/arxiv_data1/oa_pdf/00/c7/main.PMC4778590.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC4778591.pdf
http://dx.doi.org/10.1016/j.gdata.2015.11.002 2213-5960/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC4778591.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC4778591.pdf
"Under such scenario, several instances of the Mexican government started the “Global Native Maize Project” (http://www.biodiversidad.gob.mx/genes/proyectoMaices.html ), an initiative to update the data on Mexican maize landraces and their wild relatives, and to generate information that is necessary for implementing the Mexican Biosafety Law [10].",Non-OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC4778591.pdf
The results presented here can also be explored with interactive ﬁgures available at https://conabio.shinyapps.io/MaicesMx50kSNP-english .,Non-OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC4778591.pdf
Metadata of samples is available at: http://dx.doi.org/10.5061/dryad.4t20n .,OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC4778591.pdf
Interactive plots were also constructed using the package shiny [8]and are available at CONABIO's website https://conabio.shinyapps.i o/MaicesMx50kSNP-english .,Non-OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC4778591.pdf
"Data availability SNP data, maps, metadata, admixture ﬁl e sa n ds c r i p t su s e dh e r ea r e available at the Dryad Digital Repository: http://dx.doi.org/10.5061/ dryad.4t20n available upon acceptance).",OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC4778591.pdf
Interactive ﬁgures are available at CONABIO's website as part of the Global Native Maize Project results: https://conabio.shinyapps.i o/MaicesMx50kSNP-english .,Non-OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC4778591.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7c/1c/main.PMC4778592.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE71180 .2.,OADS,/arxiv_data1/oa_pdf/7c/1c/main.PMC4778592.pdf
http://dx.doi.org/10.1016/j.gdata.2015.11.006 2213-5960/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/7c/1c/main.PMC4778592.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7c/1c/main.PMC4778592.pdf
"The main package used for the analysis is CompEpiTools v1.2.6 [5], which is part of the BioConductor project [6]and it can be installed from the URL http://www.bioconductor.org /packages/release/bioc/ html/compEpiTools.html .",OADS,/arxiv_data1/oa_pdf/7c/1c/main.PMC4778592.pdf
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ff/33/main.PMC4778593.pdf
Direct link to gene expression data deposited in Gene Expression Omnibus (GEO) http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE65040 .Genomics Data 7 (2016) 92 –93 ⁎Corresponding author.,OADS,/arxiv_data1/oa_pdf/ff/33/main.PMC4778593.pdf
HMEC were http://dx.doi.org/10.1016/j.gdata.2015.11.022 2213-5960/© 2015 The Authors.,OADS,/arxiv_data1/oa_pdf/ff/33/main.PMC4778593.pdf
This is an open access article under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ff/33/main.PMC4778593.pdf
[12] https://clinicaltrials.gov/ct2/results?term=LEE011&Search=Search .,Non-OADS,/arxiv_data1/oa_pdf/ff/33/main.PMC4778593.pdf
[13] https://clinicaltrials.gov/ct2/results?term=P1446A-05&Search=Search .,Non-OADS,/arxiv_data1/oa_pdf/ff/33/main.PMC4778593.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2016) 23, 219 –228 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.05.010 1319-562X ª2015 The Author.",Non-OADS,/arxiv_data1/oa_pdf/d6/53/main.PMC4778594.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d6/53/main.PMC4778594.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d6/53/main.PMC4778594.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Chronic myelogenous leukemiaCML stem cellDipeptide transporterRNA sequencingSlc15a2 Speci ﬁcations Organism/cell line/tissueMus musculus /Bone marrow SexSequencer or array type Illumina HiSeq 2000Data format RNA sequencing: raw data (Fastq ﬁles) and processed data (tab-delimited text ﬁles include RPKM values) Experimental factors 8 RNA samples for RNA sequencing as follows: 2 samples of normal long-term stem cell1 sample of normal short-term stem cell1s a m p l eo fK L S −progenitor cell 2 samples of chronic myeloid leukemia long-term stem cell1 sample of chronic myeloid leukemia short-term stem cell1 sample of chronic myeloid leukemia KLS −progenitor cell Experimental features Immature KLS+cells and KLS−progenitor cells were obtained from healthy control and CML-affected mice byusing FACS Aria III cell sorter.,Non-OADS,/arxiv_data1/oa_pdf/78/e8/main.PMC4778595.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE70031 .2.,OADS,/arxiv_data1/oa_pdf/78/e8/main.PMC4778595.pdf
http://dx.doi.org/10.1016/j.gdata.2015.11.0172213-5960/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/78/e8/main.PMC4778595.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/e8/main.PMC4778595.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Mesenchymal stromal cellsMesenchymal stem cells Pericytes Microarrays 1.,Non-OADS,/arxiv_data1/oa_pdf/b4/b3/main.PMC4778596.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE67747 2.,OADS,/arxiv_data1/oa_pdf/b4/b3/main.PMC4778596.pdf
"Sample source locationRibeirão Preto ,São Paulo ,Brazil http://dx.doi.org/10.1016/j.gdata.2015.11.0092213-5960/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/b4/b3/main.PMC4778596.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b4/b3/main.PMC4778596.pdf
"Probes corresponding to transcripts whose levels were signiﬁcantly higher in cAT3G5Cs (2470 probes), cAT3G5Cs DME10 (1942 probes), and ATMSCs (2299 probes) as compared to PBWBCswere ﬁltered, and a Venn diagram was built using an online tool avail- able at http://bioinformatics.psb.ugent.be/cgi-bin/liste/Venn/calculate_ venn.htpl (Fig.",OADS,/arxiv_data1/oa_pdf/b4/b3/main.PMC4778596.pdf
"The probe lists at these intersections of the Venn diagram were analyzed using the Func- tional Annotation Tool in Database for Annotation, Visualization and Integrated Discovery (DAVID) v6.7 at http://david.abcc.ncifcrf.gov/ home.jsp , using AGILENT_ID as identi ﬁer, and “Homo sapiens ”as back- ground.",OADS,/arxiv_data1/oa_pdf/b4/b3/main.PMC4778596.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c9/d3/main.PMC4778597.pdf
Direct link to deposited data The data set is available at the GEO database under: http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE33212 .,OADS,/arxiv_data1/oa_pdf/c9/d3/main.PMC4778597.pdf
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE52770 .,OADS,/arxiv_data1/oa_pdf/c9/d3/main.PMC4778597.pdf
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE61749 .Genomics Data 7 (2016) 1 –3 ⁎Corresponding author.,OADS,/arxiv_data1/oa_pdf/c9/d3/main.PMC4778597.pdf
http://dx.doi.org/10.1016/j.gdata.2015.11.011 2213-5960/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c9/d3/main.PMC4778597.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c9/d3/main.PMC4778597.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Primary astrocytesInﬂammation MicroarraysGene expression Speci ﬁcations Organism/cell line/tissue Mus musculus (C57BL/6JOlaHsd) Sex Pooled male and female brainsSequencer or array type Affymetrix GeneChip Mouse Gene 1.0 ST arraysData format CEL ﬁles Experimental factors Primary astrocytes were treated with TNF α (50 ng/ml) during 24 h and compared to untreated cells Experimental features Total RNA was extracted to study gene expression changes.,Non-OADS,/arxiv_data1/oa_pdf/a7/f6/main.PMC4778598.pdf
Direct link to deposited data Deposited data can be found at: http://www.ncbi.nlm.nih.gov/geo/ query/acc.cgi?acc=GSE73022 .,OADS,/arxiv_data1/oa_pdf/a7/f6/main.PMC4778598.pdf
http://dx.doi.org/10.1016/j.gdata.2015.11.0052213-5960/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a7/f6/main.PMC4778598.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a7/f6/main.PMC4778598.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e1/4c/main.PMC4778599.pdf
Direct link to deposited data The deposited data can be found at: http://www.ncbi.nlm.nih.gov/ geo/query/acc.cgi?acc=GSE71595 .2.,OADS,/arxiv_data1/oa_pdf/e1/4c/main.PMC4778599.pdf
http://dx.doi.org/10.1016/j.gdata.2015.11.0042213-5960/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e1/4c/main.PMC4778599.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e1/4c/main.PMC4778599.pdf
"Cell Rep. 12 (2015) 1986 –1996, http://dx.doi.",OADS,/arxiv_data1/oa_pdf/e1/4c/main.PMC4778599.pdf
"Bioinformatics 25 (2009) 1105 –1111, http://dx.doi.org/10.1093/ bioinformatics/btp120 .",Non-OADS,/arxiv_data1/oa_pdf/e1/4c/main.PMC4778599.pdf
"10 (2009) R25, http://dx.doi.org/10.1186/gb-2009-10-3-r25 .",Non-OADS,/arxiv_data1/oa_pdf/e1/4c/main.PMC4778599.pdf
"Bioinformatics 28 (2012) 2184– 2185, http://dx.doi.org/10.1093/bioinformatics/bts356 .",Non-OADS,/arxiv_data1/oa_pdf/e1/4c/main.PMC4778599.pdf
"28 (2010)511–515, http://dx.doi.org/10.1038/nbt.1621 .",Non-OADS,/arxiv_data1/oa_pdf/e1/4c/main.PMC4778599.pdf
"7 (2012) 562 –578, http://dx.doi.org/10.1038/nprot.2012.016 .17 J.G.C.",Non-OADS,/arxiv_data1/oa_pdf/e1/4c/main.PMC4778599.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Dendritic cells Salt hyperosmolarityGene expression analysis Speci ﬁcations Organism/cell line/tissueBone marrow-derived dendritic cells from C57BL/6 mice Sex Male Sequencer or array typeGeneChip Mouse Gene 1.0 ST Arrays (Affymetrix) Data format Raw ﬁles (CEL) Experimental factorsBone marrow-derived dendritic cells were developed in RPMI medium (Sigma-Aldrich) GM-CSF-enriched (10 ng/mL-R&Dsystems), supplemented with endotoxin-free, cell culturetested NaCl 4 M (Sigma-Aldrich) to reach ﬁnal osmolarity of 370 mOsm/L and 450 mOsm/L.",Non-OADS,/arxiv_data1/oa_pdf/b9/9f/main.PMC4778600.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE72174 .2.,OADS,/arxiv_data1/oa_pdf/b9/9f/main.PMC4778600.pdf
http://dx.doi.org/10.1016/j.gdata.2015.11.016 2213-5960/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b9/9f/main.PMC4778600.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b9/9f/main.PMC4778600.pdf
Reactome [8]pathways from the Molecular Signatures Database (MSigDB) v4.0 [9]were used for gene set testing after mapping all pathway genes to mouse orthologues as provided by the WEHI group ( http://bioinf.wehi.edu.,OADS,/arxiv_data1/oa_pdf/b9/9f/main.PMC4778600.pdf
http://dx.doi.org/10.1038/ki.2015.292 .,Non-OADS,/arxiv_data1/oa_pdf/b9/9f/main.PMC4778600.pdf
"R Foundation for Statistical Computing, Vienna, Austria, 2011 (ISBN 3-900051-07-0,URLhttp://www.R-project.org/ ).66 F. Chessa et al.",Non-OADS,/arxiv_data1/oa_pdf/b9/9f/main.PMC4778600.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Bovine Endometrium FollicleOvarian steroidsTranscriptomicGenomics Data 7 (2016) 26 –28 Speci ﬁcations Organism/cell line/tissue Bos Taurus indicus ; endometrial tissue fragments Sex FemaleSequencer or array type Illumina HiScanSQ sequencerData format Raw Bio-Project PRJNA27 0391; SRA Experiment SRP051330 Experimental factors Large versus small ovulatory follicleExperimental features Estrous cycle of Nelore non-lactating multiparous cows was manipulated aiming to obtain cows ovulating follicles either b12 mm (small follicles) or N13 mm (large follicles) in diameter.,Non-OADS,/arxiv_data1/oa_pdf/af/e0/main.PMC4778601.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/sra/ .,OADS,/arxiv_data1/oa_pdf/af/e0/main.PMC4778601.pdf
http://dx.doi.org/10.1016/j.gdata.2015.11.0082213-5960/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/af/e0/main.PMC4778601.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/af/e0/main.PMC4778601.pdf
The mapping ﬁle was sorted using SAMTools v 0.1.18 [5]and read counts were obtained using the script from HTSeq-count v0.5.4p2 ( http://www-huber.embl.,OADS,/arxiv_data1/oa_pdf/af/e0/main.PMC4778601.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: IL-22Cytokine Sjogren's syndrome Gene expressionMicroarray 1.,Non-OADS,/arxiv_data1/oa_pdf/3b/6f/main.PMC4778602.pdf
http://dx.doi.org/10.1016/j.gdata.2015.11.0142213-5960/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3b/6f/main.PMC4778602.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3b/6f/main.PMC4778602.pdf
Blots on each ﬁlm were quanti ﬁed by using ImageJ software ( http://rsbweb.nih.gov/ij/index.htm ) with relative fold difference obtained by normalizing against respective β-actin.,OADS,/arxiv_data1/oa_pdf/3b/6f/main.PMC4778602.pdf
"The data sets supporting the results of this article are available in the NCBI Gene Expression Omnibus repository, under Series accession number GSE74389 http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?",OADS,/arxiv_data1/oa_pdf/3b/6f/main.PMC4778602.pdf
"Supplementary data associated with this article can be found in the online version, at http://dx.doi.org/10.1016/j.gdata.",OADS,/arxiv_data1/oa_pdf/3b/6f/main.PMC4778602.pdf
"All microarray data are available at the Gene Expression Omnibus(GEO) at NCBI (http://www.ncbi.nlm.nih.gov/geo), under accession number GSE72616.",OADS,/arxiv_data1/oa_pdf/ff/3b/main.PMC4778603.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ff/3b/main.PMC4778603.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE72616 2.,OADS,/arxiv_data1/oa_pdf/ff/3b/main.PMC4778603.pdf
http://dx.doi.org/10.1016/j.gdata.2015.11.020 2213-5960/© 2015 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/ff/3b/main.PMC4778603.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ff/3b/main.PMC4778603.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Chronic lymphocytic leukemia Monocyte derived cells Antibody resistanceMicroarray 1.,Non-OADS,/arxiv_data1/oa_pdf/ae/c9/main.PMC4778605.pdf
Direct link to deposited data Deposited data can be found here: http://www.ncbi.nlm.nih.gov/ geo/query/acc.cgi?acc=GSE71409 2.,OADS,/arxiv_data1/oa_pdf/ae/c9/main.PMC4778605.pdf
"Speci ﬁcations Organism Homo sapiens Sex Not applicableSequencer or array type Illumina HumanHT-12 V4.0 expression beadchipData format Raw and normalized data in plain text format.Experimental factors Monocytes on day 0 vs. monocyte derived cells (MDCs) on day 7 Experimental features Expression pro ﬁling of CD14 positive monocytes isolated from CLL patient PBMCs on day 0 and from MDCs fromCLL PBMCs cultured for seven days to identify differencesbetween the MDCs derived from sensitive or resistantCLL patients and differences in MDCs pre and postin vitro culture Consent All samples were obtained after informed consent Sample source location Brisbane, Australia http://dx.doi.org/10.1016/j.gdata.2015.11.010 2213-5960/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/ae/c9/main.PMC4778605.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ae/c9/main.PMC4778605.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Chryseobacterium indologenes Genome Multi-drug resistantbla IND Next generation sequencing Speci ﬁcations Organism/cell line/tissue Chryseobacterium indologenes Strain(s) CI_885Sequencer or array type Illumina Hi-SeqData format analyzedExperimental factors genomic sequence of pure microbial cultureExperimental features genome sequencing and annotation of multidrug-resistant Chryseobacterium indologenes Consent not applicableSample source location wound swab, Malaysia 1.",Non-OADS,/arxiv_data1/oa_pdf/93/35/main.PMC4778611.pdf
http://dx.doi.org/10.1016/j.gdata.2015.12.0242213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/93/35/main.PMC4778611.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/93/35/main.PMC4778611.pdf
"17 (4) (2015) 583 –587, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/93/35/main.PMC4778611.pdf
"81 (6) (2014) 611– 613, http://dx.doi.org/10.1007/s12098- 013-1040-9 .",Non-OADS,/arxiv_data1/oa_pdf/93/35/main.PMC4778611.pdf
"Agents 32 (5) (2008) 398 –400, http://dx.doi.org/10.1016/j.ijantimicag.",OADS,/arxiv_data1/oa_pdf/93/35/main.PMC4778611.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: DNA methylation Methylation BeadChip Genetic variationsThe 1000 Genomes ProjectMinor allele frequency 1.,Non-OADS,/arxiv_data1/oa_pdf/9e/08/main.PMC4778612.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE62733 .Genomics Data 7 (2016) 67 –69 ⁎Corresponding author.,OADS,/arxiv_data1/oa_pdf/9e/08/main.PMC4778612.pdf
"As it was impractical cost-wise to determine the whole-genome sequences of all samples, we surveyed nucleotide variants overlapping with the probe intervals from the variant data (Phase 3 dataset) of the 1000 Genomes Project [3]avail- able at the following FTP site, ftp://ftp.1000genomes.ebi.ac.uk/vol1/ftp/ http://dx.doi.org/10.1016/j.gdata.2015.11.023 2213-5960/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/9e/08/main.PMC4778612.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9e/08/main.PMC4778612.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: L.majorS.mansoni Regulatory networks Transcription factorsDatabase 1.,Non-OADS,/arxiv_data1/oa_pdf/45/1c/main.PMC4778613.pdf
"Introduction An integrated relational database of curated parasites namely L. major and S.mansoni, causative organism for leishmaniasis and schis- tosomiasis is hosted on the NCCS webportal ( http://www.nccs.res.in/ LmSmdb/ ).",OADS,/arxiv_data1/oa_pdf/45/1c/main.PMC4778613.pdf
http://dx.doi.org/10.1016/j.gdata.2015.12.012 2213-5960/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/45/1c/main.PMC4778613.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/45/1c/main.PMC4778613.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Mucositis Irradiation 3D cell culture modelMicroarraysTranscriptional pro ﬁling 1.,Non-OADS,/arxiv_data1/oa_pdf/15/1d/main.PMC4778614.pdf
Direct link to deposited data The deposited data can be found at: http://www.ncbi.nlm.nih.gov/ geo/query/acc.cgi?acc=GSE62395 .2.,OADS,/arxiv_data1/oa_pdf/15/1d/main.PMC4778614.pdf
"Consent N/ASample source location Pomona, CA http://dx.doi.org/10.1016/j.gdata.2015.12.0132213-5960/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/15/1d/main.PMC4778614.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/1d/main.PMC4778614.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Lactococcus lactisBiogenic aminesPutrescineAgmatine deiminaseAgmatine Speci ﬁcations Organism/cell line/tissue L. lactis subsp.,Non-OADS,/arxiv_data1/oa_pdf/6c/3a/main.PMC4778615.pdf
http://dx.doi.org/10.1016/j.gdata.2015.12.003 2213-5960/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/6c/3a/main.PMC4778615.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/3a/main.PMC4778615.pdf
Background subtraction and LOWESS (local- ly weighted scatterplot smoothing) normalization were performed using the standard routines provided by GENOME2D software available athttp://server.molgenrug.nl/index.php/analysis-pipeline .,OADS,/arxiv_data1/oa_pdf/6c/3a/main.PMC4778615.pdf
165 (1) (2013) 43 –50 (http://dx.doi.org/10.1016/j.ijfoodmicro.2013.04.021 ).,OADS,/arxiv_data1/oa_pdf/6c/3a/main.PMC4778615.pdf
81 (18) (2015) 6145 –6157 ( http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6c/3a/main.PMC4778615.pdf
48 (2015) 163 –170 (http://dx.doi.org/10.1016/j.fm.2014.11.018 ).,OADS,/arxiv_data1/oa_pdf/6c/3a/main.PMC4778615.pdf
"Genome Announce 2 (5) (2014) e01088-14, ( http://dx.doi.org/10.1128/genomeA.01088-14 ).",OADS,/arxiv_data1/oa_pdf/6c/3a/main.PMC4778615.pdf
77 (18) (2011) 6409 –6418 ( http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6c/3a/main.PMC4778615.pdf
Genomics Data 6 (2015) 228 –230 (http://dx.doi.org/10.1016/j.gdata.2015.10.002 ).114 B. del Rio et al.,OADS,/arxiv_data1/oa_pdf/6c/3a/main.PMC4778615.pdf
The sequences are available under accession number LDNX01000000 (http://www.ncbi.nlm.nih.gov/nuccore/LDNX00000000 ).,Non-OADS,/arxiv_data1/oa_pdf/4c/8c/main.PMC4778616.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Kocuria sp.,Non-OADS,/arxiv_data1/oa_pdf/4c/8c/main.PMC4778616.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/nuccore/LDNX000000002.,OADS,/arxiv_data1/oa_pdf/4c/8c/main.PMC4778616.pdf
"Strain SM24M-10Sequencer or array type Illumina HiSeq 2500 Data format ProcessedExperimental factors Laboratory cultivated strainExperimental features Draft genome sequence of Kocuria s p. SM24M-10 Consent N/ASample source location Brazilian Collection of Environmental and Industrial Microorganisms (CBMAI), accession number 1702 http://dx.doi.org/10.1016/j.gdata.2015.12.016 2213-5960/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/4c/8c/main.PMC4778616.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4c/8c/main.PMC4778616.pdf
"49 (1999) 167–173, http://dx.doi.org/10.1099/00207713-49-1-167 .",Non-OADS,/arxiv_data1/oa_pdf/4c/8c/main.PMC4778616.pdf
"53(2003) 183 –187, http://dx.doi.org/10.1099/ijs.0.02336-0 .",Non-OADS,/arxiv_data1/oa_pdf/4c/8c/main.PMC4778616.pdf
"54 (2004) 1617 –1620, http://dx.doi.org/10.1099/ijs.0.02742-0 .",Non-OADS,/arxiv_data1/oa_pdf/4c/8c/main.PMC4778616.pdf
"60 (2010) 914–918, http://dx.doi.org/10.1099/ijs.0.014506-0 .",Non-OADS,/arxiv_data1/oa_pdf/4c/8c/main.PMC4778616.pdf
"60 (2010) 140 –143, http://dx.doi.org/10.1099/ijs.0.012310-0 .",Non-OADS,/arxiv_data1/oa_pdf/4c/8c/main.PMC4778616.pdf
"59 (2009) 2769 –2772, http://dx.doi.org/10.1099/ijs.0.008482-0 .",Non-OADS,/arxiv_data1/oa_pdf/4c/8c/main.PMC4778616.pdf
"Microbiol.56 (2006) 1971– 1975, http://dx.doi.org/10.1099/ijs.0.63915-0 .",Non-OADS,/arxiv_data1/oa_pdf/4c/8c/main.PMC4778616.pdf
"61 (2011) 286 –289, http://dx.doi.org/10.1099/ijs.0.021469-0 .",Non-OADS,/arxiv_data1/oa_pdf/4c/8c/main.PMC4778616.pdf
"59 (2009) 1316 –1320, http://dx.doi.org/10.1099/ijs.0.",Non-OADS,/arxiv_data1/oa_pdf/4c/8c/main.PMC4778616.pdf
"Kroppenstedt, Reclassi ﬁcation of strain CCM 132, previously classiﬁ ed as Kocuria varians ,a s Kocuria carniphila s p .n o v .I n t .J .S y s t .E v o l .M i c r o b i o l .5 5( 2 0 0 5 ) 139–142, http://dx.doi.org/10.1099/ijs.0.63304-0 .",Non-OADS,/arxiv_data1/oa_pdf/4c/8c/main.PMC4778616.pdf
"Antonie Van Leeuwenhoek 99 (2011) 721–726, http://dx.doi.org/10.1007/s10482-010-9547-9 .",Non-OADS,/arxiv_data1/oa_pdf/4c/8c/main.PMC4778616.pdf
"Genomics Data (2015) 34 –35,http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/4c/8c/main.PMC4778616.pdf
"Bioinformatics 27 (2011) 764 –770, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/4c/8c/main.PMC4778616.pdf
"Nature 463 (2010) 311 –317, http://dx.doi.org/10.1038/ nature08696 .",Non-OADS,/arxiv_data1/oa_pdf/4c/8c/main.PMC4778616.pdf
"PLoS ONE 7 (2012) e30619, http://dx.doi.org/10.1371/journal.pone.",Non-OADS,/arxiv_data1/oa_pdf/4c/8c/main.PMC4778616.pdf
"18 (2008) 802 –809, http://dx.doi.org/10.1101/gr.072033.107 .",Non-OADS,/arxiv_data1/oa_pdf/4c/8c/main.PMC4778616.pdf
BMC Genomics 9 (2008) http://dx.doi.org/10.1186/ 1471-2164-9-75 .,Non-OADS,/arxiv_data1/oa_pdf/4c/8c/main.PMC4778616.pdf
4 (2008) http://dx.doi.org/10.1186/1746-1448-4-2 .,Non-OADS,/arxiv_data1/oa_pdf/4c/8c/main.PMC4778616.pdf
"26 (2002) 49 –71,http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/4c/8c/main.PMC4778616.pdf
"281 (2008) 58 –63,http://dx.doi.org/ 10.1111/j.1574-6968.2008.01073.x .",Non-OADS,/arxiv_data1/oa_pdf/4c/8c/main.PMC4778616.pdf
"47 (2003) 1723 –1732, http://dx.doi.org/10.1046/j.1365-2958.2003.",Non-OADS,/arxiv_data1/oa_pdf/4c/8c/main.PMC4778616.pdf
"215 (2012) 3467– 3477, http://dx.doi.org/10.1242/jeb.070946 .123 B.R.Z.",Non-OADS,/arxiv_data1/oa_pdf/4c/8c/main.PMC4778616.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Acinetobacter baumanniiMulti-drug resistance Paediatric Speci ﬁcations Organism/cell line/tissue Acinetobacter baumannii Sex n/a Sequencer or array type Hiseq and PacBioData format AnalyzedExperimental factors Genome sequencing of an antimicrobial resistant strain Experimental features The complete genome sequence of a clinical strain of A. baumannii was sequenced and annotated to show the multidrug resistant genes.,Non-OADS,/arxiv_data1/oa_pdf/34/22/main.PMC4778617.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/nuccore/CP010779 http://www.ncbi.nlm.nih.gov/nuccore/CP0107802.,OADS,/arxiv_data1/oa_pdf/34/22/main.PMC4778617.pdf
http://dx.doi.org/10.1016/j.gdata.2015.12.002 2213-5960/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/34/22/main.PMC4778617.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/34/22/main.PMC4778617.pdf
"The resistance genes were detected by ResFinder ( https://cge.cbs.dtu.dk/services/ResFinder/ ), and the heat map of the resistance genes was plotted by the R package “ggplot2 ”.",OADS,/arxiv_data1/oa_pdf/34/22/main.PMC4778617.pdf
"The resistance genes were detected by ResFinder ( https://cge.cbs.dtu.dk/services/ResFinder/ ), and the heat map of the resistance genes was plotted by the R package “ggplot2 ”.272 Y. Fang et al.",OADS,/arxiv_data1/oa_pdf/34/22/main.PMC4778617.pdf
The abundance of the resistance genes among A. baumannii strains XH386 and other strains in this species were detected by ResFinder (https://cge.cbs.dtu.dk/services/ResFinder/ ).,OADS,/arxiv_data1/oa_pdf/34/22/main.PMC4778617.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Deulajhari hot springIllumina sequencing 16s rRNA TOC Speci ﬁcations Organism/cell line/tissue Metagenome of Deulajhari hot springSex Not applicableSequencer or array type Illumina Genome Analyzer IIx Data format Raw data: FASTAQ ﬁle Experimental factors Environmental sample Experimental features 16S rRNA genes ampli ﬁed from the metagenome using Illumina platform followed by bacterialcommunity analysis using QIIME version 1.9.0 Consent Not applicableSample source location Sediment sample, Deulajhari hot spring, Odisha, India.",Non-OADS,/arxiv_data1/oa_pdf/72/cb/main.PMC4778618.pdf
"The ampli ﬁed PCR product was puri ﬁed by gel elu- tion using minelute column (Qiagen, India) and further leads to 150 http://dx.doi.org/10.1016/j.gdata.2015.12.004 2213-5960/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/72/cb/main.PMC4778618.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/72/cb/main.PMC4778618.pdf
"Geno- mics Data 4 (2015) 73 –75,http://dx.doi.org/10.1016/j.gdata.2015.03.005 .",OADS,/arxiv_data1/oa_pdf/72/cb/main.PMC4778618.pdf
"75 (2007) 955 –962, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/72/cb/main.PMC4778618.pdf
"88 (2014) 134 –141, http://dx.doi.org/10.1016/j.ibiod.2013.10.025 .",OADS,/arxiv_data1/oa_pdf/72/cb/main.PMC4778618.pdf
"12 (2011) 385, http://dx.doi.org/10.1186/1471-2105- 12-385 .",Non-OADS,/arxiv_data1/oa_pdf/72/cb/main.PMC4778618.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: PyrosequencingBacteriaDiversityParadip PortMetagenomics 1.,Non-OADS,/arxiv_data1/oa_pdf/5d/a3/main.PMC4778619.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/sra/SRX897055 .,OADS,/arxiv_data1/oa_pdf/5d/a3/main.PMC4778619.pdf
"Speci ﬁcations Organism/cell line/tissue Paradip Port soil sediment metagenomeSex Not applicableSequencer or array type 454 GS junior platformData format Sff ﬁle Experimental factors Environmental sampleExperimental features 16S rRNA pyrosequencing and bacterial community structure diversity analysis using MG-RAST portal Consent Not applicableSample source location Soil sediment from Paradip Port, Odisha, India http://dx.doi.org/10.1016/j.gdata.2015.12.0052213-5960/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/5d/a3/main.PMC4778619.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5d/a3/main.PMC4778619.pdf
"3 (2015), e1025, http://dx.doi.org/10.7717/peerj.1025 .96 A. Pramanik et al.",Non-OADS,/arxiv_data1/oa_pdf/5d/a3/main.PMC4778619.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Ionizing radiationRadiation exposureAstronautLong duration space travel Speci ﬁcations Organism/cell line/tissue Homo sapiens Sex MixedSequencer or array type Affymetrix® Human Gene 1.0 ST v1 ArraysData format Raw; CEL ﬁles Experimental factors 0.3 Gy exposure vs. 0.0 Gy (low radiation response); 1.5 Gy exposure vs. 0.0 Gy (mid-radiation response);3.0 Gy exposure vs. 0.0 Gy (high radiation response) Experimental features Gene expression pro ﬁling of radiation exposure using: 0.0 Gy (control; n = 4);0.3 Gy (low radiation; n = 4);1.5 Gy (mid radiation; n = 4);3.0 Gy (high radiation; n = 4)(continued ) Speci ﬁcations Consent Not applicableSample source location Not applicable 1.,Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4778620.pdf
"Direct link to deposited data Data is available in the Gene Expression Omnibus (GEO) [1,2] acces- sion GSE64375 through the direct link http://www.ncbi.nlm.nih.gov/ geo/query/acc.cgi?acc=GSE64375 2.",OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4778620.pdf
http://dx.doi.org/10.1016/j.gdata.2015.11.027 2213-5960/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4778620.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4778620.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Soda Lake Haloterrigena turkmenica CarboxylesteraseCarboxylaseXylose isomeraseWhole genome sequencing 1.,Non-OADS,/arxiv_data1/oa_pdf/fd/ea/main.PMC4778622.pdf
http://dx.doi.org/10.1016/j.gdata.2015.11.0312213-5960/© 2015 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/fd/ea/main.PMC4778622.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fd/ea/main.PMC4778622.pdf
"On the other hand, analysis of the complete 16S rRNA sequence in EzTaxonserver ( http://www.ezbiocloud.net/eztaxon; [8] ) under de- fault settings (with matches only against cultured strains) identi ﬁed H. turkmenica .",Non-OADS,/arxiv_data1/oa_pdf/fd/ea/main.PMC4778622.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Cattle Japanese BlackHolstein FriesianIntramuscular fatMusculus longissimus dorsiMicroarray Speci ﬁcation Organism/cell line/tissue Bos taurus /Musculus longissimus dorsi Sex Male (castrated) Sequencer or array type GeneChip® Bovine Genome Array (Affymetrix)Data format Raw CEL ﬁles, normalized data: PLIER signal intensity Experimental factors Japanese Black vs. Holstein FriesianExperimental features Microarray gene expression pro ﬁling to identify differentially regulated genes in MLD of JapaneseBlack steers compared to Holstein Friesiansteers Consent Publicly available from NCBI GEO Sample source location Dummerstorf, Germany 1.",Non-OADS,/arxiv_data1/oa_pdf/9a/b2/main.PMC4778623.pdf
Direct link to deposited data The deposited data can be found at: http://www.ncbi.nlm.nih.gov/ geo/query/acc.cgi?acc=GSE753482.,OADS,/arxiv_data1/oa_pdf/9a/b2/main.PMC4778623.pdf
http://dx.doi.org/10.1016/j.gdata.2015.12.014 2213-5960/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9a/b2/main.PMC4778623.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9a/b2/main.PMC4778623.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Vigna mungoTranscriptomeAnnotationRecombinant inbred lines Resource table: Name of resource VM84 Institution Division of Plant Biology, Bose Institute, Kolkata 700054, India Person who created resource Sayak Ganguli, Avishek Dey, Rahul Banik, Anirban Kundu and Amita Pal Contact person and email Amita Pal, amita@jcbose.ac.in Date archived/stock date 11.06.2015 and 07.07.2015 Type of resource Recombinant inbred line of Vigna mungo resistant to MYMIV Link to directly related literature thatemployed/validated thisresourceField Crop Res 135 (2012) 116 –125 Information in public databases•http://www.ncbi.nlm.nih.gov/sra/SRX1082731: Transcriptome Library of Vigna mungo RIL VM84 infected with MYMIV •http://www.ncbi.nlm.nih.gov/sra/SRX1032950: Transcriptome Library of mock inoculatedVigna mungo RIL VM841.",Non-OADS,/arxiv_data1/oa_pdf/72/8e/main.PMC4778624.pdf
http://dx.doi.org/10.1016/j.gdata.2016.01.0052213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/72/8e/main.PMC4778624.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/72/8e/main.PMC4778624.pdf
"[4] A. Kundu, A. Patel, S. Paul, A. Pal, Transcript dynamics at early stages of molecular interactions of MYMIV with resistant and susceptible genotypes of the leguminous host, Vigna mungo .P L o SO n e( A p r i l1 7 ,2 0 1 5 ) http://dx.doi.org/10.1371/journal.",Non-OADS,/arxiv_data1/oa_pdf/72/8e/main.PMC4778624.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Mycobacterium tuberculosisGenome MDR Extrapulmonary Speci ﬁcations Organism/cell line/tissue Mycobacterium tuberculosis Strain PR10Sequencer or array type Illumina Miseq SequencerData format ProcessedExperimental factors Microbial strainExperimental features Draft genome sequence of Mycobacterium tuberculosis PR10 assembly and annotation Consent N/ASample source location Kuala Lumpur, Malaysia 4.1936°N103.7249°E 1.",Non-OADS,/arxiv_data1/oa_pdf/15/a0/main.PMC4778625.pdf
"The genes identi ﬁed were validated using the following external gene annotation databases: TubercuList ( http://tuberculist.ep ﬂ.ch),Genomics Data 7 (2016) 245 –246 ⁎Corresponding author.",OADS,/arxiv_data1/oa_pdf/15/a0/main.PMC4778625.pdf
http://dx.doi.org/10.1016/j.gdata.2016.01.002 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/15/a0/main.PMC4778625.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/a0/main.PMC4778625.pdf
"UniProtKB ( http://www.ebi.ac.uk/uniprot ), Virulence Factor Database (VFDB) (http://www.mgc.ac.cn ), and TBDatabase (TBDB) ( http:// www.tbdb.org ).",OADS,/arxiv_data1/oa_pdf/15/a0/main.PMC4778625.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: MacrophageATF7Innate immune memoryMicroarray 1.,Non-OADS,/arxiv_data1/oa_pdf/86/98/main.PMC4778626.pdf
Direct link to deposited data[provide URL below] The data is available at the GEO database under: http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE71111 .2.,OADS,/arxiv_data1/oa_pdf/86/98/main.PMC4778626.pdf
"Speci ﬁcations Organism/cell line/tissue Wild-type and ATF7−/−mice on the C57BL/6 background peritoneal macrophages Sex MaleSequencer or array type Affymetrix Mouse Gene 1.0 ST ArrayData format Raw signal valuesExperimental factors Wild-type vs ATF7 −/−or Wild-type administrated by PBS vs LPS, PGN, IMQor BG Experimental features Identi ﬁcation of genes that expressions are regulated by ATF7 or innate immune memory Consent Publicly available from NCBI GEOSample source location Mice were maintained in the RIKEN Tsukuba facility http://dx.doi.org/10.1016/j.gdata.2015.11.0282213-5960/© 2015 The Authors.",OADS,/arxiv_data1/oa_pdf/86/98/main.PMC4778626.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/98/main.PMC4778626.pdf
"Enriched functional categorieswere identi ﬁed by Fisher's exact test using R version 2.15 and visualized using FuncTree [6](http://bioviz.tokyo/functree/ ), an online visualiza- tion tool for KEGG pathways.",OADS,/arxiv_data1/oa_pdf/86/98/main.PMC4778626.pdf
Montreal: Humanitarian Coalition; 2014. http://humanitariancoalition.ca/ info-portal/factsheets/wha t-is-a-humanitarian-crisis [accessed 20 November 2014].,Non-OADS,/arxiv_data1/oa_pdf/21/5b/ihv045.PMC4778628.pdf
Geneva: United Nations High Commissioner for Refugees; 2014. http://www.unhcr.org/ cgi-bin/texis/vtx/home/ope ndocPDFViewer.htm l?docid=5399a14f9& query=global %20trend s%202013 [accessed 24 June 2014].,Non-OADS,/arxiv_data1/oa_pdf/21/5b/ihv045.PMC4778628.pdf
Geneva: World Health Organization; 2012. http://www.who.int/hac/tech guidance/preparedness/SRH_policybrief/en/ [accessed 24 June 2014].,Non-OADS,/arxiv_data1/oa_pdf/21/5b/ihv045.PMC4778628.pdf
Geneva: World Health Organization; 2014. http://www.who.int/reproductivehealth/publications/ monitoring/maternal-mortality-2013/en/ [accessed 24 June 2014].6 WHO.,Non-OADS,/arxiv_data1/oa_pdf/21/5b/ihv045.PMC4778628.pdf
Geneva: World Health Organization; 2013. http://www.who.int/reproductive health/publications/violence/9789241564625/en/ [accessed 4 May 2014].,Non-OADS,/arxiv_data1/oa_pdf/21/5b/ihv045.PMC4778628.pdf
Geneva: World Health Organization; 2013. http://www.who.int/gho/health_equity/outcomes/ under5_mortality_text/en/ [accessed 24 June 2014].,Non-OADS,/arxiv_data1/oa_pdf/21/5b/ihv045.PMC4778628.pdf
Atlanta: Centers for Disease Control and Prevention; 2011. http://www.cdc.gov/reproductive health/Global/CrisisSituations.htm [accessed 23 September 2013].,Non-OADS,/arxiv_data1/oa_pdf/21/5b/ihv045.PMC4778628.pdf
2005. https://womensrefugeecommission.org/component/ zdocs/document/145- ﬁeld-friendly-guide-to-integrate-emergency- obstetric-care-in-humanitarian-programs- ﬁeld-friendly-guide-to- integrate-emergency-obstetric-care-in-humanitarian-programs[accessed 5 September 2013].,Non-OADS,/arxiv_data1/oa_pdf/21/5b/ihv045.PMC4778628.pdf
New York: Women ’s Refugee Commission; 2011. http://www.iawg.net/ resources/MISP2011.pdf [accessed 5 September 2013].,Non-OADS,/arxiv_data1/oa_pdf/21/5b/ihv045.PMC4778628.pdf
Geneva:World Health Organization; 2009. http://www.who.int/reproductive health/publications/monitoring/9789241547734/en/ [accessed 5 September 2013].,Non-OADS,/arxiv_data1/oa_pdf/21/5b/ihv045.PMC4778628.pdf
Division of Reproductive Health U.S. Centers for Disease Control and Prevention September 2011. http://www.cdc.gov/reproductivehealth/ Global/PDFs/ProcessEvalofRHToolkit.pdf [accessed 12 February 2014].,Non-OADS,/arxiv_data1/oa_pdf/21/5b/ihv045.PMC4778628.pdf
Geneva: World Health Organization; 2013. http://www.who.int/hac/about/erf_.pdf [accessed 4 May 2014].F.,Non-OADS,/arxiv_data1/oa_pdf/21/5b/ihv045.PMC4778628.pdf
Geneva: World Health Organization; 2014 http://www.who.int/ features/qa/12/en/ [accessed 5 January 2015].,Non-OADS,/arxiv_data1/oa_pdf/55/4e/ihv051.PMC4778630.pdf
"Washington, DC: World Bank; 2015 http://data.worldbank.org/ indicator/SH.DYN.NMRT [accessed 5 January 2015].",Non-OADS,/arxiv_data1/oa_pdf/55/4e/ihv051.PMC4778630.pdf
Amsterdam: Women on Waves; 2014 http://www.womenonwaves.org/en/page/961/how- can-i-get-misoprostol [accessed 15 January 2015].,Non-OADS,/arxiv_data1/oa_pdf/55/4e/ihv051.PMC4778630.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Cattle Charolais HolsteinIntramuscular fatMusculus longissimus dorsiMicroarray Speci ﬁcation Organism/cell line/tissueBos taurus /Musculus longissimus dorsi Sex Male Sequencer or array type GeneChip® Bovine Genome Array (Affymetrix)Data format Raw CEL ﬁles, Normalized data: PLIER signal intensity Experimental factors High vs. low intramuscular fat content in M. longissimus Experimental features Microarray gene expression pro ﬁling to identify differentially regulated genes in MLD of bulls with divergent intramuscular fat content Consent Publicly available from NCBI GEOSample source location Dummerstorf, Germany 1.",Non-OADS,/arxiv_data1/oa_pdf/74/a3/main.PMC4778632.pdf
Direct link to deposited data The deposited data can be found at: http://www.ncbi.nlm.nih.gov/ geo/query/acc.cgi?acc=GSE75347 2.,OADS,/arxiv_data1/oa_pdf/74/a3/main.PMC4778632.pdf
http://dx.doi.org/10.1016/j.gdata.2015.12.023 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/74/a3/main.PMC4778632.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/74/a3/main.PMC4778632.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Mangrove sediment, Dhulibhashani,Metagenome, Pyrosequencing, Bacterialdiversity 1.",Non-OADS,/arxiv_data1/oa_pdf/83/d4/main.PMC4778633.pdf
"Direct link to deposited data http://www.ncbi.nlm.nih.gov/sra/SRX883521 Random mutagenic events followed by natural selective pressure, inﬂames the evolutionary mechanism to give rise new lineages ofmicroorganisms in the microbial world at an alarming high frequency.",OADS,/arxiv_data1/oa_pdf/83/d4/main.PMC4778633.pdf
"Speci ﬁcations Organism/cell line/tissue Environmental metagenomes Sex Not applicable Sequencer or array type 454 GS junior platformData format raw data: Sff ﬁle Experimental factors Environmental samplesExperimental features Bar-coded pyrosequencing and community structure diversity analysis using MG-RAST pipeline Consent Not applicable Sample source location Mangrove soil sediment, Sundarbans, India http://dx.doi.org/10.1016/j.gdata.2015.11.030 2213-5960/© 2015 Published by Elsevier Inc.",Non-OADS,/arxiv_data1/oa_pdf/83/d4/main.PMC4778633.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/83/d4/main.PMC4778633.pdf
"PLoS ONE 7 (6) (2012), e38600 http://dx.doi.org/10.1371/journal.pone.0038600 .",Non-OADS,/arxiv_data1/oa_pdf/83/d4/main.PMC4778633.pdf
"Archaea (2015), Article ID968582 http://dx.doi.org/10.1155/2015/968582 .",Non-OADS,/arxiv_data1/oa_pdf/83/d4/main.PMC4778633.pdf
6 (1) (2010) http://dx.doi.org/10.1186/1746-1448-6-1 .,Non-OADS,/arxiv_data1/oa_pdf/83/d4/main.PMC4778633.pdf
15 (170) (2015) http://dx.doi.org/10.1186/s12866-015-0495-4 .,Non-OADS,/arxiv_data1/oa_pdf/83/d4/main.PMC4778633.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: EL4 T cell MicroarrayT cell activationInducible genes Speci ﬁcations Organism/cell line/tissueMus musculus Sex N/ASequencer or array typeAffymetrix Mouse Gene 1.0 ST Array Data format Raw and analyzedExperimental factorsEL4 T cells were pre-treated with either DMSO or cycloheximide in DMSO, followed by stimulation with phorbol myristate acetate (PMA) and Ionomycin (I) for 4 h or are left unstimulated.",Non-OADS,/arxiv_data1/oa_pdf/f1/16/main.PMC4778634.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE13278 (Submission number GSE13278 ).,OADS,/arxiv_data1/oa_pdf/f1/16/main.PMC4778634.pdf
http://dx.doi.org/10.1016/j.gdata.2015.12.0092213-5960/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f1/16/main.PMC4778634.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f1/16/main.PMC4778634.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Deulajhari 16S rRNA MetagenomeTOCIllumina platform 1.,Non-OADS,/arxiv_data1/oa_pdf/93/03/main.PMC4778635.pdf
http://dx.doi.org/10.1016/j.gdata.2016.01.004 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/93/03/main.PMC4778635.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/93/03/main.PMC4778635.pdf
"Genomics Data 6 (2015) 188 –190, http://dx.doi.org/10.1016/j.gdata.",OADS,/arxiv_data1/oa_pdf/93/03/main.PMC4778635.pdf
"88 (2014) 134 –141, http://dx.doi.org/10.1016/j.ibiod.2013.10.025 .",OADS,/arxiv_data1/oa_pdf/93/03/main.PMC4778635.pdf
"12 (2011) 385, http://dx.doi.org/10.1186/1471-2105-12-385 .",Non-OADS,/arxiv_data1/oa_pdf/93/03/main.PMC4778635.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Erk Mek Mouse embryonic stem cells Speci ﬁcations Organism/cell line/tissueKH2 mouse ESC line Sex MaleSequencer or array typeIllumina HiSeq 2000 Data format Raw and analyzedExperimental factorsMek inhibition in WT KH2 ESCs; Mek inhibition in Erk KO ESCs; Erk knockout in iErk1 ;Erk KO ESCs.,Non-OADS,/arxiv_data1/oa_pdf/a5/32/main.PMC4778636.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE70304 2.,OADS,/arxiv_data1/oa_pdf/a5/32/main.PMC4778636.pdf
http://dx.doi.org/10.1016/j.gdata.2015.11.029 2213-5960/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a5/32/main.PMC4778636.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a5/32/main.PMC4778636.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Plasmodium falciparumGenome-wide mapping Histone modi ﬁcations Chromatin Transcription Direct link to deposited data [provide URL below] The direct link for the ChIP-sequencing data is - http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/12/ba/main.PMC4778637.pdf
"Screening of histone modi ﬁcation antibody for chromatin immunoprecipitation (ChIP) Infected RBCs were cross-linked with 1% formaldehyde (Catalogue number 28908, Thermo Scienti ﬁc), which was directly added to the http://dx.doi.org/10.1016/j.gdata.2015.11.026 2213-5960/© 2015 The Authors.",OADS,/arxiv_data1/oa_pdf/12/ba/main.PMC4778637.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/12/ba/main.PMC4778637.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: hot spring metagenome shotgun sequencingmicrobial diversityUnkeshwar 1.,Non-OADS,/arxiv_data1/oa_pdf/bd/3a/main.PMC4778638.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/sra/SRX14990162.,OADS,/arxiv_data1/oa_pdf/bd/3a/main.PMC4778638.pdf
"Speci ﬁcations Organism/cell line/tissue Unkeshwar hot spring metagenome Sex not applicableSequencer or array type Illumina Hi seq 2500Data format raw data: fastqExperimental factors environmental sample Experimental features shotgun metagenome sequencing followed by microbial community and taxonomic analysis using KEGG pathways Consent not applicableSample source location water sample, Unkeshwar hot spring, Maharashtra State, India http://dx.doi.org/10.1016/j.gdata.2015.12.0312213-5960/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/bd/3a/main.PMC4778638.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bd/3a/main.PMC4778638.pdf
Nucleotide sequence accession number Metagenome sequence data is available in NCBI SRA under accession number http://www.ncbi.nlm.nih.gov/sra/SRX1499016 .,OADS,/arxiv_data1/oa_pdf/bd/3a/main.PMC4778638.pdf
"23 (2006) 129 –141, http://dx.doi.org/10.1080/01490450500533916 .",Non-OADS,/arxiv_data1/oa_pdf/bd/3a/main.PMC4778638.pdf
"73 (2007) 2612 –2623, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/bd/3a/main.PMC4778638.pdf
"7 (2013) 718 –729, http://dx.doi.org/10.1038/ismej.2012.157 .",Non-OADS,/arxiv_data1/oa_pdf/bd/3a/main.PMC4778638.pdf
"6 (2015) 177, http://dx.doi.org/10.3389/fmicb.2015.",Non-OADS,/arxiv_data1/oa_pdf/bd/3a/main.PMC4778638.pdf
"75 (2009) 7519 –7526, http://dx.doi.org/10.1128/AEM.00946-09 .",Non-OADS,/arxiv_data1/oa_pdf/bd/3a/main.PMC4778638.pdf
"ISME J 5 (2011) 414 –426, http://dx.doi.org/10.1038/ismej.",Non-OADS,/arxiv_data1/oa_pdf/bd/3a/main.PMC4778638.pdf
"Geobiology 3 (2005) 211 –227, http://dx.doi.org/10.1111/j.1472-4669.2005.00052 .",Non-OADS,/arxiv_data1/oa_pdf/bd/3a/main.PMC4778638.pdf
"85 (2013) 452 –464, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/bd/3a/main.PMC4778638.pdf
"8 (2014) 1166 –1174, http://dx.doi.org/10.1038/ismej.2013.237 .",Non-OADS,/arxiv_data1/oa_pdf/bd/3a/main.PMC4778638.pdf
"57 (2006) 80 –91,http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/bd/3a/main.PMC4778638.pdf
"133 (2008) 42 –49,http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/bd/3a/main.PMC4778638.pdf
"PLoS One 7 (2012), e52069 http://dx.doi.org/10.1371/journal.pone.0052069 .",Non-OADS,/arxiv_data1/oa_pdf/bd/3a/main.PMC4778638.pdf
"85 (2015) 739 –749, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/bd/3a/main.PMC4778638.pdf
"Science 338 (2012) 1622 –1626, http://dx.doi.org/10.1126/science.1229164 .",Non-OADS,/arxiv_data1/oa_pdf/bd/3a/main.PMC4778638.pdf
"17 (2007) 377 –386, http://dx.doi.org/10.1101/gr.5969107 .",Non-OADS,/arxiv_data1/oa_pdf/bd/3a/main.PMC4778638.pdf
"40 (2012), e9 http://dx.doi.org/10.1093/nar/gkr1067 .",Non-OADS,/arxiv_data1/oa_pdf/bd/3a/main.PMC4778638.pdf
"33 (2005) 5691 –5702, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/bd/3a/main.PMC4778638.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Correlation coef ﬁcient Rank correlation coef ﬁcient Cosine similarityDNAChromosomes 1.,Non-OADS,/arxiv_data1/oa_pdf/a1/ac/main.PMC4778639.pdf
http://dx.doi.org/10.1016/j.gdata.2016.01.001 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a1/ac/main.PMC4778639.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a1/ac/main.PMC4778639.pdf
[8]http://www.ncbi.nlm.nih.gov/ .,Non-OADS,/arxiv_data1/oa_pdf/a1/ac/main.PMC4778639.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Seroﬂuid dish Jiangshui16S rRNACultivation-independentMicrobial diversity 1.,Non-OADS,/arxiv_data1/oa_pdf/db/25/main.PMC4778640.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/sra/?term=SRP065370 .,OADS,/arxiv_data1/oa_pdf/db/25/main.PMC4778640.pdf
http://dx.doi.org/10.1016/j.gdata.2015.12.0192213-5960/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/db/25/main.PMC4778640.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/db/25/main.PMC4778640.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Gonad transcriptomeTestisOvaryRock bream Speci ﬁcations Organism/cell line/tissueOplegnathus fasciatus /testis and ovary Sex Male and female Sequencer or array typeIllumina Hiseq2000 Data format Raw and processed Experimental factorsTranscriptome pro ﬁling of testis and ovary at mature stages Experimental featuresTestis and Ovary at mature stages were dissected from therock bream and the total RNAs were extracted by using TRIZOLreagent.,Non-OADS,/arxiv_data1/oa_pdf/9b/58/main.PMC4778641.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/sra/SRX1406648 for male gonad.,OADS,/arxiv_data1/oa_pdf/9b/58/main.PMC4778641.pdf
http://www.ncbi.nlm.nih.gov/sra/SRX1406649 for female gonad.,Non-OADS,/arxiv_data1/oa_pdf/9b/58/main.PMC4778641.pdf
http://dx.doi.org/10.1016/j.gdata.2016.01.0072213-5960/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/9b/58/main.PMC4778641.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/58/main.PMC4778641.pdf
KEGG pathways were assigned to assembled contigs using the online KEGG Automatic Annotation Server (KAAS) ( http://www.genome.jp/tools/kaas/ ).,OADS,/arxiv_data1/oa_pdf/9b/58/main.PMC4778641.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Human tongue surfaceOral cavity Oral bacteria Virulence 1.,Non-OADS,/arxiv_data1/oa_pdf/1f/7f/main.PMC4778642.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/assembly/GCF_000710855.1/ 2.,OADS,/arxiv_data1/oa_pdf/1f/7f/main.PMC4778642.pdf
Speci ﬁcations Organism/cell line/tissue Klebsiella pneumoniae Strain T2-1-1 Sequencer or array type HiSeq (Illumina)Data format AnalyzedExperimental factors Microbial strainExperimental features Whole genome analysis and gene annotation of Klebsiella pneumoniae T2-1-2 Consent N/A Sample source location Debris on human tongue surface http://dx.doi.org/10.1016/j.gdata.2015.12.008 2213-5960/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/7f/main.PMC4778642.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1f/7f/main.PMC4778642.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Prostate cancerandrogen receptor ChIP-seq FAIRE-seq Speci ﬁcations Organism/cell line/tissueHomo Sapiens Sex MaleSequencer or array typeIllumina Hiseq 2000 genome analyzer Data format Raw: SRA study; processed: BEDExperimental factorsNormal, primary and therapy resistant tumors, lymph node metastases Experimental featuresFAIRE-seq and Androgen Receptor ChIP-seq Consent Leftover anonymized tissue (not traceable back to the patient and not interfering with care and/or prognosis) used for research purposes.",Non-OADS,/arxiv_data1/oa_pdf/67/04/main.PMC4778643.pdf
"Sample source locationSamples were from prostate cancer patients, treated at theErasmus University Medical Center (EMC; Rotterdam, The Netherlands), The Netherlands Cancer Institute/Antoni van Leeuwenhoek hospital (Amsterdam, The Netherlands)Direct link to deposited data https://www.ncbi.nlm.nih.gov/geo/ query/acc.cgi?acc=GSE65478 1.",OADS,/arxiv_data1/oa_pdf/67/04/main.PMC4778643.pdf
http://dx.doi.org/10.1016/j.gdata.2015.12.0202213-5960/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/67/04/main.PMC4778643.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/67/04/main.PMC4778643.pdf
The distance to the nearest transcription start site (TSS) was determined by theGREAT tool ( http://great.stanford.edu /)[7].,OADS,/arxiv_data1/oa_pdf/67/04/main.PMC4778643.pdf
"We obtained a total of 6 GB (Big Moose; http://www.ncbi.nlm.nih.gov/Traces/sra/?run=SRR3056882 ) and 5 GB (Munchkin; http://www.ncbi.nlm.nih.gov/Traces/sra/?run=SRR3056883 ) sequence data (NCBI SRA database SRX1502732 and SRX1502735, respectively), which correspond to 18,055,786 and 14,824,292 150-base reads.",OADS,/arxiv_data1/oa_pdf/ec/0a/main.PMC4778644.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: RNA-SeqPumpkin Contrasting cultivars Cucurbita pepo 1.,Non-OADS,/arxiv_data1/oa_pdf/ec/0a/main.PMC4778644.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/Traces/sra/?run=SRR3056882 for pumpkin cultivar ‘Big Moose ’.,Non-OADS,/arxiv_data1/oa_pdf/ec/0a/main.PMC4778644.pdf
http://www.ncbi.nlm.nih.gov/Traces/sra/?run=SRR3056883 for pumpkin cultivar ‘Munchkin ’.Genomics Data 7 (2016) 200 –201 ⁎Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/ec/0a/main.PMC4778644.pdf
"Plant materials Cucurbita pepo (squash, pumpkin, gourd), a world-wide cultivated vegetable of American origin, is extremely variable in fruit characteris- tics[1]and its genome was recently published in draft format by COMAV's Bioinformatics & Genomics and Cucurbits Breeding groups(https://cucurbigene.upv.es/genome-v3.2/ ).",Non-OADS,/arxiv_data1/oa_pdf/ec/0a/main.PMC4778644.pdf
The paired-end library preparation and sequencing were achieved using a NEBNext Ultra RNA library prep kit for Illumina (New England http://dx.doi.org/10.1016/j.gdata.2016.01.006 2213-5960/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/ec/0a/main.PMC4778644.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ec/0a/main.PMC4778644.pdf
readthedocs.org/en/stable/ ) and FastQC ( http://www.bioinformatics.,OADS,/arxiv_data1/oa_pdf/ec/0a/main.PMC4778644.pdf
( http://www.bioinformatics.babraham.ac.uk/projects/ trim_galore/ ) wrapper application.,Non-OADS,/arxiv_data1/oa_pdf/ec/0a/main.PMC4778644.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: ChIP-seqMi-2/NuRD Breast cancer Speci ﬁcations Organism/cell line/tissue Human /MDA-MB-231 (ATCC)/ Breast Sex Female Sequencer or array type Illumina NextSeq 500 Data format Raw fastq and processed bigwig ﬁles Experimental factors N/A Experimental features ChIP-seq analysis Consent N/A Sample source location N/A 1.,Non-OADS,/arxiv_data1/oa_pdf/ed/be/main.PMC4778645.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token= mvwzocmmtlshxcp&acc=GSE76116 2.,OADS,/arxiv_data1/oa_pdf/ed/be/main.PMC4778645.pdf
http://dx.doi.org/10.1016/j.gdata.2015.12.0292213-5960/Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/ed/be/main.PMC4778645.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ed/be/main.PMC4778645.pdf
The non-duplicate uniquely mapped reads were selected with the Picard tool ( http://picard.sourceforge.,OADS,/arxiv_data1/oa_pdf/ed/be/main.PMC4778645.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Hard-shelled musselHeavy metalTranscriptomeEcotoxicity Speci ﬁcations [ standardized info for the reader ] Organism/cell line/tissue Mytilus coruscus /whole organism or gill Sex N/ASequencer or array type Illumina Hiseq2000Data format Raw and processed Experimental factors Transcriptome pro ﬁling of gill tissue on copper treatment Experimental features Gill tissues from control and copper treated groups were dissected for total RNA extraction.,Non-OADS,/arxiv_data1/oa_pdf/85/d2/main.PMC4778646.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/sra/SRX1411195 SRX1411195 for contig assembly.,OADS,/arxiv_data1/oa_pdf/85/d2/main.PMC4778646.pdf
http://www.ncbi.nlm.nih.gov/sra/SRX1411193 SRX1411193 for control gill.,Non-OADS,/arxiv_data1/oa_pdf/85/d2/main.PMC4778646.pdf
http://www.ncbi.nlm.n ih.gov/sra/SRX1411194 f o rc o p p e rt r e a t e dg i l l .,Non-OADS,/arxiv_data1/oa_pdf/85/d2/main.PMC4778646.pdf
http://dx.doi.org/10.1016/j.gdata.2015.12.010 2213-5960/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/85/d2/main.PMC4778646.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/85/d2/main.PMC4778646.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Rrm3 and Pif1 DNA replication fork Rad53 and hydroxyureaDNA replication stressChIP on chip and ssDNA-BrdU IP on chip Speci ﬁcations Organism/cell line/tissueS.,Non-OADS,/arxiv_data1/oa_pdf/03/01/main.PMC4778647.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE68214 .,OADS,/arxiv_data1/oa_pdf/03/01/main.PMC4778647.pdf
http://dx.doi.org/10.1016/j.gdata.2015.11.024 2213-5960/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/03/01/main.PMC4778647.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/01/main.PMC4778647.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Mycobacterium tuberculosisGenomeExtrapulmonary CSF 1.,Non-OADS,/arxiv_data1/oa_pdf/82/43/main.PMC4778648.pdf
"The genes were validated using the following external gene annotation databases: TubercuList ( http://tuberculist.ep ﬂ.ch), UniProtKB ( http:// www.ebi.ac.uk/uniprot ), Virulence Factor Database (VFDB) ( http:// www.mgc.ac.cn ), and TBDatabase (TBDB) ( http://www.tbdb.org ).Genomics Data 7 (2016) 119 –120 ⁎Corresponding author.",OADS,/arxiv_data1/oa_pdf/82/43/main.PMC4778648.pdf
"Speci ﬁcations Organism/cell line/tissue Mycobacterium tuberculosis Strain PR08 Sequencer or array type Illumina MiSeq sequencerData format ProcessedExperimental factors Microbial strainExperimental features Draft genome sequence of Mycobacterium tuberculosis PR08 assembly and annotation Consent N/ASample source location Kuala Lumpur, Malaysia 4.1936°N103.7249°E http://dx.doi.org/10.1016/j.gdata.2015.12.0302213-5960/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/82/43/main.PMC4778648.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/82/43/main.PMC4778648.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: InterferonIFN-α IFN-γ Huh-7HuH6Gene expression pro ﬁle 1.,Non-OADS,/arxiv_data1/oa_pdf/05/9e/main.PMC4778650.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE689272.,OADS,/arxiv_data1/oa_pdf/05/9e/main.PMC4778650.pdf
Speci ﬁcations Organism/cell line/tissueHomo sapiens; cell lines HuH6 and Huh-7 Sequencer or array type Whole Genome Oligo Microarray (Affymetrix GeneChip HG-U133 Plus 2.0) Data format Raw: CEL ﬁles; normalized data: XLS ﬁles Experimental factors HuH6 and Huh-7 cells treated with IFN- αor IFN- γ Experimental features We performed a microarray-based transcriptome analysis to compare the induction of IFN-stimulated genes in the human hepatoma cell line Huh-7 and the human hepatoblastoma cell line HuH6 in response to IFN- α and IFN- γ. http://dx.doi.org/10.1016/j.gdata.2015.12.0172213-5960/© 2015 The Authors.,OADS,/arxiv_data1/oa_pdf/05/9e/main.PMC4778650.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/05/9e/main.PMC4778650.pdf
Venn diagrams were generated using BioVenn ( http://www.cmbi.ru.nl/cdd/biovenn/ )[9].,OADS,/arxiv_data1/oa_pdf/05/9e/main.PMC4778650.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6b/57/main.PMC4778651.pdf
Direct link to deposited data All samples are separately available in GEO database under accession number GSE51472 http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?,OADS,/arxiv_data1/oa_pdf/6b/57/main.PMC4778651.pdf
"The probe quality was evaluated by the 3 ′/5′hybridization ratio for the set of housekeeping genes on theGenomics Data 7 (2016) 107 –108 Speci ﬁcations Organism/cell line/tissue Human aortic valve tissue samples Sex MalesSequencer or array type Affymetrix GeneChip® Human Genome U133 Plus 2.0 Arrays Data format Raw Experimental factors Samples are from 3 groups: non-calci ﬁed control, ﬁbro(sclero)tic and stenotic valves, n = 5 in each group Experimental features RNA was extracted from valvular cups, converted to cDNA and hybridized to Affymetrix arrays Consent Not applicable Sample source location Aortic valves were removed from patients undergoing valve or aortic root surgery at Oulu University Hospital, Oulu Finland http://dx.doi.org/10.1016/j.gdata.2015.12.015 2213-5960/© 2015 Published by Elsevier Inc.",OADS,/arxiv_data1/oa_pdf/6b/57/main.PMC4778651.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6b/57/main.PMC4778651.pdf
"47 (5) (2015) 423 –429, http://dx.doi.org/10.3109/07853890.2015.1059955 .",Non-OADS,/arxiv_data1/oa_pdf/6b/57/main.PMC4778651.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Cuttle ﬁsh Gonad development Transcriptome 1.,Non-OADS,/arxiv_data1/oa_pdf/1f/86/main.PMC4778653.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/sra/SRX1409472 for immature ovary.,Non-OADS,/arxiv_data1/oa_pdf/1f/86/main.PMC4778653.pdf
http://www.ncbi.nlm.nih.gov/sra/SRX1409473 for mature ovary.,Non-OADS,/arxiv_data1/oa_pdf/1f/86/main.PMC4778653.pdf
http://dx.doi.org/10.1016/j.gdata.2015.12.0112213-5960/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/86/main.PMC4778653.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1f/86/main.PMC4778653.pdf
unigenes using the online KEGG Automatic Annotation Server (KAAS) ( http://www.genome.jp/tools/kaas/ ).,OADS,/arxiv_data1/oa_pdf/1f/86/main.PMC4778653.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Holstein cattle Copy number variationSNPAxiom genome-wide Bos 1 arrayBioinformaticsPennCNV 1.,Non-OADS,/arxiv_data1/oa_pdf/3b/0f/main.PMC4778655.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE54813 .2.,OADS,/arxiv_data1/oa_pdf/3b/0f/main.PMC4778655.pdf
http://dx.doi.org/10.1016/j.gdata.2015.12.0072213-5960/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3b/0f/main.PMC4778655.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3b/0f/main.PMC4778655.pdf
(http://www.affymetrix.com/estore/ partners_programs/programs/de- veloper/tools/powertools.affx).,OADS,/arxiv_data1/oa_pdf/3b/0f/main.PMC4778655.pdf
We also used the guideline de ﬁned in PennCNV-Affy Protocol for CNV detection in Affymetrix SNP arrays (http://penncnv.openbioinformatics.org/en/latest.user-guide/affy/ ).,OADS,/arxiv_data1/oa_pdf/3b/0f/main.PMC4778655.pdf
"Functional analysis of genes To identify gene contents and to obtain a description of each gene af- fected within the regions covered by CNVRs, we used the BioMart data- base ( http://www.biomart.org ) and the RefGen database ( http:// refgene.com ).",OADS,/arxiv_data1/oa_pdf/3b/0f/main.PMC4778655.pdf
PCR primers were designed using the NCBI Primer-BLAST ( http://www.ncbi.nlm.nih.gov/tools/primer-blast ).,OADS,/arxiv_data1/oa_pdf/3b/0f/main.PMC4778655.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Ctr9Breast cancer Microarrays Transcriptional pro ﬁling 1.,Non-OADS,/arxiv_data1/oa_pdf/51/aa/main.PMC4778656.pdf
Direct link to deposited data The deposited data can be found at: http://www.ncbi.nlm.nih.gov/ geo/query/acc.cgi?acc=GSE73388 .,OADS,/arxiv_data1/oa_pdf/51/aa/main.PMC4778656.pdf
"400 ng of total RNA for each sample was used to synthesize double-stranded cDNA and the correspondingin vitro transcription (IVT) cRNA, using the Ambion WT Expression Kit http://dx.doi.org/10.1016/j.gdata.2015.12.006 2213-5960/© 2015 The Authors.",OADS,/arxiv_data1/oa_pdf/51/aa/main.PMC4778656.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/51/aa/main.PMC4778656.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: MelanomaMDSCMIFImmunesuppression Trancriptome analysis Speci ﬁcations Organism/cell line/tissueHomo sapiens /A375 melanoma cell line Sex NA Sequencer or array typeAffymetrix Primeview® Human Gene Expression Arrays Data format Raw and Normalized DataExperimental factorsMonocytes vs.untreated tumor-monocyte co-cultures (A375-MDSC) vs.MIF inhibitor-treated tumor-monocyte co-cultures (A375-MDSC + 4-IPP) Experimental featuresExpression pro ﬁling of healthy donor CD14 +monocytes cultured for 64 h in the absence of (cultured monocytes), or in the presenceof A375 melanoma cells (A375-MDSC) or treated with MIF inhibitor, 4-IPP (MDSC +4-IPP; 100 μM, day 0 and 50 μM, day 2).",Non-OADS,/arxiv_data1/oa_pdf/6f/1a/main.PMC4778657.pdf
Direct link to deposited data Deposited data can be found here: http://www.ncbi.nlm.nih.gov/ geo/query/acc.cgi?acc=GSE73333 .,OADS,/arxiv_data1/oa_pdf/6f/1a/main.PMC4778657.pdf
http://dx.doi.org/10.1016/j.gdata.2015.12.025 2213-5960/© 2015 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/6f/1a/main.PMC4778657.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6f/1a/main.PMC4778657.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/74/f0/main.PMC4778658.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE64420 .,OADS,/arxiv_data1/oa_pdf/74/f0/main.PMC4778658.pdf
"Consent Not applicableSample source location University of Oxford, UK http://dx.doi.org/10.1016/j.gdata.2015.11.0252213-5960/© 2015 Published by Elsevier Inc.",Non-OADS,/arxiv_data1/oa_pdf/74/f0/main.PMC4778658.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/74/f0/main.PMC4778658.pdf
"–Nucleic Acids 1 (2012) e38, http://dx.doi.org/10.1038/mtna.2012.30 .",Non-OADS,/arxiv_data1/oa_pdf/74/f0/main.PMC4778658.pdf
"–Nucleic Acids 1 (2012) e39, http://dx.doi.org/10.1038/mtna.2012.26 .",Non-OADS,/arxiv_data1/oa_pdf/74/f0/main.PMC4778658.pdf
"Rep. 5 (2015) 8986, http://dx.doi.org/10.1038/srep08986 .",Non-OADS,/arxiv_data1/oa_pdf/74/f0/main.PMC4778658.pdf
"24 (2015) 6756 –6768, http://dx.doi.org/10.1093/hmg/ ddv381 .89 T.C.",Non-OADS,/arxiv_data1/oa_pdf/74/f0/main.PMC4778658.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Enterobacter sp.,Non-OADS,/arxiv_data1/oa_pdf/7c/d3/main.PMC4778659.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/assembly/GCA_001469415.1/ .,OADS,/arxiv_data1/oa_pdf/7c/d3/main.PMC4778659.pdf
http://dx.doi.org/10.1016/j.gdata.2016.01.0082213-5960/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/7c/d3/main.PMC4778659.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7c/d3/main.PMC4778659.pdf
"The data are available under GEO Access Number GSE69317(GSE69315 for tissue sample microarray data, GSE69316 for iPSCs microarray data, http://www.ncbi.nlm.nih.",OADS,/arxiv_data1/oa_pdf/ac/2b/main.PMC4778660.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Induced pluripotent stem cellCardiac development Nos3 knockout Disease modelingMicroarray analysis 1.,Non-OADS,/arxiv_data1/oa_pdf/ac/2b/main.PMC4778660.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE69317 .,OADS,/arxiv_data1/oa_pdf/ac/2b/main.PMC4778660.pdf
"(continued ) Speci ﬁcations Consent N/A Sample source locationNos3−/−(B6.129P2-Nos3tm1unc /J,The Jackson Laboratory ,Bar Harbor ,ME)and wild type (WT)CD1 (Harlan Laboratories , Indianapolis ,IN) http://dx.doi.org/10.1016/j.gdata.2015.12.0222213-5960/© 2015 The Authors.",OADS,/arxiv_data1/oa_pdf/ac/2b/main.PMC4778660.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ac/2b/main.PMC4778660.pdf
"87 (Oct 2015) 228 –236, http://dx.doi.org/10.1016/j.yjmcc.2015.08.021 (Epub 2015 Sep 4).",OADS,/arxiv_data1/oa_pdf/ac/2b/main.PMC4778660.pdf
"Genomics 46 (13) (Jul 1 2014) 482 –495, http://dx.doi.org/10.1152/ physiolgenomics.00015.2014 (Epub 2014 May 6.",Non-OADS,/arxiv_data1/oa_pdf/ac/2b/main.PMC4778660.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c0/b3/main.PMC4778661.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE52165 .2.,OADS,/arxiv_data1/oa_pdf/c0/b3/main.PMC4778661.pdf
Random samples of sperm were stained by DAPI and examined by ﬂuorescence mi- croscopy to assess the quality of the sperm isolation and con ﬁrm somatic cell removal.Genomics Data 7 (2016) 175 –177 http://dx.doi.org/10.1016/j.gdata.2015.12.021 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c0/b3/main.PMC4778661.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c0/b3/main.PMC4778661.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Seroﬂuid dish JiangshuiFungal ITSCultivation-independentMicrobial diversity 1.,Non-OADS,/arxiv_data1/oa_pdf/70/8f/main.PMC4778662.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/sra/?term=SRP067411 .2.,OADS,/arxiv_data1/oa_pdf/70/8f/main.PMC4778662.pdf
http://dx.doi.org/10.1016/j.gdata.2015.12.0282213-5960/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/70/8f/main.PMC4778662.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/70/8f/main.PMC4778662.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Figure 1.",Non-OADS,/arxiv_data1/oa_pdf/86/08/srep21233.PMC4778663.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Deulajhari16S rRNA Next-generation sequencing Metagenomics Speci ﬁcations [standardized info for the reader] Organism/cell line/tissue Deulajhari hot spring cluster metagenome.Sex Not applicableSequencer or array type Illumina Genome Analyzer IIxData format Raw data: FASTA Q ﬁle Experimental factors Environmental samplesExperimental features Ampli ﬁcation of the 16s rRNA genes from the Deulajhari hot spring cluster metagenome usingIllumina sequencing platform and furtherbacterial community structure study using QIIMEpipeline and Krona tool.,Non-OADS,/arxiv_data1/oa_pdf/1d/66/main.PMC4778664.pdf
http://dx.doi.org/10.1016/j.gdata.2016.01.0112213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1d/66/main.PMC4778664.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1d/66/main.PMC4778664.pdf
"6 (2015) 177, http://dx.doi.org/10.8689/fmicb.",Non-OADS,/arxiv_data1/oa_pdf/1d/66/main.PMC4778664.pdf
"15 (2012) 9–15,http://dx.doi.org/10.1016/j.copbio.2011.11.013 .",OADS,/arxiv_data1/oa_pdf/1d/66/main.PMC4778664.pdf
Genomics Data7 (2016) http://dx.doi.org/10.1016/j.gdata.2015.12.004 .,OADS,/arxiv_data1/oa_pdf/1d/66/main.PMC4778664.pdf
"88 (2014) 134 –141, http://dx.doi.org/10.1016/j.ibiod.2013.10.025 .",OADS,/arxiv_data1/oa_pdf/1d/66/main.PMC4778664.pdf
"12 (2011) 385, http://dx.doi.org/10.1186/1471- 2105-12-385.",Non-OADS,/arxiv_data1/oa_pdf/1d/66/main.PMC4778664.pdf
2015 http://dx.doi.org/10.1016/j.gdata.2015.12.031 .,OADS,/arxiv_data1/oa_pdf/1d/66/main.PMC4778664.pdf
2015 http://dx.doi.org/10.1016/j.gdata.2016.01.004 .225 A. Singh et al.,OADS,/arxiv_data1/oa_pdf/1d/66/main.PMC4778664.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Halophilic archaeaGenome sequenceMarine solar salternPuerto Rico Speci ﬁcations Organism Halorubrum tropicale Strain V5Sequencer or array type MiSeq systems (Illumina)Data format Analyzed Experimental factors Microbial strain Experimental features Assembled and annotated whole genomeConsent N/A Sample source location Solar salterns of Cabo Rojo, Puerto Rico 17°57 ′12″ N, 67°11 ′45″W Direct link to deposited data: http://www.ncbi.nlm.nih.gov/bioproject/PRJNA293638 1.",Non-OADS,/arxiv_data1/oa_pdf/a7/d2/main.PMC4778665.pdf
"1 )(http://rast.nmpdr.org /), 1666 predicted genes were classi ﬁed into subsystems, with 229 genes classi ﬁed intoGenomics Data 7 (2016) 284 –286 ⁎Corresponding author.",OADS,/arxiv_data1/oa_pdf/a7/d2/main.PMC4778665.pdf
http://dx.doi.org/10.1016/j.gdata.2016.02.004 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a7/d2/main.PMC4778665.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a7/d2/main.PMC4778665.pdf
"Carbohydrate- active enzyme analysis performed by dbCAN ( http://csbl.bmb.uga.edu/ dbCAN/ ) showed that most of these enzymes belonged to the glycoside hydrolase group, with 19 total enzymes in 10 different families.",Non-OADS,/arxiv_data1/oa_pdf/a7/d2/main.PMC4778665.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Rhodobacteraceae PhaeobacterEctoineIndigoidinePhenylacetate degradation Speci ﬁcations Organism/cell line/tissueLeisingera aquaemixtae CECT 8399 T Strain CECT 8399T Sequencer Illumina MiSeq Data format Processed Experimental factors Bacteria cells cultured in Marine Agar and DNA genomic extraction and sequencing Experimental features Draft genome sequence of Leisingera aquaemixtae CECT 8399T, assembly and annotation Consent Reads and contig sequences and annotation are publicly available Sample source location Jeju Island, South Korea.",Non-OADS,/arxiv_data1/oa_pdf/19/9f/main.PMC4778666.pdf
"Direct link to deposited data http://www.ebi.ac.uk/ena/data/view/CYSR00000000 The genus Leisingera is a member of the so-called Roseobacter group within the family Rhodobacteraceae ,o r d e r Rhodobacterales of the class Alphaproteobacteria.T h e Roseobacter group is widelydistributed in marine environments and contributes up to 20% of marinebacterioplankton [1].",Non-OADS,/arxiv_data1/oa_pdf/19/9f/main.PMC4778666.pdf
http://dx.doi.org/10.1016/j.gdata.2016.01.010 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/19/9f/main.PMC4778666.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/19/9f/main.PMC4778666.pdf
"71 (2005) 5665 –5677, http://dx.doi.org/10.1128/AEM.71.",Non-OADS,/arxiv_data1/oa_pdf/19/9f/main.PMC4778666.pdf
"52 (2002) 851– 859, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/19/9f/main.PMC4778666.pdf
http://dx.doi.org/ 10.1099/ijs.0.63724-0 .,Non-OADS,/arxiv_data1/oa_pdf/19/9f/main.PMC4778666.pdf
http://dx.doi.org/10.1099/ijs.0.65844-0 .,Non-OADS,/arxiv_data1/oa_pdf/19/9f/main.PMC4778666.pdf
"5 (2014) 416, http://dx.doi.org/10.3389/fmicb.2014.00416 .",Non-OADS,/arxiv_data1/oa_pdf/19/9f/main.PMC4778666.pdf
"64 (2014) 1378 –1383, http://dx.doi.org/10.1099/ijs.0.057646-0 .",Non-OADS,/arxiv_data1/oa_pdf/19/9f/main.PMC4778666.pdf
"57 (2007) 856–861,http://dx.doi.org/10.1099/ijs.0.64779-0 .",Non-OADS,/arxiv_data1/oa_pdf/19/9f/main.PMC4778666.pdf
"Bioinformatics30 (2014) 1928– 1929, http://dx.doi.org/10.1093/bioinformatics/btu135 .",Non-OADS,/arxiv_data1/oa_pdf/19/9f/main.PMC4778666.pdf
"19 (2012) 455 –477, http://dx.doi.org/10.1089/cmb.",Non-OADS,/arxiv_data1/oa_pdf/19/9f/main.PMC4778666.pdf
"(1999) 45 –56,http://dx.doi.org/10.1.1.23/7465 .",Non-OADS,/arxiv_data1/oa_pdf/19/9f/main.PMC4778666.pdf
"PLoS One 8 (2013), e60843 http://dx.doi.org/10.1371/journal.pone.0060843 .",Non-OADS,/arxiv_data1/oa_pdf/19/9f/main.PMC4778666.pdf
"Bioinformatics 30 (2014) 2068 –2069, http://dx.doi.org/10.1093/bioinformatics/btu153 .",Non-OADS,/arxiv_data1/oa_pdf/19/9f/main.PMC4778666.pdf
"BMC Genomics 9 (2008) 75,http://dx.doi.org/10.1186/1471-2164-9-75 .",Non-OADS,/arxiv_data1/oa_pdf/19/9f/main.PMC4778666.pdf
"BMC Genomics 12 (2011) 444, http://dx.doi.org/ 10.1186/1471-2164-12-444 .",Non-OADS,/arxiv_data1/oa_pdf/19/9f/main.PMC4778666.pdf
"43 (2014) D222 –D226, http://dx.doi.org/10.1093/nar/gku1221 .",Non-OADS,/arxiv_data1/oa_pdf/19/9f/main.PMC4778666.pdf
"305 (2001) 567 –580, http://dx.doi.org/10.1006/jmbi.2000.4315 .",Non-OADS,/arxiv_data1/oa_pdf/19/9f/main.PMC4778666.pdf
"41 (2013) 204 –212, http://dx.doi.org/10.1093/nar/ gkt449 .",Non-OADS,/arxiv_data1/oa_pdf/19/9f/main.PMC4778666.pdf
"35 (2007) W52 –W57, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/19/9f/main.PMC4778666.pdf
"8 (2013) 403–419, http://dx.doi.org/10.4056/sigs.3927623 .",Non-OADS,/arxiv_data1/oa_pdf/19/9f/main.PMC4778666.pdf
"8 (2013) 389 –402, http://dx.doi.org/10.4056/sigs.3858183 .",Non-OADS,/arxiv_data1/oa_pdf/19/9f/main.PMC4778666.pdf
"14 (2012) 2661 –2672, http://dx.doi.org/10.1111/j.1462-2920.2012.02806.x .",Non-OADS,/arxiv_data1/oa_pdf/19/9f/main.PMC4778666.pdf
"182 (2000) 3446 –3451, http://dx.doi.org/10.1128/JB.182.12.3446-3451.2000 .",Non-OADS,/arxiv_data1/oa_pdf/19/9f/main.PMC4778666.pdf
"18 (2010) 531 –537, http://dx.doi.org/10.1016/j.tim.2010.",OADS,/arxiv_data1/oa_pdf/19/9f/main.PMC4778666.pdf
"2011 (2011) 670349, http://dx.doi.org/10.1155/2011/670349 .",Non-OADS,/arxiv_data1/oa_pdf/19/9f/main.PMC4778666.pdf
"78 (2012) 4771– 4780, http://dx.doi.org/10.1128/AEM.00297-12 .",Non-OADS,/arxiv_data1/oa_pdf/19/9f/main.PMC4778666.pdf
"9 (2013) 142 –159, http://dx.doi.org/10.4056/sigs.",Non-OADS,/arxiv_data1/oa_pdf/19/9f/main.PMC4778666.pdf
"81 (2015) 1417 –1425, http://dx.doi.org/10.1128/AEM.02551-14 .",Non-OADS,/arxiv_data1/oa_pdf/19/9f/main.PMC4778666.pdf
"4 (2002) 193– 203, http://dx.doi.org/10.1046/j.1462- 2920.2002.00290.x .",Non-OADS,/arxiv_data1/oa_pdf/19/9f/main.PMC4778666.pdf
"9 (2013) 128 –141, http://dx.doi.org/10.4056/sigs.4297965 .",Non-OADS,/arxiv_data1/oa_pdf/19/9f/main.PMC4778666.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Halophilic archaeaHenome sequencePuerto Rico Speci ﬁcations: Organism Haloarcula rubripromontorii Strain SL3Sequencer or array type MiSeq Systems (Illumina)Data format AnalyzedExperimental factors Microbial strainExperimental features Assembled and annotated whole genome Consent N/A Sample source location Solar Salterns of Cabo Rojo, Puerto Rico 17°57 ′12″N, 67°11 ′45″W 1.",Non-OADS,/arxiv_data1/oa_pdf/33/e0/main.PMC4778667.pdf
http://dx.doi.org/10.1016/j.gdata.2016.02.005 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/33/e0/main.PMC4778667.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/e0/main.PMC4778667.pdf
"1 )(http://rast.nmpdr.org /), the largest functional category (RAST subsystems) of ORFs belong tocarbohydrate metabolism with 311 annotated genes.",Non-OADS,/arxiv_data1/oa_pdf/33/e0/main.PMC4778667.pdf
A total of 115 carbohydrate-active enzymes were annotated from the genome andcategorized ( Table 1 ) by dbCAN ( http://csbl.bmb.uga.edu/dbCAN/ ).,OADS,/arxiv_data1/oa_pdf/33/e0/main.PMC4778667.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Microarray Gene expressionFFPEOptimization Speci ﬁcations Organism/cell line/tissueHomo sapiens/colon FFPE tissue Sex FemaleSequencer or array typeAffymetrix Human Genome U133 Plus 2.0, AffymetrixU133_X3P Array Data format Raw microarray data (.CEL ﬁles) and analyzed data (.CHP ﬁles) Experimental factorsHGU133 Plus 2.0+3 ′IVT kit, X3P Array+3 ′IVT kit, HGU133 Plus 2.0+Nugen Ovation FFPE WTA System Kit, X3P Array+ Nugen Ovation FFPE WTA System Kit and tumor vs. normal for X3P Array+Nugen Ovation FFPE WTA System Kit Experimental featuresFour 8-μ m-thick colon paraf ﬁn-embedded tissue sections were used for RNA extractions.",Non-OADS,/arxiv_data1/oa_pdf/b5/e9/main.PMC4778669.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov /geo/query /acc.cgi ?acc=GSE73883 2.,OADS,/arxiv_data1/oa_pdf/b5/e9/main.PMC4778669.pdf
http://dx.doi.org/10.1016/j.gdata.2016.02.006 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b5/e9/main.PMC4778669.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b5/e9/main.PMC4778669.pdf
"(2015), http://dx.doi.org/10.1016/j.prp.2015.11.008 .306 N. Belder et al.",OADS,/arxiv_data1/oa_pdf/b5/e9/main.PMC4778669.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: RIG-I InnateImmunityAnti-viralIRF-3 Speci ﬁcations Organism/cell line/tissueHuman , PMA-differentiated THP-1 (human macrophage-like) cell line Sex N/A Sequencer or array typeHuman Agilent Microarray ,Agilent-039,494 SurePrint G3 Human GE v2 8x60K Microarray 039,381 (Feature Number version) Data format Raw and Normalized matrix provided Experimental factorsDMSO ,Sendai virus , IFNβ, compounds (KIN1400, KIN1408, KIN1409) Experimental featuresThis analysis veri ﬁed a novel class of host-directed immune modulatory molecules that produce antiviral responsesthrough IRF3 and can suppress infection by RNA viruses of distinct genera.",Non-OADS,/arxiv_data1/oa_pdf/4b/c7/main.PMC4778670.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE74047 http://ciiid.washington.edu/r_markdown/data_in_brief_012916/2.,OADS,/arxiv_data1/oa_pdf/4b/c7/main.PMC4778670.pdf
http://dx.doi.org/10.1016/j.gdata.2016.01.020 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/4b/c7/main.PMC4778670.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4b/c7/main.PMC4778670.pdf
The analysis was captured in a reproducible data re- port using RMarkdown [4]and can be found at http://ciiid.washington.,OADS,/arxiv_data1/oa_pdf/4b/c7/main.PMC4778670.pdf
"1284 (2015) 481 –501, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/4b/c7/main.PMC4778670.pdf
"The data was deposited on NCBI's Gene Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/) with accession number GSE74049.",OADS,/arxiv_data1/oa_pdf/bb/2c/main.PMC4778671.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords:Linc-YY1MyogenesisRNA-seqChIP-seqC2C12 cells Speci ﬁcations Organism/cell line/tissueMus musculus /C2C12 Sex NASequencer or array typeIllumina HiSeq 1500, Illumina Hiseq 2000, Illumina GA IIx Data format Raw data: FASTQ ﬁles Processed data: BEDGRAPH, TXT Experimental factorsMyoblast vs myotube Experimental featuresUsing RNA-seq, we identi ﬁed hundreds of high con ﬁdence novel lincRNAs in skeletal muscle.",Non-OADS,/arxiv_data1/oa_pdf/bb/2c/main.PMC4778671.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE74049 .2.,OADS,/arxiv_data1/oa_pdf/bb/2c/main.PMC4778671.pdf
http://dx.doi.org/10.1016/j.gdata.2016.01.022 2213-5960/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/bb/2c/main.PMC4778671.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bb/2c/main.PMC4778671.pdf
"The raw sequencing reads were aligned to the mousereference genome (UCSC mm9) using Tophat (v2.0.4) [7],d u r i n g which procedure the UCSC gene annotation ﬁle downloaded from Cufﬂinks website ( http://cole-trapnelllab.github.io/cuf ﬂinks/igenome_ table/index.html ) was used (the ‘-G’option).",OADS,/arxiv_data1/oa_pdf/bb/2c/main.PMC4778671.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: MicroarrayMicronutrientZinc de ﬁciency ArabidopsisbZIP 1.,Non-OADS,/arxiv_data1/oa_pdf/8d/47/main.PMC4778672.pdf
Direct link to deposited data Deposited data can be found in the Gene Expression Omnibus (GEO) database: http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE772862.,OADS,/arxiv_data1/oa_pdf/8d/47/main.PMC4778672.pdf
Speci ﬁcations Organism/cell line/tissue A. thaliana Col-0 Sex N/A Sequencer or array type Affymetrix GeneChip Arabidopsis ATH1 Genome ArrayData format RawExperimental factors Arabidopsis T-DNA insertion double mutant bzip19 bzip23 vs. Wild-type control; shoot vs. root; de ﬁcient vs. suf ﬁcient vs. excess zinc supply Experimental features Transcriptomic pro ﬁling of Arabidopsis bzip19 bzip23 gene expression in response to varying micronutrient zinc supply Consent N/ASample source location N/A http://dx.doi.org/10.1016/j.gdata.2016.01.0212213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8d/47/main.PMC4778672.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8d/47/main.PMC4778672.pdf
"Acta 1823 (2012) 1553 –1567, http://dx.doi.org/10.1016/j.bbamcr.",Non-OADS,/arxiv_data1/oa_pdf/8d/47/main.PMC4778672.pdf
"159 (2003) 411 –419, http://dx.doi.org/10.1046/j.1469-8137.2003.00819.x .",Non-OADS,/arxiv_data1/oa_pdf/8d/47/main.PMC4778672.pdf
"Bioinformatics 20 (2004) 307 –315, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/8d/47/main.PMC4778672.pdf
"43 (2015) e47, http://dx.doi.org/10.1093/nar/gkv007 .",Non-OADS,/arxiv_data1/oa_pdf/8d/47/main.PMC4778672.pdf
"173 (2007) 677 –702, http://dx.doi.org/10.1111/j.1469-8137.2007.01996.x .",Non-OADS,/arxiv_data1/oa_pdf/8d/47/main.PMC4778672.pdf
"61 (2010) 517–534, http://dx.doi.org/10.1146/annurev-arplant-042809-112156 .",Non-OADS,/arxiv_data1/oa_pdf/8d/47/main.PMC4778672.pdf
"5 (2014) 30, http://dx.doi.org/10.3389/fpls.2014.00030 .258 H. Azevedo et al.",Non-OADS,/arxiv_data1/oa_pdf/8d/47/main.PMC4778672.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: DamID-Seq Neural stem cellsSICER Speci ﬁcations Organism/cell line/tissue Human Embryonic Kidney 293 (HEK-293 T) cells and mouse neuroblastoma (Neuro-2a) cells Sex not applicable Sequencer or array type Illumina HiSeq 2500Data format Raw and analyzed Experimental factors Fusion Dam-Tox vs. Dam alone Experimental features DamID-Seq of the HMG-box transcription factor protein Tox Consent not applicable Sample source location not applicable 1.,Non-OADS,/arxiv_data1/oa_pdf/4f/0e/main.PMC4778673.pdf
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE64240 .2.,OADS,/arxiv_data1/oa_pdf/4f/0e/main.PMC4778673.pdf
http://dx.doi.org/10.1016/j.gdata.2016.02.0032213-5960/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/4f/0e/main.PMC4778673.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4f/0e/main.PMC4778673.pdf
Locations of other cell speci ﬁc enhancers [2] were obtained from http://enhancer.binf.ku.dk/Pre-de ﬁned_tracks.,OADS,/arxiv_data1/oa_pdf/4f/0e/main.PMC4778673.pdf
"Peak conservation For conservation analysis of Tox peaks, conservation scores of 99 vertebrate genomes, including human, were obtained from the UCSCgenome browser (table phastCons100way http://hgdownload.cse.",OADS,/arxiv_data1/oa_pdf/4f/0e/main.PMC4778673.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: InsectLarval gutWhole genome shot-gun sequencing 1.,Non-OADS,/arxiv_data1/oa_pdf/e6/0a/main.PMC4778674.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/assembly/GCF_001276215.1/ 2.,OADS,/arxiv_data1/oa_pdf/e6/0a/main.PMC4778674.pdf
Speci ﬁcations Organism/cell line/tissue Clostridium lituseburense Strain L74Sequencer or array type HiSeq (Illumina)Data format AnalyzedExperimental factors Microbial strainExperimental features Whole genome analysis and gene annotation of L74Consent N/ASample source location Larval gut of a rhinoceros beetle http://dx.doi.org/10.1016/j.gdata.2016.02.0082213-5960/© 2016 The Authors.,OADS,/arxiv_data1/oa_pdf/e6/0a/main.PMC4778674.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e6/0a/main.PMC4778674.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: LiverCancer Cholangiocarcinoma MicroenvironmentProﬁling 1.,Non-OADS,/arxiv_data1/oa_pdf/8b/1b/main.PMC4778675.pdf
"Direct link to deposited data http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE45001Genomics Data 7 (2016) 229 –232 ⁎Corresponding author at: Inserm, UMR991, Liver Metabolisms and Cancer, F-35033 Rennes, France.",OADS,/arxiv_data1/oa_pdf/8b/1b/main.PMC4778675.pdf
http://dx.doi.org/10.1016/j.gdata.2016.01.012 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8b/1b/main.PMC4778675.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8b/1b/main.PMC4778675.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Rhodobacteraceae Roseobacter clade PHBAromatic compounds 1.,Non-OADS,/arxiv_data1/oa_pdf/78/5a/main.PMC4778676.pdf
"Direct link to deposited data http://www.ebi.ac.uk/ena/data/view/CYSF00000000 Thalassobius is a genus of the family Rhodobacteraceae ,o r d e r Rhodobacterales within the class Alphaproteobacteria [1].",Non-OADS,/arxiv_data1/oa_pdf/78/5a/main.PMC4778676.pdf
39° 26 ′24″N 0°18 ′26″W http://dx.doi.org/10.1016/j.gdata.2016.01.013 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/78/5a/main.PMC4778676.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/5a/main.PMC4778676.pdf
"55 (2005) 2371 –2376, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/78/5a/main.PMC4778676.pdf
"439 –512, http://dx.doi.org/10.1007/ 978-3-642-30197-1_377 .",Non-OADS,/arxiv_data1/oa_pdf/78/5a/main.PMC4778676.pdf
"44 (2006) 171 –176, http://dx.doi.org/10.1099/ijs.0.027458 –0.",Non-OADS,/arxiv_data1/oa_pdf/78/5a/main.PMC4778676.pdf
"62 (2012) 8 –12,http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/78/5a/main.PMC4778676.pdf
"Antonie Van Leeuwenhoek 106 (2014) 535 –542, http://dx.doi.org/10.1007/s10482 –014-0225-1 .",Non-OADS,/arxiv_data1/oa_pdf/78/5a/main.PMC4778676.pdf
(2015) http://dx.doi.org/10.1099/ijsem.0.000758 (in press).,Non-OADS,/arxiv_data1/oa_pdf/78/5a/main.PMC4778676.pdf
"Bioinformatics 30 (2014) 2068 –2069, http://dx.doi.org/10.1093/bioinformatics/btu153 .",Non-OADS,/arxiv_data1/oa_pdf/78/5a/main.PMC4778676.pdf
"BMC Genomics 9 (2008) 75,http://dx.doi.org/10.1186/1471-2164-9-75 .",Non-OADS,/arxiv_data1/oa_pdf/78/5a/main.PMC4778676.pdf
"Bioinformatics 21 (2005) 537 –539, http://dx.doi.org/10.1093/bioinformatics/bti054 .",Non-OADS,/arxiv_data1/oa_pdf/78/5a/main.PMC4778676.pdf
"6 (2015) 1325, http://dx.doi.org/10.3389/fmicb.2015.01325 .",Non-OADS,/arxiv_data1/oa_pdf/78/5a/main.PMC4778676.pdf
"28 (2012) 1321 – 1325, http://dx.doi.org/10.1007/s11274-011-0925-x .239 L. Rodrigo-Torres et al.",Non-OADS,/arxiv_data1/oa_pdf/78/5a/main.PMC4778676.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Clustering algorithms Gene expression Co-expressionFunctional annotationAbiotic stress 1.,Non-OADS,/arxiv_data1/oa_pdf/1f/be/main.PMC4778677.pdf
http://dx.doi.org/10.1016/j.gdata.2016.01.009 2213-5960/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/1f/be/main.PMC4778677.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1f/be/main.PMC4778677.pdf
"The genes, showing response under salt stress at six different time points were considered as six samples and were downloaded from Gene Expres- sion Omnibus (GEO) database at NCBI ( http://www.ncbi.nlm.nih.gov/ geo/query/acc.cgi?acc=GSE8158 )[22].",OADS,/arxiv_data1/oa_pdf/1f/be/main.PMC4778677.pdf
"For the GO annotation, a mapping ﬁle, having the GO annotations for A. thaliana , was created using Batch SOURCE ( http://smd.stanford.edu/cgi-bin/source//sourceBatchSearch ) available in Stanford SOURCE database ( http://source.stanford.edu /).",OADS,/arxiv_data1/oa_pdf/1f/be/main.PMC4778677.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: UV-resistant bacteriaCaribbean Genome sequence Draft genome speci ﬁcations Organism Bacterium Strain MC1ASequencer or array type Illumina MiSeqData format Analyzed Experimental factors Bacterial strain Experimental features Annotated and assembled draft genome sequence of the strain MC1A namedSolirubrum puertoriconensis Consent N/ASample source location Soil in La Parguera, Lajas, Puerto Rico (17°58 ′37″N 67°2 ′32″W, 50 m elevation) 1.",Non-OADS,/arxiv_data1/oa_pdf/e8/a2/main.PMC4778678.pdf
http://dx.doi.org/10.1016/j.gdata.2016.01.018 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/a2/main.PMC4778678.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e8/a2/main.PMC4778678.pdf
"BMC Genomics 9 (1) (2008) 75, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e8/a2/main.PMC4778678.pdf
"35 (9) (2007) 3100 –3108, http://dx.doi.org/10.1093/nar/gkm160 .",Non-OADS,/arxiv_data1/oa_pdf/e8/a2/main.PMC4778678.pdf
"32 (1) (2004) 11 –16,http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/e8/a2/main.PMC4778678.pdf
"57 (10) (2007) 2259 –2261, http://dx.doi.org/ 10.1099/ijs.0.64915-0 .",Non-OADS,/arxiv_data1/oa_pdf/e8/a2/main.PMC4778678.pdf
"64 (2014) 346 –351, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/e8/a2/main.PMC4778678.pdf
2 (4) (2014) http://dx.doi.org/10.1128/genomeA.,Non-OADS,/arxiv_data1/oa_pdf/e8/a2/main.PMC4778678.pdf
The whole genome shotgun sequence of the MS-SSC91 isolate has been deposited at DDBJ/EMBL/GenBank under the accession LJJS00000000 and the sequences could be found at the site http://www.ncbi.nlm.nih.gov/assembly/GCA_001447215.1/ .,OADS,/arxiv_data1/oa_pdf/99/78/main.PMC4778679.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Draft genome Diaporthe aspalathiStem CankerSequencesSoybean pathogen Speci ﬁcations Organism/cell line/tissue Diaporthe aspalathi Strain MS-SSC91Sequencer or array type Illumina HiSeq 2000 sequencer Data format Raw and processed Experimental factors DNA extracted from a ﬁeld strain, no treatment Experimental features Genome sequencingConsent n/aSample source location Soybean ﬁeld in Stoneville, Mississippi, USA 1.",Non-OADS,/arxiv_data1/oa_pdf/99/78/main.PMC4778679.pdf
Direct link to deposited data Deposited data can be found here: http://www.ncbi.nlm.nih.gov/ nuccore/LJJS00000000 .,OADS,/arxiv_data1/oa_pdf/99/78/main.PMC4778679.pdf
http://dx.doi.org/10.1016/j.gdata.2016.02.002 2213-5960/Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/99/78/main.PMC4778679.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/99/78/main.PMC4778679.pdf
The MS-SSC91 isolate has been used to evalu- ate soybean for resistance to stem canker as part of the USDA Uniform Soybean Tests ( http://www.ars.usda.gov/SP2UserFiles/Place/60661000/ UniformSoybeanTests/2013SoyBook.pdf ).,Non-OADS,/arxiv_data1/oa_pdf/99/78/main.PMC4778679.pdf
"After trimming or removing low quality reads or bases with the Trimmomatic [7]and/ or fastx_clipper ( http://hannonlab.cshl.edu/fastx_toolkit/ ) using the threshold of base Phred score greater than 20, a total of 126,051,864 paired-end reads and 4,778,811 un-paired reads were retained.",OADS,/arxiv_data1/oa_pdf/99/78/main.PMC4778679.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Adenomatous polyposis coli Wnt signallingColorectal cancerRNA-seqGene expression Speci ﬁcation Organism/cell line/tissue SW480 Human epithelial cell line Sex Male Sequencer or array type Illumina HiSeq RNASEQData format Raw and analysedExperimental factors Colorectal cancer cell line with/without functional APCExperimental features Determine gene expression alterations in the presence/ absence of APC gene in the colorectal cancer context.,Non-OADS,/arxiv_data1/oa_pdf/a3/97/main.PMC4778681.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE76307 .,OADS,/arxiv_data1/oa_pdf/a3/97/main.PMC4778681.pdf
http://dx.doi.org/10.1016/j.gdata.2016.02.001 2213-5960/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/a3/97/main.PMC4778681.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a3/97/main.PMC4778681.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: RIP-chipAU-rich elementTIARTranslation repressionLPS 1.,Non-OADS,/arxiv_data1/oa_pdf/2f/99/main.PMC4778682.pdf
"Direct link to deposited data [provide URL below] http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE77577Genomics Data 7 (2016) 297 –300 1Current address: Cell Biology Group, Department of Experimental and Health Sciences (CDEXS), Pompeu Fabra University (UPF), CIBER on Neurodegenerative Diseases (CIBERNED), Dr. Aiguader, 88, 08,003 Barcelona, Spain.",OADS,/arxiv_data1/oa_pdf/2f/99/main.PMC4778682.pdf
Cell culture and LPS treatment RAW 264.7 cell clones were cultured in Glutamax Dubelcco Modi ﬁed Eagle Medium (Gibco-BRL®) complemented with 5% fetal bovine http://dx.doi.org/10.1016/j.gdata.2016.02.007 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2f/99/main.PMC4778682.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2f/99/main.PMC4778682.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: NGS SSRTandemRepeatDBGenomeString matchingchromosomes 1.,Non-OADS,/arxiv_data1/oa_pdf/59/70/main.PMC4778683.pdf
http://dx.doi.org/10.1016/j.gdata.2016.01.015 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/59/70/main.PMC4778683.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/59/70/main.PMC4778683.pdf
[8]http://www.ncbi.nlm.nih.gov .,Non-OADS,/arxiv_data1/oa_pdf/59/70/main.PMC4778683.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Substance use disorderTreatment American Indian Cultural adaptationMotivational interviewingCommunity reinforcement approach 1.,Non-OADS,/arxiv_data1/oa_pdf/50/05/main.PMC4778727.pdf
http://dx.doi.org/10.1016/j.abrep.2015.11.002 2352-8532/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/50/05/main.PMC4778727.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/50/05/main.PMC4778727.pdf
http://dx.doi.org/10.1046/j.1360-0443.2002.00101.x .,OADS,/arxiv_data1/oa_pdf/50/05/main.PMC4778727.pdf
Author: Washington D.C (Retrieved from https://www.ihs.gov/dps/index.cfm/publications/ trends2014/ ).,Non-OADS,/arxiv_data1/oa_pdf/50/05/main.PMC4778727.pdf
http://dx.doi.org/10.1016/j.jsat.2007.09.003 .,OADS,/arxiv_data1/oa_pdf/50/05/main.PMC4778727.pdf
This is an open access article under the CCBY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/93/87/main.PMC4778738.pdf
http://dx.doi.org/10.1016/j.jvsc.2016.01.002 28,OADS,/arxiv_data1/oa_pdf/93/87/main.PMC4778738.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: AMLLeukemiaStem cellsTelomereTelomerase Speci ﬁcations Organism/cell line/tissueMus musculus Sequencer or array typeIllumina MouseWG-6 v2.0 expression beadchip Data format Raw and processed data Experimental factors G3 Terc −/−LSC versus WT LSC Experimental features Total RNA obtained from G3 Terc −/−LSCs compared to WT LSCs (MLLAF9+gfp+, Lin −, Kit+, FcgR+) puri ﬁed from primary recipients at individual disease onset.",Non-OADS,/arxiv_data1/oa_pdf/27/74/main.PMC4778749.pdf
Direct link to deposited data The online data can be accessed at: http://www.ncbi.nlm.nih.gov/ geo/query/acc.cgi?acc=GSE632422.,OADS,/arxiv_data1/oa_pdf/27/74/main.PMC4778749.pdf
http://dx.doi.org/10.1016/j.gdata.2016.01.014 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/27/74/main.PMC4778749.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/27/74/main.PMC4778749.pdf
"""GEOquery"" %in% installed.packages()) {source(""http://bioconductor.org/biocLite.R""); biocLite(""GEOquery"")}; library(GEOquery); #download the data geoData b-getGEO('GSE63242') #extract the expressionSet classGeset b-geoData[[1]] # use sample names in the expression matrixcolnames(exprs(Geset))=as.character(pDta(Geset)[['title']]) 2.3.2.",OADS,/arxiv_data1/oa_pdf/27/74/main.PMC4778749.pdf
Translation of murine telomerase regulated genes into human AML In order to translate differentially expressed genes into human ho- mologs we used HomoloGene (downloaded at http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/27/74/main.PMC4778749.pdf
"38 (3) (2010), e17http://dx.doi.org/10.1093/nar/gkp942 .",Non-OADS,/arxiv_data1/oa_pdf/27/74/main.PMC4778749.pdf
"Speed, A comparison of normalization methods for high density oligonucleotide array data based on variance and bias.Bioinformatics 19 (2) (2003) 185 –193, http://dx.doi.org/10.1093/bioinformatics/ 19.2.185 .",OADS,/arxiv_data1/oa_pdf/27/74/main.PMC4778749.pdf
"45 (1) (2001) 5 –32,http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/27/74/main.PMC4778749.pdf
"Cell Stem Cell 15 (6) (2014) 775–790, http://dx.doi.org/10.1016/j.stem.2014.11.010 .",OADS,/arxiv_data1/oa_pdf/27/74/main.PMC4778749.pdf
"Bio- informatics 24 (13) (2008) 1547 –1548, http://dx.doi.org/10.1093/bioinformatics/ btn224 .",Non-OADS,/arxiv_data1/oa_pdf/27/74/main.PMC4778749.pdf
"F1000Research 121 (May) (2015) 1 –24,http://dx.doi.org/10.12688/ f1000research.6536.1 .",Non-OADS,/arxiv_data1/oa_pdf/27/74/main.PMC4778749.pdf
"28 (1) (1979) 100, http://dx.doi.org/10.2307/2346830 .",Non-OADS,/arxiv_data1/oa_pdf/27/74/main.PMC4778749.pdf
"2 (3) (2008) 841 –860, http://dx.doi.org/10.1214/08-AOAS169 .",Non-OADS,/arxiv_data1/oa_pdf/27/74/main.PMC4778749.pdf
"Bioinformatics 25 (3) (2009) 415–416, http://dx.doi.org/10.1093/bioinformatics/btn647 .",Non-OADS,/arxiv_data1/oa_pdf/27/74/main.PMC4778749.pdf
"Blood 118 (10) (2011) 2849 –2856, http://dx.doi.org/10.1182/blood-2011- 03-345165 .",Non-OADS,/arxiv_data1/oa_pdf/27/74/main.PMC4778749.pdf
"Nature 515 (7527) (2014)355–364, http://dx.doi.org/10.1038/nature13992 .280 F.O.",Non-OADS,/arxiv_data1/oa_pdf/27/74/main.PMC4778749.pdf
"Keywords: Artificial urinary sphincter; Prostatectomy; Stress urinary incontinence; Suburethral slings; Urodynamics This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Review Article Received: 19 October, 2015  •  Accepted: 16 December, 2015 Corresponding Author: Craig V. Comiter Department of Urology, Stanford University School of Medicine, 300 Pasteur Drive, S-287, Stanford, CA 94305, USATEL: +1-650-723-3391, FAX: +1-650-724-9608, E-mail: ccomiter@stanford.edu ⓒ The Korean Urological Association, 2016reign as the most predictably efficacious treatment for  PPI.",Non-OADS,/arxiv_data1/oa_pdf/09/ec/icu-57-3.PMC4778750.pdf
"The Kaufman device, comprised of a hemispherical  silicone-gel filled prosthesis and polyurethane straps  www.icurology.orgInvestig Clin Urol 2016;57:3-13.http://dx.doi.org/10.4111/icu.2016.57.1.3pISSN 2466-0493  •  eISSN 2466-054X",Non-OADS,/arxiv_data1/oa_pdf/09/ec/icu-57-3.PMC4778750.pdf
"4 www.icurology.orgComiter and Dobberfuhl http://dx.doi.org/10.4111/icu.2016.57.1.3 compressing the urethra, was replaced by the pubourethral  sling [7], which was in turn supplanted by the bone- anchored male sling (BAMS, InVance, American Medical  Systems, Minnetonka, MN, USA) and the transobturator  (TO) sling (AdVance, American Medical Systems).",Non-OADS,/arxiv_data1/oa_pdf/09/ec/icu-57-3.PMC4778750.pdf
6 www.icurology.orgComiter and Dobberfuhl http://dx.doi.org/10.4111/icu.2016.57.1.3 3.,Non-OADS,/arxiv_data1/oa_pdf/09/ec/icu-57-3.PMC4778750.pdf
"8 www.icurology.orgComiter and Dobberfuhl http://dx.doi.org/10.4111/icu.2016.57.1.3 weight test, cure rate decreases by 0.4%, such that with a  pad weight of greater than 400 g/d, success was 80% lower  than those patients with just 200 g/d leakage [60] .",Non-OADS,/arxiv_data1/oa_pdf/09/ec/icu-57-3.PMC4778750.pdf
"10 www.icurology.orgComiter and Dobberfuhl http://dx.doi.org/10.4111/icu.2016.57.1.3 In a man demonstrating leakage with straining that  stops at the cessation of the straining maneuver, the  diagnosis of ISD can made without further testing.",Non-OADS,/arxiv_data1/oa_pdf/09/ec/icu-57-3.PMC4778750.pdf
http://dx.doi.org/10.1002/nau.22683.,Non-OADS,/arxiv_data1/oa_pdf/09/ec/icu-57-3.PMC4778750.pdf
12 www.icurology.orgComiter and Dobberfuhl http://dx.doi.org/10.4111/icu.2016.57.1.3 39.,Non-OADS,/arxiv_data1/oa_pdf/09/ec/icu-57-3.PMC4778750.pdf
http://dx.doi.org/10.1002/nau.22731.,Non-OADS,/arxiv_data1/oa_pdf/09/ec/icu-57-3.PMC4778750.pdf
"Keywords: Diagnosis; Drug delivery systems; Nanomedicine; Prostate neoplasms; Therapy This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Review Article Received: 16 November, 2015  •  Accepted: 9 December, 2015 Corresponding Author: Vinoth-Kumar Lakshmanan Department of Biomedical Sciences, Chonnam National University Medical School, 160 Baekseo-ro, Dong-gu, Gwangju 61469, KoreaTEL: +82-61-379-2653, FAX: +82-61-379-2680, E-mail: vinoth.lakshmanan@gmail.com ⓒ The Korean Urological Association, 2016The emergence of nanotechnology has drawn much  attention in the 21st century for applications in medicine  such as “nanomedicine.” Nanomedicine combines  engineering, physics, biology, chemistry, mathematics,  and medicine and strives to improve disease detection,  imaging, and drug delivery through the use of nanodevices  [3] .",Non-OADS,/arxiv_data1/oa_pdf/b2/e1/icu-57-21.PMC4778751.pdf
"Nanotechnology-based medicine can hurdle both physiological and biological barriers, such as the blood- brain barrier, endothelial barriers, cell membranes, and  www.icurology.orgInvestig Clin Urol 2016;57:21-29. http://dx.doi.org/10.4111/icu.2016.57.1.21pISSN 2466-0493  •  eISSN 2466-054X",Non-OADS,/arxiv_data1/oa_pdf/b2/e1/icu-57-21.PMC4778751.pdf
"22 www.icurology.orgLakshmanan http://dx.doi.org/10.4111/icu.2016.57.1.21 even nuclear envelopes, achieving both passive and active  disease targeting [4] .",Non-OADS,/arxiv_data1/oa_pdf/b2/e1/icu-57-21.PMC4778751.pdf
"24 www.icurology.orgLakshmanan http://dx.doi.org/10.4111/icu.2016.57.1.21 In the area of novel drug inhibitors, histone deacetylase  inhibitors (HDACIs) do not have significantly better  outcomes in solid malignancies than current standard  therapies [61].",Non-OADS,/arxiv_data1/oa_pdf/b2/e1/icu-57-21.PMC4778751.pdf
"26 www.icurology.orgLakshmanan http://dx.doi.org/10.4111/icu.2016.57.1.21 NANOGENE DELIVERY FOR PROSTATE  CANCER  Gene therapy offers a solution to controlled and specific  delivery of DNA, RNA, and protein to cells.",Non-OADS,/arxiv_data1/oa_pdf/b2/e1/icu-57-21.PMC4778751.pdf
Available from: http://www.pharmamanufacturing.,Non-OADS,/arxiv_data1/oa_pdf/b2/e1/icu-57-21.PMC4778751.pdf
28 www.icurology.orgLakshmanan http://dx.doi.org/10.4111/icu.2016.57.1.21 34.,Non-OADS,/arxiv_data1/oa_pdf/b2/e1/icu-57-21.PMC4778751.pdf
http://dx.doi.org/10.1111/cbdd.12624.,Non-OADS,/arxiv_data1/oa_pdf/b2/e1/icu-57-21.PMC4778751.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/b2/e1/icu-57-21.PMC4778751.pdf
http://dx.doi.org/10.3109/10717544.,Non-OADS,/arxiv_data1/oa_pdf/b2/e1/icu-57-21.PMC4778751.pdf
"Another URL http://www.icurology.com, is  also directed to same page.",Non-OADS,/arxiv_data1/oa_pdf/11/e4/icu-57-1.PMC4778752.pdf
www.icurology.org Investig Clin Urol 2016;57:1-2. http://dx.doi.org/10.4111/icu.2016.57.1.1pISSN 2466-0493  •  eISSN 2466-054X,Non-OADS,/arxiv_data1/oa_pdf/11/e4/icu-57-1.PMC4778752.pdf
"2 www.icurology.orgPark http://dx.doi.org/10.4111/icu.2016.57.1.1 Kwangsung Park, MD, PhD Editor-in-Chief Department of Urology, Chonnam National University  Medical School, 160 Baekseo-ro, Dong-gu, Gwangju 61469, Korea E-mail: uropark@gmail.comREFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/11/e4/icu-57-1.PMC4778752.pdf
"Keywords: Chromosomes; Genes; Hyperplasia; Prostate This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article - Genomics/Stem Cells in Urology Received: 25 September, 2015  •  Accepted: 2 December, 2015 Corresponding Author: Muammer Altok Department of Urology, Faculty of Medicine, Suleyman Demirel University, 32260 Isparta, TurkeyTEL: +90-246-211-9266, FAX: +90-246-211-2830, E-mail: muammeraltok@sdu.edu.tr ⓒ The Korean Urological Association, 2016hormonal levels, permanent chronic inflammation, abnormal  wound repair processes, and prostate stem or progenitor cell  expansion are the main factors that promote BPH [2] .",Non-OADS,/arxiv_data1/oa_pdf/65/b8/icu-57-45.PMC4778753.pdf
"In recent years, cytogenetic  studies have focused on prostate cancer; however, a variety  of specific chromosomal changes have been identified in  www.icurology.orgInvestig Clin Urol 2016;57:45-49. http://dx.doi.org/10.4111/icu.2016.57.1.45pISSN 2466-0493  •  eISSN 2466-054X",Non-OADS,/arxiv_data1/oa_pdf/65/b8/icu-57-45.PMC4778753.pdf
46 www.icurology.orgAltok et al http://dx.doi.org/10.4111/icu.2016.57.1.45 several benign neoplasms [3].,Non-OADS,/arxiv_data1/oa_pdf/65/b8/icu-57-45.PMC4778753.pdf
48 www.icurology.orgAltok et al http://dx.doi.org/10.4111/icu.2016.57.1.45 presence of BPH was not confirmed by any pathologic  specimens.,OADS,/arxiv_data1/oa_pdf/65/b8/icu-57-45.PMC4778753.pdf
"Keywords: Guideline; Lower urinary tract symptoms; Prostate; Prostatic hyperplasia This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Special Article Received: 22 October, 2015  •  Accepted: 24 December, 2015                    See Editorial on page 43.",Non-OADS,/arxiv_data1/oa_pdf/36/05/icu-57-30.PMC4778754.pdf
METHODS USED TO FORMULATE THE  GUIDELINE The Korean Urological Association (KUA) launched a  committee to develop a clinical practice guideline for BPH  with the participation of the Korean Academy of Family  Medicine (KAFM) and the Korean Continence Society  www.icurology.orgInvestig Clin Urol 2016;57:30-44. http://dx.doi.org/10.4111/icu.2016.57.1.30pISSN 2466-0493  •  eISSN 2466-054X,Non-OADS,/arxiv_data1/oa_pdf/36/05/icu-57-30.PMC4778754.pdf
32 www.icurology.orgYeo et al http://dx.doi.org/10.4111/icu.2016.57.1.30 Table 1.,Non-OADS,/arxiv_data1/oa_pdf/36/05/icu-57-30.PMC4778754.pdf
34 www.icurology.orgYeo et al http://dx.doi.org/10.4111/icu.2016.57.1.30 of the 24-hour urine excretion overnight) can be diagnosed  only by a bladder diary [13] .,Non-OADS,/arxiv_data1/oa_pdf/36/05/icu-57-30.PMC4778754.pdf
36 www.icurology.orgYeo et al http://dx.doi.org/10.4111/icu.2016.57.1.30 retention (more than 1 year) [48-50] .,Non-OADS,/arxiv_data1/oa_pdf/36/05/icu-57-30.PMC4778754.pdf
38 www.icurology.orgYeo et al http://dx.doi.org/10.4111/icu.2016.57.1.30 KQ 11.,OADS,/arxiv_data1/oa_pdf/36/05/icu-57-30.PMC4778754.pdf
"ACKNOWLEDGMENTS Technical Panels Jeong Kyun Yeo (Inje University), Hun Choi (Korea  University), Jae Hyun Bae (Korea University), Kwang  Tac Kim (Gachon University), Tae Byum Kim (Gachon  University), Myung Ki Kim (Chonbuk University), Jae Heon  Kim (Soonchunhyang University), Jun Hwa No (Kwangju  Christian Hospital), Ho Song Rhu (Chonnam national  University), Seong Ok Yang (VHS medical center), Chul  Young Oh (Hallym University), Seong Wook Lee (Hanyang  University), Seong Hwan Lee (Yonsei University), Young  Sam Cho (Sungkyunkwan University), Won Jin Cho (Chosun  University), Kyoung Woo Kim (Inje University), Hyung Ji  Kim (Dankook University), External Reviewers Ho seok Koo (Internal Medicine, Inje University), Doo  Sang Kim (Soonchunhyang University), Keong Hyun Moon  (Ulsan University), Hyun Jun Park (Pusan University),  Sang Kook Yang (Konkuk University), Seung Hyo Woo (Eulji  University), Dong Hee Yoon (Tower Urology Clinic),  Advisory Boards Methodology: Ho Jang Kwan (Dankook University), Hyun Jeong Kim (Korea University) The full version of guideline can be downloaded at KUA  (Korean Urological Association) http://www.urology.or.kr/ notice/view.php?code=notice&page=1&sid=2948) and KoMGI  (Korean Medical Guideline Information Center) (http://www.",Non-OADS,/arxiv_data1/oa_pdf/36/05/icu-57-30.PMC4778754.pdf
Available from: http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0033879/pdf/PubMedHealth_PMH0033879.pdf.,Non-OADS,/arxiv_data1/oa_pdf/36/05/icu-57-30.PMC4778754.pdf
40 www.icurology.orgYeo et al http://dx.doi.org/10.4111/icu.2016.57.1.30 11.,Non-OADS,/arxiv_data1/oa_pdf/36/05/icu-57-30.PMC4778754.pdf
42 www.icurology.orgYeo et al http://dx.doi.org/10.4111/icu.2016.57.1.30 59.,Non-OADS,/arxiv_data1/oa_pdf/36/05/icu-57-30.PMC4778754.pdf
44 www.icurology.orgYeo et al http://dx.doi.org/10.4111/icu.2016.57.1.30 four levels [5] .,Non-OADS,/arxiv_data1/oa_pdf/36/05/icu-57-30.PMC4778754.pdf
Available from: http://www.agreetrust.org/wp-content/ uploads/2013/10/AGREE-II-Users-Manual-and-23-item- Instrument_2009_UPDATE_2013.pdf.,Non-OADS,/arxiv_data1/oa_pdf/36/05/icu-57-30.PMC4778754.pdf
"Keywords: Prostatectomy; Prostatic neoplasms; Watchful waiting This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Review Article Received: 10 November, 2015  •  Accepted: 1 December, 2015 Corresponding Author: Seung Hwan Lee Department of Urology, Urological Science Institute, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, KoreaTEL: +82-2-2019-3470, FAX: +82-2-3462-8887, E-mail: leeseh@yuhs.ac ⓒ The Korean Urological Association, 2016of symptoms, change in exam, or prostate specific antigen  (PSA) that suggests symptoms are imminent, AS is mainly  applicable to younger men with seemingly indolent cancer,  with the goal of deferring treatment and its potential side  effects ( Table 1 ).",Non-OADS,/arxiv_data1/oa_pdf/57/5d/icu-57-14.PMC4778755.pdf
The debate  www.icurology.orgInvestig Clin Urol 2016;57:14-20.http://dx.doi.org/10.4111/icu.2016.57.1.14pISSN 2466-0493  •  eISSN 2466-054X,Non-OADS,/arxiv_data1/oa_pdf/57/5d/icu-57-14.PMC4778755.pdf
16 www.icurology.orgChung and Lee http://dx.doi.org/10.4111/icu.2016.57.1.14 have been developed to predict tumor aggressiveness.,OADS,/arxiv_data1/oa_pdf/57/5d/icu-57-14.PMC4778755.pdf
"18 www.icurology.orgChung and Lee http://dx.doi.org/10.4111/icu.2016.57.1.14 careful individualized weighing of numerous factors: life  expectancy, general health condition, disease characteristics,  potential side effects of treatment, and patient preference.",Non-OADS,/arxiv_data1/oa_pdf/57/5d/icu-57-14.PMC4778755.pdf
20 www.icurology.orgChung and Lee http://dx.doi.org/10.4111/icu.2016.57.1.14 temporary protocols at a high-volume Korean center.,Non-OADS,/arxiv_data1/oa_pdf/57/5d/icu-57-14.PMC4778755.pdf
"Keywords: Cell line; Cisplatin; Drug resistance; Microarray analysis; Urinary bladder neoplasms This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article - Basic and Translational Research Received: 15 October, 2015  •  Accepted: 16 November, 2015 Corresponding Author: Seok-Soo Byun Department of Urology, Seoul National University Bundang Hospital, 82 Gumi-ro 173beon-gil, Bundang-gu, Seongnam 13620, KoreaTEL: +82-31-787-7349, FAX: +82-31-787-4057, E-mail: ssbyun@snubh.org ⓒ The Korean Urological Association, 2016 www.icurology.orgInvestig Clin Urol 2016;57:63-72.http://dx.doi.org/10.4111/icu.2016.57.1.63pISSN 2466-0493  •  eISSN 2466-054X",Non-OADS,/arxiv_data1/oa_pdf/ec/55/icu-57-63.PMC4778756.pdf
"64 www.icurology.orgKim et al http://dx.doi.org/10.4111/icu.2016.57.1.63 INTRODUCTION Cisplatin-based combination chemotherapy protocols  such as methotrexate, vinblastine, doxorubicin and cisplatin,  or gemcitabine and cisplatin have been a mainstay for  advanced (or metastatic) bladder cancer (BC) treatment for  a number of years and have prolonged the survival of these  patients by up to 19 months [1-4] .",Non-OADS,/arxiv_data1/oa_pdf/ec/55/icu-57-63.PMC4778756.pdf
GenMAPP software was also used to represent gene  expression data (http://www.genmapp.org).,OADS,/arxiv_data1/oa_pdf/ec/55/icu-57-63.PMC4778756.pdf
"66 www.icurology.orgKim et al http://dx.doi.org/10.4111/icu.2016.57.1.63 blocked with 5% milk for 1 hour at room temperature and  incubated overnight at 4oC with the corresponding primary  antibodies to BCL2, CCNE1, and MCM7, respectively (Cell  Signaling Technology, Beverly, MA, USA).",Non-OADS,/arxiv_data1/oa_pdf/ec/55/icu-57-63.PMC4778756.pdf
"After analysis  of the data according to the Gene Set Enrichment Analysis  computational method (http://www.broadinstitute.org/gsea),  we identified 448 significant candidate gene sets in the  differentially expressed genetic suppressor element genes  and 69 KEGG pathways.",OADS,/arxiv_data1/oa_pdf/ec/55/icu-57-63.PMC4778756.pdf
68 www.icurology.orgKim et al http://dx.doi.org/10.4111/icu.2016.57.1.63 Table 1.,OADS,/arxiv_data1/oa_pdf/ec/55/icu-57-63.PMC4778756.pdf
"70 www.icurology.orgKim et al http://dx.doi.org/10.4111/icu.2016.57.1.63 study have already been confirmed as CR BC cell lines  with the change of p53 expressions in our previously  published studies [6,9-11] .",Non-OADS,/arxiv_data1/oa_pdf/ec/55/icu-57-63.PMC4778756.pdf
72 www.icurology.orgKim et al http://dx.doi.org/10.4111/icu.2016.57.1.63 platinum resistant human bladder cancer cells induced by long- term cisplatinum treatment.,Non-OADS,/arxiv_data1/oa_pdf/ec/55/icu-57-63.PMC4778756.pdf
"Keywords: Database; Kidney neoplasms; Population characteristics This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article - Urological Oncology Received: 14 October, 2015  •  Accepted: 16 December, 2015 Corresponding Author: Seok-Soo Byun Department of Urology, Seoul National University Bundang Hospital, 82 Gumi-ro 173beon-gil, Bundang-gu, Seongnam 13620, KoreaTEL: +82-31-787-7349, FAX: +82-31-787-4057, E-mail: ssbyun@snubh.org ⓒ The Korean Urological Association, 2016malignancy of the kidney and a cancer of increasing  incidence [1] .",Non-OADS,/arxiv_data1/oa_pdf/2f/1f/icu-57-50.PMC4778757.pdf
"In Korea, RCC accounted for 1.85% of the  total cancer occurrence in 2012, and the incidence rate was  www.icurology.orgInvestig Clin Urol 2016;57:50-57.http://dx.doi.org/10.4111/icu.2016.57.1.50pISSN 2466-0493  •  eISSN 2466-054X",Non-OADS,/arxiv_data1/oa_pdf/2f/1f/icu-57-50.PMC4778757.pdf
52 www.icurology.orgByun et al http://dx.doi.org/10.4111/icu.2016.57.1.50 surgical treatments.,Non-OADS,/arxiv_data1/oa_pdf/2f/1f/icu-57-50.PMC4778757.pdf
54 www.icurology.orgByun et al http://dx.doi.org/10.4111/icu.2016.57.1.50 DISCUSSION We report the 1st establishment of a Web-based DB  system to collect clinicopathological characteristics of  RCC in Korea.,Non-OADS,/arxiv_data1/oa_pdf/2f/1f/icu-57-50.PMC4778757.pdf
"56 www.icurology.orgByun et al http://dx.doi.org/10.4111/icu.2016.57.1.50 Nowadays, the use of minimally invasive surgery is a  growing trend.",Non-OADS,/arxiv_data1/oa_pdf/2f/1f/icu-57-50.PMC4778757.pdf
"Keywords: Replantation; Ureter; Vesicoureteral reflux This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article - Pediatric Urology Received: 3 November, 2015  •  Accepted: 24 December, 2015 Corresponding Author: Sang Don Lee Department of Urology, Pusan National University Yangsan Hospital, 20 Geumo-ro, Mulgeum-eup, Yangsan 50612, KoreaTEL: +82-55-360-2134, FAX: +82-55-360-2164, E-mail: lsd@pusan.ac.kr ⓒ The Korean Urological Association, 2016these complications.",Non-OADS,/arxiv_data1/oa_pdf/06/b9/icu-57-58.PMC4778758.pdf
"In 1984, endoscopic injections of tissue- augmenting material for the correction of VUR were  introduced; since then, many urologists prefer this procedure  www.icurology.orgInvestig Clin Urol 2016;57:58-62.http://dx.doi.org/10.4111/icu.2016.57.1.58pISSN 2466-0493  •  eISSN 2466-054X",Non-OADS,/arxiv_data1/oa_pdf/06/b9/icu-57-58.PMC4778758.pdf
"60 www.icurology.orgLee et al http://dx.doi.org/10.4111/icu.2016.57.1.58 surgery, 7 of  their children had low-grade reflux, and 4 had  high-grade reflux.",Non-OADS,/arxiv_data1/oa_pdf/06/b9/icu-57-58.PMC4778758.pdf
62 www.icurology.orgLee et al http://dx.doi.org/10.4111/icu.2016.57.1.58 occurrence and long-term risks.,OADS,/arxiv_data1/oa_pdf/06/b9/icu-57-58.PMC4778758.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/57/52/ott-9-1023.PMC4778772.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1023–1028OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1023Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S10068 5Quality of life of patients with lung cancer Jacek Polanski1 Beata Jankowska-Polanska2 Joanna Rosinczuk3 Mariusz Chabowski4 Anna Szymanska- Chabowska5 1Lower Silesian Oncology Center,   Home Hospice, 2Department  of Clinical Nursing, 3Department  of Nervous System Diseases,   Department of Clinical Nursing,   4Division of Nursing in Surgical  Procedures, Department of  Clinical Nursing, Faculty of Health  Science, 5Department of internal  Medicine, Occupational Diseases  and Hypertension, wroclaw Medical  University, wroclaw, PolandAbstract:  Lung cancer is the major cause of oncologic-related death worldwide.",Non-OADS,/arxiv_data1/oa_pdf/57/52/ott-9-1023.PMC4778772.pdf
"Radiation therapy is administered as a Correspondence: Mariusz Chabowski Department of Surgery, 4th Military  Teaching Hospital, 5 weigla Street,  50-981 wroclaw, Poland Tel +48 261 660 247 Fax +48 261 660 245 email mariusz.chabowski@gmail.co m Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2016 Volume: 9 Running head verso: Polanski et al Running head recto: Quality of life of patients with lung cancer DOI: http://dx.doi.org/10.2147/OTT.S100685",Non-OADS,/arxiv_data1/oa_pdf/57/52/ott-9-1023.PMC4778772.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/57/52/ott-9-1023.PMC4778772.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/57/52/ott-9-1023.PMC4778772.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0b/08/tcrm-12-327.PMC4778773.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 327–334Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  327ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S9108 5Evaluation of safety and efficacy of zonisamide  in adult patients with partial, generalized,  and combined seizures: an open labeled,  noncomparative, observational indian study amitabh Dash,1 sangeeta  Ravat,2 avathvadi Venkatesan  srinivasan,3 ashutosh shetty,4  Vivek Kumar,5 Renu achtani,6  Vivek narain Mathur,7  Boby Varkey Maramattom,8  Veeresh Bajpai,9 nanjappa C  Manjunath,10 Randhi Venkata  narayana,11 suyog Mehta12 1eisai Co. ltd., 2Department of  neurology, seth gs Medical College &  KeM hospital, Mumbai, 3Department  of neurology, Trinity acute Care  hospital, Chennai, 4Department of  neurology, Criticare Multispeciality  hospital & Research Centre,   Mumbai, 5Department of neurology,   Metro Multispeciality hospital,   noida, 6Department of neurology,   Mata Chanan Devi hospital, new  Delhi, 7Department of neurology,   Vivekananda hospital, hyderabad,   8Department of n eurology, lourdes  hospital, Kochi, 9Department of  neurology, sai neurology Clinic,   lucknow, 10Department of neurology,   Brain and nerve Care, Bangalore,   11Department of neurology, seven  hills hospital, Visakhapatnam,   12Department of Pharmacology &  Therapeutics, government Medical  College, solapur, indiaAbstract:  A prospective, multicentric, noncomparative open-label observational study was  conducted to evaluate the safety and efficacy zonisamide in Indian adult patients for the treatment  of partial, generalized, or combined seizures.",Non-OADS,/arxiv_data1/oa_pdf/0b/08/tcrm-12-327.PMC4778773.pdf
"Keywords:  zonisamide, partial onset seizures, generalized seizures, responder rate, mono - therapy, adjunctive therapy Introduction Epilepsy is one of the most common serious neurological disorders, affecting more  than 50 million people worldwide.1 It has been estimated that approximately 80%  of them are in developing countries.2 The overall prevalence of epilepsy in India is  reported as 1%, which is slightly higher in the rural areas (1.9%).2 Approximately two- thirds of the patients experience simple or complex partial (focal) seizures, whereas  the remaining one-third experience generalized seizures.3 Uncontrolled seizures can  lead to a wide variety of consequences, including shortened lifespan, neuronal death,  excessive bodily injury, physiological dysfunction, neuropsychological and psychiatric  impairment, and social disability.4 The goal of epilepsy management currently is to maximize the quality of life of  patients, by minimizing the seizure episodes, with the least possible therapy-related Correspondence: amitabh Dash eisai Co. ltd., 1st Floor, B Wing, Marwah  Centre, Krishanlal Marwah Marg, andheri  east, Mumbai - 400072, india Tel +91 91 6752 6147 email a-dash@eisai.co.i n Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Dash et al Running head recto: Safety and efficacy of zonisamide in adult patients with seizures DOI: http://dx.doi.org/10.2147/TCRM.S91085",Non-OADS,/arxiv_data1/oa_pdf/0b/08/tcrm-12-327.PMC4778773.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/0b/08/tcrm-12-327.PMC4778773.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/0b/08/tcrm-12-327.PMC4778773.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c0/8e/ndt-12-533.PMC4778774.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 533–540Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  533Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S9590 3Assistive technologies for managing language  disorders in dementia Blanka Klimova1 Petra Maresova2 Kamil Kuca3,4 1Department of Applied Linguistics,   2Department of economics, Faculty  of informatics and Management,   University of Hradec Kralove,   3Biomedical Research Centre,   University Hospital Hradec Kralove,   4Center for Basic and Applied  Research, Faculty of informatics and  Management, University of Hradec  Kralove, Hradec Kralove, Czech  RepublicAbstract:  At present, the number of elderly people is rapidly increasing, which represents a  significant threat in terms of their care when they fall ill. One of the most common aging diseases  nowadays is dementia, whose symptoms sooner or later include loss of cognitive functioning.",Non-OADS,/arxiv_data1/oa_pdf/c0/8e/ndt-12-533.PMC4778774.pdf
"The most common types of  dementia are as follows: Alzheimer’s disease (AD), vascular dementia, dementia with  Lewy bodies, mixed dementia, Parkinson’s disease, frontotemporal lobar degeneration,  Creutzfeldt–Jakob disease, and normal pressure hydrocephalus.1Correspondence: Kamil Kuca Biomedical Research Centre, University  Hospital Hradec Kralove, Sokolska 581,  Hradec Kralove 500 05, Czech Republic Tel +420 603 289 166 Fax +420 495 835 200 email kamil.kuca@fnhk.c z Journal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2016 Volume: 12 Running head verso: Klimova et al Running head recto: ATs for managing language disorders in dementia DOI: http://dx.doi.org/10.2147/NDT.S95903",Non-OADS,/arxiv_data1/oa_pdf/c0/8e/ndt-12-533.PMC4778774.pdf
"Available from: http://www.alz.org/ downloads/Facts_Figures_2012.pd f. Accessed July 5, 2015.",OADS,/arxiv_data1/oa_pdf/c0/8e/ndt-12-533.PMC4778774.pdf
"Available  from: http://www.who.int/mediacentre/factsheets/fs362/e n. Accessed  May 8, 2015.",Non-OADS,/arxiv_data1/oa_pdf/c0/8e/ndt-12-533.PMC4778774.pdf
Available  from: http://www.asha.org/policy/RP1993-00208 /.,Non-OADS,/arxiv_data1/oa_pdf/c0/8e/ndt-12-533.PMC4778774.pdf
"Available from: http://www.enotes.com/nursing-ency - clopedia/language-disorder s. Accessed May 8, 2015.",Non-OADS,/arxiv_data1/oa_pdf/c0/8e/ndt-12-533.PMC4778774.pdf
Avail - able from: http://www.alzheimers.org.uk/site/scripts/documents_info.,Non-OADS,/arxiv_data1/oa_pdf/c0/8e/ndt-12-533.PMC4778774.pdf
Available from: http://www.atia.org/i4a/ pages/index.cfm?pageid =3859.,Non-OADS,/arxiv_data1/oa_pdf/c0/8e/ndt-12-533.PMC4778774.pdf
"Available from: http://carerslink.org.uk/ wp-content/uploads/00259-Telecare-and-dementia-Scotland-free- download.pd f. Accessed May 8, 2015.",Non-OADS,/arxiv_data1/oa_pdf/c0/8e/ndt-12-533.PMC4778774.pdf
Available from: http://www.alzheimers.org.uk/ site/scripts/documents_info.php?documentID =109.,Non-OADS,/arxiv_data1/oa_pdf/c0/8e/ndt-12-533.PMC4778774.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/c0/8e/ndt-12-533.PMC4778774.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c0/8e/ndt-12-533.PMC4778774.pdf
"Available from: http://www.ohsu.edu/xd/research/centers- institutes/institute-on-development-and-disability/reknew/research/ upload/Communication-Supports-for-Persons-with-Dementia.pd f.  Accessed May 8, 2015.",Non-OADS,/arxiv_data1/oa_pdf/c0/8e/ndt-12-533.PMC4778774.pdf
Available from: http://www.aetna.com/cpb/medical/data/400_499/0437.,OADS,/arxiv_data1/oa_pdf/c0/8e/ndt-12-533.PMC4778774.pdf
"Available from: http://www.disabled-world.com/assis - tivedevices/computer/screen-readers.ph p. Accessed July 14, 2015.",Non-OADS,/arxiv_data1/oa_pdf/c0/8e/ndt-12-533.PMC4778774.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/53/f6/ott-9-993.PMC4778775.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2016:9 993–1000OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  993Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9290 7The pro-apoptotic effects of TiPe2 on aa rat  fibroblast-like synoviocytes via regulation of the  Dr5–caspase–nF- κB pathway in vitro chunyan shi1,2,* shifeng Zhang1,3,* shifu hong1 Jinglong Pang1 Yeletai Yesibulati1 Ping Yin4 guohong Zhuang1 1Organ Transplantation institute, anti- cancer research center, Medical  college, Xiamen University, Xiamen,   Fujian, 2The Department of Oncology,   Jiujiang no.1 People’s hospital,   Jiujiang, Jiangxi city, 3Division of  gastroenterology surgery, Zhongshan  hospital, gastroenterology  institute of Xiamen University,   gastroenterology center of Xiamen,   4The Department of Pathology,   Zhongshan hospital, Xiamen  University, Xiamen, Fujian, People’s  Republic of China *These authors contributed equally  to this workAbstract:  TIPE2, also known as TNFAIP8L2, a member of the tumor necrosis factor-   alpha-induced protein-8 (TNFAIP8) family, is known as an inhibitor in inflammation and  cancer, and its overexpression induces cell death.",Non-OADS,/arxiv_data1/oa_pdf/53/f6/ott-9-993.PMC4778775.pdf
"Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) induces  apoptosis by binding to TRAIL receptor 1 (death receptor 4, DR4) and TRAIL receptor  2 (DR5), which antagonize the death signal.6 Previous reports have indicated that RA  synovial tissue and fibroblasts express high levels of DR5 and are highly susceptible  to DR5-mediated apoptosis.7 A novel agonistic antihuman DR5 single chain variable correspondence: Ping Yin The Department of Pathology,  Zhongshan hospital, Xiamen University,  Hubin South Road, Xiamen 361100,  Fujian, People’s Republic of China email yinping2002@163.co m guohong Zhuang Organ Transplantation institute,  anti-cancer research center, Medical  college, Xiamen University, Xiang’an  south road, Xiamen 361100, Fujian,  People’s Republic of China Tel +86 592 218 7157 Fax +86 592 218 7157 email zghxmu@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Shi et al Running head recto: TIPE2-enhanced fibroblast apoptosis DOI: http://dx.doi.org/10.2147/OTT.S92907",Non-OADS,/arxiv_data1/oa_pdf/53/f6/ott-9-993.PMC4778775.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/53/f6/ott-9-993.PMC4778775.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/53/f6/ott-9-993.PMC4778775.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4b/35/dddt-10-861.PMC4778776.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2016:10 861–871Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  861Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S8049 6The interplay of post-translational modification  and gene therapy victor Chukwudi Osamor,1–3  Shalom N Chinedu,3,4 Dominic e  Azuh,3,5 emeka Joshua iweala,3,4  Olubanke Olujoke Ogunlana,3,4 1Covenant University Bioinformatics  Research (CUBRe) Unit, Department  of Computer and information Sciences,   College of Science and Technology  (CST), Covenant University, Ota,   Ogun State, Nigeria; 2institute of  informatics (Computational biology and  Bioinformatics), Faculty of Mathematics,   informatics and Mechanics, University  of warsaw (Uniwersytet warszawski),   warszawa, Poland; 3Covenant University  Public Health and well-being Research  Group (CUPH weRG), Covenant  University, 4Biochemistry and Molecular  Biology Unit, Department of Biological  Sciences, College of Science and  Technology, Covenant University, Canaan  Land, 5Department of economics and  Development Studies, Covenant University,   Ota, Ogun State, NigeriaAbstract:  Several proteins interact either to activate or repress the expression of other genes  during transcription.",Non-OADS,/arxiv_data1/oa_pdf/4b/35/dddt-10-861.PMC4778776.pdf
"This may perhaps be by recruitment of epigenetic enzymes to epigenetic  sites in the genome.Correspondence: victor Chukwudi Osamor Department of Computer and information  Sciences, College of Science and Technology  (CST), Covenant University, PMB 1023, Ota,  Ogun State, Nigeria email vcosamor@gmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Osamor et al Running head recto: The interplay of post-translational modification and gene therapy DOI: http://dx.doi.org/10.2147/DDDT.S80496 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/4b/35/dddt-10-861.PMC4778776.pdf
Or use: http://youtu.be/L63IeZwb5q Uvideo abstract,Non-OADS,/arxiv_data1/oa_pdf/4b/35/dddt-10-861.PMC4778776.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/4b/35/dddt-10-861.PMC4778776.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4b/35/dddt-10-861.PMC4778776.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/4b/7a/ndt-12-517.PMC4778777.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 517–521Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  517Case repor Topen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/NDT .S10299 3severe water intoxication and secondary  depressive syndrome in relation to delusional  infestation Jianbo Lai1 Qiaoqiao Lu1 Yi Xu1,2 shaohua Hu1,2 1Department of psychiatry, First  affiliated Hospital, Zhejiang University  school of Medicine, Hangzhou,   people’s republic of China; 2The  Key Laboratory of Mental Disorder’s  Management in Zhejiang province,   Hangzhou, people’s republic of ChinaAbstract:  This study presents a case of severe water intoxication in a female patient with  delusional infestation.",Non-OADS,/arxiv_data1/oa_pdf/4b/7a/ndt-12-517.PMC4778777.pdf
"Managing primary diseases is  the immediate task, and antipsychotics can be used to eliminate psychotic symptoms Correspondence: shaohua Hu Department of Psychiatry, First Affiliated  Hospital, Zhejiang University school  of Medicine, No 79, Qingchun road,  Hangzhou 310003, people’s republic  of China Tel +86 571 5672 3002 Fax +86 571 5672 3001 email dorhushaohua@zju.edu.c n Journal name: Neuropsychiatric Disease and Treatment Article Designation: Case report Y ear: 2016 Volume: 12 Running head verso: Lai et al Running head recto: Severe water intoxication and secondary depressive syndrome DOI: http://dx.doi.org/10.2147/NDT.S102993",Non-OADS,/arxiv_data1/oa_pdf/4b/7a/ndt-12-517.PMC4778777.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/4b/7a/ndt-12-517.PMC4778777.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4b/7a/ndt-12-517.PMC4778777.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/03/c7/ndt-12-523.PMC4778778.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 523–531Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  523OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S10317 3The efficacy and safety of 10 mg vortioxetine  in the treatment of major depressive disorder:  a meta-analysis of randomized controlled trials Guangjian Li Xu Wang Dihui Ma Department of Neurology and  Neuroscience center, First hospital  of Jilin University, Changchun,   People’s republic of chinaBackground:  Vortioxetine is an investigational multimodal antidepressant.",Non-OADS,/arxiv_data1/oa_pdf/03/c7/ndt-12-523.PMC4778778.pdf
"Moreover, it is also associated with a  higher risk of suicide.3,4 There are many antidepressants available for the treatment of MDD; however,  only ~50% of patients respond to these drugs and ~30% achieve remission.5–7 More - over, antidepressant treatment could result in several adverse events, such as weight correspondence: Dihui Ma Department of Neurology and  Neuroscience center, First hospital  of Jilin University, No 71, Xinmin street,  Changchun, Jilin 130021, People’s  republic of china Tel +86 431 8878 2380 email madihui@263.ne t Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Li et al Running head recto: 10 mg vortioxetine in the treatment of major depressive disorder: a meta-analysis DOI: http://dx.doi.org/10.2147/NDT.S103173",Non-OADS,/arxiv_data1/oa_pdf/03/c7/ndt-12-523.PMC4778778.pdf
"Available from: http://www.accessdata.fda.gov/ drugsatfda_docs /label/2013/204447s000lbl.pd f. Accessed November  15, 2015.",Non-OADS,/arxiv_data1/oa_pdf/03/c7/ndt-12-523.PMC4778778.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/03/c7/ndt-12-523.PMC4778778.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/03/c7/ndt-12-523.PMC4778778.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7f/a4/cia-11-265.PMC4778779.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 265–273Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  265OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S10056 6Correlation between bone mineral density and  serum trace elements in response to supervised  aerobic training in older adults Ahmad h Alghadir1 sami A gabr1,2 einas s Al-eisa1 Muaz h Alghadir3 1rehabilitation research Chair,   College of Applied Medical sciences,   King saud University, riyadh, Kingdom  of saudi Arabia; 2Department of  Anatomy, Faculty of Medicine,   Mansoura University, Mansoura, egypt;   3Department of Orthopedics, King  Fahad Medical City, riyadh, Kingdom  of saudi ArabiaBackground:  Life style and physical activity play a pivotal role in prevention and treatment  of osteoporosis.",Non-OADS,/arxiv_data1/oa_pdf/7f/a4/cia-11-265.PMC4778779.pdf
"Keywords:  essential minerals, osteoporosis, bone density, aerobic exercise, BMD, bone  metabolism Introduction Trace elements perform many important physiologic functions as a catalyst or as  an enzyme component within biological systems;1 they are involved in many physi - ologic roles including antioxidant activity and bone health, and maintain an essential Correspondence: sami A gabr rehabilitation research Chair, College  of Applied Medical sciences, King saud  University, PO Box 10219, riyadh 11433,  Kingdom of saudi Arabia Tel +966 5 6206 0018 Fax +966 1 469 8541 email nadalab2009@hotmail.co m Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Alghadir et al Running head recto: Trace elements and bone health in physically active older adults DOI: http://dx.doi.org/10.2147/CIA.S100566",Non-OADS,/arxiv_data1/oa_pdf/7f/a4/cia-11-265.PMC4778779.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/7f/a4/cia-11-265.PMC4778779.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/7f/a4/cia-11-265.PMC4778779.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/62/3b/vhrm-12-045.PMC4778780.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).vascular Health and Risk Management 2016:12 45–51submit your manuscript | www.dovepress.co m Dove press  45 http: //dx.doi.org/10.2147/VHRM.S8156 9edoxaban in venous thromboembolism and stroke  prevention: an appraisal Marco Proietti1,2 Gregory YH Lip1,3 1University of Birmingham institute  of Cardiovascular Sciences,   City Hospital, Birmingham, UK;   2Department of internal Medicine  and Medical Specialties, Sapienza- University of Rome, Rome, italy;   3Aalborg Thrombosis Research Unit,   Department of Clinical Medicine,   Aalborg University, Aalborg, Denmark Correspondence: Gregory YH Lip   University of Birmingham institute of  Cardiovascular Sciences, City Hospital,  Dudley Road, Birmingham, west Midlands  B18 7QH, UK   T el +44 121 507 5080   Fax +44 121 554 4083   email g.y.h.lip@bham.ac.u kAbstract:  Oral anticoagulation is the therapeutic cornerstone in preventing thromboembolic  risk in both atrial fibrillation (AF) and venous thromboembolism (VTE).",Non-OADS,/arxiv_data1/oa_pdf/62/3b/vhrm-12-045.PMC4778780.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/62/3b/vhrm-12-045.PMC4778780.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/62/3b/vhrm-12-045.PMC4778780.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/bc/68/copd-11-417.PMC4778781.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 417International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/bc/68/copd-11-417.PMC4778781.pdf
"Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.Dove pres s 417COrrIgenDumopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S103721The utility of inflammatory markers to predict readmissions and mortality  in COPD cases with or without eosinophilia [Corrigendum] Duman D, Aksoy E, Agca MC, et al.",Non-OADS,/arxiv_data1/oa_pdf/bc/68/copd-11-417.PMC4778781.pdf
The correct column heading is “Hazard ratio”.Journal name: International Journal of COPD Article Designation: Corrigendum Y ear: 2016 Volume: 11 Running head verso: Duman et al Running head recto: The utility of inflammatory markers to predict readmissions DOI: http://dx.doi.org/10.2147/COPD.S103721,Non-OADS,/arxiv_data1/oa_pdf/bc/68/copd-11-417.PMC4778781.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/de/3d/ppa-10-213.PMC4778782.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 213–222Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  213OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S9487 8The Diabetes intention, Attitude, and Behavior  Questionnaire: evaluation of a brief questionnaire  to measure physical activity, dietary control,  maintenance of a healthy weight, and psychological  antecedents shana B Traina1 susan D Mathias2 hilary h colwell2 ross D crosby2–4 charles Abraham5 1Patient-reported Outcomes,   Janssen global services, llc,   raritan, nJ, UsA; 2health Outcomes  solutions, Winter Park, Fl, UsA;   3Biomedical statistics & Methodology,   neuropsychiatric research institute,   Fargo, nD, UsA; 4Department of  clinical neuroscience, University of  north Dakota school of Medicine and  health sciences, grand Forks, nD,   UsA; 5Psychology Applied to health,   University of exeter Medical school,   exeter, UKBackground:  This study assessed measurement properties of the 17-item Diabetes Inten - tion, Attitude, and Behavior Questionnaire (DIAB-Q), which measures intention to engage in  self-care behaviors, including following a diabetes diet and engaging in appropriate physical  activity.",Non-OADS,/arxiv_data1/oa_pdf/de/3d/ppa-10-213.PMC4778782.pdf
"Keywords:  diabetes, Theory of Planned Behavior, DIAB-Q, attitude, intention, behavior,  patient-reported outcome, questionnairecorrespondence: shana B Traina 700 route 202 s, raritan, nJ, 08869, UsA Tel +1 908 927 7759 Fax +1 908 253 3784 email straina@its.jnj.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Traina et al Running head recto: DIAB-Q to measure diabetes-related cognitions and behaviors DOI: http://dx.doi.org/10.2147/PPA.S94878",Non-OADS,/arxiv_data1/oa_pdf/de/3d/ppa-10-213.PMC4778782.pdf
Available from: http://people.umass.edu/aizen/pdf/tpb.measurement.,Non-OADS,/arxiv_data1/oa_pdf/de/3d/ppa-10-213.PMC4778782.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/de/3d/ppa-10-213.PMC4778782.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/aa/70/jmdh-9-097.PMC4778783.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/aa/70/jmdh-9-097.PMC4778783.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Journal of Multidisciplinary Healthcare 2016:9 97–102Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  97R E V I E W open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JMDH.S10120 8A review of analgesic and emotive breathing:   a multidisciplinary approach Bruno Bordoni1–3 Fabiola Marelli2,3 Giovannni Bordoni2,3 1Department of Cardiology, Santa  Maria Nascente IRCCS, Milan, Don  Carlo Gnocchi Foundation, Milan,   Italy; 2Department of Osteopathy,   Centre de recherche d’emploi du  Sud-Ouest (CRESO), Osteopathic  Centre for Research and Studies,   Falconara Marittima, Ancona, Italy;   3Department of  Osteopathy, Centre  de recherche d’emploi du Sud-Ouest  (CRESO), Osteopathic Centre for  Research and Studies, Castellanza,   Varese, Italy Correspondence: Bruno Bordoni   Department of Cardiology, Santa  Maria Nascente Institute IRCCS, Don  Carlo Gnocchi Foundation, via Alfonso  Capecelatro 66, Milan 20142, Italy   T el +39 2 349 630 0617   Email bordonibruno@hotmail.co mAbstract:  The diaphragm is the primary muscle involved in breathing and other  non-primarily respiratory functions such as the maintenance of correct posture and lumbar  and sacroiliac movement.",Non-OADS,/arxiv_data1/oa_pdf/aa/70/jmdh-9-097.PMC4778783.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/aa/70/jmdh-9-097.PMC4778783.pdf
Visit http://www.dove - press.com/testimonials.php to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/aa/70/jmdh-9-097.PMC4778783.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/84/11/dddt-10-885.PMC4778784.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 885–896Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  885Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9645 4The aqueous extract of Glycyrrhiza inflata  can  upregulate unfolded protein response-mediated  chaperones to reduce tau misfolding in cell models  of alzheimer’s disease Kuo-hsuan chang1,* i-cheng chen1,* hsuan-Yuan lin2 hsuan-chiang chen2 chih-hsin lin1 T e-hsien lin2 Yu-Ting Weng1 chih-Ying chao1 Yih-ru Wu1 Jung-Yaw lin2 guey-Jen lee-chen2 chiung-Mei chen1 1Department of neurology, chang  gung Memorial hospital, chang  gung University college of Medicine,   2Department of life science, national  Taiwan normal University, Taipei,   Taiwan, republic of china *These authors contributed equally  to this workBackground:  Alzheimer’s disease (AD) and several neurodegenerative disorders known as  tauopathies are characterized by misfolding and aggregation of tau protein.",Non-OADS,/arxiv_data1/oa_pdf/84/11/dddt-10-885.PMC4778784.pdf
"Keywords:  Alzheimer’s disease, tauopathy, tau misfolding, TCM extracts, G. inflata , UPR- mediated chaperones Introduction Several neurodegenerative disorders known as tauopathies, such as Alzheimer’s  disease (AD), frontotemporal dementia, progressive supranuclear palsy, and corti - cobasal degeneration, are characterized by abnormal aggregation of tau protein.1 In  these diseases, tau becomes abnormally hyperphosphorylated and misfolded, forming  insoluble aggregations.2 Such misfolded tau proteins are toxic to cells, particularly  neurons, and several lines of evidence have shown that these aberrant proteins are  responsible for neurodegeneration.2 Tau, mainly expressed in neurons, plays an important role in the constitution of  neuronal microtubule network by assembling tubulin monomers into microtubules.3 It  also provides links between microtubules and other cytoskeletal components.4 Under correspondence: guey-Jen lee-chen Department of life science, national  Taiwan normal University, 88  Ting-chou rd, sec 4, Taipei 11677,  Taiwan, republic of china Tel +886 2 7734 6359 Fax +886 2 2931 2904 email t43019@ntnu.edu.t w  chiung-Mei chen Department of neurology, chang  gung Memorial hospital, chang  gung University college of Medicine,  199 Tun-hwa north rd, Taipei 10507,  Taiwan, republic of china Tel +886 3 328 1200 Fax +886 3 328 7226 email cmchen@adm.cgmh.org.t w Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Chang et al Running head recto: Reduction of tau misfolding in cell models of Alzheimer’s disease  DOI: http://dx.doi.org/10.2147/DDDT.S96454",Non-OADS,/arxiv_data1/oa_pdf/84/11/dddt-10-885.PMC4778784.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/84/11/dddt-10-885.PMC4778784.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/84/11/dddt-10-885.PMC4778784.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a5/f2/ott-9-1011.PMC4778785.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1011–1021submit your manuscript | www.dovepress.co m Dove press  1011 http: //dx.doi.org/10.2147/OTT .S9373 8OncoTargets and Therapy Dove press Original researchopen access to scientific and medical research Open access Full T ext article Overexpression of livin promotes migration and  invasion of colorectal cancer cells by induction  of epithelial–mesenchymal transition via nF- κB  activation Yang ge1,2 Xiankui cao1 Dalu Wang3 Wei sun1 hongli sun1 Bing han1 Junpeng cui1 Baolin liu1 1The sixth Department of general  surgery, shengjing hospital of  china Medical University, shenyang,   2Department of general surgery,   general hospital Under the Fushun  Mining affairs Bureau, Fushun,   3The eighth Department of general  surgery, shengjing hospital of china  Medical University, shenyang, liaoning,   People’s republic of chinaAbstract:  Livin is a novel member of the inhibitors of apoptosis protein family and has been  implicated in the development and progression of colorectal cancer (CRC).",Non-OADS,/arxiv_data1/oa_pdf/a5/f2/ott-9-1011.PMC4778785.pdf
"More recently, Livin was correspondence: Baolin liu The sixth Department of general  surgery, shengjing hospital of china  Medical University, 36 sanhao street,  shenyang, liaoning 110004,   People’s republic of china email baolinliu716@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Ge et al Running head recto: Migration and invasion promotion of Livin on colorectal cancer cells DOI: http://dx.doi.org/10.2147/OTT.S93738",Non-OADS,/arxiv_data1/oa_pdf/a5/f2/ott-9-1011.PMC4778785.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/a5/f2/ott-9-1011.PMC4778785.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a5/f2/ott-9-1011.PMC4778785.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/50/2b/ott-9-1029.PMC4778786.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1029–1032submit your manuscript | www.dovepress.co m Dove press  1029 http: //dx.doi.org/10.2147/OTT .S9891 4Dove press Case repO rTopen access to scientific and medical research Open access Full T ext article Osseous oligometastases from thymic carcinoma:  a case report suggesting the effectiveness of  palliative-intent radiotherapy treatment Jumpei Kashima1 Hirotoshi Horio1 Yusuke Okuma1,2 Yukio Hosomi1 Tsunekazu Hishima3 1Department of Thoracic Oncology  and respiratory Medicine, Tokyo  Metropolitan Cancer and Infectious  Diseases Center Komagome Hospital,   T okyo, Japan; 2Division of Oncology,   research Center for Medical sciences,   Jikei University school of Medicine,   T okyo, Japan; 3Department of  pathology, Tokyo Metropolitan Cancer  and Infectious Diseases Center  Komagome Hospital, T okyo, JapanBackground:  Oligometastasis, a recently proposed concept, is defined as an intermediate state  of cancer, between localized and systemic disease, that may be well controlled by local ablative  treatment.",Non-OADS,/arxiv_data1/oa_pdf/50/2b/ott-9-1029.PMC4778786.pdf
"In a  single-institutional retrospective study of thymic carcinoma patients, we showed that  staging and grade of atypia are significant prognostic factors, and that surgical interven - tion is associated with better survival.8,9 We also found that the most common sites of Correspondence: Yusuke Okuma Department of Thoracic Oncology  and respiratory Medicine, Tokyo  Metropolitan Cancer and Infectious  Diseases Center Komagome Hospital,  3-18-22 Honkomagome, Bunkyo, Tokyo  113–8677, Japan Tel +81 3 3823 2101 Fax +81 3 3824 1552 email y-okuma@cick.j p Journal name: OncoTargets and Therapy Article Designation: Case report Y ear: 2016 Volume: 9 Running head verso: Kashima et al Running head recto: Oligometastases from recurrent thymic carcinoma DOI: http://dx.doi.org/10.2147/OTT.S98914",Non-OADS,/arxiv_data1/oa_pdf/50/2b/ott-9-1029.PMC4778786.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/50/2b/ott-9-1029.PMC4778786.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/50/2b/ott-9-1029.PMC4778786.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/55/11/ott-9-959.PMC4778787.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 959–976OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  959Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10049 9Clinical efficacy and safety of T -DM1 for patients  with HER2-positive breast cancer Bo Ma1 Qianqian Ma2 hongqiang Wang3 guolei Zhang1 huiying Zhang1 Xiaohong Wang1 1affiliated central hospital of huzhou  T eachers college, huzhou, Zhejiang,   People’s Republic of China; 2University  Hospital of T uebingen, T uebingen,   Germany; 3Department of Oncology,   hospital of Zhoushan, Zhoushan,   Zhejiang, People’s Republic of ChinaPurpose:  The aim of this study was to evaluate the therapeutic efficacy and safety of trastuzumab  emtansine (T-DM1) for the treatment of patients with human epidermal growth factor receptor  2-positive breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/55/11/ott-9-959.PMC4778787.pdf
"Trastuzumab correspondence: Xiaohong Wang Affiliated Central Hospital of Huzhou  Teachers college, no 198, hongqi  road, huzhou 313000, Zhejiang,  People’s Republic of China Tel +86 572 202 3301 Fax +86 572 202 3301 email dr_wangxiaohong@aliyun.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Ma et al Running head recto: Clinical efficacy and safety of T-DM1 DOI: http://dx.doi.org/10.2147/OTT.S100499",Non-OADS,/arxiv_data1/oa_pdf/55/11/ott-9-959.PMC4778787.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/55/11/ott-9-959.PMC4778787.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/55/11/ott-9-959.PMC4778787.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/39/35/ott-9-985.PMC4778788.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 985–991OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  985Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9617 6a comparative study of idarubicin 12 mg/m2  and 8 mg/m2 combined with cytarabine as the  first induction regimen for adult acute myeloid  leukemia patients li Zhou Xin liu huilan liu Weibo Zhu Xiaoyan cai Kaidi song changcheng Zheng Baolin Tang Zimin sun Department of hematology, anhui  Provincial hospital, hefei, anhui,   People’s republic of chinaObjective:  This study aimed to explore a suitable dose of idarubicin (IDA) combined with  cytarabine for the initial induction regimen for acute myeloid leukemia (AML) patients.",Non-OADS,/arxiv_data1/oa_pdf/39/35/ott-9-985.PMC4778788.pdf
"However, it remains unclear if the correspondence: Zimin sun Department of hematology, anhui  Provincial hospital, no 17 lujing road,  hefei, anhui, People’s republic of china Tel +86 136 0551 8126 Fax +86 551 6228 3306 email zmsun_vip@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Zhou et al Running head recto: Idarubicin 12 mg/m2 vs 8 mg/m2 DOI: http://dx.doi.org/10.2147/OTT.S96176",Non-OADS,/arxiv_data1/oa_pdf/39/35/ott-9-985.PMC4778788.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/39/35/ott-9-985.PMC4778788.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/39/35/ott-9-985.PMC4778788.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0f/f6/cia-11-255.PMC4778789.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 255–263Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  255ExpErt OpInIO nopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/CIA.S9790 8the Senior Living Lab: an example of nursing  leadership Susie riva-Mossman thomas Kampel Christine Cohen Henk Verloo School of nursing Sciences, La  Source, University of Applied Sciences  and Arts of Western Switzerland,   Lausanne, SwitzerlandAbstract:  The Senior Living Lab (SLL) is dedicated to the care of older adults and exemplifies  how nursing leadership can influence clinical practice by designing research models capable of  configuring interdisciplinary partnerships with the potential of generating innovative practices  and better older patient outcomes.",Non-OADS,/arxiv_data1/oa_pdf/0f/f6/cia-11-255.PMC4778789.pdf
"Many current attitudes to  aging were developed during the twentieth century when there were far fewer older  people and when social patterns were very different.6 These outdated conceptions  limit our capacity to identify the real challenges, and to seize the opportunities, of  population aging in the twenty-first century.5 We need to envision and develop new  models of aging that will help us create the future society in which we want to live.5 Correspondence: Susie riva-Mossman School of nursing Sciences, La Source,  University of Applied Sciences and Arts  of Western Switzerland, Lausanne,  30, Avenue Vinet, 1004 Lausanne,  Switzerland tel +41 21 641 3867 Fax +41 21 641 3810 Email su.riva@bluewin.c h Journal name: Clinical Interventions in Aging Article Designation: Expert Opinion Y ear: 2016 Volume: 11 Running head verso: Riva-Mossman et al Running head recto: Nursing leadership in interdisciplinary research DOI: http://dx.doi.org/10.2147/CIA.S97908",Non-OADS,/arxiv_data1/oa_pdf/0f/f6/cia-11-255.PMC4778789.pdf
Available from: http://www.seniorlivinglab.ch /.,Non-OADS,/arxiv_data1/oa_pdf/0f/f6/cia-11-255.PMC4778789.pdf
"Available from: http://www.grstiftung.ch/en.htm l. Accessed June 6,  2015.",Non-OADS,/arxiv_data1/oa_pdf/0f/f6/cia-11-255.PMC4778789.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/0f/f6/cia-11-255.PMC4778789.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/0f/f6/cia-11-255.PMC4778789.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6a/26/ott-9-1001.PMC4778790.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1001–1009OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1001Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S9399 5Orchestrating epigenetic roles targeting ocular  tumors Xuyang wen* Linna Lu* He Zhang Xianqun Fan Department of Ophthalmology,   Ninth People’s Hospital, Shanghai Jiao  T ong University School of Medicine,   Shanghai, People’s Republic of China *These authors contributed equally  to this workAbstract:  Epigenetics is currently one of the most promising areas of study in the field of  biomedical research.",Non-OADS,/arxiv_data1/oa_pdf/6a/26/ott-9-1001.PMC4778790.pdf
"Quantity of research  has been carried out to explore the relationship between ocular tumors and these  variations.6–8 These findings are explained in further detail below.Correspondence: He Zhang; Xianqun Fan Department of Ophthalmology, Ninth  People’s Hospital, Shanghai Jiao Tong  University School of Medicine, Shanghai,  200025, People’s Republic of China email zhanghe@sjtu.edu.c n;  drfanxianqun@126.co m Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2016 Volume: 9 Running head verso: Wen et al Running head recto: Orchestrating epigenetic roles targeting ocular tumors DOI: http://dx.doi.org/10.2147/OTT.S93995",Non-OADS,/arxiv_data1/oa_pdf/6a/26/ott-9-1001.PMC4778790.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/6a/26/ott-9-1001.PMC4778790.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6a/26/ott-9-1001.PMC4778790.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/75/37/tcrm-12-313.PMC4778791.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 313–325Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  313Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S7803 9Clinical utility of nivolumab in the treatment of  advanced melanoma Ramsey Asmar1 Jessica Yang1 Richard D Carvajal1,2 1Department of Medicine, College  of Physicians and Surgeons, 2Herbert  irving Comprehensive Cancer Center,   Columbia University, New Y ork,   NY, USAAbstract:  Melanomas are highly immunogenic tumors that evade the immune system by exploiting  innate checkpoint pathways, rendering effector T-cells anergic.",Non-OADS,/arxiv_data1/oa_pdf/75/37/tcrm-12-313.PMC4778791.pdf
"Systemic chemotherapy has been the mainstay of treatment Correspondence: Richard D Carvajal Herbert irving Comprehensive Cancer  Center, Columbia University, 177 Fort  washington Avenue, MHB 6GN-435,  New York, NY 10032, USA Tel +1 646 317 6330 email rdc2150@cumc.columbia.ed u Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2016 Volume: 12 Running head verso: Asmar et al Running head recto: Nivolumab therapy for advanced melanoma DOI: http://dx.doi.org/10.2147/TCRM.S78039",Non-OADS,/arxiv_data1/oa_pdf/75/37/tcrm-12-313.PMC4778791.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/75/37/tcrm-12-313.PMC4778791.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/75/37/tcrm-12-313.PMC4778791.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ad/ca/dddt-10-873.PMC4778792.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 873–884submit your manuscript | www.dovepress.co m Dove press  873 http: //dx.doi.org/10.2147/DDDT .S9345 9Dove press Reviewopen access to scientific and medical research Open Access Full T ext Article Spotlight on lenvatinib in the treatment of thyroid  cancer: patient selection and perspectives Ricardo Costa1 Benedito A Carneiro1,2 Sunandana Chandra1,2 Sachin G Pai1 Y oung Kwang Chae1,2 Jason B Kaplan1,2 Hannah B Garrett1 Mark Agulnik1,2 Peter A Kopp3 Francis J Giles1,2 1Northwestern Medicine  Developmental Therapeutics institute,   Robert H Lurie Comprehensive  Cancer Center of Northwestern  University, 2Division of Hematology  and Oncology, Feinberg School of  Medicine, 3Division of endocrinology,   Metabolism, and Molecular Medicine,   Feinberg School of Medicine,   Northwestern University, Chicago,   iL, USAAbstract:  Thyroid cancer is the most common endocrine malignancy, with over 60,000 cases  reported per year in the US alone.",Non-OADS,/arxiv_data1/oa_pdf/ad/ca/dddt-10-873.PMC4778792.pdf
"These subtypes account for  90%–95% of all cases and are collectively referred to as differentiated thyroid cancers  (DTCs).3 In general, these are indolent tumors associated with a favorable prognosis as  reflected by long-term survival rates of ~90% with standard treatments of surgery and  radioactive iodine therapy.4 Nevertheless, patients who develop recurrent or metastatic  radioactive iodine refractory disease have 10-year survival rates of only 15%–20%.5 Before the advent of targeted therapies, chemotherapy was the only option for the  treatment of patients with advanced thyroid cancer of follicular origin refractory to  radioactive iodine.6 Doxorubicin (with its known cardiac and hematologic toxicities)  alone or in combination with other compounds formed the backbone of palliative Correspondence: Ricardo Costa Northwestern Medicine Developmental  Therapeutics institute, Robert H Lurie  Comprehensive Cancer Center of  Northwestern University, 233 east  Superior Street, Olson Pavilion, Chicago,  iL 60611, USA Tel +1 312 472 1234 Fax +1 312 472 0564 email ricardo.costa@northwestern.ed u Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Costa et al Running head recto: Lenvatinib for the treatment of advanced thyroid cancer DOI: http://dx.doi.org/10.2147/DDDT.S93459",Non-OADS,/arxiv_data1/oa_pdf/ad/ca/dddt-10-873.PMC4778792.pdf
"Available from: http://www.nccn.org/ professionals /physician_gls/pdf/thyroid.pd f. Accessed December 20,  2015.",Non-OADS,/arxiv_data1/oa_pdf/ad/ca/dddt-10-873.PMC4778792.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/ad/ca/dddt-10-873.PMC4778792.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/ca/dddt-10-873.PMC4778792.pdf
"METHODS The methods used in this article have been de- scribed in detail in a previous study by the authors of this article 14 and are described here briefly.Data	Collection By using data from the Blue-Ridge Institute for  Medical Research (http://www.brimr.org/), the  top 50 university-based and 5 hospital-based depart- ments of surgery based on the NIH funding were  identified.",OADS,/arxiv_data1/oa_pdf/20/47/gox-4-e614.PMC4778885.pdf
Two independent sourc- es of NIH funding information were used: the NIH  Research Portfolio Online Reporting Tools database  and the Grantome online database (http://www.grantome.com/).,OADS,/arxiv_data1/oa_pdf/20/47/gox-4-e614.PMC4778885.pdf
Available at: http://www.bumc.bu.edu/facdev-med-icine/key-documents/appointments-and-promotions/.,Non-OADS,/arxiv_data1/oa_pdf/20/47/gox-4-e614.PMC4778885.pdf
"This is available in the “Related  Videos” section of the Full-Text article on PRSGlobalO- pen.com or available at http://links.lww.com/PRSGO/ A165; see Video 2, Supplemental Digital Content 2,   which demonstrates an 1-year follow-up after subto-tal lower lip resection and reconstruction by means of Stein’s double cross-lip flaps and a Johansons’s step  technique.",Non-OADS,/arxiv_data1/oa_pdf/2c/d2/gox-4-e615.PMC4778886.pdf
This is available in the “Related Videos” sec-tion of the Full-Text article on PRSGlobalOpen.com or available at http://links.lww.com/PRSGO/A166.,Non-OADS,/arxiv_data1/oa_pdf/2c/d2/gox-4-e615.PMC4778886.pdf
This is available in the “Related Videos” section of the Full-Text article on PRSGlobalOpen.com or available at   http://links.lww.com/PRSGO/A165).,Non-OADS,/arxiv_data1/oa_pdf/2c/d2/gox-4-e615.PMC4778886.pdf
this is available in the “Related Videos” section of  the Full- text article on PRSglobalOpen.com or available at   http://links.lww.com/PRSGO/A165.,Non-OADS,/arxiv_data1/oa_pdf/2c/d2/gox-4-e615.PMC4778886.pdf
this is available in the “Related Videos” sec - tion of the Full- text article on PRSglobalOpen.com or avail- able at http://links.lww.com/PRSGO/A166.,Non-OADS,/arxiv_data1/oa_pdf/2c/d2/gox-4-e615.PMC4778886.pdf
This is available in the “Related Videos” section of the Full-Text article on PRSGlobalOpen.com or available at http://links.lww.com/PRSGO/A166).,Non-OADS,/arxiv_data1/oa_pdf/2c/d2/gox-4-e615.PMC4778886.pdf
t his  is available in the “Related Videos” section of the Full- text ar - ticle on PRSglobalOpen.com or available at http://links.lww.,Non-OADS,/arxiv_data1/oa_pdf/2c/d2/gox-4-e615.PMC4778886.pdf
"Full face allograft harvest with periorbital contents  is described in Supplemental Digital Content 1, which describes full face allograft harvest with periorbital  contents (http://links.lww.com/PRSGO/A167).",Non-OADS,/arxiv_data1/oa_pdf/80/bf/gox-4-e628.PMC4778899.pdf
Available at: http://www.fda.gov/downloads/advisory committees/comitteesmeetingmaterials/drugs/arthritisdrugadviso-rycommittee/ucm182015.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8a/5a/gox-4-e629.PMC4778900.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ Correspondence to: Arunabh Talwar, MD, FCCP, Department of Pulmonary, Critical Care and Sleep Medicine, North Shore - LIJ  Health System, 410 Lakeville Rd.",Non-OADS,/arxiv_data1/oa_pdf/a8/f1/nihms729866.PMC4778975.pdf
The data were analyzed in Stata 11 ICand in the free program WinPepi available from http://www.brix-tonhealth.com/pepi4windows.html.,OADS,/arxiv_data1/oa_pdf/8c/4b/medi-95-e2368.PMC4778989.pdf
"We also searched ClinicalTrials.gov (https://clinicaltrials.gov/), Euro- pean Union Clinical Trials Register (https://www.clinicaltrials-register.eu/), and 4 main Chinese literature databases, that is,Wan Fang, VIP, China National Knowledge Infrastructure, and SinoMed.",OADS,/arxiv_data1/oa_pdf/8a/4e/medi-95-e2562.PMC4778993.pdf
Available at: ftp://ftp.fao.org/es/esn/food/wgreport2.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8a/4e/medi-95-e2562.PMC4778993.pdf
Available at: ftp://ftp.fao.org/es/esn/food/ wgreport2.pdf.,Non-OADS,/arxiv_data1/oa_pdf/be/a7/medi-95-e2581.PMC4778994.pdf
"The detailed selection code used inSEER /C3Stat Software were attached (Supplementary File 1, http://links.lww.com/MD/A657).",OADS,/arxiv_data1/oa_pdf/62/e3/medi-95-e2593.PMC4778995.pdf
"HR /C0/HER2 þpatients were more likely to have grade III (71.4% vs 21.7%), T2 (45.6%vs 28.2%), node-positive (37.9% vs 26.8%), or stage II–III (56.7% vs 37.9%) diseases than HR þ/HER2 /C0patients (Supple- mentary Table 1, http://links.lww.com/MD/A657).TABLE 1.",Non-OADS,/arxiv_data1/oa_pdf/62/e3/medi-95-e2593.PMC4778995.pdf
"We also noticed that age, race, county type, grade, primary site, T-stage, N-stage, and AJCC stage were significantly associated with BCS in univariate analyses (Supplementary Table 2, http://links.lww.com/MD/A657).",OADS,/arxiv_data1/oa_pdf/62/e3/medi-95-e2593.PMC4778995.pdf
"Bethesda, MD, http://seer.cancer.gov/csr/1975_2010/, based on November 2012 SEER data submission, posted to the SEER website, April 2013.",Non-OADS,/arxiv_data1/oa_pdf/62/e3/medi-95-e2593.PMC4778995.pdf
"2015; Version 2, http://www.nccn.org.",Non-OADS,/arxiv_data1/oa_pdf/62/e3/medi-95-e2593.PMC4778995.pdf
http://www.allergy.or.kr/file/150527_01.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d8/2a/medi-95-e2609.PMC4778996.pdf
Available from: http://www.nccn.org/.,Non-OADS,/arxiv_data1/oa_pdf/67/5b/medi-95-e2751.PMC4779000.pdf
Hospice Palliative Care Act 2013. http://law.moj.gov.tw/LawClass/LawAll.aspx?PCode ¼L0020066.,Non-OADS,/arxiv_data1/oa_pdf/f7/24/medi-95-e2782.PMC4779004.pdf
The trial program of hospice inpatient care of National Health Insurance Taipei 2004.http://www.nhi.gov.tw.,Non-OADS,/arxiv_data1/oa_pdf/f7/24/medi-95-e2782.PMC4779004.pdf
http://grbsearch.stpi.narl.org.tw/GRB_Search/grb/show_doc.jsp?id ¼2935101&q ¼ /C3%3A/C3.,Non-OADS,/arxiv_data1/oa_pdf/f7/24/medi-95-e2782.PMC4779004.pdf
"2015;2015:12Article ID 765921, http://dx.doi.org/10.1155/2015/765921.Medicine /C15Volume 95, Number 8, February 2016 Left Ventricular Diastolic Dysfunction in Hypertensive Adolescents Copyright #2016 Wolters Kluwer Health, Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/fa/eb/medi-95-e2820.PMC4779008.pdf
Available at: http://www.improvement.nh-s.uk/documents/er_better_journey.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b9/f0/medi-95-e2835.PMC4779010.pdf
"Meta-Analysis As for the meta-analysis, 77 papers were excluded,12,14–16, 20–23,26–31,33–39,41,43–47,49–51,53–55,57–60,63,64,66,68–73,75,78,79,81–83,85,86,88–90,92,93,95,96,99–101,103,105,106,113,114,118,120–124,126,128 because 76 studies were lacking of relevant data12,14–16,20–23,26– 31,33–39,41,43–47,49–51,53–55,57–59,63,64,66,68–73,75,78,79,81–83,85–86, 88–90,92,93,95,96,99–101,103,105,106,113,114,118,120–124,126,128and 1 study had the endpoint unrelated to the prognosis.60Finally, 42 papers were included (Figure 1).10,11,13,17–19,24,25,32, 40,42,48,52,56,61–63,67,74,76,77,80,84,87,91,94,97,98,102,104,107–112,115–117, 119,125,127Data extracted from these papers were summarized in Supplementary Table 1, http://links.lww.com/MD/A716.",Non-OADS,/arxiv_data1/oa_pdf/f7/6f/medi-95-e2877.PMC4779019.pdf
The sample size ofthe study was calculated using a free software (http://www.statpages.org/#Power) based on a pilot study.,OADS,/arxiv_data1/oa_pdf/6e/6a/medi-95-e2880.PMC4779021.pdf
These specific subject datasets are including all the inpatientinformation of Taiwan residents from 1996 to 2011 (source: http://nhird.nhri.org.tw/en/Data_Subsets.html).,OADS,/arxiv_data1/oa_pdf/00/00/medi-95-e2883.PMC4779022.pdf
Available at: http://www.censusdata.abs.gov.au/census_services/getproduct/census/2011.,OADS,/arxiv_data1/oa_pdf/09/c9/medi-95-e2885.PMC4779023.pdf
"Available at: http://www.bom.gov.au/climate/current/annual/nt/summary.shtml, Accessed3 August, 2015 17.",Non-OADS,/arxiv_data1/oa_pdf/09/c9/medi-95-e2885.PMC4779023.pdf
"The fixed costs of setting up a facility for precutting includecosts for a Moria Evolution 3 Console, Moria ALTK artificial chamber, turbine, hose, 300 and 350 head, storage trays, eye bank refrigerator, slit-lamp biomicroscope, specular micro-scope, ultrasound pachymeter, laminar flow hood, small boxfreezer, instruments, autoclave, trolley, nitrogen tank, nitrogen stand, regulator, and hose (appendix 1, supplemental digital content, http://links.lww.com/MD/A721).",Non-OADS,/arxiv_data1/oa_pdf/5f/01/medi-95-e2887.PMC4779024.pdf
"(Refer to Appendix 1, supplemental content, http://links.lww.com/MD/A721, for details on facility costs of surgeon-cut, setup precut an d purchase precut strategies).",Non-OADS,/arxiv_data1/oa_pdf/5f/01/medi-95-e2887.PMC4779024.pdf
"(Refer to Appendix 2, supplemental content, http://links.lww.com/MD/A721, for details on comparison o f procedural costs for DSAEK & phaco/DSAEK).Medicine /C15Volume 95, Number 8, February 2016 Cost-Minimization of Precut Cornea in Endothelial Keratoplasty Copyright #2016 Wolters Kluwer Health, Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/5f/01/medi-95-e2887.PMC4779024.pdf
"Sensitivity Ranges/C3 Variable Base Value Sensitivity Range Set of full ALTK $80,000 $40,000–$120,000 Number of cases 164 82–246Cost of each cornea $3000 $1500–$4500 Surgeon and ambulatory surgical fees Precut DSAEK $7904 $3952–$11,856Precut phaco/DSAEK $11,051 $5526–$16,577 Surgeon-cut DSAEK $10,160 $5080–$15,240 Surgeon-cut phaco/DSAEK $12,660 $6330–$18,990 ALTK ¼automated lamellar therapeutic keratoplasty, DSAEK ¼Descemet stripping automated endothelial keratoplasty./C3Refer to Appendix 3, supplemental content, http://links.lww.com/MD/A721, on details of sensitivity ranges and cost evaluation for 5 years.Yong et al Medicine /C15Volume 95, Number 8, February 2016 6|www.md-journal.com Copyright #2016 Wolters Kluwer Health, Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/5f/01/medi-95-e2887.PMC4779024.pdf
"For the ease of measurement, we stacked images1,3,5,7 using Image J software ( http://imagej.net/Welcome ).",OADS,/arxiv_data1/oa_pdf/c6/4b/JIPB-57-757.PMC4779058.pdf
"For shade treatment, seedlings were ﬁrst grown in Wc (66mmol m /C02s/C01) for 5 d, they were then transferred to simulated shade (Red: 13 mmol m/C02s/C01, Blue: 3.5 mmol m/C02s/C01, Far red: 21 mmol m/C02s/C01) and grew for 3 d. Hypocotyls of dark grown seedlings were measured after seedlings weregrown in the dark for 3.0 /C03.5 d. Quantitative measurements of hypocotyls were performed on scanned images (100%original size for hypocotyl length measurement and 400%enlarged images for hypocotyl width measurement) ofseedlings using scion image software ( http://www.scioncorp.",Non-OADS,/arxiv_data1/oa_pdf/c6/4b/JIPB-57-757.PMC4779058.pdf
"We scanned eight images (Zeiss LSM 780, 63 /C2oil immersion objective) with 3.5 s interval, and images 1, 3, 5 and 7 werestacked using Image J ( http://rsb.info.nih.gov/ij/ ).",OADS,/arxiv_data1/oa_pdf/c6/4b/JIPB-57-757.PMC4779058.pdf
"http://www.mhtf.org/wp-content/uploads/sites/32/2014/09/HSPH- Tanzania5.pdf, accessed 4 March 2015.",Non-OADS,/arxiv_data1/oa_pdf/82/b0/czv054.PMC4779143.pdf
"https://www.healthresearchweb.org/ﬁles/Tanzania%20National%20Health%20Policy%202003.pdf, accessed 2 March 2015.",Non-OADS,/arxiv_data1/oa_pdf/82/b0/czv054.PMC4779143.pdf
"http://www.who.int/reproductivehealth/publications/mater nal_perinatal_health/effective_antenatal_care.pdf, accessed 4 November 2014.",Non-OADS,/arxiv_data1/oa_pdf/82/b0/czv054.PMC4779143.pdf
"314 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/29/84/czv060.PMC4779144.pdf
"http://www.mohp.gov.np/english/ﬁles/news_events/5-1-National-Policy- on-Traditional-Medicine.pdf,accessed 25 October 2013.",Non-OADS,/arxiv_data1/oa_pdf/29/84/czv060.PMC4779144.pdf
"http://curis.ku.dk/ws/ ﬁles/125231441/IFRO_Documentation_2014_4.pdf, accessed 21 November 2014.",Non-OADS,/arxiv_data1/oa_pdf/29/84/czv060.PMC4779144.pdf
"http://apps.who.int/ medicinedocs/pdf/h2943e/h2943e.pdf, accessed 25 October 2014. WHO.",Non-OADS,/arxiv_data1/oa_pdf/29/84/czv060.PMC4779144.pdf
http://apps.who.int/medicinedocs/documents/s19582en/s19582en.,Non-OADS,/arxiv_data1/oa_pdf/29/84/czv060.PMC4779144.pdf
"Data available from http://data.worldbank.org/country/nepal, accessed 1 November 2014.",OADS,/arxiv_data1/oa_pdf/29/84/czv060.PMC4779144.pdf
"http://jhpiego.pk/site/wp-con- tent/uploads/2015/01/IID_QoC_SA_16-19Sept13.pdf, accessed 26 January2015.",Non-OADS,/arxiv_data1/oa_pdf/e7/95/czv065.PMC4779145.pdf
"http://www.reproductive-health-journal.com/content/8/1/40, accessed 26 January 2015.",Non-OADS,/arxiv_data1/oa_pdf/e7/95/czv065.PMC4779145.pdf
"http://jhpiego.pk/site/annual-household-survey/mch13/, accessed 15 January 2015.",OADS,/arxiv_data1/oa_pdf/e7/95/czv065.PMC4779145.pdf
"http://esa.un.org/unpd/wpp/index.htm, accessed 27 January 2015.",Non-OADS,/arxiv_data1/oa_pdf/e7/95/czv065.PMC4779145.pdf
"http://www.trfpakistan.org/LinkClick.aspx?ﬁle ticket¼0WOWUr-6vQI%3D&tabid ¼2618, accessed 1 May 2015.",Non-OADS,/arxiv_data1/oa_pdf/e7/95/czv065.PMC4779145.pdf
PLoS One http://journals.plos.org/plosone/article?id ¼10.,Non-OADS,/arxiv_data1/oa_pdf/e7/95/czv065.PMC4779145.pdf
"356 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d0/fc/czv069.PMC4779147.pdf
"377 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5f/bd/czv076.PMC4779148.pdf
http://www.jhuccp.org/sites/all/ﬁles/4.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5f/bd/czv076.PMC4779148.pdf
http://www.measuredhs.com/What-We-Do/Survey- Types/SPA.cfm.,OADS,/arxiv_data1/oa_pdf/5f/bd/czv076.PMC4779148.pdf
Political declaration on HIV/AIDS: intensifying our efforts to eliminate HIV/AIDS.. http://www.unaids.org/en/aboutunaids/ unitednationsdeclarationsandgoals/2011highlevelmeetingonaids/.,Non-OADS,/arxiv_data1/oa_pdf/5f/bd/czv076.PMC4779148.pdf
Available at http://ww.un.org/millenniumgoals/ pdf/report-2013/mdg-report-2013-english.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5f/bd/czv076.PMC4779148.pdf
"Global report: UNAIDS Report on the Global AIDS Epidemic 2012. http://www.unaids.org/en/resources/publications/2012/ name, 76121,en.asp.",Non-OADS,/arxiv_data1/oa_pdf/5f/bd/czv076.PMC4779148.pdf
"World Health Organization, http://www.who.int/healthinfo/systems/sara_introduction/en/.",Non-OADS,/arxiv_data1/oa_pdf/5f/bd/czv076.PMC4779148.pdf
WHO 2013. http://apps.who.int/gho/data/view.main.22100.,OADS,/arxiv_data1/oa_pdf/5f/bd/czv076.PMC4779148.pdf
"Global HIV/AIDS response: epidemic update and health sector progress towards Universal Access Progress Report 2011. http://www.who.int/hiv/pub/progress_report2011/en/.Health Policy and Planning , 2016, Vol.",Non-OADS,/arxiv_data1/oa_pdf/5f/bd/czv076.PMC4779148.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International  License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original  work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/8a/d2/hepatmon-15-12-32918.PMC4779190.pdf
"Oncocytomas activate 5 ′  adenosine monophosphate-activated protein kinase (AMPK) and Tp53 (p53) and display  disruption of Golgi and autophagy/lysosome trafficking, events attributed to defective  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/88/03/nihms762760.PMC4779191.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, two figures, and twelve tables and can be found with this  article online at http://dx.doi.org/10.1016/j.celrep.2015.10.059 .",OADS,/arxiv_data1/oa_pdf/88/03/nihms762760.PMC4779191.pdf
"Identification of Two Main Subtypes of Renal Oncocytoma (A) Copy-number variations in renal oncocytomas in comparison to eosinophilic ChRCC  (eosinophilic ChRCC sequencing data were downloaded from the TCGA CGHub repository  [https://cghub.ucsc.edu/ ]) (Davis et al., 2014 ).",OADS,/arxiv_data1/oa_pdf/88/03/nihms762760.PMC4779191.pdf
(B) Somatic mutations in renal oncocytomas in comparison to ChRCC (ChRCC sequencing  data were downloaded from the TCGA CGHub repository [ https://cghub.ucsc.edu/ ]) (Davis Joshi et al.,OADS,/arxiv_data1/oa_pdf/88/03/nihms762760.PMC4779191.pdf
Each graph represents the top 15 canonical pathways  enriched for the corresponding gene set ( http://www.ingenuity.com/ ).,OADS,/arxiv_data1/oa_pdf/88/03/nihms762760.PMC4779191.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International  License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original  work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/19/1d/hepatmon-15-12-33626.PMC4779251.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International  License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original  work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/c1/1f/hepatmon-15-12-26407.PMC4779252.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International  License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original  work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/25/50/hepatmon-15-12-33710.PMC4779253.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International  License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original  work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/24/4e/hepatmon-15-12-35238.PMC4779254.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.TISSUE ENGINEERING: Part A Volume 22, Numbers 3 and 4, 2016 Mary Ann Liebert, Inc.DOI: 10.1089/ten.tea.2015.0316 244",Non-OADS,/arxiv_data1/oa_pdf/01/93/ten.tea.2015.0316.PMC4779276.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use, d is- tribution, and reproduction in any medium, provided the original author(s) and the source are credited.JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY Volume 26, Number 1, 2016Mary Ann Liebert, Inc.Pp.",Non-OADS,/arxiv_data1/oa_pdf/9e/d2/cap.2015.0126.PMC4779282.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.",Non-OADS,/arxiv_data1/oa_pdf/10/c2/hum.2016.007.PMC4779296.pdf
http://europa.eu/rapid/ press-release_MEMO-14–254_en.htm122.,Non-OADS,/arxiv_data1/oa_pdf/10/c2/hum.2016.007.PMC4779296.pdf
http://ec.europa.eu/health/ﬁles/adv therapies/2015_pc/publ_cons_doc_2015.pdf 126.,Non-OADS,/arxiv_data1/oa_pdf/10/c2/hum.2016.007.PMC4779296.pdf
http://ec.europa.eu/health/ﬁles/eudralex/vol-1/reg_2007_1394/reg_2007_1394_en.pdf 128.,Non-OADS,/arxiv_data1/oa_pdf/10/c2/hum.2016.007.PMC4779296.pdf
http://ec.europa.eu/health/ﬁles/committee/stamp/2015–10_stamp3/stamp_3_ 16_3b_guideline_on_accelerated_assessment_ -_public_consultation.pdf 129.,Non-OADS,/arxiv_data1/oa_pdf/10/c2/hum.2016.007.PMC4779296.pdf
"This is an OpenAccess article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/ licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of thework, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/38/3b/jiv427.PMC4779300.pdf
"This is an Open Access article distributed under the terms of the Creative CommonsAttribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/50/8d/jiv757.PMC4779307.pdf
http://www.who.int/tb/en/ .,Non-OADS,/arxiv_data1/oa_pdf/50/8d/jiv757.PMC4779307.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/9a/48/num-08-01-33571.PMC4779308.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/d7/69/num-08-01-34017.PMC4779309.pdf
Available from:  https://web.emmes.com/.,Non-OADS,/arxiv_data1/oa_pdf/d7/69/num-08-01-34017.PMC4779309.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/5b/cc/num-08-01-29967.PMC4779310.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/55/cf/rjw007.PMC4779317.pdf
"2016 Feb; 70(1): 57-60 Received: November 15th 2015 | Accepted: January  05th 2016 © 2016 Koorosh Ahmadi, Amir Masoud  Hashemian, Ehsan Bolvardi, Peyman Khadem Hosseini This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Published online: 31/01/2016 Published print: 02/2016",Non-OADS,/arxiv_data1/oa_pdf/cb/2f/MA-70-57.PMC4779343.pdf
"2016 Feb; 70(1): 39-43 Received: August 25th 2015 | Accepted: October 05th  2015 © 2016 Mithad Hajder, Elmira Hajder,  Amela Husic This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Published online: 31/01/2016 Published print: 02/2016",Non-OADS,/arxiv_data1/oa_pdf/47/7b/MA-70-39.PMC4779344.pdf
http://orcid.org/0000-0003-2393-7990.,Non-OADS,/arxiv_data1/oa_pdf/1b/ce/MA-70-79.PMC4779346.pdf
"2016 Feb; 70(1): 79-81 Received: December 09th 2015 | Accepted: January  11th 2016 © 2016 Mete Akin, Tolga Yalcinkaya,  Erhan Alkan, Gokhan Arslan, Yasar Tuna, Bulent Yildirim This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Published online: 31/01/2016 Published print: 02/2016",Non-OADS,/arxiv_data1/oa_pdf/1b/ce/MA-70-79.PMC4779346.pdf
"2016 Feb; 70(1): 61-65 Received: October 25th 2015 | Accepted: December  25th 2015 © 2016 Nabi Fatahi, Ferid Krupic This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Published online: 31/01/2016 Published print: 02/2016",Non-OADS,/arxiv_data1/oa_pdf/10/c6/MA-70-61.PMC4779347.pdf
"2016 Feb; 70(1): 35-38 Received: September 24th 2015 | Accepted: November  30th 2015 © 2016 Mohsen Soroush, Mahmood  Mominzadeh, Younes Ghelich, Soosan Soroosh, Morteza Aghajanpoor Pasha This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Published online: 31/01/2016 Published print: 02/2016",Non-OADS,/arxiv_data1/oa_pdf/d9/ae/MA-70-35.PMC4779348.pdf
ORCID ID:  http://orcid.org/0000-0003-2313-9008 .,OADS,/arxiv_data1/oa_pdf/8b/2a/MA-70-31.PMC4779349.pdf
"2016 Feb; 70(1): 31-34 Received: October 25th 2015 | Accepted: December  25th 2015 © 2016 Emina Kiseljakovic, Mirela  Mackic-Djurovic, Sabaheta Hasic, Amela Beciragic, Amina Valjevac, Lejla Alic, Halima Resic This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Published online: 31/01/2016 Published print: 02/2016",Non-OADS,/arxiv_data1/oa_pdf/8b/2a/MA-70-31.PMC4779349.pdf
ORCID ID: http://orcid.org/0000-0002-0178-7066.,OADS,/arxiv_data1/oa_pdf/58/62/MA-70-44.PMC4779350.pdf
"2016 Feb; 70(1): 44-47 Received: November 24th 2015 | Accepted: January  16th 2015 © 2016 Ramadan Dacaj, Sebija  Izetbegovic, Goran Stojkanovic, Skender Dresha This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Published online: 31/01/2016 Published print: 02/2016",Non-OADS,/arxiv_data1/oa_pdf/58/62/MA-70-44.PMC4779350.pdf
Phone: +385 21 556 599; ORCID ID:  http://orcid.org/0000-0002-1002-938X .,Non-OADS,/arxiv_data1/oa_pdf/a2/dd/MA-70-69.PMC4779351.pdf
"2016 Feb; 70(1): 69-71 Received: November 25th 2015 | Accepted: December  28th 2015 © 2016 Anka Aleksic-Shihabi, Eni  Jadrijevic, Nina Milekic, Ana Repic Bulicic, Marina Titlic, Enra Suljic This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Published online: 31/01/2016 Published print: 02/2016",Non-OADS,/arxiv_data1/oa_pdf/a2/dd/MA-70-69.PMC4779351.pdf
"2016 Feb; 70(1): 72-75 Received: December 20th 2015 | Accepted: January  18th 2016 © 2016 Vesna Cukic This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Published online: 31/01/2016 Published print: 02/2016",Non-OADS,/arxiv_data1/oa_pdf/66/23/MA-70-72.PMC4779352.pdf
"INSTRUCTIONS FOR THE AUTHORS All papers need to be sent to: Editorial board of the journal Mat Soc Med, elec - tronically over the web site http://scopemed.org/?jid=16.",Non-OADS,/arxiv_data1/oa_pdf/66/23/MA-70-72.PMC4779352.pdf
"2016 Feb; 70(1): 82-82 Received: January 05th 2016 | Accepted: January  15th  2016 © 2016 Francis Roger France This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9a/15/MA-70-82.PMC4779353.pdf
"2016 Feb; 70(1): 76-78 Received: December 05th 2015 | Accepted: January  15th 2016 © 2016 Hakan Demirtaş, Ahmet Orhan  Çelik, Mustafa Kayan, Ayşe Umul1, İsa Döngel This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Published online: 31/01/2016 Published print: 02/2016",Non-OADS,/arxiv_data1/oa_pdf/17/66/MA-70-76.PMC4779354.pdf
ORCID  ID: http://orcid.org/0000-0001-9148-1230 .,OADS,/arxiv_data1/oa_pdf/a2/1e/MA-70-66.PMC4779355.pdf
"2016 Feb; 70(1): 66-68 Received: November 29th 2015 | Accepted: January  11th 2016 © 2016 Radojka Bijelic, Snjezana  Milicevic, Jagoda Balaban This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Published online: 31/01/2016 Published print: 02/2016",Non-OADS,/arxiv_data1/oa_pdf/a2/1e/MA-70-66.PMC4779355.pdf
ORCID ID: http://orcid.org/0000-0002- 9080-5456.,OADS,/arxiv_data1/oa_pdf/e0/22/MA-70-4.PMC4779356.pdf
"2016 Feb; 70(1): 4-17 Received: December 25th 2015 | Accepted: January  15th 2016 © 2016 Izet Masic This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e0/22/MA-70-4.PMC4779356.pdf
ORCID ID: http://orcid.org/0000-0003-0036-5002 .,OADS,/arxiv_data1/oa_pdf/06/09/MA-70-27.PMC4779357.pdf
"2016 Feb; 70(1): 27-30 Received: August 25th 2015 | Accepted: October 05th  2015 © 2016 Amina Selimovic, Ermina Mujicic,  Selma Milisic, Tanja Pejicic, Milan Rancic, Senka Mesihovic-Dinarevic, Lada Lukic-Bilela, Mahir Moro This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Published online: 31/01/2016 Published print: 02/2016",Non-OADS,/arxiv_data1/oa_pdf/06/09/MA-70-27.PMC4779357.pdf
ORCID ID: http://orcid.org/0000-0002-8922-9041.,OADS,/arxiv_data1/oa_pdf/02/b9/MA-70-48.PMC4779358.pdf
"2016 Feb; 70(1): 48-52 Received: November 25th 2015 | Accepted: January  05th 2016 © 2016 Dzanela Prohic, Rusmir Mesihovic,  Nenad Vanis, Amra Puhalovic This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Cirrhosis, Prognostic Parameters, Mortality Published online: 31/01/2016 Published print: 02/2016",Non-OADS,/arxiv_data1/oa_pdf/02/b9/MA-70-48.PMC4779358.pdf
"2016 Feb; 70(1): 53-56 Received: November 28th 2015 | Accepted: January  06th 2016 © 2016 Ali Yeganeh, Roozbeh Taghavi,  Mehdi Moghtadaei This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Published online: 31/01/2016 Published print: 02/2016",Non-OADS,/arxiv_data1/oa_pdf/7b/67/MA-70-53.PMC4779359.pdf
ORCID ID: http://orcid.org/0000-0002- 9080-5456.,OADS,/arxiv_data1/oa_pdf/50/20/MA-70-18.PMC4779360.pdf
"2016 Feb; 70(1): 18-26 Received: December 30th 2015 | Accepted: January  25th 2016 © 2016 Izet Masic, Edin Begic, Lejla Zunic This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Published online: 31/01/2016 Published print: 02/2016",Non-OADS,/arxiv_data1/oa_pdf/50/20/MA-70-18.PMC4779360.pdf
"Retrieved December 24, 2015, from  http://www.scimagojr.com .",Non-OADS,/arxiv_data1/oa_pdf/50/20/MA-70-18.PMC4779360.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/e0/9b/num-08-01-33240.PMC4779587.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/5b/a7/num-08-01-33180.PMC4779590.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6f/e8/evv256.PMC4779604.pdf
"To verify and complete the annotation of the plastid genome, DOGMA ( http://dogma.ccbb.utexas.edu/ ,l a s t accessed January 11, 2016; Wyman et al.",OADS,/arxiv_data1/oa_pdf/6f/e8/evv256.PMC4779604.pdf
"The two circles show annotation-based syntenic regions between Hydnora and Piper and, respectively, Hydnora andConopholis (generated in mGSV, http://cas-bioinfo.cas.unt.edu/mgsv/ , last accessed January 11, 2016).",OADS,/arxiv_data1/oa_pdf/6f/e8/evv256.PMC4779604.pdf
"2004 ;http://dogma.ccbb.utexas.edu/ , last accessed January 11, 2016) provided only ﬁve protein-coding genes (accD,rps12,rpl14,rpl16, and rpl36) and the three tRNAs (60% identity cutoff for protein coding genes, 80% identitycutoff for tRNAs, and e-value of 1e /C05).",OADS,/arxiv_data1/oa_pdf/6f/e8/evv256.PMC4779604.pdf
"The structures of the three tRNAs on the plastid genome werecalculated using tRNA-Scan ( http://lowelab.ucsc.edu/ tRNAscan-SE/ , last accessed January 11, 2016) and redrawn in RNAfold ( http://rna.tbi.univie.ac.at/cgi-bin/RNAfold.cgi ,l a s t accessed January 11, 2016) to obtain higher resolution ﬁg- ures.",OADS,/arxiv_data1/oa_pdf/6f/e8/evv256.PMC4779604.pdf
Supplementary Material Supplementary ﬁgures S1–S7 andtables S1–S3 are available atGenome Biology and Evolution online ( http://www.gbe.,Non-OADS,/arxiv_data1/oa_pdf/6f/e8/evv256.PMC4779604.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/24/ee/evv259.PMC4779605.pdf
"thaliana Aux/IAA and ARF protein sequences were downloaded from the Arabidopsis Information Resource data- base ( http://www.arabidopsis.org/ ;supplementary table S1 , Supplementary Material online).",OADS,/arxiv_data1/oa_pdf/24/ee/evv259.PMC4779605.pdf
B. rapa genome sequence data were obtained from the Brassica database (BRAD; http://brassicadb.org/brad/ ;Wang et al.,OADS,/arxiv_data1/oa_pdf/24/ee/evv259.PMC4779605.pdf
trichopoda genes was retrieved from the Amborella Genome Database (http://www.amborella.org/ ;Albert et al.,OADS,/arxiv_data1/oa_pdf/24/ee/evv259.PMC4779605.pdf
reinhardtii were down- loaded from Phytozome v9.1 ( http://www.phytozome.net/ ; Goodstein et al.,OADS,/arxiv_data1/oa_pdf/24/ee/evv259.PMC4779605.pdf
"To identify putative Aux/IAA and ARF family members, the Hidden Markov Model (HMM) proﬁles of Aux/IAA (PF02309), ARF (PF06507), and B3 (B3, PF02362) were re- tained from the Pfam database ( http://pfam.xfam.org/ )a n d were used to identify the putative Aux/IAA and ARF proteins with the best domain e-value cutoffs of <1/C210/C04.T h e Arabidopsis Aux/IAA and ARF sequences were used as the query to perform a BLAST search in these species, with a cutoff e-value of <10/C010.",OADS,/arxiv_data1/oa_pdf/24/ee/evv259.PMC4779605.pdf
"To validate the HMM and BLAST search, these potential sequences were analyzed using theSMART tool ( http://smart.embl-heidelberg.de/ ;Ludwig- Muller 2011 ) and the National Center for Biotechnology Information (NCBI) database ( http://www.ncbi.nlm.nih.gov/ ).",OADS,/arxiv_data1/oa_pdf/24/ee/evv259.PMC4779605.pdf
"Then, the FGENESH program ( http://linux1.softberry.com/ berry.phtml?topic=fgenesh&group=programs&subgroup=- gﬁnd ) was used to rectify incorrect start codon predictions, splicing errors, and missed or extra exons; manual reannota- tion was performed.",OADS,/arxiv_data1/oa_pdf/24/ee/evv259.PMC4779605.pdf
"thaliana and B. rapa genomes was constructed by McScanX ( http://chibba.pgml.uga.edu/ mcscan2/ ; MATCH_SCORE: 50, MATCH_SIZE: 5, GAP_SCORE: /C03, E_VALUE: 1 /C210/C05;Wang, Deng, et al.",OADS,/arxiv_data1/oa_pdf/24/ee/evv259.PMC4779605.pdf
Conservation of chromosomal synteny around the BraAL and ARF4 genes was derived from CoGe ( http://www.geno mevolution.org/CoGe/GEvo.pl ).,OADS,/arxiv_data1/oa_pdf/24/ee/evv259.PMC4779605.pdf
"thaliana and the three subgenomes of B. rapa (LF, MF1, and MF2) in BRAD (http://brassicadb.org/brad/searchSynteny.php ;Cheng et al.",OADS,/arxiv_data1/oa_pdf/24/ee/evv259.PMC4779605.pdf
Supplementary Material Supplementary ﬁgures S1–S9 andtables S1–S11 are available atGenome Biology and Evolution online ( http://www.gbe.,OADS,/arxiv_data1/oa_pdf/24/ee/evv259.PMC4779605.pdf
Data deposition: This project has been deposited at EBI’s ENA ( https://www.ebi.ac.uk/ena ) under the accession number PRJEB11698.,OADS,/arxiv_data1/oa_pdf/30/9d/evv263.PMC4779607.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/30/9d/evv263.PMC4779607.pdf
Reads for each isolate were mapped to S. cerevisiae refer- ence genome (UCSC version sacCer3) using SMALT v0.7.5aligner ( http://www.sanger.ac.uk/resources/software/smalt/ ).,OADS,/arxiv_data1/oa_pdf/30/9d/evv263.PMC4779607.pdf
Data Accessibility Genome sequencing data have been deposited in EBI’s ENA (https://www.ebi.ac.uk/ena ) as PRJEB11698.,OADS,/arxiv_data1/oa_pdf/30/9d/evv263.PMC4779607.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d0/c4/evw001.PMC4779608.pdf
Supplementary Material Supplementary tables S1–S5 and ﬁgures S1–S5 are available atGenome Biology and Evolution online ( http://www.gbe.,OADS,/arxiv_data1/oa_pdf/d0/c4/evw001.PMC4779608.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/08/8c/evw003.PMC4779610.pdf
"This ﬁgure was generated with TreeMap v3 build 1243 (https://sites.google.com/site/cophylogeny/home , last accessed December 21, 2015).Linear Plasmids and Rates of Sequence Evolution GBE Genome Biol.",OADS,/arxiv_data1/oa_pdf/08/8c/evw003.PMC4779610.pdf
"Available from: http://www.mobot.org/MOBOT/research/APweb/ Sto¨ver BC, Mu ¨ ller KF.",Non-OADS,/arxiv_data1/oa_pdf/08/8c/evw003.PMC4779610.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8b/f0/evw006.PMC4779613.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e8/63/evw007.PMC4779614.pdf
Supplementary Material Supplementary ﬁgures S1–S7 andtables S1–S5 are available atGenome Biology and Evolution online ( http://www.gbe.,OADS,/arxiv_data1/oa_pdf/e8/63/evw007.PMC4779614.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/02/37/evw009.PMC4779615.pdf
"The sum of all TE content from these human-speciﬁcruns was then compared with species-appropriate analy-ses available at RepeatMasker.org ( http://repeatmasker.org/ genomicDatasets/RMGenomicDatasets.html , last accessed August 10, 2014) which are assumed to be the most accuraterepresentations available for most species.",OADS,/arxiv_data1/oa_pdf/02/37/evw009.PMC4779615.pdf
Available from: http://repeatmasker.org/genomic Datasets/RMGenomicDatasets.,OADS,/arxiv_data1/oa_pdf/02/37/evw009.PMC4779615.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f5/9e/evw011.PMC4779616.pdf
"Materials and Methods Culturing of D. rotans , DNA Extraction, and Mitochondrial DNA Sequencing Diphylleia rotans NIES-3764 was cultivated with the cyanobac- terial strain Microcystis aeruginosa NIES-298 as a food source, in C-Si medium ( http://mcc.nies.go.jp/02medium.html; jsessionid=72A858BC9BF571F6DC50B3EC0896E57D#csi , last accessed February 9, 2016) at 20/C14C under 10–50 micro- mole photons/m2/s with the 14 h light/10 h dark cycle.",Non-OADS,/arxiv_data1/oa_pdf/f5/9e/evw011.PMC4779616.pdf
"Removalof adapter sequences, all the reads containing “ N,” and all the reads containing adapter sequences at the 3 0-ends were per- formed using cutadapt ver.1.1 ( https://cutadapt.readthedocs.",OADS,/arxiv_data1/oa_pdf/f5/9e/evw011.PMC4779616.pdf
"Genes encoding proteins and rRNAs were identiﬁed by BLASTx and BLASTN searches ag ainst the nonredundant data- bases at the National Center for Biotechnology Information(http://blast.ncbi.nlm.nih.gov/Blast.cgi , last accessed February 9, 2016; Altschul et al.",OADS,/arxiv_data1/oa_pdf/f5/9e/evw011.PMC4779616.pdf
"Annotation was also performed by MFANNOT ( http:// megasun.bch.umontreal.ca/cgi-bin/mfannot/mfannotInterface.pl , last accessed February 9, 2016) and RNAweasal (http://megasun.bch.umontreal.ca/cgi-bin/RNAweasel/ RNAweaselInterface.pl , last accessed February 9, 2016) with the standard genetic code.",OADS,/arxiv_data1/oa_pdf/f5/9e/evw011.PMC4779616.pdf
"Palindromic sequence elements were detected by EMBOSS explorer ( http://emboss.bioinformatics.nl/cgi-bin/ emboss/palindrome , last accessed February 9, 2016) with the following parameters: Minimum length of palindromeswas 8, maximum length of palindromes was 100, maximum gap between elements was 10, and no mismatch was allowed in palindrome.",OADS,/arxiv_data1/oa_pdf/f5/9e/evw011.PMC4779616.pdf
Supplementary Material Supplementary ﬁgures S1–S5 andtables S1–S3 are available atGenome Biology and Evolution online ( http://www.gbe.,Non-OADS,/arxiv_data1/oa_pdf/f5/9e/evw011.PMC4779616.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c6/b7/evw012.PMC4779617.pdf
"Clayton S, Manning C, Hodge C. Beyond storms and droughts: The psychological impacts of climate change momentus.Available from URL http://ecoamerica.org/wpcontent/uploads/2014/06/eA_Beyond_Storms_and_Droughts_Psych_ Impacts_of_Climate_Change.pdf2014.",OADS,/arxiv_data1/oa_pdf/4e/3a/APA-105-358.PMC4779656.pdf
Published online 23 January 2015; http://dx.doi.org/10.1016/j.simyco.2014.11.003 .,OADS,/arxiv_data1/oa_pdf/ac/5e/main.PMC4779793.pdf
http://dx.doi.org/10.1016/j.simyco.2014.11.002 .,OADS,/arxiv_data1/oa_pdf/ac/5e/main.PMC4779793.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ac/5e/main.PMC4779793.pdf
Published online 23 January 2015; http://dx.doi.org/10.1016/j.simyco.2014.11.002 .,OADS,/arxiv_data1/oa_pdf/dd/6d/main.PMC4779794.pdf
"meliolae (Herb /C19ario Virtual da Flora e dos Fungos –http://inct.splink.org.br ) have also been reported from Brazil, but we regard these taxa as dubious, pending their re-examination.",Non-OADS,/arxiv_data1/oa_pdf/dd/6d/main.PMC4779794.pdf
Available from: http://www.geneious.com/ .,Non-OADS,/arxiv_data1/oa_pdf/dd/6d/main.PMC4779794.pdf
http://dx.doi.org/10.1016/ j.simyco.2014.1 1.003 .,OADS,/arxiv_data1/oa_pdf/dd/6d/main.PMC4779794.pdf
http://dx.doi.org/ 10.1016/j.simyco.2014.12.002 .,OADS,/arxiv_data1/oa_pdf/dd/6d/main.PMC4779794.pdf
Available at: http://pragawall.cenargen.embrapa.br/ aiqweb/michtml/fgbanco01.asp .,Non-OADS,/arxiv_data1/oa_pdf/dd/6d/main.PMC4779794.pdf
Published online 22 January 2015; http://dx.doi.org/10.1016/j.simyco.2014.11.001 .,OADS,/arxiv_data1/oa_pdf/9e/97/main.PMC4779795.pdf
"Manyof these studies relied on ITS and the identi ﬁcation routines on the ISTH webpage ( http://www.isth.info/ ), implicating that some detected species were species clusters.",OADS,/arxiv_data1/oa_pdf/9e/97/main.PMC4779795.pdf
http://www.aemet.es/documentos/es/conocermas/publicaciones/ 2Atlas_climatologico/Atlas_Clima_Macaronesia___Baja.pdf .TRICHODERMA INSOUTHERN EUROPE www.studiesinmycology.org 85,Non-OADS,/arxiv_data1/oa_pdf/9e/97/main.PMC4779795.pdf
http://www.eoearth.org/view/article/162272 .,Non-OADS,/arxiv_data1/oa_pdf/9e/97/main.PMC4779795.pdf
http://dx.doi.org/10.1109/IPDPS.2006.1639535 .,Non-OADS,/arxiv_data1/oa_pdf/9e/97/main.PMC4779795.pdf
Published online 23 January 2015; http://dx.doi.org/10.1016/j.simyco.2014.12.001 .,OADS,/arxiv_data1/oa_pdf/18/08/main.PMC4779798.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/3.0/ ).available online at www.studiesinmycology.org STUDIES IN MYCOLOGY 80: 131 –150.,Non-OADS,/arxiv_data1/oa_pdf/18/08/main.PMC4779798.pdf
2004 ;http://isolate.fusariumdb.org ) using the basic local align- ment search tool (BLAST) search algorithm ( Altschul et al.,OADS,/arxiv_data1/oa_pdf/18/08/main.PMC4779798.pdf
Multiple sequence alignments were generated with MAFFT v. 7.0 ( http://mafft.cbrc.jp/alignment/software/ ) with the L-INS-i option selected ( Katoh et al.,OADS,/arxiv_data1/oa_pdf/18/08/main.PMC4779798.pdf
Sequence analysis Comparison of the tef1 sequences against those in the NCBI database and the Fusarium Identi ﬁcation Database (Fusarium- ID) ( http://isolate.fusariumdb.org/ ) revealed that 49 of the 57 Fusarium isolates examined in this study represented members of the FFSC.,OADS,/arxiv_data1/oa_pdf/18/08/main.PMC4779798.pdf
http://www.csdassn.org/softlist.cfm .,Non-OADS,/arxiv_data1/oa_pdf/18/08/main.PMC4779798.pdf
Published online 29 January 2015; http://dx.doi.org/10.1016/j.simyco.2014.12.002 .,OADS,/arxiv_data1/oa_pdf/0c/f2/main.PMC4779799.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/3.0/ ).available online at www.studiesinmycology.org STUDIES IN MYCOLOGY 80: 189 –245.,Non-OADS,/arxiv_data1/oa_pdf/0c/f2/main.PMC4779799.pdf
The ML analysis was performed using RAxML v. 8.0.9 (randomised accelerated (sic) maximum likelihood for high per-formance computing; Stamatakis 2014 ) through the CIPRES website ( http://www.phylo.org) to obtain a second measure of branch support.,OADS,/arxiv_data1/oa_pdf/0c/f2/main.PMC4779799.pdf
Sequence comparisons on the FUSARIUM-ID ( http://isolate.fusariumdb.org ;O'Donnell et al.,OADS,/arxiv_data1/oa_pdf/0c/f2/main.PMC4779799.pdf
2010 ) and Fusarium MLST ( http://www.cbs.knaw.nl/ fusarium ;O'Donnell et al.,Non-OADS,/arxiv_data1/oa_pdf/0c/f2/main.PMC4779799.pdf
Presentlythere is an under-representation of Nectriaceae in the available whole genome sequences (nine genomes; http://genome.jgi.doe.,OADS,/arxiv_data1/oa_pdf/0c/f2/main.PMC4779799.pdf
Phytopathologia Mediterranea 53.http://dx.doi.org/10.14601/Phyto- pathol_Mediterr-14976 .,Non-OADS,/arxiv_data1/oa_pdf/0c/f2/main.PMC4779799.pdf
Bioinformatics .http://dx.doi.org/10.1093/ bioinformatics/btu033 .,OADS,/arxiv_data1/oa_pdf/0c/f2/main.PMC4779799.pdf
"Keywords: Knee, o steoarthritis, a rthroplasty, Satisfaction Review Article Knee Surg Relat Res 2016;28(1):1-15http://dx.doi.org/10.5792/ksrr.2016.28.1.1pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received April 16, 2015; Revised August 12, 2015;  Accepted September 12, 2015Correspondence to: Ho Jong Ra, MDDepartment of Orthopedic Surgery, Gangneung Asan Hospital, Ulsan University College of Medicine, 38 Bangdong-gil, Gangneung, 25440, Korea Tel: +82-33-610-3244, Fax: +82-33-641-8050E-mail: os_rahj@naver.com 1This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/07/79/ksrr-28-1.PMC4779800.pdf
"Keywords: t ibia, o steotomy, c omputer-assisted, n avigation, m eta-analysisReview Article Knee Surg Relat Res 2016;28(1):16-26http://dx.doi.org/10.5792/ksrr.2016.28.1.16pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received April 22, 2015; Revised June 25, 2015;  Accepted June 28, 2015Correspondence to: Jae-Hyuk Y ang, MDDepartment of Orthopaedic Surgery, Veterans Health Service Medical Center, 53 Jinhwangdo-ro 61-gil, Gangdong-gu, Seoul 05368, KoreaTel: +82-2-2225-1609, Fax: +82-2-2225-1910E-mail: jaekorea@gmail.com*The first two authors contributed equally to this study.",Non-OADS,/arxiv_data1/oa_pdf/9c/89/ksrr-28-16.PMC4779801.pdf
"16This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9c/89/ksrr-28-16.PMC4779801.pdf
The entire search process was conducted in four phases as per guidelines from PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses) statement (http://www.prisma-statement.org).,OADS,/arxiv_data1/oa_pdf/9c/89/ksrr-28-16.PMC4779801.pdf
Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.,Non-OADS,/arxiv_data1/oa_pdf/9c/89/ksrr-28-16.PMC4779801.pdf
"Keywords: Knee, a rthroplasty, f emoral posterior condylar offset, t ibial posterior slope angle, Joint line heightOriginal Article Knee Surg Relat Res 2016;28(1):27-33http://dx.doi.org/10.5792/ksrr.2016.28.1.27pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received July 27, 2015; Revised (1st) September 1, 2015; (2nd) October 25, 2015; Accepted January 18, 2016Correspondence to: Dae Kyung Bae, MDDepartment of Orthopaedic Surgery, Kyung Hee University School of Medicine, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Korea Tel: +82-2-958-8366, Fax: +82-2-964-3865E-mail: tesstore@empas.com 27This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c1/f4/ksrr-28-27.PMC4779802.pdf
"Keywords: Knee, a rthroplasty, p osterior tibial slope, a nterior cruciate ligament, m ucoid degenerationOriginal Article Knee Surg Relat Res 2016;28(1):34-38http://dx.doi.org/10.5792/ksrr.2016.28.1.34pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received July 27, 2015; Accepted September 9, 2015Correspondence to: Sung-Do Cho, MDDepartment of Orthopedic Surgery, Ulsan University Hospital, 877 Bangeojinsunhwan-doro, Dong-gu, Ulsan 44033, KoreaTel: +82-52-250-7129, Fax: +82-52-235-2823E-mail: sdcho@uuh.ulsan.kr 34This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b3/39/ksrr-28-34.PMC4779803.pdf
"Keywords: Knee, a rthroplasty, r ange of motion, p rosthesis design, o utcome assessmentOriginal Article Knee Surg Relat Res 2016;28(1):39-45http://dx.doi.org/10.5792/ksrr.2016.28.1.39pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received September 13, 2015; Revised (1st) October 28, 2015; (2nd) December 2, 2015; Accepted December 15, 2015Correspondence to: Y ong In, MDDepartment of Orthopaedic Surgery, Seoul St. Mary’s Hospital, The Catholic University of Korea College of Medicine, 222 Banpo-daero, Seocho-gu, Seoul 06591, KoreaTel: +82-2-2258-2838, Fax: +82-2-535-9834E-mail: iy1000@catholic.ac.kr 39This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bd/01/ksrr-28-39.PMC4779804.pdf
"Keywords: Knee, o steoarthritis, u nicompartmental arthroplasty, c omplicationOriginal Article Knee Surg Relat Res 2016;28(1):46-54http://dx.doi.org/10.5792/ksrr.2016.28.1.46pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received June 18, 2015; Revised (1st) September 4, 2015; (2nd) October 19, 2015; (3rd) October 20, 2015; Accepted November 3, 2015Correspondence to: Kyung Tae Kim, MDDepartment of Orthopedic Surgery, Seoul Sacred Heart General Hospital, 259 Wangsan-ro, Dongdaemun-gu, Seoul 02488, KoreaTel: +82-2-966-1616, Fax: +82-2-968-2394E-mail: kktkimos@hanmail.net 46This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7b/3e/ksrr-28-46.PMC4779805.pdf
"Keywords: Knee, r evision arthroplasty, m odular metal augmentation, r adiologic stabilityOriginal Article Knee Surg Relat Res 2016;28(1):55-61http://dx.doi.org/10.5792/ksrr.2016.28.1.55pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received March 23, 2015; Revised (1st) August 12, 2015;  (2nd) October 13, 2015; Accepted November 3, 2015Correspondence to: Ki-Cheor Bae, MDDepartment of Orthopedic Surgery, Keimyung University School of Medicine, 56 Dalseong-ro, Jung-gu, Daegu 41931, KoreaTel: +82-53-250-7038, Fax: +82-53-250-7205E-mail: bkc@dsmc.or.kr 55This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/41/6b/ksrr-28-55.PMC4779806.pdf
"Keywords: Knee, t ibia, p atellar tendon, o sgood-Schlatter disease, t endinopathy, m agnetic resonance imagingOriginal Article Knee Surg Relat Res 2016;28(1):62-67http://dx.doi.org/10.5792/ksrr.2016.28.1.62pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received July 13, 2015; Revised September 13, 2015;  Accepted September 18, 2015Correspondence to: Jin Goo Kim, MDDepartment of Orthopedic Surgery, Konkuk University Medical Center, 120 Neungdong-ro, Gwangjin-gu, Seoul 05030, KoreaTel: +82-2-2270-0028, Fax: +82-2-2270-0023E-mail: boram107@hanmail.net 62This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4a/f0/ksrr-28-62.PMC4779807.pdf
http://dx.doi.org/10.1136/bcr-2014-206734.,Non-OADS,/arxiv_data1/oa_pdf/4a/f0/ksrr-28-62.PMC4779807.pdf
"Keywords: Knee, o steoarthritis,  p atellofemoral, u nicompartmental arthroplastyOriginal Article Knee Surg Relat Res 2016;28(1):68-74http://dx.doi.org/10.5792/ksrr.2016.28.1.68pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received May 19, 2015; Revised (1st) September 25, 2015; (2nd) October 26, 2015; (3rd) October 27, 2015;  Accepted December 4, 2015Correspondence to: Rafik Y assa, MRCSDepartment of Trauma and Orthopaedics, North Manchester General Hospital, Delaunays Roadm, Crumpsall, M8 5RB, UK.Tel: +44-0161-720-2302, Fax: +44-0161-720-2399E-mail: rafikragai@yahoo.com 68This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7b/b8/ksrr-28-68.PMC4779808.pdf
Available from: http://www.njrcentre.org.uk/njrcentre/portals/0/njr%207th%20annual%20report%202010.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7b/b8/ksrr-28-68.PMC4779808.pdf
"Keywords: Small patella syndrome, m agnetic resonance imagingCase Report Knee Surg Relat Res 2016;28(1):75-78http://dx.doi.org/10.5792/ksrr.2016.28.1.75pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received January 30, 2015; Revised April 28, 2015;  Accepted May 20, 2015Correspondence to: Sang-Heon Song, MDDepartment of Orthopaedic Surgery, Myongji Hospital, Seonam University College of Medicine, 55 Hwasu-ro 14beon-gil, Deokyang-gu, Goyang 10475, KoreaTel: +82-31-810-5424, Fax: +82-31-969-0500E-mail: sh.gabriel.song@gmail.com 75This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fd/a0/ksrr-28-75.PMC4779809.pdf
"Keywords: Knee, c hondromatosis, Synovial, a diposeCase Report Knee Surg Relat Res 2016;28(1):79-82http://dx.doi.org/10.5792/ksrr.2016.28.1.79pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received December 10, 2014; Revised March 20, 2015;  Accepted May 11, 2015Correspondence to: Dae-Hee Lee, MDDepartment of Orthopaedic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, KoreaTel: +82-2-3410-3509, Fax: +82-2-3410-0061E-mail: eoak22@empal.com 79This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/45/26/ksrr-28-79.PMC4779810.pdf
"Keywords: Knee, Anterior cruciate ligament, Reconstruction, Outside-in technique, Suspensory fixation deviceCase Report Knee Surg Relat Res 2016;28(1):83-87http://dx.doi.org/10.5792/ksrr.2016.28.1.83pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received April 16, 2015; Revised June 1, 2015;  Accepted June 21, 2015Correspondence to: Kohei Kawaguchi, MDDepartment of Orthopaedic Surgery, Tokyo Teishin Hospital, 2-14-23 Fujimi, Chiyoda-ku, Tokyo 102-8798, JapanTel: +81-3-5214-7111, Fax: +81-3-5214-7391E-mail: kkohei0602@yahoo.co.jp 83This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/06/70/ksrr-28-83.PMC4779811.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Zika Virus Infection: New Threat in Global Health Jacob Lee Division of Infectious Disease, College of Medicine, Hallym University, Seoul, Koreahttp://dx.doi.org/10.3346/jkms.2016.31.3.331  • J Korean Med Sci 2016; 31: 331-332 Zika virus is one Flavi virus, which is similar to dengue virus.",Non-OADS,/arxiv_data1/oa_pdf/e2/c6/jkms-31-331.PMC4779854.pdf
Lee J • Zika Virus Infection: New Threat in Global Health 332  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.331global warming are the major reasons for the spread of mosqui - to-borne infections.,Non-OADS,/arxiv_data1/oa_pdf/e2/c6/jkms-31-331.PMC4779854.pdf
Available at: http://www.paho.org/hq/index.php?option=  com_content&view=article&id=11603&Itemid=41696&lang=en.,Non-OADS,/arxiv_data1/oa_pdf/e2/c6/jkms-31-331.PMC4779854.pdf
Available at http://www.cdc.go.kr/CDC/main.jsp.,Non-OADS,/arxiv_data1/oa_pdf/e2/c6/jkms-31-331.PMC4779854.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Celebrating the Achievements and Fulfilling the Mission of the  Korean Association of Medical Journal Editors Armen Yuri Gasparyan1 and Sung-Tae Hong2 1Section Editor, Journal of Korean Medical Science ; Departments of Rheumatology and Research & Development, Dudley Group NHS Foundation Trust (Teaching Trust of  University of Birmingham, UK), Russells Hall Hospital, Dudley, West Midlands, UK; 2President, Korean Association of Medical Journal Editors; Editor-in-Chief, Journal of  Korean Medical Science , Korean Academy of Medical Sciences, Seoul, Koreahttp://dx.doi.org/10.3346/jkms.2016.31.3.333  • J Korean Med Sci 2016; 31: 333-335 Global and regional editorial associations are gradually evolv - ing to meet the growing challenges of the current stage of digiti - zation.",Non-OADS,/arxiv_data1/oa_pdf/30/83/jkms-31-333.PMC4779855.pdf
"• Celebrating the Achievements of KAMJE 334  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.333the Journal opened an important Section on Editing, Writing &  Publishing to cover issues in science editing, ethical publishing,  and scientometrics and to improve the journal editors’ science  communication skills further.",Non-OADS,/arxiv_data1/oa_pdf/30/83/jkms-31-333.PMC4779855.pdf
• Celebrating the Achievements of KAMJE http://jkms.org   335 http://dx.doi.org/10.3346/jkms.2016.31.3.333Box 1.,Non-OADS,/arxiv_data1/oa_pdf/30/83/jkms-31-333.PMC4779855.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Catastrophic Health Expenditures for Households with Disabled  Members: Evidence from the Korean Health Panel Persons with disabilities use more health care services due to ill health and face higher  health care expenses and burden.",Non-OADS,/arxiv_data1/oa_pdf/09/14/jkms-31-336.PMC4779856.pdf
13-2014-009).http://dx.doi.org/10.3346/jkms.2016.31.3.336  • J Korean Med Sci 2016; 31: 336-344 INTRODUCTION The National Health Insurance (NHI) program in Korea is an  essential social security net covering the entire population.,Non-OADS,/arxiv_data1/oa_pdf/09/14/jkms-31-336.PMC4779856.pdf
"• Catastrophic Health Expenditures for Households with Disabled Members http://jkms.org   337 http://dx.doi.org/10.3346/jkms.2016.31.3.336disability contributes to job loss or reduced earnings (19), low  family income as well as high healthcare needs due to disability  also cause high medical expenditure burdens.",Non-OADS,/arxiv_data1/oa_pdf/09/14/jkms-31-336.PMC4779856.pdf
• Catastrophic Health Expenditures for Households with Disabled Members 338  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.336Explanatory variables We included variables for the household characteristics and the  demographic and disability characteristics of members using  KHI data as explanatory variables.,OADS,/arxiv_data1/oa_pdf/09/14/jkms-31-336.PMC4779856.pdf
• Catastrophic Health Expenditures for Households with Disabled Members http://jkms.org   339 http://dx.doi.org/10.3346/jkms.2016.31.3.336ties with chi-square and t-tests respectively.,Non-OADS,/arxiv_data1/oa_pdf/09/14/jkms-31-336.PMC4779856.pdf
"• Catastrophic Health Expenditures for Households with Disabled Members 340  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.336Out-of-pocket healthcare expenditure Households with disabled members reported annual OOP health - care expenditures of 1,465.10 USD, which was 1.29 times higher  than households without disabled members.",Non-OADS,/arxiv_data1/oa_pdf/09/14/jkms-31-336.PMC4779856.pdf
• Catastrophic Health Expenditures for Households with Disabled Members http://jkms.org   341 http://dx.doi.org/10.3346/jkms.2016.31.3.336and mental illness.,Non-OADS,/arxiv_data1/oa_pdf/09/14/jkms-31-336.PMC4779856.pdf
• Catastrophic Health Expenditures for Households with Disabled Members 342  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.336lower occurrence rate of catastrophic health expenditure than  those with physical disabilities with a 10% threshold (31).,Non-OADS,/arxiv_data1/oa_pdf/09/14/jkms-31-336.PMC4779856.pdf
"• Catastrophic Health Expenditures for Households with Disabled Members http://jkms.org   343 http://dx.doi.org/10.3346/jkms.2016.31.3.336health expenditures, health disparities as well as differences in  health service use between people with and without disabilities  would be reduced.",Non-OADS,/arxiv_data1/oa_pdf/09/14/jkms-31-336.PMC4779856.pdf
ORCID Jeong-Eun Lee http://orcid.org/0000-0001-6104-3168 Hyung-Ik Shin http://orcid.org/0000-0001-8805-3104 Young Kyung Do http://orcid.org/0000-0001-5024-8264 Eun Joo Yang http://orcid.org/0000-0003-2417-2416 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/09/14/jkms-31-336.PMC4779856.pdf
Available at http://dx.doi.org/10.1787/ health_glance-2013-en [accessed on 26 May 2015].,Non-OADS,/arxiv_data1/oa_pdf/09/14/jkms-31-336.PMC4779856.pdf
• Catastrophic Health Expenditures for Households with Disabled Members 344  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.336ability and health care costs in the Medicare population.,Non-OADS,/arxiv_data1/oa_pdf/09/14/jkms-31-336.PMC4779856.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Prevalence of Frailty and Aging-Related Health Conditions in  Older Koreans in Rural Communities: A Cross-Sectional Analysis  of the Aging Study of Pyeongchang Rural Area Frailty has been previously studied in Western countries and the urban Korean population;  however, the burden of frailty and geriatric conditions in the aging populations of rural  Korean communities had not yet been determined.",Non-OADS,/arxiv_data1/oa_pdf/42/cb/jkms-31-345.PMC4779857.pdf
"http://dx.doi.org/10.3346/jkms.2016.31.3.345  • J Korean Med Sci 2016; 31: 345-352 INTRODUCTION  Korea is one of the most rapidly aging developed countries (1),  due to its increasing life expectancy in tandem with extremely  low birth rates.",Non-OADS,/arxiv_data1/oa_pdf/42/cb/jkms-31-345.PMC4779857.pdf
• Aging Study in Pyeongchang Rural Area 346  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.345reans living in rural communities has not been established.,Non-OADS,/arxiv_data1/oa_pdf/42/cb/jkms-31-345.PMC4779857.pdf
"• Aging Study in Pyeongchang Rural Area http://jkms.org   347 http://dx.doi.org/10.3346/jkms.2016.31.3.345ity, mood, nutritional status, and frailty status using validated  instruments as described follows: 1) We administered the Ko - rean version of the Mini-Mental State Examination (K-MMSE)  (range: 0-30).",Non-OADS,/arxiv_data1/oa_pdf/42/cb/jkms-31-345.PMC4779857.pdf
• Aging Study in Pyeongchang Rural Area 348  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.345requires a lengthy physical activity questionnaire and a mea - surement of physical performance.,Non-OADS,/arxiv_data1/oa_pdf/42/cb/jkms-31-345.PMC4779857.pdf
"• Aging Study in Pyeongchang Rural Area http://jkms.org   349 http://dx.doi.org/10.3346/jkms.2016.31.3.345ing home (n = 9), a hospital (n = 1), or bed ridden and receiv - ing nursing care in their home (n = 2).",Non-OADS,/arxiv_data1/oa_pdf/42/cb/jkms-31-345.PMC4779857.pdf
• Aging Study in Pyeongchang Rural Area 350  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.345Table 4.,Non-OADS,/arxiv_data1/oa_pdf/42/cb/jkms-31-345.PMC4779857.pdf
• Aging Study in Pyeongchang Rural Area http://jkms.org   351 http://dx.doi.org/10.3346/jkms.2016.31.3.345A member of our investigator team met community leaders and  local councilors at the town hall meetings to raise awareness  and engage them in our study to uncover prevalent aging-relat - ed issues in the local community.,Non-OADS,/arxiv_data1/oa_pdf/42/cb/jkms-31-345.PMC4779857.pdf
"• Aging Study in Pyeongchang Rural Area 352  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.345Young Soo Lee, one of coauthors of this study, donated the ex - pense for this field work but his donation made no influence on  research and publication integrity.",Non-OADS,/arxiv_data1/oa_pdf/42/cb/jkms-31-345.PMC4779857.pdf
ORCID Hee-Won Jung http://orcid.org/0000-0002-2583-3354 Il-Young Jang http://orcid.org/0000-0003-3617-3301 Young Soo Lee http://orcid.org/0000-0003-1278-4597 Chang Ki Lee http://orcid.org/0000-0002-6475-4675 Eun-Il Cho http://orcid.org/0000-0001-6290-3772 Woo Young Kang http://orcid.org/0000-0003-3888-8490 Jeoung Hee Chae http://orcid.org/0000-0001-5814-1250 Eun Ju Lee http://orcid.org/0000-0003-4612-0625 Dae Hyun Kim http://orcid.org/0000-0001-7290-6838 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/42/cb/jkms-31-345.PMC4779857.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Association between Short Maternal Height and Low Birth  Weight: A Hospital-based Study in Japan Anthropometry measurements, such as height and weight, have recently been used to  predict poorer birth outcomes.",Non-OADS,/arxiv_data1/oa_pdf/64/61/jkms-31-353.PMC4779858.pdf
"Keywords:  Maternal Height; Low Birth Weight; Neonatal Intensive Care UnitSachiko Inoue,1 Hiroo Naruse,2,3   Takashi Yorifuji,4 Tsuguhiko Kato,5  Takeshi Murakoshi,3 Hiroyuki Doi,6   and SV Subramanian7 1Department of Nursing, Okayama Prefectural  University, Soja, Okayama, Japan; 2Department of  Obstetrics, Kaba Memorial Hospital, Hamamatsu,  Shizuoka, Japan; 3Department of Obstetrics, Seirei  Hamamatsu General Hospital, Hamamatsu,  Shizuoka, Japan; 4Department of Human Ecology,  Okayama University Graduate School of  Environmental and Life Science, Okayama, Japan;  5Department of Social Medicine, National Center for  Child Health and Development, Tokyo, Japan;  6Department of Epidemiology, Okayama University  Graduate School of Medicine, Dentistry, and  Pharmaceutical Sciences, Okayama, Japan;  7Department of Social and Behavioral Sciences,  Harvard School of Public Health, Boston, MA, USA  Received: 19 June 2015 Accepted: 19 November 2015 Address for Correspondence: Sachiko Inoue, PhD Department of Nursing, Okayama Prefectural University,   111 Kuboki, Soja, Okayama 719-1197, Japan E-mail: sinoue@fhw.oka-pu.ac.jphttp://dx.doi.org/10.3346/jkms.2016.31.3.353  • J Korean Med Sci 2016; 31: 353-359 INTRODUCTION Several studies examining the relationship between maternal  height and low birth weight showed that shorter maternal height  was associated with reduced fetal growth and low birth weight  (LBW) (1-4) and concluded that the primary reason for this as - sociation was undernutrition/malnutrition.",Non-OADS,/arxiv_data1/oa_pdf/64/61/jkms-31-353.PMC4779858.pdf
• Short Maternal Height and Low Birth Weight 354  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.353maternal height on birth outcomes are rarely investigated.,Non-OADS,/arxiv_data1/oa_pdf/64/61/jkms-31-353.PMC4779858.pdf
"• Short Maternal Height and Low Birth Weight http://jkms.org   355 http://dx.doi.org/10.3346/jkms.2016.31.3.353ic status and divided into seven categories: homemaker married  to self-employed worker, homemaker married to company-em - ployed worker (salaried worker), homemaker married to pro - fessional worker, all other homemakers, company-employed  worker, professional worker, and all other types of workers.",Non-OADS,/arxiv_data1/oa_pdf/64/61/jkms-31-353.PMC4779858.pdf
• Short Maternal Height and Low Birth Weight 356  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.353lines at Seirei Hamamatsu General Hospital with respect to the  usage of individual information.,Non-OADS,/arxiv_data1/oa_pdf/64/61/jkms-31-353.PMC4779858.pdf
• Short Maternal Height and Low Birth Weight http://jkms.org   357 http://dx.doi.org/10.3346/jkms.2016.31.3.353that the association remained after adjusting for potential con - founders.,Non-OADS,/arxiv_data1/oa_pdf/64/61/jkms-31-353.PMC4779858.pdf
• Short Maternal Height and Low Birth Weight 358  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.353cient to explain the mechanism of the relationship between ma - ternal height and LBW.,Non-OADS,/arxiv_data1/oa_pdf/64/61/jkms-31-353.PMC4779858.pdf
ORCID Sachiko Inoue http://orcid.org/0000-0003-1840-5631 Hiroo Naruse http://orcid.org/0000-0002-9424-0616 Takashi Yorifuji http://orcid.org/0000-0003-2543-5441 Tsuguhiko Kato http://orcid.org/0000-0002-6009-7962 Takeshi Murakoshi http://orcid.org/0000-0003-3212-1782 Hiroyuki Doi http://orcid.org/0000-0002-1485-6825 SV Subramanian http://orcid.org/0000-0003-2365-4165 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/64/61/jkms-31-353.PMC4779858.pdf
Available at http://www.mhlw.go.jp/stf/houdou/  2r98520000020qbb.html.,Non-OADS,/arxiv_data1/oa_pdf/64/61/jkms-31-353.PMC4779858.pdf
• Short Maternal Height and Low Birth Weight http://jkms.org   359 http://dx.doi.org/10.3346/jkms.2016.31.3.353Obstet 2006; 92: 272-8.,Non-OADS,/arxiv_data1/oa_pdf/64/61/jkms-31-353.PMC4779858.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Dual-Blocking of PI3K and mTOR Improves Chemotherapeutic  Effects on SW620 Human Colorectal Cancer Stem Cells by  Inducing Differentiation Cancer stem cells (CSCs) have tumor initiation, self-renewal, metastasis and chemo- resistance properties in various tumors including colorectal cancer.",Non-OADS,/arxiv_data1/oa_pdf/c8/88/jkms-31-360.PMC4779859.pdf
"Received: 10 August 2015 Accepted: 19 November 2015 Address for Correspondence: Chan-Wha Kim, PhD Department of Biotechnology, College of Life Sciences and  Biotechnology, Korea University, 145 Anam-ro, Seongbuk-gu,  Seoul 02841, Korea E-mail: cwkim@korea.ac.kr Funding:  This work was supported by Ministry of Trade, Industry  and Energy (1147890, 2014).http://dx.doi.org/10.3346/jkms.2016.31.3.360  • J Korean Med Sci 2016; 31: 360-370 INTRODUCTION Cancer stem cells (CSCs) are a subset of cells within a tumor  that have the ability to initiate tumor formation and induce me - tastasis.",Non-OADS,/arxiv_data1/oa_pdf/c8/88/jkms-31-360.PMC4779859.pdf
"• Anti-Cancer Effects of Dual-Blocking of PI3K and mTOR http://jkms.org   361 http://dx.doi.org/10.3346/jkms.2016.31.3.360MATERIALS AND METHODS Cell culture  The SW620 human colorectal cancer cell line was purchased  from the Korean cell line bank (Seoul, Korea).",Non-OADS,/arxiv_data1/oa_pdf/c8/88/jkms-31-360.PMC4779859.pdf
"• Anti-Cancer Effects of Dual-Blocking of PI3K and mTOR 362  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.360ment plates (Corning Inc. Corning, NY, USA).",Non-OADS,/arxiv_data1/oa_pdf/c8/88/jkms-31-360.PMC4779859.pdf
"• Anti-Cancer Effects of Dual-Blocking of PI3K and mTOR http://jkms.org   363 http://dx.doi.org/10.3346/jkms.2016.31.3.360er, in dual-inhibited cells, SMO expression level was significant - ly decreased (0.85 ± 0.082) ( P< 0.001).",Non-OADS,/arxiv_data1/oa_pdf/c8/88/jkms-31-360.PMC4779859.pdf
• Anti-Cancer Effects of Dual-Blocking of PI3K and mTOR 364  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.360of DMSO-treated CD133+ cells was defined as “1” .,Non-OADS,/arxiv_data1/oa_pdf/c8/88/jkms-31-360.PMC4779859.pdf
• Anti-Cancer Effects of Dual-Blocking of PI3K and mTOR http://jkms.org   365 http://dx.doi.org/10.3346/jkms.2016.31.3.360suppressed their stemness properties.,Non-OADS,/arxiv_data1/oa_pdf/c8/88/jkms-31-360.PMC4779859.pdf
• Anti-Cancer Effects of Dual-Blocking of PI3K and mTOR 366  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.360and “9.67 ± 0.7” (LY294002).,Non-OADS,/arxiv_data1/oa_pdf/c8/88/jkms-31-360.PMC4779859.pdf
• Anti-Cancer Effects of Dual-Blocking of PI3K and mTOR http://jkms.org   367 http://dx.doi.org/10.3346/jkms.2016.31.3.360Fig.,Non-OADS,/arxiv_data1/oa_pdf/c8/88/jkms-31-360.PMC4779859.pdf
• Anti-Cancer Effects of Dual-Blocking of PI3K and mTOR 368  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.360cancer (18-20).,Non-OADS,/arxiv_data1/oa_pdf/c8/88/jkms-31-360.PMC4779859.pdf
"• Anti-Cancer Effects of Dual-Blocking of PI3K and mTOR http://jkms.org   369 http://dx.doi.org/10.3346/jkms.2016.31.3.360of data: Kim MJ, Koo JE, Han GY, Kim B, Lee YS, Kim CW.",OADS,/arxiv_data1/oa_pdf/c8/88/jkms-31-360.PMC4779859.pdf
ORCID Min-Jung Kim http://orcid.org/0000-0002-5544-8676 Jeong-Eun Koo http://orcid.org/0000-0001-6733-2518 Gi-Yeon Han http://orcid.org/0000-0001-9825-169X Yoo-Sun Lee http://orcid.org/0000-0002-2258-6749 Chiyoung Ahn http://orcid.org/0000-0002-3747-0175 Chan-Wha Kim http://orcid.org/0000-0003-2329-8834 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/c8/88/jkms-31-360.PMC4779859.pdf
"• Anti-Cancer Effects of Dual-Blocking of PI3K and mTOR 370  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.360M, Mangiapane LR, Giammona A, Cordova A, et al.",Non-OADS,/arxiv_data1/oa_pdf/c8/88/jkms-31-360.PMC4779859.pdf
• Anti-Cancer Effects of Dual-Blocking of PI3K and mTOR http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.360Supplementary Fig.,Non-OADS,/arxiv_data1/oa_pdf/c8/88/jkms-31-360.PMC4779859.pdf
• Anti-Cancer Effects of Dual-Blocking of PI3K and mTOR http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.360Supplementary Fig.,Non-OADS,/arxiv_data1/oa_pdf/c8/88/jkms-31-360.PMC4779859.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Multiple Human Papillomavirus Infection Is Associated with  High-Risk Infection in Male Genital Warts in Ulsan, Korea Further understanding of male human papillomavirus (HPV) infection is necessary to  prevent infection in men, as well as transmission to women.",Non-OADS,/arxiv_data1/oa_pdf/db/8f/jkms-31-371.PMC4779860.pdf
"Keywords:  Human Papillomavirus; Oncogenic; Genotype; Human Papillomavirus-6;  Human Papillomavirus-11; Condyloma Acuminata; Men, UlsanTaekmin Kwon,1 Kyung Hyun Moon,1  Sung-Hak Yang,2 Min Cheol Roh,3   Sang Hoon Lee,4 Je Won Kim,5   In Kyu Kim,6 Kyoung Ho Roh,7   and Sungchan Park1,8 1University of Ulsan College of Medicine, Ulsan  University Hospital, Ulsan, Korea; 2Yang Sung-Hak  Urology Clinic, Ulsan, Korea; 3Dream Urology Clinic,  Ulsan, Korea; 4Gilman Urology Clinic, Ulsan, Korea;  5Mediforman Urology Clinic, Ulsan, Korea; 6Top  Urology Clinic, Ulsan, Korea; 7Seegene Institute of  Life Sciences, Seoul, Korea; 8School of Life Sciences,  Ulsan National Institute of Science and Technology,  Ulsan, Korea Received: 2 August 2015 Accepted: 9 November 2015 Address for Correspondence: Sungchan Park, MD Department of Urology, Ulsan University Hospital, 877  Bangeojinsunhwando-ro, Dong-gu, Ulsan 44033, Korea E-mail: scpark@amc.seoul.kr Funding:  This work was supported by Priority Research Center  Program through the National Research Foundation of Korea  (NRF) funded by the Ministry of Education, Science and  Technology (2009-0094050).http://dx.doi.org/10.3346/jkms.2016.31.3.371  • J Korean Med Sci 2016; 31: 371-375 INTRODUCTION Human papillomavirus (HPV) is the most common sexually  transmitted pathogen and is the cause of various urogenital  cancers (1,2).",Non-OADS,/arxiv_data1/oa_pdf/db/8f/jkms-31-371.PMC4779860.pdf
• High-Risk Human Papillomavirus Infection 372  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.371as well as transmission to women.,Non-OADS,/arxiv_data1/oa_pdf/db/8f/jkms-31-371.PMC4779860.pdf
• High-Risk Human Papillomavirus Infection http://jkms.org   373 http://dx.doi.org/10.3346/jkms.2016.31.3.371obtained by tissue excision due to a definite lesion ( P= 0.001).,Non-OADS,/arxiv_data1/oa_pdf/db/8f/jkms-31-371.PMC4779860.pdf
• High-Risk Human Papillomavirus Infection 374  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.371the appropriate treatment.,Non-OADS,/arxiv_data1/oa_pdf/db/8f/jkms-31-371.PMC4779860.pdf
ORCID Taekmin Kwon http://orcid.org/0000-0003-2280-319X Sungchan Park http://orcid.org/0000-0002-2337-983X,Non-OADS,/arxiv_data1/oa_pdf/db/8f/jkms-31-371.PMC4779860.pdf
• High-Risk Human Papillomavirus Infection http://jkms.org   375 http://dx.doi.org/10.3346/jkms.2016.31.3.371REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/db/8f/jkms-31-371.PMC4779860.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Predictors of Poor Retention in Care of HIV-infected Patients  Receiving Antiretroviral Therapy in Korea: Five-Year Hospital- based Retrospective Cohort Study Poor retention in care (RIC) is associated with higher antiretroviral therapy (ART) failure and  worse survival.",Non-OADS,/arxiv_data1/oa_pdf/a2/40/jkms-31-376.PMC4779861.pdf
"Keywords:  HIV; Antiretroviral Therapy; Retention; Visit ConstancyShinwon Lee,1 Sun Hee Lee,1 Su Jin Lee,1  Kye-Hyung Kim,1 Jeong Eun Lee,1   Heerim Cho,1 Seung Geun Lee,1   Dong Hwan Chen,2 Joo Seop Chung,1   and Ihm Soo Kwak1 1Department of Internal Medicine, Pusan National  University School of Medicine, Medical Research  Institute, Pusan National University Hospital, Busan,  Korea; 2Namgu Public Health Center, Busan, Korea Received: 3 August 2015 Accepted: 19 November 2015 Address for Correspondence: Sun Hee Lee, MD Department of Internal Medicine, Pusan National University  School of Medicine, Medical Research Institute, Pusan National  University Hospital, 179 Gudeok-ro, Seo-gu, Busan 49241,  Korea E-mail: zzanmery@gmail.comhttp://dx.doi.org/10.3346/jkms.2016.31.3.376  • J Korean Med Sci 2016; 31: 376-381 INTRODUCTION Retaining patients with human immunodeficiency virus (HIV)  in medical care after initiation of effective antiretroviral therapy  (ART) is essential for successful HIV treatment.",Non-OADS,/arxiv_data1/oa_pdf/a2/40/jkms-31-376.PMC4779861.pdf
"• Predictors of Poor Retention in Care of HIV Patients http://jkms.org   377 http://dx.doi.org/10.3346/jkms.2016.31.3.376 First, based on the follow-up status of patients to the study  hospital as of 5 years after ART initiation, each patient was ini - tially classified as remained in care, dead at the study hospital,  transfer-out to other hospitals, or lost.",Non-OADS,/arxiv_data1/oa_pdf/a2/40/jkms-31-376.PMC4779861.pdf
• Predictors of Poor Retention in Care of HIV Patients 378  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.376ysis (Table 2).,Non-OADS,/arxiv_data1/oa_pdf/a2/40/jkms-31-376.PMC4779861.pdf
"• Predictors of Poor Retention in Care of HIV Patients http://jkms.org   379 http://dx.doi.org/10.3346/jkms.2016.31.3.376DISCUSSION In this study, we evaluated the factors predicting poor retention  in care after initiating ART in a retrospective cohort.",Non-OADS,/arxiv_data1/oa_pdf/a2/40/jkms-31-376.PMC4779861.pdf
• Predictors of Poor Retention in Care of HIV Patients 380  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.376as well as differences in healthcare systems and characteristics  of the study populations are likely to influence the estimates.,Non-OADS,/arxiv_data1/oa_pdf/a2/40/jkms-31-376.PMC4779861.pdf
"• Predictors of Poor Retention in Care of HIV Patients http://jkms.org   381 http://dx.doi.org/10.3346/jkms.2016.31.3.376AUTHOR CONTRIBUTION Study design: Lee S, Lee SH.",Non-OADS,/arxiv_data1/oa_pdf/a2/40/jkms-31-376.PMC4779861.pdf
ORCID Shinwon Lee http://orcid.org/0000-0001-7652-7093 Sun Hee Lee http://orcid.org/0000-0003-2093-3628 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/a2/40/jkms-31-376.PMC4779861.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Urinary Albumin Excretion and Vascular Function in  Rheumatoid Arthritis Rheumatoid arthritis (RA) is associated with significant cardiovascular (CV) morbidity and  mortality.",Non-OADS,/arxiv_data1/oa_pdf/50/ed/jkms-31-382.PMC4779862.pdf
"9, A-4020 Linz, Austria E-mail: herwigpi@yahoo.comhttp://dx.doi.org/10.3346/jkms.2016.31.3.382  • J Korean Med Sci 2016; 31: 382-388 INTRODUCTION It is well established that rheumatoid arthritis (RA) is associated  with increased cardiovascular (CV) morbidity and mortality (1,  2).",Non-OADS,/arxiv_data1/oa_pdf/50/ed/jkms-31-382.PMC4779862.pdf
• Urinary Albumin Excretion in Rheumatoid Arthritis http://jkms.org   383 http://dx.doi.org/10.3346/jkms.2016.31.3.382the n-RA group both were recruited from our inpatient as well  as from the outpatient clinic.,Non-OADS,/arxiv_data1/oa_pdf/50/ed/jkms-31-382.PMC4779862.pdf
• Urinary Albumin Excretion in Rheumatoid Arthritis 384  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.382Ethics statement The study was approved by the institutional review board of  Ethikkommission Land Oberösterreich (EK-Nr.,Non-OADS,/arxiv_data1/oa_pdf/50/ed/jkms-31-382.PMC4779862.pdf
• Urinary Albumin Excretion in Rheumatoid Arthritis http://jkms.org   385 http://dx.doi.org/10.3346/jkms.2016.31.3.382lying “more to the left” than F_6.,Non-OADS,/arxiv_data1/oa_pdf/50/ed/jkms-31-382.PMC4779862.pdf
• Urinary Albumin Excretion in Rheumatoid Arthritis 386  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.382development of MA.,Non-OADS,/arxiv_data1/oa_pdf/50/ed/jkms-31-382.PMC4779862.pdf
"Analysis and interpretation of data: Pier - inger H, Brummaier T, Schmid M, Pohanka E, Puchner R. Writ - ing or revision of the manuscript: Pieringer H, Brummaier T,  Schmid M, Piringer B, Auer-Hackenberg L, Hartl A, Puchner R,  Pohanka E. Study supervision: Pieringer H, Schmid M. ORCID Herwig Pieringer http://orcid.org/0000-0003-0401-7849 Tobias Brummaier http://orcid.org/0000-0002-9739-2084 Bettina Piringer http://orcid.org/0000-0002-5532-0373 Lorenz Auer-Hackenberg  http://orcid.org/0000-0002-5634-5791 Andreas Hartl http://orcid.org/0000-0003-2645-373X Rudolf Puchner http://orcid.org/0000-0003-3151-033X Erich Pohanka http://orcid.org/0000-0003-2598-0255 Michael Schmid http://orcid.org/0000-0003-4977-2258 REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/50/ed/jkms-31-382.PMC4779862.pdf
• Urinary Albumin Excretion in Rheumatoid Arthritis http://jkms.org   387 http://dx.doi.org/10.3346/jkms.2016.31.3.382mendations for diabetes and chronic kidney disease.,Non-OADS,/arxiv_data1/oa_pdf/50/ed/jkms-31-382.PMC4779862.pdf
"• Urinary Albumin Excretion in Rheumatoid Arthritis 388  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.382arthritis in the post penicillamine/gold era: association with hyperten - sion, but not therapy or inflammation.",Non-OADS,/arxiv_data1/oa_pdf/50/ed/jkms-31-382.PMC4779862.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Elevated Erythrocyte Sedimentation Rate Is Predictive of  Interstitial Lung Disease and Mortality in Dermatomyositis:   a Korean Retrospective Cohort Study Interstitial lung disease (ILD) is a major cause of death in patients with dermatomyositis  (DM).",Non-OADS,/arxiv_data1/oa_pdf/62/8e/jkms-31-389.PMC4779863.pdf
"Keywords:  Erythrocyte Sedimentation Rate; Interstitial Lung Disease; DermatomyositisDong Jin Go,1,2 Eun Young Lee,1   Eun Bong Lee,1 Yeong Wook Song,1,2  Maximilian Ferdinand Konig,3   and Jin Kyun Park1,2 1Department of Internal Medicine, Seoul National  University Hospital, Seoul, Korea; 2Department of  Molecular Medicine and Biopharmaceutical  Sciences, Graduate School of Convergence Science  and Technology, and College of Medicine, Medical  Research Institute, Seoul National University, Seoul,  Korea; 3Department of Medicine, Johns Hopkins  University School of Medicine, Baltimore, MD, USA Received: 31 August 2015 Accepted: 26 November 2015 Address for Correspondence: Jin Kyun Park, MD Department of Internal Medicine, Seoul National University  Hospital, 101 Daehak-ro, Jongno-gu, Seoul 03080, Korea E-mail: jinkyunpark@gmail.comhttp://dx.doi.org/10.3346/jkms.2016.31.3.389  • J Korean Med Sci 2016; 31: 389-396 INTRODUCTION Dermatomyositis (DM) is an autoimmune connective tissue  disease primarily involving the skeletal muscle and skin.",Non-OADS,/arxiv_data1/oa_pdf/62/8e/jkms-31-389.PMC4779863.pdf
"• Elevated ESR in Dermatomyositis 390  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.389able baseline ESR data at the time of DM diagnosis were exclud - ed, resulting in a final study cohort of 114 patients (Fig.",Non-OADS,/arxiv_data1/oa_pdf/62/8e/jkms-31-389.PMC4779863.pdf
"• Elevated ESR in Dermatomyositis http://jkms.org   391 http://dx.doi.org/10.3346/jkms.2016.31.3.389tive steroid dose (mg/year) was higher in DM patients with ILD  than in those without (6,352.0 [IQR, 3,774.0–8,545.0] vs. 4,665.0  [IQR, 2,022.5–7,430.0], respectively, P= 0.047).",Non-OADS,/arxiv_data1/oa_pdf/62/8e/jkms-31-389.PMC4779863.pdf
"• Elevated ESR in Dermatomyositis 392  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.389 In the ILD group, 10 (24.4%) of 41 patients with a baseline  ESR ≥ 30 mm/hour and none (0%) of 12 patients with a base - line ESR < 30 mm/hour died during follow-up ( P= 0.088, log- rank test; power 0.523) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/62/8e/jkms-31-389.PMC4779863.pdf
• Elevated ESR in Dermatomyositis http://jkms.org   393 http://dx.doi.org/10.3346/jkms.2016.31.3.389turn induce hepatic production of acute phase proteins (19).,Non-OADS,/arxiv_data1/oa_pdf/62/8e/jkms-31-389.PMC4779863.pdf
"• Elevated ESR in Dermatomyositis 394  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.389stream, whereas cytokine production in the context of ILD is  sufficient to induce an acute phase response.",Non-OADS,/arxiv_data1/oa_pdf/62/8e/jkms-31-389.PMC4779863.pdf
• Elevated ESR in Dermatomyositis http://jkms.org   395 http://dx.doi.org/10.3346/jkms.2016.31.3.389and statistical analyses: Go DJ.,Non-OADS,/arxiv_data1/oa_pdf/62/8e/jkms-31-389.PMC4779863.pdf
ORCID Dong Jin Go http://orcid.org/0000-0001-7350-3491 Eun Young Lee http://orcid.org/0000-0001-6975-8627 Eun Bong Lee http://orcid.org/0000-0003-0703-1208 Yeong Wook Song http://orcid.org/0000-0002-5384-3437 Maximilian Konig http://orcid.org/0000-0001-5045-5255 Jin Kyun Park http://orcid.org/0000-0003-2167-9393  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/62/8e/jkms-31-389.PMC4779863.pdf
• Elevated ESR in Dermatomyositis 396  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.389Dermatol  2012; 167: 1236-44.,Non-OADS,/arxiv_data1/oa_pdf/62/8e/jkms-31-389.PMC4779863.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Ultrasonographic Characteristics of the Follicular Variant  Papillary Thyroid Cancer according to the Tumor Size Follicular variant papillary thyroid cancer (FVPTC) is the second most common subtype after  conventional PTC.",Non-OADS,/arxiv_data1/oa_pdf/88/24/jkms-31-397.PMC4779864.pdf
"Keywords:  Follicular Variant; Papillary; Thyroid NeoplasmsEon Ju Jeon,1 Young Ju Jeong,2   Sung Hwan Park,2 Chang Ho Cho,3   Ho Sang Shon,1 and Eui Dal Jung1 1Department of Internal Medicine, Catholic  University of Daegu School of Medicine, Daegu,  Korea; 2Department of Surgery, Catholic University  of Daegu School of Medicine, Daegu, Korea;  3Department of Pathology, Catholic University of  Daegu School of Medicine, Daegu, Korea Received: 27 May 2015 Accepted: 9 November 2015 Address for Correspondence: Eui Dal Jung, MD Department of Internal Medicine, Catholic University of Daegu  School of Medicine, 33 Duryugongwon-ro 17-gil, Nam-gu,  Daegu 42472, Korea E-mail: jed15@cu.ac.krhttp://dx.doi.org/10.3346/jkms.2016.31.3.397  • J Korean Med Sci 2016; 31: 397-402 INTRODUCTION  Thyroid nodules are a common clinical problem, and differen - tiated thyroid cancer is becoming increasingly prevalent (1).",Non-OADS,/arxiv_data1/oa_pdf/88/24/jkms-31-397.PMC4779864.pdf
"• Ultrasonographic Characteristics of the Follicular Variant Papillary Thyroid Cancer 398  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.397MATERIALS AND METHODS  Subjects All patients who underwent thyroidectomy and were finally di - agnosed with PTC at our hospital between January 2007 and  December 2012 were searched and a total of 249 cases (83 FVPTCs,  166 conventional PTCs) were included in statistical analysis for  this study.",Non-OADS,/arxiv_data1/oa_pdf/88/24/jkms-31-397.PMC4779864.pdf
• Ultrasonographic Characteristics of the Follicular Variant Papillary Thyroid Cancer http://jkms.org   399 http://dx.doi.org/10.3346/jkms.2016.31.3.397 A B Fig.,Non-OADS,/arxiv_data1/oa_pdf/88/24/jkms-31-397.PMC4779864.pdf
"• Ultrasonographic Characteristics of the Follicular Variant Papillary Thyroid Cancer 400  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.397only 13 of 166 conventional PTCs (7.8%, P= 0.001).",Non-OADS,/arxiv_data1/oa_pdf/88/24/jkms-31-397.PMC4779864.pdf
• Ultrasonographic Characteristics of the Follicular Variant Papillary Thyroid Cancer http://jkms.org   401 http://dx.doi.org/10.3346/jkms.2016.31.3.397graphic features of FVPTC in comparison with conventional  PTCs.,Non-OADS,/arxiv_data1/oa_pdf/88/24/jkms-31-397.PMC4779864.pdf
"ORCID Eon Ju Jeon http://orcid.org/0000-0002-8858-5343 Young Ju Jeong http://orcid.org/0000-0002-7005-0850 Sung Hwan Park http://orcid.org/0000-0002-7225-1250 Chang Ho Cho http://orcid.org/0000-0003-2708-6011 Ho Sang Shon http://orcid.org/0000-0002-7443-9206 Eui Dal Jung http://orcid.org/0000-0003-2905-5382 REFERENCES 1. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Maz - zaferri EL, McIver B, Pacini F , Schlumberger M, et al.",Non-OADS,/arxiv_data1/oa_pdf/88/24/jkms-31-397.PMC4779864.pdf
"• Ultrasonographic Characteristics of the Follicular Variant Papillary Thyroid Cancer 402  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.397ogy, 1992, p42-121.",Non-OADS,/arxiv_data1/oa_pdf/88/24/jkms-31-397.PMC4779864.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Trends and Patterns of Hepatocellular Carcinoma Treatment in  Korea Multiple therapeutic modalities are available for hepatocellular carcinoma (HCC) treatment.",Non-OADS,/arxiv_data1/oa_pdf/1e/1a/jkms-31-403.PMC4779865.pdf
"Keywords:  Carcinoma; Hepatocellular; Treatment; Trend; KoreaYoung Mi Hong,1 Ki Tae Yoon,1   Mong Cho,1 Dae Hwan Kang,1   Hyung Wook Kim,1 Cheol Woong Choi,1  Su Bum Park,1 Jeong Heo,2   Hyun Young Woo,2 and Won Lim2 1Department of Internal Medicine, Research  Institute for Convergence of Biomedical Science  and Technology, Pusan National University Yangsan  Hospital, Yangsan, Korea; 2Department of Internal  Medicine, Pusan National University Hospital,  Busan, Korea  Received: 23 September 2015 Accepted: 9 November 2015 Address for Correspondence: Ki Tae Yoon, MD Department of Internal Medicine, Pusan National University  School of Medicine, Pusan National University Yangsan Hospital,  20 Geumo-ro, Mulgeum-eup, Yangsan 50612, Korea E-mail: ktyoon@pusan.ac.krhttp://dx.doi.org/10.3346/jkms.2016.31.3.403  • J Korean Med Sci 2016; 31: 403-409 INTRODUCTION Hepatocellular carcinoma (HCC) is the fifth most common can - cer and the third leading cause of cancer-related deaths world - wide (1,2).",Non-OADS,/arxiv_data1/oa_pdf/1e/1a/jkms-31-403.PMC4779865.pdf
• Trends and Patterns of HCC Treatment 404  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.403medical costs from the government.,Non-OADS,/arxiv_data1/oa_pdf/1e/1a/jkms-31-403.PMC4779865.pdf
• Trends and Patterns of HCC Treatment http://jkms.org   405 http://dx.doi.org/10.3346/jkms.2016.31.3.403Table 2.,Non-OADS,/arxiv_data1/oa_pdf/1e/1a/jkms-31-403.PMC4779865.pdf
• Trends and Patterns of HCC Treatment 406  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.403rean HCC patients according to the national cancer registry’s  report (6).,Non-OADS,/arxiv_data1/oa_pdf/1e/1a/jkms-31-403.PMC4779865.pdf
• Trends and Patterns of HCC Treatment http://jkms.org   407 http://dx.doi.org/10.3346/jkms.2016.31.3.403metastatic lesions.,Non-OADS,/arxiv_data1/oa_pdf/1e/1a/jkms-31-403.PMC4779865.pdf
"• Trends and Patterns of HCC Treatment 408  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.403our study was relatively shorter than that in Child-Pugh A pa - tients, as reported in the final analysis of the global investiga - tion of therapeutic decisions in HCC and of its treatment with  sorafenib (20).",Non-OADS,/arxiv_data1/oa_pdf/1e/1a/jkms-31-403.PMC4779865.pdf
ORCID Young Mi Hong http://orcid.org/0000-0001-5427-7505 Ki Tae Yoon http://orcid.org/0000-0002-8580-0239 Mong Cho http://orcid.org/0000-0002-0498-6300 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/1e/1a/jkms-31-403.PMC4779865.pdf
• Trends and Patterns of HCC Treatment http://jkms.org   409 http://dx.doi.org/10.3346/jkms.2016.31.3.403271: 909-18.,Non-OADS,/arxiv_data1/oa_pdf/1e/1a/jkms-31-403.PMC4779865.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357The Risk of Abdominal Obesity according to the Degree of Non- Alcoholic Fatty Liver Disease in Korean Men Although non-alcoholic fatty liver disease has been reported as a cardiometabolic risk  factor, the effect of non-alcoholic fatty liver is yet to be clarified on abdominal obesity.",Non-OADS,/arxiv_data1/oa_pdf/b7/b3/jkms-31-410.PMC4779866.pdf
"Keywords:  Non-Alcoholic Fatty Liver Disease; Obesity, Abdominal; Waist CircumferenceSung Keun Park,1,2 Jae-Hong Ryoo,2  Joong-Myung Choi,2 Min Woo Seo,2   and Chung Min Park2 1Total Healthcare Center, Kangbuk Samsung  Hospital, Sungkyunkwan University, School of  Medicine, Seoul, Korea; 2Departments of Preventive  Medicine, School of Medicine, Kyung Hee University,  Seoul, Korea Received: 10 June 2015 Accepted: 13 November 2015 Address for Correspondence: Joong-Myung Choi, MD Department of Preventive Medicine, Kyung Hee University  School of Medicine, 26 Kyungheedae-ro, Dongdaemun-gu,  Seoul 02447, Korea E-mail: jmchoi@khu.ac.krhttp://dx.doi.org/10.3346/jkms.2016.31.3.410  • J Korean Med Sci 2016; 31: 410-416 INTRODUCTION  Obesity is a significant medical issue threatening public health  not only in Western countries but also in Asian countries.",Non-OADS,/arxiv_data1/oa_pdf/b7/b3/jkms-31-410.PMC4779866.pdf
"• Non-Alcoholic Fatty Liver Disease and Obesity http://jkms.org   411 http://dx.doi.org/10.3346/jkms.2016.31.3.410a positive serologic marker for hepatitis C virus antibody (HCV - Ab); 308 had abnormal ultrasonographical findings of chronic  liver disease, liver cirrhosis, and/or current or past history of  clonorchiasis; 149 had a past history of a malignancy; 226 had a  past history of cardiovascular disease; 2,107 were receiving med - ication for lipid-lowering agents; 4,479 had an alcohol intake of  ≥ 20 g/day; 2,002 had elevated γ-glutamyltransferase (GGT)  levels ( > 100 U/L); 375 had elevated alanine aminotransferase  (ALT) levels ( > 100 U/L) and 6,245 were diagnosed as baseline  abdominal obesity (WC > 90 cm) at initial examinations.",Non-OADS,/arxiv_data1/oa_pdf/b7/b3/jkms-31-410.PMC4779866.pdf
• Non-Alcoholic Fatty Liver Disease and Obesity 412  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.410ticipants at the time of enrollment in relation to the NAFLD cat - egories.,Non-OADS,/arxiv_data1/oa_pdf/b7/b3/jkms-31-410.PMC4779866.pdf
• Non-Alcoholic Fatty Liver Disease and Obesity http://jkms.org   413 http://dx.doi.org/10.3346/jkms.2016.31.3.410Table 2.,Non-OADS,/arxiv_data1/oa_pdf/b7/b3/jkms-31-410.PMC4779866.pdf
• Non-Alcoholic Fatty Liver Disease and Obesity 414  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.410participants and people with incident obesity.,Non-OADS,/arxiv_data1/oa_pdf/b7/b3/jkms-31-410.PMC4779866.pdf
"• Non-Alcoholic Fatty Liver Disease and Obesity http://jkms.org   415 http://dx.doi.org/10.3346/jkms.2016.31.3.410spite this limitation, US might be clinically reasonable and prop - er modality to diagnose NAFLD in this study.",Non-OADS,/arxiv_data1/oa_pdf/b7/b3/jkms-31-410.PMC4779866.pdf
ORCID Sung Keun Park http://orcid.org/0000-0003-4703-9917 Jae-Hong Ryoo http://orcid.org/0000-0002-5232-1426 Joong-Myung Choi http://orcid.org/0000-0002-3610-6662 Min Woo Seo http://orcid.org/0000-0002-6574-8453 Chung Min Park http://orcid.org/0000-0003-0604-4672   REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/b7/b3/jkms-31-410.PMC4779866.pdf
• Non-Alcoholic Fatty Liver Disease and Obesity 416  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.41023.,Non-OADS,/arxiv_data1/oa_pdf/b7/b3/jkms-31-410.PMC4779866.pdf
• Non-Alcoholic Fatty Liver Disease and Obesity http://jkms.org  http://dx.doi.org/10.3346/jkms.2016.31.3.410Supplementary Table 1.,Non-OADS,/arxiv_data1/oa_pdf/b7/b3/jkms-31-410.PMC4779866.pdf
• Non-Alcoholic Fatty Liver Disease and Obesity http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.410Supplementary Table 2.,Non-OADS,/arxiv_data1/oa_pdf/b7/b3/jkms-31-410.PMC4779866.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Correlations between the CagA Antigen and Serum Levels of  Anti- Helicobacter pylori  IgG and IgA in Children We tested correlations between anti- Helicobacter pylori  IgG and IgA levels and the urease  test, anti-CagA protein antibody, degree of gastritis, and age.",Non-OADS,/arxiv_data1/oa_pdf/41/c4/jkms-31-417.PMC4779867.pdf
"Keywords:  Antibodies IgG/IgA; Helicobacter pylori ; CagA Protein; Urease; ChildrenJi-Hyun Seo,1 Chun Woo Lim,1   Ji Sook Park,1 Jung Sook Yeom,1   Jae-Young Lim,1 Jin-Su Jun,1   Hyang-Ok Woo,1 Hee-Shang Youn,1  Seung-Chul Baik,2 Woo-Kon Lee,2  Myung-Je Cho,2 and Kwang-Ho Rhee2 1Department of Pediatrics, Gyeongsang National  University School of Medicine, Gyeongsang Institute  of Health Science, Jinju, Korea; 2Department of  Microbiology, Gyeongsang National University  School of Medicine, Gyeongsang Institute of Health  Science, Jinju, Korea  Received: 1 September 2015 Accepted: 10 December 2015 Address for Correspondence: Hee-Shang Youn, MD Department of Pediatrics, Gyeongsang National University  School of Medicine, 15 Jinju-daero 816-beon-gil, Jinju 52727,  Korea E-mail: hsyoun@gnu.ac.kr Funding:  This study was supported by a grant from the National  R&D Program for Cancer Control of the Ministry of Health &  Welfare of the Republic of Korea (0820050).http://dx.doi.org/10.3346/jkms.2016.31.3.417  • J Korean Med Sci 2016; 31: 417-422 INTRODUCTION Helicobacter pylori  is an important etiological factor for acute  and chronic gastritis, gastric and duodenal ulcers, and gastric  adenocarcinoma (1).",Non-OADS,/arxiv_data1/oa_pdf/41/c4/jkms-31-417.PMC4779867.pdf
• CagA and Serum Levels of Anti- H. pylori  IgG and IgA 418  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.417Table 1.,Non-OADS,/arxiv_data1/oa_pdf/41/c4/jkms-31-417.PMC4779867.pdf
"• CagA and Serum Levels of Anti- H. pylori  IgG and IgA http://jkms.org   419 http://dx.doi.org/10.3346/jkms.2016.31.3.417Results of the urease test and histopathological findings The positivity rates for the urease test were 37.1% at 0-4 years,  38.0% at 5-9 years, and 39.9% at 10-15 years ( P= 0.003).",Non-OADS,/arxiv_data1/oa_pdf/41/c4/jkms-31-417.PMC4779867.pdf
"• CagA and Serum Levels of Anti- H. pylori  IgG and IgA 420  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.417DISCUSSION In the present study, we found that the presence of the CagA  antigen was the major factor related to high levels of anti- H. py - lori IgG and IgA antibodies, regardless of age.",Non-OADS,/arxiv_data1/oa_pdf/41/c4/jkms-31-417.PMC4779867.pdf
• CagA and Serum Levels of Anti- H. pylori  IgG and IgA http://jkms.org   421 http://dx.doi.org/10.3346/jkms.2016.31.3.417antigens in the same strain (9).,Non-OADS,/arxiv_data1/oa_pdf/41/c4/jkms-31-417.PMC4779867.pdf
ORCID Ji-Hyun Seo http://orcid.org/0000-0002-0691-3957 Chun Woo Lim http://orcid.org/0000-0003-4146-4349 Ji Sook Park http://orcid.org/0000-0002-4704-2246 Jung Sook Yeom http://orcid.org/0000-0003-0688-7493  Jae-Young Lim http://orcid.org/0000-0001-5205-202X  Jin-Su Jun http://orcid.org/0000-0002-6382-6286 Hyang-Ok Woo http://orcid.org/0000-0001-8849-9341 Hee-Shang Youn http://orcid.org/0000-0002-5498-838X Seung-Chul Baik http://orcid.org/0000-0001-6033-4078 Woo-Kon Lee http://orcid.org/0000-0003-3913-2265 Myung-Je Cho http://orcid.org/ 0000-0002-4958-9827 Kwang-Ho Rhee http://orcid.org/0000-0002-4422-4992 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/41/c4/jkms-31-417.PMC4779867.pdf
• CagA and Serum Levels of Anti- H. pylori  IgG and IgA 422  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.417say for the diagnosis of Helicobacter pylori infection in children from dif - ferent age groups with and without duodenal ulcer.,Non-OADS,/arxiv_data1/oa_pdf/41/c4/jkms-31-417.PMC4779867.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Trends in Survival and Incidence of Bronchopulmonary  Dysplasia in Extremely Preterm Infants at 23-26 Weeks Gestation The aim of this study was to investigate the relationship between survival and incidence of  bronchopulmonary dysplasia (BPD) in extremely premature infants, and identify clinical  factors responsible for this association.",Non-OADS,/arxiv_data1/oa_pdf/47/6b/jkms-31-423.PMC4779868.pdf
"Received: 17 July 2015 Accepted: 14 December 2015 Address for Correspondence: Won Soon Park, MD Department of Pediatrics, Samsung Medical Center,  Sungkyunkwan University School of Medicine, 81 Irwon-ro,  Gangnam-gu, Seoul 06351, Korea E-mail: wonspark@skku.eduhttp://dx.doi.org/10.3346/jkms.2016.31.3.423  • J Korean Med Sci 2016; 31: 423-429 INTRODUCTION Bronchopulmonary dysplasia (BPD), a chronic lung disease in  premature infants that requires prolonged ventilator and oxy - gen therapy, is a serious complication of preterm birth (1,2).",Non-OADS,/arxiv_data1/oa_pdf/47/6b/jkms-31-423.PMC4779868.pdf
• Survival and Bronchopulmonary Dysplasia in Premature Infants 424  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.423CU.,Non-OADS,/arxiv_data1/oa_pdf/47/6b/jkms-31-423.PMC4779868.pdf
"• Survival and Bronchopulmonary Dysplasia in Premature Infants http://jkms.org   425 http://dx.doi.org/10.3346/jkms.2016.31.3.423Changes in survival rate, BPD incidence, and other  morbidity rates  The mortality, BPD incidence, and other morbidity rates among  infants during period I and II are shown in Table 3.",Non-OADS,/arxiv_data1/oa_pdf/47/6b/jkms-31-423.PMC4779868.pdf
• Survival and Bronchopulmonary Dysplasia in Premature Infants 426  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.423pared to period I (32.9%; P= 0.004).,Non-OADS,/arxiv_data1/oa_pdf/47/6b/jkms-31-423.PMC4779868.pdf
"• Survival and Bronchopulmonary Dysplasia in Premature Infants http://jkms.org   427 http://dx.doi.org/10.3346/jkms.2016.31.3.423sible for these changes include higher antenatal steroid use and  improved 5-min Apgar scores, which were associated with im - proved survival in infants at 23-24 weeks gestation.",Non-OADS,/arxiv_data1/oa_pdf/47/6b/jkms-31-423.PMC4779868.pdf
ORCID  Jin Kyu Kim http://orcid.org/0000-0002-3502-7604 Yun Sil Chang http://orcid.org/0000-0001-9201-2938,Non-OADS,/arxiv_data1/oa_pdf/47/6b/jkms-31-423.PMC4779868.pdf
• Survival and Bronchopulmonary Dysplasia in Premature Infants 428  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.423Sein Sung http://orcid.org/0000-0002-8717-6142 So Yoon Ahn http://orcid.org/0000-0002-1821-3173 Hye Soo Yoo http://orcid.org/0000-0001-7230-1839 Won Soon Park http://orcid.org/0000-0002-8245-4692 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/47/6b/jkms-31-423.PMC4779868.pdf
• Survival and Bronchopulmonary Dysplasia in Premature Infants http://jkms.org   429 http://dx.doi.org/10.3346/jkms.2016.31.3.423birth weight infants.,Non-OADS,/arxiv_data1/oa_pdf/47/6b/jkms-31-423.PMC4779868.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Interleukin-6 Receptor Polymorphisms Contribute to the  Neurological Status of Korean Patients with Ischemic Stroke To investigate the contribution of the interleukin-6 receptor (IL-6R) gene single nucleotide  polymorphisms (SNPs) to the neurological status of Korean patients with ischemic stroke  (IS), two SNPs of the IL-6R gene (rs4845617, 5 UTR; rs2228144, Ala31Ala) were selected.",Non-OADS,/arxiv_data1/oa_pdf/cd/db/jkms-31-430.PMC4779869.pdf
"Keywords:  Interleukin 6-Interleukin 6 Receptor Fusion Protein, Recombinant; Brain  Ischemia; Stroke; Neurological Manifestations; PolymorphismDong Hwan Kim,1 Seung Don Yoo,1  Jinmann Chon,1 Dong Hwan Yun,1   Hee-Sang Kim,1 Hae Jeong Park,2   Su Kang Kim,2 Joo-Ho Chung,2   Jin Kyu Kang,1 and Seung Ah Lee1 1Department of Physical Medicine & Rehabilitation,  College of Medicine, Kyung Hee University, Seoul,  Korea; 2Kohwang Medical Research Institute, Kyung  Hee University, Seoul, Korea Received: 25 March 2015 Accepted: 23 September 2015 Address for Correspondence: Seung Ah Lee, MD Department of Physical Medicine & Rehabilitation, College of  Medicine, Kyung Hee University, 26 Kyungheedae-ro,  Dongdaemun-gu, Seoul 02447, Korea E-mail: lsarang80@gmail.com Funding:  This work was supported by a grant from Kyung Hee  University in 2015 (KHU-20150830).http://dx.doi.org/10.3346/jkms.2016.31.3.430  • J Korean Med Sci 2016; 31: 430-434 INTRODUCTION Despite the recent advancements in prevention and treatment  of stroke, stroke remains the leading cause of disability and the  fifth leading cause of death in the US.",Non-OADS,/arxiv_data1/oa_pdf/cd/db/jkms-31-430.PMC4779869.pdf
• IL-6R Polymorphisms in Korean Ischemic Stroke http://jkms.org   431 http://dx.doi.org/10.3346/jkms.2016.31.3.430MATERIALS AND METHODS  All participants with stroke were patients who visited the De - partments of Rehabilitation Medicine at Kyung Hee Medical  Center and Kyung Hee University Hospital at Gangdong.,Non-OADS,/arxiv_data1/oa_pdf/cd/db/jkms-31-430.PMC4779869.pdf
"To obtain odds ratios (ORs), 95% confidence intervals (CIs),  and P values adjusted for age and sex as covariates, SNPAnalyz - er Pro (ISTECH, Goyang, Korea), Helixtree (Golden Helix, Boz - eman, MT, USA), and SNPStats (http://bioinfo.iconcologia.net/ index.php?",Non-OADS,/arxiv_data1/oa_pdf/cd/db/jkms-31-430.PMC4779869.pdf
• IL-6R Polymorphisms in Korean Ischemic Stroke 432  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.430Table 2.,Non-OADS,/arxiv_data1/oa_pdf/cd/db/jkms-31-430.PMC4779869.pdf
"• IL-6R Polymorphisms in Korean Ischemic Stroke http://jkms.org   433 http://dx.doi.org/10.3346/jkms.2016.31.3.430of the GG haplotype was higher in the NIHSS 2 group of IS pa - tients ( P= 0.014, P= 0.0024, respectively).",Non-OADS,/arxiv_data1/oa_pdf/cd/db/jkms-31-430.PMC4779869.pdf
ORCID Dong Hwan Kim http://orcid.org/0000-0002-3812-5509 Seung Ah Lee http://orcid.org/0000-0002-3426-6259 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/cd/db/jkms-31-430.PMC4779869.pdf
• IL-6R Polymorphisms in Korean Ischemic Stroke 434  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.4302.,Non-OADS,/arxiv_data1/oa_pdf/cd/db/jkms-31-430.PMC4779869.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Simplified Radiographic Damage Index for Affected Joints in  Chronic Gouty Arthritis  The aim of this study was to develop and validate a new radiographic damage scoring  method (DAmagE index of GoUt; DAEGU) in chronic gout using plain radiography.",Non-OADS,/arxiv_data1/oa_pdf/4e/f3/jkms-31-435.PMC4779870.pdf
"http://dx.doi.org/10.3346/jkms.2016.31.3.435  • J Korean Med Sci 2016; 31: 435-442 INTRODUCTION Gout, one of the most common types of inflammatory arthritis,  occurs when monosodium urate (MSU) crystals are deposited  within or around the joints (1).",Non-OADS,/arxiv_data1/oa_pdf/4e/f3/jkms-31-435.PMC4779870.pdf
"• Radiographic Damage Index of Gout 436  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.435so far (8,11,12).",OADS,/arxiv_data1/oa_pdf/4e/f3/jkms-31-435.PMC4779870.pdf
• Radiographic Damage Index of Gout http://jkms.org   437 http://dx.doi.org/10.3346/jkms.2016.31.3.435graphs for the assessment of intraobserver and interobserver  agreement.,Non-OADS,/arxiv_data1/oa_pdf/4e/f3/jkms-31-435.PMC4779870.pdf
• Radiographic Damage Index of Gout 438  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.435(IQR 10.0-123.0) months.,OADS,/arxiv_data1/oa_pdf/4e/f3/jkms-31-435.PMC4779870.pdf
"• Radiographic Damage Index of Gout http://jkms.org   439 http://dx.doi.org/10.3346/jkms.2016.31.3.435  The Kappa coefficients for the total score between the DAE - GU and SvdH methods were 0.869 (0.618-1.000) for radiologist  1 and 1.000 (1.000-1.000) for radiologist 2 (Table 4), illustrating  very good agreement.",OADS,/arxiv_data1/oa_pdf/4e/f3/jkms-31-435.PMC4779870.pdf
"• Radiographic Damage Index of Gout 440  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.435DISCUSSION  Although nearly half of all patients experience radiographic  changes over the course of disease, a reliable and simple radio - graphic outcome measure for structural joint damage in pa - tients with chronic gout has not yet been established (2).",Non-OADS,/arxiv_data1/oa_pdf/4e/f3/jkms-31-435.PMC4779870.pdf
"• Radiographic Damage Index of Gout http://jkms.org   441 http://dx.doi.org/10.3346/jkms.2016.31.3.435new method, which uses plain radiography, is reliable and fea - sible for assessing radiographic changes, even though our meth - od has somewhat low sensitivity and accuracy for the detection  of bone erosion at the joint affected by gout.",Non-OADS,/arxiv_data1/oa_pdf/4e/f3/jkms-31-435.PMC4779870.pdf
ORCID Chang-Nam Son http://orcid.org/0000-0002-1722-2190 Tae Eun Kim http://orcid.org/0000-0001-7710-5263 Kyungmin Park http://orcid.org/0000-0002-0049-574X Jun Hyun Hwang http://orcid.org/0000-0001-8547-0893 Seong-Kyu Kim http://orcid.org/0000-0002-7780-0167 REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/4e/f3/jkms-31-435.PMC4779870.pdf
"• Radiographic Damage Index of Gout 442  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.435T, Lobo M, Gamble G, McQueen FM.",OADS,/arxiv_data1/oa_pdf/4e/f3/jkms-31-435.PMC4779870.pdf
• Radiographic Damage Index of Gout http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.435Supplementary Table 1.,Non-OADS,/arxiv_data1/oa_pdf/4e/f3/jkms-31-435.PMC4779870.pdf
• Radiographic Damage Index of Gout http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.435Supplementary Table 2.,Non-OADS,/arxiv_data1/oa_pdf/4e/f3/jkms-31-435.PMC4779870.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Is Routine Thromboprophylaxis Needed in Korean Patients  Undergoing Unicompartmental Knee Arthroplasty?",Non-OADS,/arxiv_data1/oa_pdf/f1/17/jkms-31-443.PMC4779871.pdf
"Keywords:  Venous Thromboembolism; Natural History; Arthroplasty; Replacement; Knee;  ThromboprophylaxisIn Jun Koh,1,2 Ju Hwan Kim,3 Man Soo Kim,1  Sung Won Jang,1 Chulkyu Kim,1 and  Yong In1,2 1Department of Orthopaedic Surgery, The Catholic  University of Korea, Seoul St. Mary’s Hospital, Seoul,  Korea; 2Department of Orthopaedic Surgery, The  Catholic University of Korea College of Medicine,  Seoul, Korea; 3Gangseo Himchan Hospital, Seoul,  Korea Received: 13 September 2015 Accepted: 10 December 2015 Address for Correspondence: Yong In, MD Department of Orthopaedic Surgery, The Catholic University of  Korea, Seoul St. Mary’s Hospital, 222 Banpo-daero, Seocho-gu,  Seoul 06591, Korea E-mail: iy1000@catholic.ac.krhttp://dx.doi.org/10.3346/jkms.2016.31.3.443  • J Korean Med Sci 2016; 31: 443-448 INTRODUCTION Venous thromboembolism (VTE), either deep vein thrombosis  (DVT) or pulmonary embolism (PE) is one of the most common  complications following total knee arthroplasty (TKA) (1,2).",Non-OADS,/arxiv_data1/oa_pdf/f1/17/jkms-31-443.PMC4779871.pdf
• Venous Thromboembolism Following UKA in Korean Patients 444  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.44378 primary UKAs (unilateral or same-day bilateral) between  March 2013 and March 2014 at single institution were reviewed  using a prospectively collected database.,OADS,/arxiv_data1/oa_pdf/f1/17/jkms-31-443.PMC4779871.pdf
• Venous Thromboembolism Following UKA in Korean Patients http://jkms.org   445 http://dx.doi.org/10.3346/jkms.2016.31.3.443Table 1.,Non-OADS,/arxiv_data1/oa_pdf/f1/17/jkms-31-443.PMC4779871.pdf
• Venous Thromboembolism Following UKA in Korean Patients 446  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.443ulation.,Non-OADS,/arxiv_data1/oa_pdf/f1/17/jkms-31-443.PMC4779871.pdf
"• Venous Thromboembolism Following UKA in Korean Patients http://jkms.org   447 http://dx.doi.org/10.3346/jkms.2016.31.3.443boprophylaxis rather than VTE screening test is recommended  in all patients undergoing TKA (1,3,4), routine MDCT for VTE  screening is not generally accepted in real clinical practice.",Non-OADS,/arxiv_data1/oa_pdf/f1/17/jkms-31-443.PMC4779871.pdf
ORCID In Jun Koh http://orcid.org/0000-0002-7941-1587 Ju Hwan Kim http://orcid.org/0000-0002-8288-8853 Man Soo Kim http://orcid.org/0000-0002-1374-9964 Sung Won Jang http://orcid.org/0000-0003-1276-1141 Chulkyu Kim http://orcid.org/0000-0001-7220-6938 Yong In http://orcid.org/0000-0002-5932-3934  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/f1/17/jkms-31-443.PMC4779871.pdf
• Venous Thromboembolism Following UKA in Korean Patients 448  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.443embolic prophylaxis guidelines applicable to unicompartmental knee  replacement?,Non-OADS,/arxiv_data1/oa_pdf/f1/17/jkms-31-443.PMC4779871.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Epidemiology of Emergency Medical Services-Assessed Mass  Casualty Incidents according to Causes  To effectively mitigate and reduce the burden of mass casualty incidents (MCIs),  preparedness measures should be based on MCIs’ epidemiological characteristics.",Non-OADS,/arxiv_data1/oa_pdf/4e/1c/jkms-31-449.PMC4779872.pdf
"Keywords:  Wound and Injuries; Mass Casualty Incidents; EpidemiologyJu Ok Park,1 Sang Do Shin,2   Kyoung Jun Song,2 Ki Jeong Hong,2   and Jungeun Kim3 1Department of Emergency Medicine, Hallym  University College of Medicine and Dongtan Sacred  Heart Hospital, Hwaseong, Korea; 2Department of  Emergency Medicine, Seoul National University  College of Medicine, Seoul, Korea; 3Laboratory of  Emergency Medical Service, Seoul National  University Hospital Biomedical Research Institute,  Seoul, Korea Received: 4 September 2015 Accepted: 19 November 2015 Address for Correspondence: Ju Ok Park, MD Department of Emergency Medicine, Hallym University College  of Medicine and Dongtan Sacred Heart Hospital,   7 Keunjaebong-gil, Hwaseong 18450, Korea E-mail: juok.park@gmail.com Funding:  This work was supported by the Research Program,  which is funded by the Korea Centers for Disease Control and  Prevention (2014-E33011-00).http://dx.doi.org/10.3346/jkms.2016.31.3.449  • J Korean Med Sci 2016; 31: 449-456 INTRODUCTION Mass casualty incidents (MCIs) are defined as accidents that re - sult in a number of victims that exceed the local medical or  health care system’s ability to meet the victims’ healthcare  needs.",Non-OADS,/arxiv_data1/oa_pdf/4e/1c/jkms-31-449.PMC4779872.pdf
• Epidemiology of Mass Casualty Incidents 450  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.449hospital variables.,Non-OADS,/arxiv_data1/oa_pdf/4e/1c/jkms-31-449.PMC4779872.pdf
"The intentional nature of the events, mechanism of  injury, and place of injury were categorized according to ver - sion 1.2 of the International Classification of External Causes of  Injuries (ICECI version 1.2; http://www.iceci.org).",OADS,/arxiv_data1/oa_pdf/4e/1c/jkms-31-449.PMC4779872.pdf
• Epidemiology of Mass Casualty Incidents http://jkms.org   451 http://dx.doi.org/10.3346/jkms.2016.31.3.449dominantly rural area).,Non-OADS,/arxiv_data1/oa_pdf/4e/1c/jkms-31-449.PMC4779872.pdf
"• Epidemiology of Mass Casualty Incidents 452  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.449 Among the 2,578 patients, 1,640 (63.6%) patients were dis - charged from the ED and 617 (23.9%) were admitted.",OADS,/arxiv_data1/oa_pdf/4e/1c/jkms-31-449.PMC4779872.pdf
• Epidemiology of Mass Casualty Incidents http://jkms.org   453 http://dx.doi.org/10.3346/jkms.2016.31.3.449Table 4.,Non-OADS,/arxiv_data1/oa_pdf/4e/1c/jkms-31-449.PMC4779872.pdf
• Epidemiology of Mass Casualty Incidents 454  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.449be possible to determine the number of patients that would ex - ceed the available resources at a given time if we could measure  the available resources at the time of the MCI.,Non-OADS,/arxiv_data1/oa_pdf/4e/1c/jkms-31-449.PMC4779872.pdf
"• Epidemiology of Mass Casualty Incidents http://jkms.org   455 http://dx.doi.org/10.3346/jkms.2016.31.3.449MCI, with RTAs typically resulting in blunt trauma and FAs typi - cally resulting in respiratory difficulty.",Non-OADS,/arxiv_data1/oa_pdf/4e/1c/jkms-31-449.PMC4779872.pdf
"• Epidemiology of Mass Casualty Incidents 456  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.449on prehospital EMS and ED resources, and MCIs from CBs may  create a burden on hospital resources.",Non-OADS,/arxiv_data1/oa_pdf/4e/1c/jkms-31-449.PMC4779872.pdf
ORCID Ju Ok Park http://orcid.org/0000-0002-1024-3626 Sang Do Shin http://orcid.org/0000-0003-4953-2916 Kyoung Jun Song http://orcid.org/0000-0002-0027-6352 Ki Jeong Hong http://orcid.org/0000-0003-3334-817X Jeungeun Kim http://orcid.org/0000-0002-5457-745XREFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/4e/1c/jkms-31-449.PMC4779872.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Mammographic Breast Density Evaluation in Korean Women  Using Fully Automated Volumetric Assessment The purpose was to present mean breast density of Korean women according to age using  fully automated volumetric assessment.",Non-OADS,/arxiv_data1/oa_pdf/b1/90/jkms-31-457.PMC4779873.pdf
"Keywords:  Mammographic Density; Breast; Korea; Radiographic Image Interpretation,  Computer-Assisted; MammographyInyoung Youn, SeonHyeong Choi,   Shin Ho Kook, and Yoon Jung Choi Department of Radiology, Kangbuk Samsung  Hospital, Sungkyunkwan University School of  Medicine, Seoul, Korea Received: 31 March 2015 Accepted: 9 November 2015 Address for Correspondence: SeonHyeong Choi, MD Department of Radiology, Kangbuk Samsung Hospital,   29 Saemunan-ro, Jongno-gu, Seoul 03181, Korea E-mail: seonhyeong.choi@samsung.comhttp://dx.doi.org/10.3346/jkms.2016.31.3.457  • J Korean Med Sci 2016; 31: 457-462 INTRODUCTION Breast density is defined as the proportion of fibroglandular tis ­ sue in the total breast volume.",Non-OADS,/arxiv_data1/oa_pdf/b1/90/jkms-31-457.PMC4779873.pdf
"• Mammographic Density Using Automated Volumetric Assessment 458  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.457VA, which could be used for standard reference.",OADS,/arxiv_data1/oa_pdf/b1/90/jkms-31-457.PMC4779873.pdf
• Mammographic Density Using Automated Volumetric Assessment http://jkms.org   459 http://dx.doi.org/10.3346/jkms.2016.31.3.457Fig.,Non-OADS,/arxiv_data1/oa_pdf/b1/90/jkms-31-457.PMC4779873.pdf
• Mammographic Density Using Automated Volumetric Assessment 460  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.457Number (%) Year < 50 ≥ 50100 80 60 40 20 0VDG 4 VDG 3 VDG 2 VDG 1 Fig.,Non-OADS,/arxiv_data1/oa_pdf/b1/90/jkms-31-457.PMC4779873.pdf
"• Mammographic Density Using Automated Volumetric Assessment http://jkms.org   461 http://dx.doi.org/10.3346/jkms.2016.31.3.457this is true even for patients who are in the 40­54 year age group  (15,20).",Non-OADS,/arxiv_data1/oa_pdf/b1/90/jkms-31-457.PMC4779873.pdf
• Mammographic Density Using Automated Volumetric Assessment 462  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.457ORCID Inyoung Youn http://orcid.org/0000­0002­3518­3332 SeonHyeong Choi http://orcid.org/0000­0002­4323­6481 Shin Ho Kook http://orcid.org/0000­0003­2330­2135 Yoon Jung Choi http://orcid.org/0000­0001­7223­5421  REFERENCES 1.,OADS,/arxiv_data1/oa_pdf/b1/90/jkms-31-457.PMC4779873.pdf
Available at http://globocan.iarc.fr [accessed on March 2015].,Non-OADS,/arxiv_data1/oa_pdf/b1/90/jkms-31-457.PMC4779873.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Genetic Variants in the Wnt Signaling Pathway Are Not  Associated with Survival Outcome of Non-Small Cell Lung  Cancer in a Korean Population Recently, genetic variants in the WNT signaling pathway have been reported to affect the  survival outcome of Caucasian patients with early stage non-small cell lung cancer  (NSCLC).",Non-OADS,/arxiv_data1/oa_pdf/e6/e5/jkms-31-463.PMC4779874.pdf
"Received: 1 October 2015 Accepted: 14 December 2015 Address for Correspondence: Jae Yong Park, MD Departments of Internal Medicine and Biochemistry and Cell  Biology, Kyungpook National University School of Medicine,   807 Hoguk-ro, Buk-gu, Daegu 41404, Korea  E-mail: jaeyong@knu.ac.kr Funding:  This study was supported by the R &D program of  MKE/KEIT (10040393, Development and commercialization of  molecular diagnostic technologies for lung cancer through  clinical validation).http://dx.doi.org/10.3346/jkms.2016.31.3.463  • J Korean Med Sci 2016; 31: 463-466 Lung cancer is the most common cause of cancer-related deaths.",Non-OADS,/arxiv_data1/oa_pdf/e6/e5/jkms-31-463.PMC4779874.pdf
• Variants in WNT Pathway Genes and Prognosis of NSCLC 464  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.463patients with surgically resected NSCLC for curative purpose  collected by Seoul National University Hospital (SNUH) be - tween September 2005 and October 2010 were also included in  this study.,OADS,/arxiv_data1/oa_pdf/e6/e5/jkms-31-463.PMC4779874.pdf
"• Variants in WNT Pathway Genes and Prognosis of NSCLC http://jkms.org   465 http://dx.doi.org/10.3346/jkms.2016.31.3.463related factors, such as age, gender, smoking status, histological  type, or pathological stage (data not shown).",Non-OADS,/arxiv_data1/oa_pdf/e6/e5/jkms-31-463.PMC4779874.pdf
ORCID Seung Soo Yoo http://orcid.org/0000-0002-7309-9254 Mi Jeong Hong http://orcid.org/0000-0002-9504-334X Jin Eun Choi http://orcid.org/0000-0001-7833-2257 Jang Hyuck Lee http://orcid.org/0000-0001-5537-3013 Sun Ah Baek http://orcid.org/0000-0002-8088-9764 Won Kee Lee http://orcid.org/0000-0003-4217-5792 So Yeon Lee http://orcid.org/0000-0002-1868-7715 Shin Yup Lee http://orcid.org/0000-0002-2121-7335 Jaehee Lee http://orcid.org/0000-0001-8111-7320  Seung Ick Cha http://orcid.org/0000-0002-7246-0909 Chang Ho Kim http://orcid.org/0000-0002-1550-5752 Sukki Cho http://orcid.org/0000-0002-9309-8865 Jae Yong Park http://orcid.org/0000-0001-7993-4495 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/e6/e5/jkms-31-463.PMC4779874.pdf
• Variants in WNT Pathway Genes and Prognosis of NSCLC 466  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.463activation of the Wnt signaling pathway by CTNNB1 (beta-catenin) mu - tations in a subset of human lung adenocarcinoma.,Non-OADS,/arxiv_data1/oa_pdf/e6/e5/jkms-31-463.PMC4779874.pdf
• Variants in WNT Pathway Genes and Prognosis of NSCLC http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.463Supplementary Table 1.,Non-OADS,/arxiv_data1/oa_pdf/e6/e5/jkms-31-463.PMC4779874.pdf
• Variants in WNT Pathway Genes and Prognosis of NSCLC http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.463Supplementary Table 2.,Non-OADS,/arxiv_data1/oa_pdf/e6/e5/jkms-31-463.PMC4779874.pdf
• Variants in WNT Pathway Genes and Prognosis of NSCLC http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.463Supplementary Fig.,Non-OADS,/arxiv_data1/oa_pdf/e6/e5/jkms-31-463.PMC4779874.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Implementing the Use of Rapid HIV Tests in Public Health  Centers in Seoul: Results of a Pilot Project, 2014 To determine whether rapid HIV tests in public health centers might encourage voluntary  HIV testing, a pilot project was conducted in four selected public health centers in Seoul,  2014.",Non-OADS,/arxiv_data1/oa_pdf/68/15/jkms-31-467.PMC4779875.pdf
:  800-20120448).http://dx.doi.org/10.3346/jkms.2016.31.3.467  • J Korean Med Sci 2016; 31: 467-469 The number of newly diagnosed HIV cases has been declining worldwide (1).,Non-OADS,/arxiv_data1/oa_pdf/68/15/jkms-31-467.PMC4779875.pdf
• Rapid HIV tests in Public Health Centers 468  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.467staff in charge of HIV/AIDS management at the public health  centers for post-test counseling.,Non-OADS,/arxiv_data1/oa_pdf/68/15/jkms-31-467.PMC4779875.pdf
• Rapid HIV tests in Public Health Centers http://jkms.org   469 http://dx.doi.org/10.3346/jkms.2016.31.3.467ORCID Cho Ryok Kang http://orcid.org/0000-0002-9212-8292 Ji Hwan Bang http://orcid.org/0000-0002-7628-1182 Sung-Il Cho http://orcid.org/0000-0003-4085-1494 Kui Nam Kim http://orcid.org/0000-0001-5110-2179 Hee-jin Lee http://orcid.org/0000-0002-8748-8146 Young Hwa Lee http://orcid.org/0000-0003-2073-993X Bo Yeong Ryu http://orcid.org/0000-0001-9336-8098 Soo Kyung Cho http://orcid.org/0000-0003-3767-1994 Myoung-don Oh http://orcid.org/0000-0002-2344-7695 Jong-Koo Lee http://orcid.org/0000-0003-4833-1178 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/68/15/jkms-31-467.PMC4779875.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Tension Pneumopericardium after Pericardiocentesis Pneumopericardium is defined as the presence of air inside the pericardial space.",Non-OADS,/arxiv_data1/oa_pdf/e5/c9/jkms-31-470.PMC4779876.pdf
"Keywords:  Pericardiocentesis; Pneumopericardium; Iatrogenic Disease; ComplicationJinhyuck Lee, Bo Seung Kang,   Changsun Kim, and Hyuk Joong Choi Department of Emergency Medicine, Hanyang  University Guri Hospital, Hanyang University College  of Medicine, Guri, Korea Received: 12 February 2015 Accepted: 27 April 2015 Address for Correspondence: Bo Seung Kang, MD Department of Emergency Medicine, Hanyang University   Guri Hospital, Hanyang University College of Medicine,   153 Gyeongchun-ro, Guri 11923, Korea E-mail: olivertw@hanyang.ac.krhttp://dx.doi.org/10.3346/jkms.2016.31.3.470  • J Korean Med Sci 2016; 31: 470-472 INTRODUCTION  Pericardiocentesis is an invasive procedure which is usually  performed in a patient who has pericardial effusion to resolve  the pressure in the pericardial sac.",Non-OADS,/arxiv_data1/oa_pdf/e5/c9/jkms-31-470.PMC4779876.pdf
"• Tension Pneumopericardium after Pericardiocentesis http://jkms.org   471 http://dx.doi.org/10.3346/jkms.2016.31.3.470air-containing organ, and trauma.",Non-OADS,/arxiv_data1/oa_pdf/e5/c9/jkms-31-470.PMC4779876.pdf
• Tension Pneumopericardium after Pericardiocentesis 472  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.470al of final manuscript: all authors.,Non-OADS,/arxiv_data1/oa_pdf/e5/c9/jkms-31-470.PMC4779876.pdf
ORCID Jinhyuck Lee http://orcid.org/0000-0002-5217-1632 Bo Seung Kang http://orcid.org/0000-0002-0792-0198 Hyuk Joong Choi http://orcid.org/0000-0002-5458-5919 Changsun Kim http://orcid.org/0000-0001-8475-3453  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/e5/c9/jkms-31-470.PMC4779876.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Promoting Education Regarding Conflict of Interest Management  Even among highly educated health professionals, there is inconsistency in the knowledge  and perception concerning both conflict of interest (COI) itself and COI disclosure.",Non-OADS,/arxiv_data1/oa_pdf/17/69/jkms-31-473.PMC4779877.pdf
"Keywords:  Conflict of Interest; Educating Journal Editors; Editorial Policy; Management;  Transparency; Research Integrity; GuidelinesTakako Kojima Department of International Medical Communications,  Tokyo Medical University, Tokyo, Japan Received: 25 November 2015 Accepted: 25 November 2015 Address for Correspondence: Takako Kojima, MA Department of International Medical Communications, Tokyo  Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku,   Tokyo 160-0023, Japan E-mail: tkojima@tokyo-med.ac.jphttp://dx.doi.org/10.3346/jkms.2016.31.3.473  • J Korean Med Sci 2016; 31: 473-474 The issue of publication ethics is attracting ever increasing scru - tiny.",Non-OADS,/arxiv_data1/oa_pdf/17/69/jkms-31-473.PMC4779877.pdf
Kojima T • Education of Conflict of Interest Management 474  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.3.473appointment.,Non-OADS,/arxiv_data1/oa_pdf/17/69/jkms-31-473.PMC4779877.pdf
ORCID Takako Kojima http://orcid.org/0000-0001-8300-2690   REFERENCES 1. International Committee of Medical Journal Editors.,Non-OADS,/arxiv_data1/oa_pdf/17/69/jkms-31-473.PMC4779877.pdf
Available at http://www.icmje.org/recommendations/  [accessed on 1 November 2015].,Non-OADS,/arxiv_data1/oa_pdf/17/69/jkms-31-473.PMC4779877.pdf
Available  at http://publicationethics.org/files/What%20to%20do%20if%20a%20re - viewer%20suspects%20undisclosed%20conflict%20of%20interest%20 %28CoI%29%20in%20a%20submitted%20manuscript%20%282%29.pdf.,Non-OADS,/arxiv_data1/oa_pdf/17/69/jkms-31-473.PMC4779877.pdf
Available at  http://www.ismpp.org/ [accessed on 1 November 2015].,Non-OADS,/arxiv_data1/oa_pdf/17/69/jkms-31-473.PMC4779877.pdf
Available at http://www.icmje.org/ [accessed on 8 November 2015].,Non-OADS,/arxiv_data1/oa_pdf/17/69/jkms-31-473.PMC4779877.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357http://dx.doi.org/10.3346/jkms.2016.31.3.475  • J Korean Med Sci 2016; 31: 475 Letter to the Editor: Publication Activity of Scientific   Authors Beuy Joob1 and Viroj Wiwanitkit2 1Sanitation 1 Medical Academic Center, Bangkok, Thailand; 2Hainan Medical  University, China Dear editor, the recent report by Yessirkepov et al.",Non-OADS,/arxiv_data1/oa_pdf/47/be/jkms-31-475.PMC4779878.pdf
” ORCID Beuy Joob http://orcid.org/0000-0002-5281-0369 Viroj Wiwanitkit http://orcid.org/0000-0003-1039-3728  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/47/be/jkms-31-475.PMC4779878.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357http://dx.doi.org/10.3346/jkms.2016.31.3.476  • J Korean Med Sci 2016; 31: 476-477 The Author’s Response: Educating Researchers and Editors:  Contributing to Ethical Publication  Activity Marlen Yessirkepov,1 Bekaidar Nurmashev,2 Mariya Anartayeva,2  and Bakhytzhan Seksenbayev2 1Department of Biochemistry, Biology and Microbiology, South Kazakhstan State  Pharmaceutical Academy, Shymkent, Kazakhstan; 2South Kazakhstan State  Pharmaceutical Academy, Shymkent, Kazakhstan We are pleased to know that our recent report on publication  activity in Kazakhstan (1) attracted attention of our colleagues,  who commented on it and contacted us to share their impres - sions.",Non-OADS,/arxiv_data1/oa_pdf/f4/9c/jkms-31-476.PMC4779879.pdf
• Educating Researchers and Editors: Contributing to Ethical Publication Activity http://jkms.org   477 http://dx.doi.org/10.3346/jkms.2016.31.3.476ORCID Marlen Yessirkepov http://orcid.org/0000-0003-2511-6918 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/f4/9c/jkms-31-476.PMC4779879.pdf
Available at:  http://blog.scopus.com/posts/titles-indexed-in-scopus-check-before- you-publish [accessed on 2 February 2016].3.,Non-OADS,/arxiv_data1/oa_pdf/f4/9c/jkms-31-476.PMC4779879.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/18/e4/rjw028.PMC4779960.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS Volume 32, Number 2, 2016Mary Ann Liebert, Inc.DOI: 10.1089/jop.2015.0054 109",Non-OADS,/arxiv_data1/oa_pdf/f8/63/jop.2015.0054.PMC4779975.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncom- mercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS Volume 32, Number 2, 2016Mary Ann Liebert, Inc.DOI: 10.1089/jop.2015.0128 83",Non-OADS,/arxiv_data1/oa_pdf/66/af/jop.2015.0128.PMC4779994.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/fd/b0/bmjgast-2015-000072.PMC4780040.pdf
"Recommendations for testing, managing, and treating hepatitis C. 2015. http://www.hcvguidelines.org/full-report/retreatment-persons-whom-prior-therapy-has-failed 12.",Non-OADS,/arxiv_data1/oa_pdf/23/92/bmjgast-2015-000056.PMC4780041.pdf
2014. http://files.easl.eu/easl-recommendations-on-treatment-of-hepatitis-C.pdf 13.,Non-OADS,/arxiv_data1/oa_pdf/23/92/bmjgast-2015-000056.PMC4780041.pdf
https://clinicaltrials.gov/ct2/show/NCT02114151?term=simeprevir+AND+sofosbuvir&rank=6 33.,Non-OADS,/arxiv_data1/oa_pdf/23/92/bmjgast-2015-000056.PMC4780041.pdf
https://clinicaltrials.gov/ct2/show/NCT02057003?term=simeprevir&rank=19 34.,Non-OADS,/arxiv_data1/oa_pdf/23/92/bmjgast-2015-000056.PMC4780041.pdf
https://clinicaltrials.gov/ct2/show/NCT02165189?term=simeprevir+AND+sofosbuvir&rank=1 35.,Non-OADS,/arxiv_data1/oa_pdf/23/92/bmjgast-2015-000056.PMC4780041.pdf
https://clinicaltrials.gov/ct2/show/NCT02250807?term=simeprevir&rank=9 36.,Non-OADS,/arxiv_data1/oa_pdf/23/92/bmjgast-2015-000056.PMC4780041.pdf
https://clinicaltrials.gov/ct2/show/NCT02278419?term=simeprevir&rank=12 37.,Non-OADS,/arxiv_data1/oa_pdf/23/92/bmjgast-2015-000056.PMC4780041.pdf
"https://clinicaltrials.gov/ct2/show/NCT02253550?term=simeprevir&rank=14 Yee BE, Nguyen NH, Jin M, et al.BMJ Open Gastro 2016; 3:e000056.",OADS,/arxiv_data1/oa_pdf/23/92/bmjgast-2015-000056.PMC4780041.pdf
http://www.idf.,Non-OADS,/arxiv_data1/oa_pdf/1b/a4/bmjdrc-2015-000161.PMC4780042.pdf
http://www.un.org.,Non-OADS,/arxiv_data1/oa_pdf/1b/a4/bmjdrc-2015-000161.PMC4780042.pdf
http://www.who.int 31.,Non-OADS,/arxiv_data1/oa_pdf/1b/a4/bmjdrc-2015-000161.PMC4780042.pdf
2015. http://data.worldbank.org 33.,Non-OADS,/arxiv_data1/oa_pdf/1b/a4/bmjdrc-2015-000161.PMC4780042.pdf
2015. http://www.oecd.org 34.,Non-OADS,/arxiv_data1/oa_pdf/1b/a4/bmjdrc-2015-000161.PMC4780042.pdf
http://www.efta.int/eea 35.,Non-OADS,/arxiv_data1/oa_pdf/1b/a4/bmjdrc-2015-000161.PMC4780042.pdf
http://www.apec.org 37.,Non-OADS,/arxiv_data1/oa_pdf/1b/a4/bmjdrc-2015-000161.PMC4780042.pdf
2013. http://www.idf.,Non-OADS,/arxiv_data1/oa_pdf/1b/a4/bmjdrc-2015-000161.PMC4780042.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/7e/87/bmjdrc-2015-000158.PMC4780043.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Extended Results, Extended Discussion, Extended Experimental Procedures, three figures, and  one table and can be found with this article online at http://dx.doi.org/10.1016/j.celrep.2013.06.027 .",OADS,/arxiv_data1/oa_pdf/7f/b9/nihms-748075.PMC4780052.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-009347).,Non-OADS,/arxiv_data1/oa_pdf/a6/04/bmjopen-2015-009347.PMC4780057.pdf
fMRI tasks willbe displayed using E-Prime software (http://www.pstnet.,OADS,/arxiv_data1/oa_pdf/a6/04/bmjopen-2015-009347.PMC4780057.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/a6/04/bmjopen-2015-009347.PMC4780057.pdf
"Secondary Bariatric Surgery Program, 2015. http://www.stjoes.ca/default.asp?action=article&ID=1612 43.",Non-OADS,/arxiv_data1/oa_pdf/a6/04/bmjopen-2015-009347.PMC4780057.pdf
"Female Genital Mutilation Risk and Safeguarding; Guidance for professionals, Department of Health Guidance, Published date:March 2015. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/418564/2903800_DH_FGM_Accessible_v0.1.pdf (accessed 18 Aug 2015).",Non-OADS,/arxiv_data1/oa_pdf/37/80/bmjopen-2015-010311.PMC4780059.pdf
2015 c.9 Part 5. http://www.legislation.gov.uk/ukpga/2015/9/part/5/crossheading/female-genital-mutilation/enacted (accessed 18 Aug2015).,Non-OADS,/arxiv_data1/oa_pdf/37/80/bmjopen-2015-010311.PMC4780059.pdf
"Geneva: Division of Family Health,17–19 July 1995. http://www.who.int/reproductivehealth/topics/fgm/ overview/en (accessed 19 Aug 2015).",Non-OADS,/arxiv_data1/oa_pdf/37/80/bmjopen-2015-010311.PMC4780059.pdf
https://www.gov.uk/government/publications/statement-opposing-female-genital-mutilation (accessed 24 Aug2015).,Non-OADS,/arxiv_data1/oa_pdf/37/80/bmjopen-2015-010311.PMC4780059.pdf
UNICEF Report 2013. http://www.childinfo.org/files/FGCM_Lo_res.pdf (accessed 26 Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/37/80/bmjopen-2015-010311.PMC4780059.pdf
Tran M. The Guardian 30 April 2015. http://www.theguardian.com/ society/2015/apr/30/female-genital-mutilation-england-fgm-girls(accessed 19 Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/37/80/bmjopen-2015-010311.PMC4780059.pdf
2015. http://www.e-lfh.org.uk/programmes/female-genital-mutilation (accessed 19 Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/37/80/bmjopen-2015-010311.PMC4780059.pdf
"London: RCOG, 2015. https://www.rcog.org.uk/en/guidelines-research-services/guidelines/gtg53/ 14.",Non-OADS,/arxiv_data1/oa_pdf/37/80/bmjopen-2015-010311.PMC4780059.pdf
2015. http://www.rcn.org.uk/__data/assets/pdf_file/0010/608914/RCNguidance_FGM_WEB2.pdf 15.,OADS,/arxiv_data1/oa_pdf/37/80/bmjopen-2015-010311.PMC4780059.pdf
Sir James Munby 2015 https://www.judiciary.gov.uk/wp-content/uploads/2015/01/BandG_2_.pdf 16.,Non-OADS,/arxiv_data1/oa_pdf/37/80/bmjopen-2015-010311.PMC4780059.pdf
"For additional details, the LCPM is described in an online technical appendix (http://www.cisnet.cancer.",Non-OADS,/arxiv_data1/oa_pdf/a2/56/bmjopen-2015-010227.PMC4780060.pdf
http://www.cancer.gov/newscenter/pressreleases/NLSTresultsRelease 3.,Non-OADS,/arxiv_data1/oa_pdf/a2/56/bmjopen-2015-010227.PMC4780060.pdf
Decision Memo for Screening for Lung Cancer with Low Dose Computed Tomography(LDCT) (CAG-00439N) 2015 (5 February 2015 and 29 July 2015).http://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=274&NcaName=Screening+for+Lung+Cancer+with+Low+Dose+Computed+Tomography+(LDCT)&TimeFrame=7&DocType=All&bc=AQAAIAAAAgAAAA%3d%3d& 6.,Non-OADS,/arxiv_data1/oa_pdf/a2/56/bmjopen-2015-010227.PMC4780060.pdf
"http://www.cancernepa.org: Northeast Regional Cancer Institute, 2011.",Non-OADS,/arxiv_data1/oa_pdf/a2/56/bmjopen-2015-010227.PMC4780060.pdf
https://apps.health.pa.gov/EpiQMS/asp/SelectParams_BRFSS_Tbl_Region.asp 13.,Non-OADS,/arxiv_data1/oa_pdf/a2/56/bmjopen-2015-010227.PMC4780060.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-010357).,Non-OADS,/arxiv_data1/oa_pdf/ab/cf/bmjopen-2015-010357.PMC4780061.pdf
http://www.neurodegenerationresearch.eu/initiatives/jpnd-alignment-actions/longitudinal-cohorts/call-for-working-groups/call-results/ 2.,Non-OADS,/arxiv_data1/oa_pdf/ab/cf/bmjopen-2015-010357.PMC4780061.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-010246).,Non-OADS,/arxiv_data1/oa_pdf/ae/de/bmjopen-2015-010246.PMC4780062.pdf
2008. http://www.medschools.ac.uk/AboutUs/Projects/Documents/Final%20MMC%20Inquiry%20Jan2008.pdf 2.,Non-OADS,/arxiv_data1/oa_pdf/ae/de/bmjopen-2015-010246.PMC4780062.pdf
The state of medical education and practice in the UK report: 2014. http://www.gmc-uk.org/publications/25452.asp 5.,Non-OADS,/arxiv_data1/oa_pdf/ae/de/bmjopen-2015-010246.PMC4780062.pdf
"General Medical Council, 2014. http://www.gmc-uk.org/How_Prepared_are_UK_ Medical_Graduates_for_Practice_SUBMITTED_Revised_140614.pdf_58034815.pdf 8.",Non-OADS,/arxiv_data1/oa_pdf/ae/de/bmjopen-2015-010246.PMC4780062.pdf
2009. http://www.gmc-uk.org/Tomorrow_s_Doctors_1214.pdf_48905759.pdf 11.,Non-OADS,/arxiv_data1/oa_pdf/ae/de/bmjopen-2015-010246.PMC4780062.pdf
"Final report to the General Medical Coucil, April 2008. http://www.gmc-uk.org/FINAL_How_prepared_are_medical_graduates_to_begin_practice_September_08.pdf_ 29697834.pdf 15.",Non-OADS,/arxiv_data1/oa_pdf/ae/de/bmjopen-2015-010246.PMC4780062.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 010469).,Non-OADS,/arxiv_data1/oa_pdf/92/ce/bmjopen-2015-010469.PMC4780063.pdf
"NICE guidelines [CG66] —Type 2 diabetes, 2008. https://www.nice.org.uk/guidance/cg66 9.",Non-OADS,/arxiv_data1/oa_pdf/92/ce/bmjopen-2015-010469.PMC4780063.pdf
"NICE guidelines [CG87] —Type 2 diabetes: The management of type 2 diabetes, 2009. https://www.nice.org.uk/guidance/cg87 10.",Non-OADS,/arxiv_data1/oa_pdf/92/ce/bmjopen-2015-010469.PMC4780063.pdf
"Dapagliflozin in combination therapy for treating type 2 diabetes: NICE technologyappraisals [TA288], 2013. http://www.nice.org.uk/Guidance/ta288 11.",Non-OADS,/arxiv_data1/oa_pdf/92/ce/bmjopen-2015-010469.PMC4780063.pdf
"Adherance to long-term therapies: Evidence for action, 2003. http://www.who.int/chp/knowledge/publications/adherence_full_report.pdf 19.",Non-OADS,/arxiv_data1/oa_pdf/92/ce/bmjopen-2015-010469.PMC4780063.pdf
2015. http://www.gradeworkinggroup.org/ 23.,Non-OADS,/arxiv_data1/oa_pdf/92/ce/bmjopen-2015-010469.PMC4780063.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/12/69/10.1177_2048004016633371.PMC4780070.pdf
http://www.ic.nhs.uk/pubs/opad12 (2012).,Non-OADS,/arxiv_data1/oa_pdf/12/69/10.1177_2048004016633371.PMC4780070.pdf
http://archive.ahrq.gov/news/press/ pr2007/obesjumppr.htm.,Non-OADS,/arxiv_data1/oa_pdf/12/69/10.1177_2048004016633371.PMC4780070.pdf
"Physical examinationrevealed a ﬁrm mass on the dorsal aspect of the right 1Department of Radiology, T eikyo University Mizonokuchi Hospital, Kanagawa, Japan 2Department of Radiology, National Center Hospital of Neurology and Psychiatry, T okyo, Japan 3Department of Orthopedics, T eikyo University Mizonokuchi Hospital, Kanagawa, Japan 4Department of Diagnostic Pathology, T eikyo University Mizonokuchi Hospital, Kanagawa, Japan Corresponding author: Kaoru Sumida, Department of Radiology, National Center Hospital of Neurology and Psychiatry, 4-1-1 Ogawa-higashimachi Kodaira, T okyo187-8551, Japan.Email: sumida.cold@gmail.comActa Radiologica Open 5(3) 1–4 !The Foundation Acta Radiologica 2016Reprints and permissions:sagepub.co.uk/journalsPermissions.navDOI: 10.1177/2058460115617352 arr.sagepub.com Creative Commons CC-BY -NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License (h ttp:// www.creativecommons.org/licenses/by-nc-nd/3.0/) which permits non-commercial use, reproduction and distribution of the work as published wit hout adaptation or alteration, without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub .com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/a1/c9/10.1177_2058460115617352.PMC4780096.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/12/c2/10.1177_2325967116631949.PMC4780097.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/7c/56/10.1177_2325967116632692.PMC4780099.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/51/81/num-08-01-29527.PMC4780113.pdf
Available from: http://www.graphpad.com.,Non-OADS,/arxiv_data1/oa_pdf/7f/34/PR-8-105.PMC4780135.pdf
Available from: http://www.afro.who.int/en/publications.html.,Non-OADS,/arxiv_data1/oa_pdf/ed/c4/PR-8-128.PMC4780139.pdf
Available from:  http://www.books.google.co.in/books.,Non-OADS,/arxiv_data1/oa_pdf/91/06/PR-8-147.PMC4780142.pdf
Available  from: https://www.idf.org/sites/default/files/EN_6E_Atlas_Full_0.pdf.,Non-OADS,/arxiv_data1/oa_pdf/60/24/PR-8-85.PMC4780143.pdf
Available from: http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/60/24/PR-8-85.PMC4780143.pdf
"Statistical analysis The values of  the biochemical parameters obtained in the patients before and after treatment with the raw liquid extract were subjected to statistical analysis to determine the mean values, standard deviation, and Student’s t-test,  for t value, P value, and level of  signi ﬁ cant at 0.01 (99%)  using online Student t-test calculator for two independent means online at http://www.socscistatistics.com/tests/ studentttest.",Non-OADS,/arxiv_data1/oa_pdf/4e/99/JNSBM-7-47.PMC4780167.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e0/37/copd-11-431.PMC4780180.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 431–437International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  431OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S9865 9Risk stratification for COPD diagnosis through  an active search strategy in primary care Pedro J Marcos1 rosa Malo de Molina2 ricard Casamor3 1Servicio de Neumología, Instituto de  investigación Biomédica de A Coruña  (INIBIC), Complejo Hospitalario  Universitario de A Coruña (CHUAC),   Sergas Universidade da Coruña  (UDC), A Coruña, 2servicio de  Neumología, Hospital Universitario  Puerta de Hierro, Majadahonda,   Madrid, 3Medical Department,   Novartis Farmacéutica SA, Barcelona,   spainBackground:  The aim of this study was to identify the percentage of undiagnosed patients with  COPD through the implementation of an active search strategy in a selected subject population.",Non-OADS,/arxiv_data1/oa_pdf/e0/37/copd-11-431.PMC4780180.pdf
"According to the EPI-SCAN study, 10% of the Spanish population suffers from  COPD,14 and despite a recent trend of a reduction in the number of cases,15 EPI-SCAN  study showed that there was a 73% underdiagnosis of COPD in Spain.15 Epidemio - logical studies show that mortality is increasing and estimate that by 2020 COPD  will be the third leading cause of mortality worldwide.16,17 Together, these negative  effects on health status lead to undiagnosed COPD being a major problem for health  care systems.14,18 General practitioners (GPs) are the health care professionals (HCPs) most  closely linked to patients who have either respiratory symptoms or other acute health Correspondence: rosa Malo de Molina Servicio de Neumología, Hospital  Universitario Puerta de Hierro, Calle  Manuel de Falla, 1, 28222 Majadahonda,  Madrid, Spain email rmm02004@yahoo.e s Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Marcos et al Running head recto: New COPD diagnosis through an active search DOI: http://dx.doi.org/10.2147/COPD.S98659",Non-OADS,/arxiv_data1/oa_pdf/e0/37/copd-11-431.PMC4780180.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/e0/37/copd-11-431.PMC4780180.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e0/37/copd-11-431.PMC4780180.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a2/5c/dddt-10-927.PMC4780181.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2016:10 927–931Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  927Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9541 8effect of picroside ii on erythrocyte deformability  and lipid peroxidation in rats subjected to hind  limb ischemia reperfusion injury Faruk Metin Çomu1 Yig ˘it Kılıç2 abdullah Özer2 Mehmet Kirişçi3 Ali Dog ˘an Dursun4 T olga Tatar2 Mustafa hakan Zor2 Hakan Kartal2 Ayşegül Küçük5 Hakan Boyunag ˘a6 Mustafa arslan7 1Department of Physiology, Kirikkale  University Medical Faculty, Kirikkale,   2Department of cardiovascular  surgery, gazi University Medical  Faculty, ankara, 3Department of  Cardiovascular Surgery, Necip Fazıl  State Hospital, Kahramanmaras,   4Department of Physiology,   ankara University Medical Faculty,   ankara, 5Department of Physiology,   Dumlupinar University Medical  Faculty, Kütahya, 6Department of  Biochemistry, Kirikkale University  Medical Faculty, Kirikkale,   7Department of anaesthesiology and  reanimation, gazi University Medical  Faculty, ankara, T urkeyBackground:  Ischemia reperfusion injury (I/R) in hind limb is a frequent and important clinical  phenomenon.",Non-OADS,/arxiv_data1/oa_pdf/a2/5c/dddt-10-927.PMC4780181.pdf
"Local  edema and muscle tissue necrosis are likely to be followed by systemic inflammatory  response syndrome and multiple organ failure (kidney, respiratory, and circulatory  system) as reperfusion advances.1–3correspondence: Mustafa arslan Department of anaesthesiology and  reanimation, gazi University Medical  Faculty, 06510, Beşevler, Ankara, Turkey Tel +90 312 202 67 39 email mustarslan@gmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Çomu et al Running head recto: Effect of picroside II on erythrocyte deformability and lipid peroxidation DOI: http://dx.doi.org/10.2147/DDDT.S95418",Non-OADS,/arxiv_data1/oa_pdf/a2/5c/dddt-10-927.PMC4780181.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/a2/5c/dddt-10-927.PMC4780181.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a2/5c/dddt-10-927.PMC4780181.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/15/83/ott-9-1085.PMC4780182.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1085–1092OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1085Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9670 7Prognostic value of preoperative lymphocyte- to-monocyte ratio in pancreatic adenocarcinoma guang-Jun li1 hong-Wei Xu1 Juan-Juan Ji2 Fang Yang2 Bao-Qin gao1 1First Department of general surgery,   2Department of gastroenterology,   First affiliated hospital of Xin-Xiang  Medical University, henan, People’s  republic of chinaBackground:  Inflammation and immunity have an important role in the development of  cancer.",Non-OADS,/arxiv_data1/oa_pdf/15/83/ott-9-1085.PMC4780182.pdf
"Keywords:  lymphocyte to monocyte ratio, survival, pancreatic adenocarcinoma Introduction In People’s Republic of China, the morbidity and mortality of pancreatic adeno - carcinoma show an increasing trend due to changes in dietary composition and habits,  and pancreatic adenocarcinoma has been ranked as the seventh most common cancer  and the ninth leading cause of cancer-related deaths.1 Although currently there are  several conventional and emerging treatment options available for pancreatic adeno - carcinoma, surgery remains the main treatment approach, but is possible for only 20%  of localized diseases.2 Moreover, patients who underwent curative resection continue  to suffer from high rates of perioperative morbidity.3,4 Classification of pancreatic  adenocarcinoma patients can help to predict survival and thus aid in providing indi - vidualized therapies that can improve clinical outcomes; therefore, the importance of  prognostic and predictive biomarkers has been increasingly recognized.5 However,  biomarkers actually utilized in clinical practice are currently limited to clinicopathologi - cal characteristics such as the histological stage, pathological type, resection margins,  or tumor–node–metastasis (TNM) stage, which can be evaluated only through postop - erative histological studies and findings during surgery.6–8 Therefore, new biomarkers  that are inexpensive and technically feasible are required.correspondence: Juan-Juan Ji Department of gastroenterology,  First Affiliated Hospital of Xin-Xiang  Medical University, 88 Jiankang road,  Weihui, henan 463000, People’s  republic of china Tel/fax +86 37 3440 2120 email yangfang880@sina.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Li et al Running head recto: Prognostic value of preoperative LMR in pancreatic adenocarcinoma DOI: http://dx.doi.org/10.2147/OTT.S96707",Non-OADS,/arxiv_data1/oa_pdf/15/83/ott-9-1085.PMC4780182.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/15/83/ott-9-1085.PMC4780182.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/15/83/ott-9-1085.PMC4780182.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9c/49/ott-9-1057.PMC4780183.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1057–1066OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1057Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8975 5Feasibility, tolerability, and efficacy of the  concurrent addition of erlotinib to thoracic  radiotherapy in locally advanced unresectable  non-small-cell lung cancer: a Phase ii trial enrique Martínez1 Maite Martínez1 Mikel rico1 Berta hernández1 Francesc casas2 nuria Viñolas2 ana Pérez-casas3 Manuel Dómine3 Julián Mínguez4 1radiation Oncology services,   hospital of navarra, Pamplona, spain;   2Medical Oncology Department,   clinical hospital of Barcelona,   Barcelona, spain; 3Department  of radiation Oncology, Jiménez  Díaz Foundation, Madrid, spain;   4Department of radiation Oncology,   University hospital of Donostia,   san sebastian, spainPurpose:  Although many studies have confirmed the synergic effects of combining  chemotherapy (CT) and radiotherapy (RT), clinical data evaluating safety and efficacy of erlotinib  in combination with RT in locally advanced non-small-cell lung cancer (NSCLC) are limited.",Non-OADS,/arxiv_data1/oa_pdf/9c/49/ott-9-1057.PMC4780183.pdf
"Keywords:  non-small-cell lung cancer, radiotherapy, erlotinib, concurrent Introduction Non-small-cell lung cancer (NSCLC) represents the most common type of lung cancer  (80%–85%) and is one of the leading causes of cancer-related mortality worldwide.1,2  Overall 5-year survival rate is ~15%, but depending on the stage of the disease ranges  from 73%, in stage IA, to 2%, in stage IV.3 The majority of patients present with  unresectable disease, and ~40% of them in advanced stages.4,5 In the last decades,  the standard treatment for unresectable or locally advanced NSCLC has varied from  single thoracic radiotherapy (RT) to its combination with chemotherapy (CT), ie,  chemoradiotherapy.6–8 Several trials have shown the higher efficiency, in disease correspondence: enrique Martínez radiation Oncology services, hospital  of navarra, calle irunlarrea, 3, 31008  Pamplona, navarra, spain Tel +34 948 255 400 Fax +34 948 296 500 email enrique.martinez.lopez@cfnavarra.e sJournal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Martínez et al Running head recto: Concurrent addition of erlotinib to radiotherapy DOI: http://dx.doi.org/10.2147/OTT.S89755",Non-OADS,/arxiv_data1/oa_pdf/9c/49/ott-9-1057.PMC4780183.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/9c/49/ott-9-1057.PMC4780183.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9c/49/ott-9-1057.PMC4780183.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/51/73/opth-10-365.PMC4780184.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 365–371submit your manuscript | www.dovepress.co m Dove press  365 http: //dx.doi.org/10.2147/OPTH.S10084 0Dove press Original researChopen access to scientific and medical research Open access Full T ext article retreatments after multifocal intraocular lens  implantation: an analysis Kjell gunnar gundersen1 sarah Makari2 steffen Ostenstad1 rick Potvin2 1ifocus eye Clinic, haugesund,   norway; 2science in Vision, akron,   nY, UsaPurpose:  To determine the incidence and etiology of required retreatment after multifocal intraoc - ular lens (IOL) implantation and to evaluate the methods and clinical outcomes of retreatment.",Non-OADS,/arxiv_data1/oa_pdf/51/73/opth-10-365.PMC4780184.pdf
"Where issues  are intractable, the lens may be explanted and replaced with a single-vision IOL.1 As  the use of multifocal IOLs increases, retreatment cases have also increased.1,8 There are a number of surgical and patient factors that can lead to the requirement  for retreatment when a multifocal lens is implanted.9 Surgical factors include vari - ability in the effective lens position, IOL centration, IOL tilt, and surgically induced  astigmatism, all of which may contribute to residual refractive error.1,9 Patient factors  may include an inability to adapt to the multifocal IOL or a change in the patient’s Correspondence: Kjell gunnar  gundersen ifocus eye Clinic, sørhauggaten 111,  haugesund 5527, norway Tel +47 5280 8900 email kg@ifocus.n o Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Gundersen et al Running head recto: Retreatments after multifocal intraocular lens implantation: an analysis DOI: http://dx.doi.org/10.2147/OPTH.S100840",Non-OADS,/arxiv_data1/oa_pdf/51/73/opth-10-365.PMC4780184.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/51/73/opth-10-365.PMC4780184.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/51/73/opth-10-365.PMC4780184.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/eb/23/ott-9-1047.PMC4780185.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1047–1055submit your manuscript | www.dovepress.co m Dove press  1047 http: //dx.doi.org/10.2147/OTT .S10290 7Dove press Reviewopen access to scientific and medical research Open Access Full T ext Article Myeloid cell signatures in tumor microenvironment  predicts therapeutic response in cancer Bhagelu R Achyut Ali S Arbab T umor Angiogenesis Laboratory,   Department of Biochemistry and  Molecular Biology, Cancer Center,   Georgia Regents University, Augusta,   GA, USAAbstract:  Tumor microenvironment (TME) consists of several immune and nonimmune  cell populations including tumor cells.",Non-OADS,/arxiv_data1/oa_pdf/eb/23/ott-9-1047.PMC4780185.pdf
"Finally, we have discussed  targeting of myeloid cell populations as a combination therapy with chemo-, targeted-,  or radiation therapies.Correspondence: Ali S Arbab Tumor Angiogenesis Laboratory,  Biochemistry and Molecular Biology,  Cancer Center, Georgia Regents  University, 1410 Laney walker Blvd,  CN3141, Augusta, GA 30912, USA Tel +1 706 721 8909 Fax +1 706 434 6406 email aarbab@gru.ed u Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2016 Volume: 9 Running head verso: Achyut and Arbab Running head recto: Myeloid cells and therapeutic response DOI: http://dx.doi.org/10.2147/OTT.S102907",Non-OADS,/arxiv_data1/oa_pdf/eb/23/ott-9-1047.PMC4780185.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/eb/23/ott-9-1047.PMC4780185.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/eb/23/ott-9-1047.PMC4780185.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/88/cc/cia-11-225.PMC4780186.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 225–236Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  225OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S9145 3Aging-associated oxidized albumin promotes  cellular senescence and endothelial damage Carlos luna1,* Matilde Alique2,* estefanía navalmoral2 Maria-Victoria noci3 lourdes Bohorquez-Magro2 Julia Carracedo1 rafael ramírez2 1nephrology Unit, Instituto  Maimónides de Investigación  Biomédica de Córdoba (IMIBIC),   reina sofía University hospital,   Córdoba, spain; 2Department of  systems Biology, Physiology Unit,   Universidad de Alcalá, Madrid,   spain; 3Anesthesia Unit, reina sofía  University hospital, Córdoba, spain *These authors contributed equally  to this workAbstract:  Increased levels of oxidized proteins with aging have been considered a cardiovascular  risk factor.",Non-OADS,/arxiv_data1/oa_pdf/88/cc/cia-11-225.PMC4780186.pdf
"The major protein present in the plasma is  albumin, which constitutes ~55% of the plasma proteins.7 As a result, it is most susceptible Correspondence: Matilde Alique Departamento Biología de sistemas,  Facultad de Medicina y Ciencias de la  salud, Universidad de Alcalá, Alcalá de  henares e-28871, Madrid, spain Tel +34 91 885 6436 email matilde.alique@uah.e s Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Luna et al Running head recto: Oxidized album in aging and endothelial dysfunction DOI: http://dx.doi.org/10.2147/CIA.S91453",Non-OADS,/arxiv_data1/oa_pdf/88/cc/cia-11-225.PMC4780186.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/88/cc/cia-11-225.PMC4780186.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/88/cc/cia-11-225.PMC4780186.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/58/3b/ndt-12-541.PMC4780187.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 541–557Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  541Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S9131 1The noradrenergic paradox: implications in the  management of depression and anxiety Alonso Montoya1 Robert Bruins1 Martin A Katzman2 Pierre Blier3 1eli Lilly Canada inc, 2START Clinic  for the Mood and Anxiety Disorders,   T oronto, 3Mood Disorders Research  Unit, institute of Mental Health  Research, University of Ottawa,   Ottawa, ON, CanadaAbstract:  Both major depressive disorder and the anxiety disorders are major causes of  disability  and markedly contribute to a significant global burden of the disease worldwide.",Non-OADS,/arxiv_data1/oa_pdf/58/3b/ndt-12-541.PMC4780187.pdf
"A 2013 analysis of data obtained from the Global Burden of Diseases,  Injuries, and Risk Factors Study 2010 found that mental and substance abuse disorders  accounted for 7.4% of the global burden of disease; MDD alone represented 40% of  this burden.1 The anxiety disorders, which include generalized anxiety disorder (GAD),  panic disorder, posttraumatic stress disorder (PTSD), social anxiety disorder, and  simple phobias, follow MDD and represent 14.6% of the burden of disease attributed  to mental health and substance abuse.1 The mid-1950s ushered in an era of intense interest in the treatment of mental  disorders, thanks to the serendipitous discoveries of lithium’s ability to treat bipolar Correspondence: Alonso Montoya eli Lilly Canada inc., 3650 Danforth  Avenue, Toronto, ON M1N 2e8, Canada Tel +1 800 268 4446 ext 9536 email montoya_alonso@lilly.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2016 Volume: 12 Running head verso: Montoya et al Running head recto: Noradrenergic paradox in depression and anxiety DOI: http://dx.doi.org/10.2147/NDT.S91311",Non-OADS,/arxiv_data1/oa_pdf/58/3b/ndt-12-541.PMC4780187.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/58/3b/ndt-12-541.PMC4780187.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/58/3b/ndt-12-541.PMC4780187.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6b/98/ott-9-1077.PMC4780194.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1077–1084OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1077Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S8108 7Clinical utility of letrozole in the treatment of  breast cancer: a Chinese perspective Dong-xu He1 Xin Ma2 1National engineering Laboratory  for Cereal Fermentation T echnology,   2School of Pharmaceutical Sciences,  Jiangnan University, wuxi, People’s  Republic of ChinaAbstract:  The incidence rate of breast cancers in People’s Republic of China has increased  in the last decade, and many cases are responsive to hormone therapies.",Non-OADS,/arxiv_data1/oa_pdf/6b/98/ott-9-1077.PMC4780194.pdf
"In premenopausal women, high levels of Correspondence: Xin Ma School of Pharmaceutical Sciences,  Jiangnan University, wuxi 214122,  People’s Republic of China Tel/fax +86 510 8591 8219 email maxin@jiangnan.edu.c n Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2016 Volume: 9 Running head verso: He and Ma Running head recto: The use of letrozole for breast cancer in Chinese patients DOI: http://dx.doi.org/10.2147/OTT.S81087",Non-OADS,/arxiv_data1/oa_pdf/6b/98/ott-9-1077.PMC4780194.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/6b/98/ott-9-1077.PMC4780194.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6b/98/ott-9-1077.PMC4780194.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ca/34/copd-11-445.PMC4780195.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 445–453International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  445RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S9339 8Bacterial–viral load and the immune response in   stable and exacerbated COPD: significance and   therapeutic prospects Silvestro ennio D’Anna1 Bruno Balbi2 Francesco Cappello3,4 Mauro Carone2 Antonino Di Stefano2 1Department of Rehabilitation,   Cardiorespiratory Unit, Fondazione  Istituto G. Giglio di Cefalù,   2Pneumology Unit and Laboratory  of Cytoimmunopathology of Heart  and Lung, Fondazione Salvatore  Maugeri, IRCCS, veruno (NO) and  Cassano delle Murge (BA), 3Human  Anatomy Section, Department of  experimental Biomedicine and Clinical  Neuroscience, University of Palermo,   Palermo, Italy; 4euro-Mediterranean  Institute of Science and T echnology,   Palermo, ItalyAbstract:  Chronic obstructive pulmonary disease (COPD) is characterized by persistent airflow  limitation and an abnormal inflammatory response of the lung.",Non-OADS,/arxiv_data1/oa_pdf/ca/34/copd-11-445.PMC4780195.pdf
"Microbiological examination of sputum from  COPD patients hospitalized during an exacerbation shows that infections are mostly  associated with bacterial pathogens of the sputum, followed by combined bacteria and  viruses or sputum viruses.3 Another study,4 followed COPD patients for 1 year, observed  a high rate of exacerbations in one subgroup – 37% of these were caused by bacteria,  10% by viruses, 12% by bacteria and viruses, while 14% were of undefined origin.4 Many  investigators have observed a change of the inflammatory response in COPD patients  during acute exacerbations, showing a general increase in the inflammatory state.2 These  exacerbations are associated with an increase in neutrophils, T-lymphocytes, and, in some  cases, eosinophils.4–6 Viruses and bacteria may cause acute exacerbations of COPD, or  alternatively, they may amplify chronic inflammation in stable COPD.7Correspondence: Bruno Balbi Pneumology Unit and Laboratory of  Cytoimmunopathology of Heart and  Lung, Fondazione Salvatore Maugeri,  IRCCS, via per Revislate 13, 28010  veruno (NO), Italy email bruno.balbi@fsm.i tJournal name: International Journal of COPD Article Designation: Review Y ear: 2016 Volume: 11 Running head verso: D’Anna et al Running head recto: Microbiome and immune response in COPD DOI: http://dx.doi.org/10.2147/COPD.S93398",Non-OADS,/arxiv_data1/oa_pdf/ca/34/copd-11-445.PMC4780195.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/ca/34/copd-11-445.PMC4780195.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ca/34/copd-11-445.PMC4780195.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c2/e8/ott-9-1033.PMC4780196.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1033–1045OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1033Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9942 8Polymorphisms of vitamin D receptor gene Taqi  susceptibility of prostate cancer: a meta-analysis Xiawei Fei1 nannan liu2 huifeng li1 Yanting shen3 Jianming guo1,4 Zhenqi Wu1 1Department of Urology surgery,   Qingpu Branch of Zhongshan hospital  affiliated to Fudan University,   shanghai, 2Department of clinical  laboratory, The Third affiliated  hospital of suzhou University,   changzhou, Jiangsu, 3research center  for learning science, southeast  University, nanjing, 4Department of  Urology surgery, Zhongshan hospital  affiliated to Fudan University,   shanghai, People’s republic of chinaObjective:  Many studies have investigated the association of the vitamin D receptor gene TaqI  polymorphism with prostate cancer (PCa) risk.",Non-OADS,/arxiv_data1/oa_pdf/c2/e8/ott-9-1033.PMC4780196.pdf
"Recently, some studies have shown that VDR gene polymorphisms have functional  significance for the stability of mRNA and the protein translation efficiency and may be  responsible for the reduced VDR level.6,7 The human VDR gene is located on chromo - some 12q13.11 and consists of 14 exons spanning ∼75 kb.8,9 It is highly polymorphic  with at least 618 variants reported, most of which are either undetectable or present correspondence: Zhenqi Wu Department of Urology surgery, Qingpu  Branch of Zhongshan Hospital Affiliated  to Fudan University, The seventh  Building 9c, no 1158, east-Park road,  Qingpu District, shanghai, People’s  republic of china Tel +86 21 6971 9190 ext 7920 email zhenqi_wu1976@sina.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Fei et al Running head recto: A meta-analysis of Taql genetic polymorphisms DOI: http://dx.doi.org/10.2147/OTT.S99428",Non-OADS,/arxiv_data1/oa_pdf/c2/e8/ott-9-1033.PMC4780196.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/c2/e8/ott-9-1033.PMC4780196.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c2/e8/ott-9-1033.PMC4780196.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/a6/96/num-08-01-30245.PMC4780197.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ce/a1/ppa-10-223.PMC4780198.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and adherence 2016:10 223–231submit your manuscript | www.dovepress.co m Dove press  223 http: //dx.doi.org/10.2147/PPA.S9989 5a set of four simple performance measures  reflecting adherence to guidelines predicts  hospitalization: a claims-based cohort study  of patients with diabetes carola a huber1 Michael Brändle2 roland rapold1 Oliver reich1 Thomas rosemann3 1Department of health sciences,   helsana group, Zürich, 2Division  of Endocrinology and Diabetes,   Department of internal Medicine,   Kantonsspital st gallen, st gallen,   3institute of Primary care, University  of Zürich, University hospital Zürich,   Zürich, switzerlandBackground:  The link between guideline adherence and outcomes is a highly demanded issue  in diabetes care.",Non-OADS,/arxiv_data1/oa_pdf/ce/a1/ppa-10-223.PMC4780198.pdf
"Diabetes is one of the  leading health problems in the 21st century and requires continuous medical care,  patients’ self-management, and risk reduction strategies.1–3 Several multidisciplinary  expert committees, including the American Diabetes Associations, the European Society  of Cardiology, and the European Association for the Study of Diabetes, report and  adapt annually clinical guidelines to improve diabetes outcomes.3,4 In view of the big  discussion on how to measure guideline adherence, evidence suggests that intermediate  outcomes such as hemoglobin A1c (HbA1c) can be improved and complications of  diabetes can be reduced by controlling for even a simple set of performance measures  such as HbA1c, blood pressure, and low-density lipoprotein (LDL) cholesterol.5–8 correspondence: carola a huber Department of health sciences,  helsana group, PO Box, 8081 Zürich,  switzerland Tel +41 43 340 6341 Fax +41 43 340 0434 email carola.huber@helsana.c h Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Huber et al Running head recto: Guideline adherence predicts hospitalization DOI: http://dx.doi.org/10.2147/PPA.S99895",Non-OADS,/arxiv_data1/oa_pdf/ce/a1/ppa-10-223.PMC4780198.pdf
"Available from: http://www.sgedssed.ch/ fileadmin / files/6_empfehlungen_fachpersonen/ 63_praxis -empfehlungen / Kriterien -DMD_v2014_14-08-19.pd f. Accessed February 11, 2016.",OADS,/arxiv_data1/oa_pdf/ce/a1/ppa-10-223.PMC4780198.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/ce/a1/ppa-10-223.PMC4780198.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c6/d0/dddt-10-897.PMC4780199.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 897–910Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  897Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9820 0cost-effectiveness comparison of lamivudine plus  adefovir combination treatment and nucleos(t)ide  analog monotherapies in chinese chronic  hepatitis B patients chi Zhang* Weixia Ke* li liu Yanhui gao Zhenjiang Yao Xiaohua Ye shudong Zhou Yi Yang Department of epidemiology and  Biostatistics, school of Public health,   guangdong Pharmaceutical University,   guangzhou, guangdong, People’s  republic of china *These authors contributed equally  to this workBackground/aim:  Lamivudine (LAM) plus adefovir (ADV) combination therapy is clinically  efficacious for treating chronic hepatitis B (CHB) patients in China, but no pharmacoeconomic  evaluations of this strategy are available.",Non-OADS,/arxiv_data1/oa_pdf/c6/d0/dddt-10-897.PMC4780199.pdf
"Each year, approximately 650,000 patients die from  hepatic decompensation, cirrhosis, and hepatocellular carcinoma (HCC) caused by  hepatitis B chronic infection.1 According to a national seroepidemiological survey,  there are an estimated 93 million chronic hepatitis B virus (HBV) carriers in China,  and among them 30 million are CHB patients.2 Recently, HBV DNA levels were  found to be an important risk factor associated with the development of advanced  liver diseases in CHB patients.3 Thus, the current primary goal of antiviral therapy is  to delay or prevent progression of liver diseases by suppressing HBV DNA replication  to the lowest possible levels.2,4–6correspondence: Yi Yang Department of epidemiology and  Biostatistics, school of Public health,  guangdong Pharmaceutical University,  Jianghai avenue 283, guangzhou 510310,  guangdong, People’s republic of china Tel +86 20 3405 5802 Fax +86 20 3405 5355 email yangyigz@163.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Zhang et al Running head recto: Cost-effectiveness analysis of combination therapy DOI: http://dx.doi.org/10.2147/DDDT.S98200",Non-OADS,/arxiv_data1/oa_pdf/c6/d0/dddt-10-897.PMC4780199.pdf
Available from: http://data.stats.,OADS,/arxiv_data1/oa_pdf/c6/d0/dddt-10-897.PMC4780199.pdf
Available from:  http://d.wanfangdata.com.cn/Thesis/D44643 8.,Non-OADS,/arxiv_data1/oa_pdf/c6/d0/dddt-10-897.PMC4780199.pdf
Available from: http://www.zgyyjgw.,Non-OADS,/arxiv_data1/oa_pdf/c6/d0/dddt-10-897.PMC4780199.pdf
Available from: http://www.who.int/hiv/ pub/hepatitis/hepatitis-b-guidelines/en /.,Non-OADS,/arxiv_data1/oa_pdf/c6/d0/dddt-10-897.PMC4780199.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/c6/d0/dddt-10-897.PMC4780199.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c6/d0/dddt-10-897.PMC4780199.pdf
Available  from: http://d.wanfangdata.com.cn/Thesis/Y132654 6.,Non-OADS,/arxiv_data1/oa_pdf/c6/d0/dddt-10-897.PMC4780199.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1a/eb/ott-9-977.PMC4780200.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 977–983OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  977Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9452 4analyses of prognostic factors in cases of non-small  cell lung cancer with multiple brain metastases Xiaomei gong1 Daoan Zhou1 shixiong liang1 caicun Zhou2 1Department of radiation Oncology,   2Department of Oncology, shanghai  Pulmonary hospital, T ongji University  school of Medicine, shanghai, People’s  republic of chinaAim:  To observe the therapeutic efficacy and prognostic factors that influence survival rates  in non-small cell lung cancer (NSCLC) patients with multiple brain metastases (BMs), (more  than three and less than ten).",Non-OADS,/arxiv_data1/oa_pdf/1a/eb/ott-9-977.PMC4780200.pdf
"It is currently the most common malignant cancer, and its incidence of  brain metastasis (BM) is up to 30%–55%.1 Since the 1970s, radiotherapy has become  the standard treatment for BM, and is able to increase the median survival time to correspondence: caicun Zhou Department of Oncology, shanghai  Pulmonary hospital, Tongji University  school of Medicine, no 507 Zhengmin  road, Yangpu District, shanghai 200433,  People’s republic of china Tel +86 21 6511 5006 email zhoucc20157@sina.co m shixiong liang Department of radiation Oncology,  shanghai Pulmonary hospital, Tongji  University school of Medicine, shanghai  200433, People’s republic of china email liangsx2015@sina.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Gong et al Running head recto: Prognostic factors in NSCLC patients with multiple BM DOI: http://dx.doi.org/10.2147/OTT.S94524",Non-OADS,/arxiv_data1/oa_pdf/1a/eb/ott-9-977.PMC4780200.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/1a/eb/ott-9-977.PMC4780200.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/eb/ott-9-977.PMC4780200.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/2d/1f/copd-11-439.PMC4780202.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 439–444International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  439RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S9607 0Striving for optimal bronchodilation: focus on  olodaterol Cristoforo Incorvaia1 Marcello Montagni2 elena Makri1 Gian Galeazzo Riario- Sforza1 erminia Ridolo2 1Allergy/Pulmonary Rehabilitation,   Istituti Clinici di Perfezionamento  Hospital, Milan, Italy; 2Department of  Clinical and experimental Medicine,   University of Parma, Parma, ItalyAbstract:  β2-agonists were introduced in the 1940s as bronchodilators to be used in obstructive  respiratory diseases.",Non-OADS,/arxiv_data1/oa_pdf/2d/1f/copd-11-439.PMC4780202.pdf
"The first agent of this class demonstrating efficacy and safety was  indacaterol.10 Because of its prolonged duration of action, a denomination of “ultra- LABA” was proposed,11 but defining these drugs as “very-long-acting β2-agonists  (VLABAs)” seems to fit better with the usual nomenclature.12 Other VLABAs were Correspondence: Cristoforo Incorvaia Allergy/Pulmonary Rehabilitation, ICP  Hospital, via Bignami 1, 20126 Milan, Italy Tel +39 02 5799 3289 Fax +39 02 5799 3579 email cristoforo.incorvaia@gmail.co m Journal name: International Journal of COPD Article Designation: Review Y ear: 2016 Volume: 11 Running head verso: Incorvaia et al Running head recto: Striving for optimal bronchodilation DOI: http://dx.doi.org/10.2147/COPD.S96070",Non-OADS,/arxiv_data1/oa_pdf/2d/1f/copd-11-439.PMC4780202.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/2d/1f/copd-11-439.PMC4780202.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2d/1f/copd-11-439.PMC4780202.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/59/bd/opth-10-359.PMC4780203.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 359–364Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  359Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S9631 8Measurement of central corneal thickness by  ultrasonic pachymeter and oculus pentacam in  patients with well-controlled glaucoma: hospital- based comparative study riyam Faihan rashid Qasim K Farhood Department of Ophthalmology,   College of Medicine, University of  Babylon, Babylon, iraqBackground:  The measurement of central corneal thickness (CCT) plays an important role in  the diagnosis and treatment of glaucoma and many corneal diseases.",Non-OADS,/arxiv_data1/oa_pdf/59/bd/opth-10-359.PMC4780203.pdf
"The cornea is  aspheric, although its radius of curvature is often recorded as a spherocylindrical  convex mirror representing the central anterior corneal surface, also called the  corneal cap.1 The cornea is the principal refractive surface of human eye and along with sclera  forms the outermost coat of the eyeball.2 The precorneal tear film consists of: “outer lipid” layer, which is secreted by the  meibomian glands (0.1 µm thick); “intermediate aqueous” layer, which is secreted  by the lacrimal glands (7 µm thick); “inner mucous” layer secreted by conjunctival  goblet cells (0.3 µm thick).3Correspondence: Qasim K Farhood Department of Ophthalmology, College  of Medicine, University of Babylon,  Babylon 52001, iraq Tel +964 780 117 9098 email qasim_1964@ymail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Rashid and Farhood Running head recto: Measurement of CCT by ultrasonic pachymeter and oculus pentacam DOI: http://dx.doi.org/10.2147/OPTH.S96318",Non-OADS,/arxiv_data1/oa_pdf/59/bd/opth-10-359.PMC4780203.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/59/bd/opth-10-359.PMC4780203.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/59/bd/opth-10-359.PMC4780203.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://uk.sagepub.com/en-us/nam/open-access-at-sage).Journal of the Royal Society of Medicine Open; 0(0) 1–10 DOI: 10.1177/2054270415623695",Non-OADS,/arxiv_data1/oa_pdf/f0/52/10.1177_2054270415623695.PMC4780204.pdf
The Manchester TriageSystem (http://www.triagenet.net/en/) is widelyimplemented in the UK and a modiﬁed scale wasused prospectively to identify parents of childrentriaged as P3–P6 (Figure 1).,Non-OADS,/arxiv_data1/oa_pdf/f0/52/10.1177_2054270415623695.PMC4780204.pdf
The College of Emergency Medicine has recently produceda multi-agency report (https://www.rcplondon.ac.uk/sites/default/ﬁles/acute_and_emergency_care_prescribing_the_remedy.pdf) outlining recommendations toaddress the pressures faced by emergency services.,Non-OADS,/arxiv_data1/oa_pdf/f0/52/10.1177_2054270415623695.PMC4780204.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9a/32/ott-9-1067.PMC4780205.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1067–1075OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1067Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9872 7sPag9 is involved in hepatocarcinoma cell migration  and invasion via modulation of elK1 expression Qiuyue Yan1,2 guohua lou3 Ying Qian1 Bo Qin1 Xiuping Xu1,2 Yanan Wang1,2 Yanning liu3 Xuejun Dong1 1shaoxing People’s hospital, shaoxing  hospital Zhejiang University, shaoxing,   Zhejiang, 2The Key laboratory  of laboratory Medicine, Ministry  of education of china, school  of laboratory Medicine and life  science, Wenzhou Medical University,   Wenzhou, 3state Key laboratory  for Diagnosis and Treatment of  infectious Diseases, collaborative  innovation center for Diagnosis and  Treatment of infectious Diseases,   The First affiliated hospital, school  of Medicine, Zhejiang University,   hangzhou, Zhejiang, People’s republic  of chinaBackground:  Sperm-associated antigen 9 (SPAG9) is upregulated in several malignancies and  its overexpression is positively correlated with cancer cell malignancies.",Non-OADS,/arxiv_data1/oa_pdf/9a/32/ott-9-1067.PMC4780205.pdf
"Cancer-testis (CT) antigens are a unique family of tumor antigens that have aberrant  expression in various tumors and restricted expression in normal testis.3 CT antigens have  been reported to play an important role in a number of malignant properties of cancer  cells.4,5 Sperm-associated antigen 9 (SPAG9) protein, a new member of CT antigen family, correspondence: Xuejun Dong shaoxing People’s hospital, shaoxing  hospital Zhejiang University,  568 Zhongxing north road, shaoxing,  Zhejiang 312000, People’s republic  of china Tel/fax +86 575 8822 8576 email dxj9666@163.co m  Yanning liu state Key laboratory for Diagnosis  and Treatment of infectious Diseases,  collaborative innovation center for  Diagnosis and Treatment of infectious  Diseases, The First Affiliated Hospital,  Zhejiang University, 79 Qingchun road,  6a-17, hangzhou, Zhejiang 310000,  People’s republic of china Tel/fax +86 571 8723 6579 email rainyliu2002@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Y an et al Running head recto: SPAG9: a potential anti-metastasis target in HCC therapy DOI: http://dx.doi.org/10.2147/OTT.S98727",Non-OADS,/arxiv_data1/oa_pdf/9a/32/ott-9-1067.PMC4780205.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/9a/32/ott-9-1067.PMC4780205.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9a/32/ott-9-1067.PMC4780205.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ae/6c/dddt-10-911.PMC4780207.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 911–925Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  911Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9773 8naringenin-loaded solid lipid nanoparticles:  preparation, controlled delivery, cellular uptake,  and pulmonary pharmacokinetics Peng Ji T ong Yu Ying liu Jie Jiang Jie Xu Ying Zhao Yanna hao Yang Qiu Wenming Zhao chao Wu college of Pharmacy, liaoning Medical  University, Jinzhou, liaoning Province,   People’s republic of chinaAbstract:  Naringenin (NRG), a flavonoid compound, had been reported to exhibit extensive  pharmacological effects, but its water solubility and oral bioavailability are only ~46±6 μg/mL  and 5.8%, respectively.",Non-OADS,/arxiv_data1/oa_pdf/ae/6c/dddt-10-911.PMC4780207.pdf
"Keywords:  naringenin, solid lipid nanoparticles, group contribution method, sustained profile,  instillation technology, MTT, cellular uptake, pulmonary pharmacokineticscorrespondence: chao Wu college of Pharmacy, liaoning Medical  University, 40 songpo road, linghe  District, Jinzhou, liaoning Province  121001, People’s republic of china   Tel +86 416 467 3439 email zifengas123@163.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Ji et al Running head recto: Naringenin-loaded solid lipid nanoparticles DOI: http://dx.doi.org/10.2147/DDDT.S97738",Non-OADS,/arxiv_data1/oa_pdf/ae/6c/dddt-10-911.PMC4780207.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/ae/6c/dddt-10-911.PMC4780207.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ae/6c/dddt-10-911.PMC4780207.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6d/a1/ott-9-1095.PMC4780208.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1095–1103OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1095Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9713 1Benefit from thoracic radiotherapy in patients  with extensive-disease small-cell lung cancer  with elevated lactate dehydrogenase Tao Qin1,* ningning Zhou1,* Yin-duo Zeng2 Xiaoxiao Dinglin2 Yuanyuan Zhao1 huai liu3,4 likun chen1 1Department of Medical Oncology,   sun Yat-sen University cancer  center, The state Key laboratory  of Oncology in South China,   collaborative innovation center  for Cancer Medicine, 2Breast  Tumor center, sun Yat-sen  University Sun Yat-sen Memorial  hospital, guangzhou, guangdong,   3Department of Radiotherapy, Hunan  cancer hospital, 4Department of  Radiotherapy, The Affiliated Cancer  Hospital of Xiangya School of  Medicine, Central South University,   Key Laboratory of Translational  radiation Oncology, changsha, hunan,   People’s Republic of China *These authors contributed equally  to this workBackground:  High lactate dehydrogenase (LDH) is associated with a large tumor burden  in extensive-disease small-cell lung cancer (ED-SCLC).",Non-OADS,/arxiv_data1/oa_pdf/6d/a1/ott-9-1095.PMC4780208.pdf
"The median survival time with - out treatment was reported as 2–4 months.9 Furthermore, another study reported a correspondence: likun chen Department of Medical Oncology, Sun  Yat-sen University cancer center, The  State Key Laboratory of Oncology in  south china, collaborative innovation  Center for Cancer Medicine, No 651  Dongfeng Road East, Guangzhou,  guangdong 510060, People’s republic  of China Tel +86 20 8734 2475 email chenlk@sysucc.org.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Qin et al Running head recto: Benefit from TRT in patients with ED-SCLC DOI: http://dx.doi.org/10.2147/OTT.S97131",Non-OADS,/arxiv_data1/oa_pdf/6d/a1/ott-9-1095.PMC4780208.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/6d/a1/ott-9-1095.PMC4780208.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6d/a1/ott-9-1095.PMC4780208.pdf
Methods Study Design The hybrid mobile HIV testing approach is the primary testing strategy in the Sustainable  East Africa Research in Community Health (SEARCH) HIV test and treat cluster- randomized controlled Trial (NCT:01864603: https://clinicaltrials.gov/ct2/show/ NCT01864603 ).,Non-OADS,/arxiv_data1/oa_pdf/7f/74/nihms755590.PMC4780220.pdf
"15-20 (2016) http://dx.doi.org/10.5487/TR.2016.32.1.015 plSSN: 1976-8257 eISSN: 2234-2753 Special Issue ArticleOpen Access Addressing Early Life Sensitivity Using Physiologically Based Pharmacokinetic Modeling and In Vitro to In Vivo Extrapolation Miyoung Y oon and Harvey J. Clewell, III The Hamner Institutes  for Health Sciences (Received December 1, 2015; Revised December 24, 2015; Accepted January 5, 2016) Physiologically based pharmacokinetic (PBPK) modeling can provide an effective way to utilize in vitro and in silico based information in modern risk assessment for children and other potentially sensitive pop- ulations.",Non-OADS,/arxiv_data1/oa_pdf/99/ec/tr-32-015.PMC4780231.pdf
"57-64 (2016) http://dx.doi.org/10.5487/TR.2016.32.1.057 plSSN: 1976-8257 eISSN: 2234-2753 Special Issue ArticleOpen Access Associations of Low Environmental Exposure to Multiple Metals with Renal Tubular Impairment in Korean Adults Hyungryul Lim1, Ji-ae Lim1, Jong Hyuk Choi1, Ho-jang Kwon1, Mina Ha1, Heon Kim2 and Jung-duck Park3 1Department of Preventive Medicine, Dankook University College of Medicine, Cheonan, Korea 2Department of Preventive Medicine, Chungbuk Nation al University College of Medicine, Cheongju, Korea 3Department of Preventive Medicine, Chung-ang University College of Medicine, Seoul, Korea (Received December 1, 2015; Revised December 15, 2015; Accepted January 3, 2016) Recently several studies reported that the renal toxicity of lead (Pb) and cadmium (Cd) may exist in even a low level exposure.",Non-OADS,/arxiv_data1/oa_pdf/59/d5/tr-32-057.PMC4780232.pdf
"73-80 (2016) http://dx.doi.org/10.5487/TR.2016.32.1.073 plSSN: 1976-8257 eISSN: 2234-2753 Special Issue ArticleOpen Access Different Regulation of p53 Expressi on by Cadmium Exposure in Kidney,  Liver, Intestine, Vasculature, and Brain Astrocytes Jin-Y ong Lee1, Maki Tokumoto1, Yuta Hattori1,2, Yasuyuki Fujiwara1,3, Akinori Shimada4 and Masahiko Satoh1 1Laboratory of Pharmaceutical Health Sciences, School of Pharmacy, Aichi Gakuin University, 1-100 Kusumoto-cho, Chikusa-ku, Nagoya 464-8650, Japan 2Department of Preventive Medicine, Graduate School of Medicine, Nagoya University, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan 3Department of Environmental Health, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji , Tokyo 192-0392, Japan 4Laboratory of Pathology, Department of Medical Technology, School of Life and Environmental Science, Azabu University, 1-17-71 Fuchinobe, Chuo -ku, Sagamihara, Kanagawa 252-5201, Japan (Received November 14, 2015; Revised December 18, 2015; Accepted January 4, 2016) Chronic exposure to cadmium (Cd) is known to adversely affect renal function.",Non-OADS,/arxiv_data1/oa_pdf/8e/ed/tr-32-073.PMC4780233.pdf
"5-8 (2016) http://dx.doi.org/10.5487/TR.2016.32.1.005 plSSN: 1976-8257 eISSN: 2234-2753 Special Issue ArticleOpen Access Advancing Risk Assessment through the Application of Systems Toxicology John Michael Sauer1, André Kleensang2, Manuel C. Peitsch3 and A. Wallace Hayes4 1Predictive Safety Testing Consortium, Critical Path Institute, Tucson, AZ, USA 2Johns Hopkins University, Center for Alternatives to Animal Test ing (CAAT), Bloomberg School of Public Health, Baltimore, MD US A 3PMI Research and Development, Neuchatel, Switzerland 4Harvard University and Michigan State University In stitute for Integrative Toxicology, Andover, MA 01810 (Received December 2, 2015; Revised January 12, 2016; Accepted January 13, 2016) Risk assessment is the process of quantifying the probability of a harmful effect to individuals or popula- tions from human activities.",Non-OADS,/arxiv_data1/oa_pdf/77/26/tr-32-005.PMC4780234.pdf
"65-72 (2016) http://dx.doi.org/10.5487/TR.2016.32.1.065 plSSN: 1976-8257 eISSN: 2234-2753 Special Issue ArticleOpen Access Cadmium Exposure and Potential Health Risk from Foods in Contaminated Area, Thailand Rodjana Chunhabundit Graduate Program in Nutrition, Faculty of Medicine at Ra mathibodi Hospital, Mahidol University, Bangkok, Thailand (Received December 2, 2015; Revised December 24, 2015; Accepted January 12, 2016) Man-made cadmium (Cd) emissions can be transported between environmental matrices and the food chain.",Non-OADS,/arxiv_data1/oa_pdf/59/63/tr-32-065.PMC4780235.pdf
Available from: http://consumption.acfs.go.th/index.php.,Non-OADS,/arxiv_data1/oa_pdf/59/63/tr-32-065.PMC4780235.pdf
"21-33 (2016) http://dx.doi.org/10.5487/TR.2016.32.1.021 plSSN: 1976-8257 eISSN: 2234-2753 Special Issue ArticleOpen Access Toxicity and Carcinogenicity of Dichlorodiphenyltrichloroethane (DDT) Takanori Harada, Makio Takeda, Sayuri Kojima and Naruto Tomiyama The Institute of Environmental To xicology, 4321 Uchimoriya-machi, Joso-shi, Ibaraki 303-0043, Japan (Received December 1, 2015; Revised December 18, 2015; Accepted January 6, 2016) Dichlorodiphenyltrichloroethane (DDT) is still used in certain areas of tropics and subtropics to control malaria and other insect-transmitted diseases.",Non-OADS,/arxiv_data1/oa_pdf/d7/44/tr-32-021.PMC4780236.pdf
"81-87 (2016) http://dx.doi.org/10.5487/TR.2016.32.1.081 plSSN: 1976-8257 eISSN: 2234-2753 Special Issue ArticleOpen Access A Rapid and Sensitive Detection of Aflatoxin-producing Fungus Using an Optimized Polymerase Chain Reaction (PCR) Anong Bintvihok1, Supitchaya Treebonmuang2, Kitiya Srisakwattana2, Wisut Nuanchun2, Koranis Patthanachai1 and Sungworn Usawang2 1Department of Veterinary Pharmacology, 2Research and Development Center for Livestock Prod uction Technology, Faculty of Veterinary Science, Chulalongkorn University, Bangkok 10330, Thailand (Received November 13, 2015; Revised December 20, 2015; Accepted January 7, 2016) Aflatoxin B1 (AFB1) is produced by Aspergillus flavus  growing in feedstuffs.",Non-OADS,/arxiv_data1/oa_pdf/aa/db/tr-32-081.PMC4780237.pdf
Available From: http://www.wrc.org.za .,Non-OADS,/arxiv_data1/oa_pdf/aa/db/tr-32-081.PMC4780237.pdf
"1-3 (2016) http://dx.doi.org/10.5487/TR.2016.32.1.001 plSSN: 1976-8257 eISSN: 2234-2753 PrefaceOpen Access Shedding New Lights with the Breakt hrough Ideas to Understand Current  Trends in Modern Toxicology Ok-Nam Bae1 and Joo Y oung Lee2 1College of Pharmacy, Institute of Pharmaceutical Sciences, Hanyang University, Ansan, Korea 2Integrated Research Institute of Pharmaceutical Sciences, College of Pharmacy, The Catholic University of Korea, Bucheon, Korea (Received January 13, 2016; Accepted January 14, 2016) Along with the development of cutting-edge technolo- gies in biology and chemistry, the scope and the criteria intoxicological research have been rapidly expanding (1).Under the main theme of ‘New Frontier in Modern Toxicol-ogy’, the 7 th International Congress of Asian Society of Toxicology (ASIATOX 2015) at Jeju Island in Korea onJune 2015 provided a platform to talk about the current top-ics in toxicology.",Non-OADS,/arxiv_data1/oa_pdf/df/69/tr-32-001.PMC4780238.pdf
"9-14 (2016) http://dx.doi.org/10.5487/TR.2016.32.1.009 plSSN: 1976-8257 eISSN: 2234-2753 Special Issue ArticleOpen Access Advances in the Development and Validation of Test Methods in the United States Warren M. Casey Director, NTP Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM) Executive Director, Interagency Coordinating Committee on the Validation of Alternative Toxicological Methods (ICCVAM) Division of the National Toxicology Program, National Institute of Environmental Health Sciences, RTP , NC, USA (Received October 23, 2015; Revised December 30, 2015; Accepted January 7, 2016) The National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM) provides validation support for US Federal agencies and the US Tox21 interagencyconsortium, an interagency collaboration that is using high throughput screening (HTS) and other advanced approaches to better understand and predict chemical hazards to humans and the environment.",Non-OADS,/arxiv_data1/oa_pdf/94/86/tr-32-009.PMC4780239.pdf
Moreinformation about Tox21 can be found on the NTP website(http://ntp.niehs.nih.gov/go/tox21).,OADS,/arxiv_data1/oa_pdf/94/86/tr-32-009.PMC4780239.pdf
"Detailsof the in vitro assays have been previously published (7,8)and are also are described on EPA’s ToxCast website (http://actor.epa.gov/dashboard/).",OADS,/arxiv_data1/oa_pdf/94/86/tr-32-009.PMC4780239.pdf
More information aboutthe ICCV AM plan to evaluate alternative skin sensitizationtest methods can be obtained on the NTP website (http://ntp.niehs.nih.go v/go/40498).,Non-OADS,/arxiv_data1/oa_pdf/94/86/tr-32-009.PMC4780239.pdf
"35-46 (2016) http://dx.doi.org/10.5487/TR.2016.32.1.035 plSSN: 1976-8257 eISSN: 2234-2753 Special Issue ArticleOpen Access Autophagy in Ischemic Li vers: A Critical Role of Sirtuin 1/Mitofusin 2 Axis in Autophagy Induction Sung Kook Chun, Kristina Go, Ming-Jim Yang, Iv an Zendejas, Kevin E. Behrns and Jae-Sung Kim Department of Surgery, University of  Florida, Gainesville, FL 32610, USA (Received December 6, 2015; Revised December 20, 2015; Accepted December 29, 2015) No-flow ischemia occurs during cardiac arrest, hemorrhagic shock, liver resection and transplantation.",Non-OADS,/arxiv_data1/oa_pdf/9a/e2/tr-32-035.PMC4780240.pdf
"47-56 (2016) http://dx.doi.org/10.5487/TR.2016.32.1.047 plSSN: 1976-8257 eISSN: 2234-2753 Special Issue ArticleOpen Access Pyruvate Kinase M2: A Novel Biomarker for the Early Detection of Acute Kidney Injury Ji Hyun Cheon1, Sun Y oung Kim2, Ji Y eon Son1, Y e Rim Kang1, Ji Hye An1, Ji Hoon Kwon1, Ho Sub Song1, Aree Moon2, Byung Mu Lee1 and Hyung Sik Kim1 1School of Pharmacy, Sungkyunkwan University, Suwon, Korea 2College of Pharmacy, Duksung Women’s University, Seoul, Korea (Received December 14, 2015; Revised December 22, 2015; Accepted December 23, 2015) The identification of biomarkers for the early detection of acute kidney injury (AKI) is clinically import- ant.",Non-OADS,/arxiv_data1/oa_pdf/80/5c/tr-32-047.PMC4780241.pdf
"The toy mouse was obtained from a pet shop ( http://www.zoowelt.cc ), which offered it as a toy/training object for cats.",Non-OADS,/arxiv_data1/oa_pdf/45/53/fbp-27-279.PMC4780246.pdf
"The toy mouse was washed in a washing machine for about 70 min at 30 °C with an apparently nonscented detergent for wool ( ‘Lana/Wolle ’,http://www.glenfield.it ) before each conditioning experiment.",Non-OADS,/arxiv_data1/oa_pdf/45/53/fbp-27-279.PMC4780246.pdf
All statistical analyses were carried out using Prism 6(http://www.graphpad.com ).,OADS,/arxiv_data1/oa_pdf/45/53/fbp-27-279.PMC4780246.pdf
The lower part of the table summarizes the statistical analysis of the various samples by Fisher ’s Exact test (two-sided Pvalues) as obtained with the Prism 6 software ( http://www.graphpad.com ).Pvalue <0.05 are represented in bold.,Non-OADS,/arxiv_data1/oa_pdf/45/53/fbp-27-279.PMC4780246.pdf
"Acknowledgements Austrian Science Fund grants W1206-B18 (PhD program ‘Signal Processing in Neurons ’,http://www.neurospin.at , B.S.P.",Non-OADS,/arxiv_data1/oa_pdf/45/53/fbp-27-279.PMC4780246.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/f2/1a/num-08-01-32286.PMC4780280.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/83/b3/num-08-01-35352.PMC4780281.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/02/db/num-08-01-34421.PMC4780282.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/rmdopen-2015- 000217).,Non-OADS,/arxiv_data1/oa_pdf/ed/22/rmdopen-2015-000217.PMC4780312.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/ed/22/rmdopen-2015-000217.PMC4780312.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/rmdopen-2015- 000197).,Non-OADS,/arxiv_data1/oa_pdf/2e/a1/rmdopen-2015-000197.PMC4780313.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1. van Nies JAB, Krabben A, Schoones JW, et al.",Non-OADS,/arxiv_data1/oa_pdf/2e/a1/rmdopen-2015-000197.PMC4780313.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/da/b5/aapm-06-01-33071.PMC4780391.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fc/c5/prom-7-019.PMC4780393.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPatient Related Outcome Measures 2016:7 19–28Patient Related Outcome Measures Dove press submit your manuscript | www.dovepress.co m Dove press  19ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/PROM.S9330 8structure, process, and outcomes of care in a  telemonitoring program for patients with type   2 diabetes Jill M nocella1 Victoria Vaughan Dickson2 charles M cleland2 gail D’eramo Melkus2 1Department of nursing, William  Paterson University, Wayne, nJ,   2college of nursing, new Y ork  University, new Y ork, nY, Usa correspondence: Jill M nocella   Department of nursing, William Paterson  University, 300 Pompton Road, 207  hunziker Wing, Wayne, nJ 07470, Usa   email nocellaj1@wpunj.ed uBackground:  Using Donabedian’ s structure-process-outcomes (SPO) framework, this descrip - tive, exploratory study examined the structure of a telemonitoring program in a population of  patients with type 2 diabetes (T2D), the process of nurse–patient telephonic interactions, and  patients’ clinical outcomes.",Non-OADS,/arxiv_data1/oa_pdf/fc/c5/prom-7-019.PMC4780393.pdf
"Patient Related Outcome Measures Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-related-outcome-measures-journa lPatient Related Outcome Measures is an international, peer-reviewed,  open access journal focusing on treatment outcomes specifically  relevant to patients.",Non-OADS,/arxiv_data1/oa_pdf/fc/c5/prom-7-019.PMC4780393.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/fc/c5/prom-7-019.PMC4780393.pdf
The full terms of this license are available at https://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/94/6a/prbm-9-021.PMC4780394.pdf
"com/terms.ph p and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/94/6a/prbm-9-021.PMC4780394.pdf
"For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Psychology Research and Behavior Management Psychology Research and Behavior Management 2016:9 21–29Dove press submit your manuscript | www.dovepress.co m Dove press  Reviewopen access to scientific and medical research Open Access Full T ext Article 21 http: //dx.doi.org/10.2147/PRBM.S8458 9Cognitive behavioral therapy for suicidal  behaviors: improving patient outcomes Louise Mewton1 Gavin Andrews2 1National Health and Medical  Research Council Centre for  Research excellence in Mental Health  and Substance Use, National Drug and  Alcohol Research Centre, University  of New South wales, 2Clinical  Research Unit for Anxiety and  Depression (CRUfAD), St vincent’s  Hospital, Sydney, NSw , Australia Correspondence: Louise Mewton   National Health and Medical Research  Council  Centre for Research excellence  in Mental Health and Substance Use,  National Drug and Alcohol Research  Centre, University of New South wales,  Sydney, NSw , 2052 Australia   T el +61 2 8936 1131   email louisem@unsw.edu.a uAbstract:  This systematic review provides an overview of the effectiveness of cognitive  behavioral therapy (CBT) in reducing suicidal cognitions and behavior in the adult population.",Non-OADS,/arxiv_data1/oa_pdf/94/6a/prbm-9-021.PMC4780394.pdf
"Psychology Research and Behavior Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/psychology-research-and-behavior-management-journa lPsychology Research and Behavior Management is an international, peer- reviewed, open access journal focusing on the science of psychology and  its application in behavior management to develop improved outcomes  in the clinical, educational, sports and business arenas.",Non-OADS,/arxiv_data1/oa_pdf/94/6a/prbm-9-021.PMC4780394.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/94/6a/prbm-9-021.PMC4780394.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c9/65/tcrm-12-339.PMC4780395.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 339–350Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  339Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S8509 9Dimethyl fumarate in the management of multiple  sclerosis: appropriate patient selection and special  considerations Luca Prosperini Simona Pontecorvo Department of Neurology and  Psychiatry, Sapienza University,   Rome, italyAbstract:  Delayed-release dimethyl fumarate (DMF), also known as gastroresistant DMF,  is the most recently approved oral disease-modifying treatment (DMT) for relapsing multiple  sclerosis.",Non-OADS,/arxiv_data1/oa_pdf/c9/65/tcrm-12-339.PMC4780395.pdf
"Keywords:  multiple sclerosis, dimethyl fumarate, oral drugs, therapeutic algorithm Introduction Multiple sclerosis (MS) is a chronic immunomediated inflammatory disease of the  central nervous system (CNS) that typically affects young adults.1 The risk of MS is  greater in women than in men; female:male ratios are between 1.5:1 and 3.5:1 in most  populations, with a trend toward greater values in the most recent studies.2 The etiology of MS is still not completely known, but presumably involves interac - tion among genetic, environmental, and other factors triggering an aberrant autoimmune  attack, resulting in damage to myelin and axons.3 The pathogenesis of MS involves  immune attack against CNS antigens mediated through activated CD4+ myelin-reactive  T cells, with contribution by B cells.4 Therefore, MS is believed to be an autoimmune  disorder, but the antigen specificity of the immune response is still unknown.4 Pathologi - cally, MS is characterized by perivascular infiltrates of mononuclear cells, demyelina - tion, remyelination, oligodendrocyte depletion, astrocytosis, axonal loss, and neuronal  degeneration that result in the formation of MS plaques in the brain and spinal cord.5Correspondence: Luca Prosperini Department of Neurology and  Psychiatry, Sapienza University, 30 viale  dell’Università, Rome 00185, italy Tel +39 06 4991 4716 Fax +39 06 3377 5900 email luca.prosperini@uniroma1.i t Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2016 Volume: 12 Running head verso: Prosperini and Pontecorvo Running head recto: DMF in MS management DOI: http://dx.doi.org/10.2147/TCRM.S85099",Non-OADS,/arxiv_data1/oa_pdf/c9/65/tcrm-12-339.PMC4780395.pdf
"Available from: http://www.ema.europa.eu/docs/en_ GB/document_library/EPAR_-_Product_Information/human/000603/ WC500044686.pd f. Accessed January 26, 2016.",OADS,/arxiv_data1/oa_pdf/c9/65/tcrm-12-339.PMC4780395.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/c9/65/tcrm-12-339.PMC4780395.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c9/65/tcrm-12-339.PMC4780395.pdf
Available from: http://www.ema.europa.eu/ema/index.,Non-OADS,/arxiv_data1/oa_pdf/c9/65/tcrm-12-339.PMC4780395.pdf
Available from:  https://clinicaltrials.gov/ct2/show/NCT0243053 2.,Non-OADS,/arxiv_data1/oa_pdf/c9/65/tcrm-12-339.PMC4780395.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/03/15/tcrm-12-353.PMC4780396.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 353–360Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  353ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S9601 6Reduction in total recurrent cardiovascular events  in acute coronary syndrome patients with low- density lipoprotein cholesterol goal 70 mg/dl:  a real-life cohort in a developing country surarong Chinwong1 Jayanton Patumanond2 Dujrudee Chinwong1 John Joseph hall3 arintaya Phrommintikul4 1Department of Pharmaceutical  Care, Faculty of Pharmacy, Chiang  Mai University, Chiang Mai, Thailand;   2Center of excellence in applied  epidemiology, Faculty of Medicine,   Thammasat University, Pathum  Thani, Thailand; 3Centre for Clinical  epidemiology and Biostatistics,   school of Medicine and Public health,   Faculty of health, University of  newcastle, Callaghan, nsW, australia;   4Department of internal Medicine,   Faculty of Medicine, Chiang Mai  University, Chiang Mai, ThailandBackground:  For investigations into cardiovascular disease, the first problematic event (ie, nonfatal  acute coronary syndrome (ACS), nonfatal stroke, or all-cause mortality) generally was considered  as the primary end point; however, ACS patients often experience subsequent events, which are  rarely considered.",Non-OADS,/arxiv_data1/oa_pdf/03/15/tcrm-12-353.PMC4780396.pdf
"However, the occurrence of subsequent events in addition to the first event Correspondence: arintaya Phrommintikul Department of internal Medicine, Faculty  of Medicine, Chiang Mai University,  Chiang Mai 50200, Thailand Tel +66 53 946 716 Fax +66 53 289 177 email arintayap@gmail.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Chinwong et al Running head recto: LDL-C goal and total recurrent cardiovascular events in ACS patients DOI: http://dx.doi.org/10.2147/TCRM.S96016",Non-OADS,/arxiv_data1/oa_pdf/03/15/tcrm-12-353.PMC4780396.pdf
"Avail - able from: http://www.med.cmu.ac.th/2013/academic-departments-2/ maharaj-nakorn-chiang-mai-hospital.htm l. Accessed May 15, 2015.",Non-OADS,/arxiv_data1/oa_pdf/03/15/tcrm-12-353.PMC4780396.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/03/15/tcrm-12-353.PMC4780396.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/03/15/tcrm-12-353.PMC4780396.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/96/02/ppa-10-233.PMC4780397.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 233–241Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  233OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S9552 8The association between cognitive function and  objective adherence to dietary sodium guidelines  in patients with heart failure Mary A Dolansky1 Julie T schaefer2 Misty AW hawkins3 John gunstad2 Anup Basuray4 Joseph D redle5 James c Fang6 richard A Josephson7,8 shirley M Moore1 Joel W hughes2 1school of nursing, case Western  reserve University, cleveland, Oh,   UsA; 2Department of Psychology,   Kent state University, Kent, Oh, UsA;   3Department of Psychology, Oklahoma  state University, stillwater, OK, UsA;   4Ohio health heart and Vascular  Physicians, columbus, Oh, UsA;   5Department of cardiology, summa  health system, Akron city hospital,   Oh, UsA; 6Department of internal  Medicine, Division of cardiology,   University hospital, salt lake city,   UT, UsA; 7Department of Medicine,   case Western reserve University,   cleveland, Oh, UsA; 8harrington  heart & Vascular institute, University  hospitals, cleveland, Oh, UsABackground:  Although cognitive impairment is common in heart failure (HF) patients, its  effects on sodium adherence recommendations are unknown.",Non-OADS,/arxiv_data1/oa_pdf/96/02/ppa-10-233.PMC4780397.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/96/02/ppa-10-233.PMC4780397.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d6/7d/tcrm-12-351.PMC4780398.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 351–352Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  351LeTTeRopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S10319 6The use of oral suspension and rationally  prescribing alternatives may be supplemental to  the implementation of clopidogrel new algorithm  comprising CYP2C19  pharmacogenetics and drug  interactions Meng Chen Quan Zhou Department of Pharmacy, The  Second Affiliated Hospital, School  of Medicine, Zhejiang University,   Hangzhou, Zhejiang Province, People’s  Republic of ChinaDear editor We read with great interest the study by Saab et al,1 which shows that all patients who  received combination therapy of clopidogrel and cytochrome P540 2C19 (CYP2C19)  substrates require clopidogrel dose adjustment if they are not CYP2C19 *1/*1 car - riers and that therapeutic dose of 75 mg clopidogrel should be tailored in patients  with different genotypes (eg, lowered to 6 mg or increased to 215 mg) for the sake  of efficacy and safety.",Non-OADS,/arxiv_data1/oa_pdf/d6/7d/tcrm-12-351.PMC4780398.pdf
"It is promising to develop a liquid pharmaceutical formulation of  clopidogrel for the sake of convenience and dose accuracy.Correspondence: Quan Zhou Department of Pharmacy, The Second  Affiliated Hospital, School of Medicine,  Zhejiang University, 88 Jiefang Road,  Hangzhou 310009, Zhejiang Province,  People’s Republic of China Tel +86 571 8778 4615 Fax +86 571 8702 2776 email zhouquan142602@zju.edu.c n Journal name: Therapeutics and Clinical Risk Management Article Designation: Letter Y ear: 2016 Volume: 12 Running head verso: Chen and Zhou Running head recto: Clopidogrel and personalized therapy DOI: http://dx.doi.org/10.2147/TCRM.S103196",Non-OADS,/arxiv_data1/oa_pdf/d6/7d/tcrm-12-351.PMC4780398.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/d6/7d/tcrm-12-351.PMC4780398.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/7d/tcrm-12-351.PMC4780398.pdf
Available from: http://www.rxlist.,Non-OADS,/arxiv_data1/oa_pdf/d6/7d/tcrm-12-351.PMC4780398.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ad/a5/ppa-10-251.PMC4780399.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 251–256Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  251OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S10139 1Prediction of pain in orthodontic patients based  on preoperative pain assessment Baoyu Zheng1 Manman ren2 Feiou lin3 linjie Yao4 1Periodontic Department, 2Oral and  Maxillofacial surgery Department,   school and hospital of stomatology,   3Orthodontic Department,   4Pedodontic Department, school and  hospital of stomatology, Wenzhou  Medical University, Wenzhou, Zhejiang,   People’s republic of chinaAim:  To investigate whether pretreatment assessment of experimental pain can predict the  level of pain after archwire placement.",Non-OADS,/arxiv_data1/oa_pdf/ad/a5/ppa-10-251.PMC4780399.pdf
"However, NSAIDs may cause side effects, including thrombocytopenia, correspondence: linjie Yao Pedodontic Department, school and  hospital of stomatology, Wenzhou  Medical University, no 113 West  Xueyuan road, Wenzhou, Zhejiang,  People’s republic of china Tel/fax +86 577 8806 3008 email yaolinjiesci@163.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Zheng et al Running head recto: Prediction of pain in orthodontic patients DOI: http://dx.doi.org/10.2147/PPA.S101391",Non-OADS,/arxiv_data1/oa_pdf/ad/a5/ppa-10-251.PMC4780399.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/ad/a5/ppa-10-251.PMC4780399.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/8d/01/vhrm-12-053.PMC4780400.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/8d/01/vhrm-12-053.PMC4780400.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Vascular Health and Risk Management 2016:12 53–63Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  53ReViewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/VHRM.S8127 5Type ii endoleaks: challenges and solutions Andrew Brown1 Greta K Saggu1 Matthew J Bown2 Robert D Sayers2 David A Sidloff1,2 1Department of Vascular Surgery,   Queens Medical Centre, University  of Nottingham, Nottingham,   2Department of Cardiovascular  Sciences, National institute for Health  Research Leicester Cardiovascular  Biomedical Research Unit, University  of Leicester, Leicester, UK Correspondence: David A Sidloff   Department of Cardiovascular Sciences,  Level 2, RKCSB, Leicester Royal Infirmary,  Infirmary Square, Leicester, LE2 7LX, UK   T el +44 773 683 3606   email ds343@le.ac.u kAbstract:  Type II endoleaks are the most common endovascular complications of endovascular  abdominal aortic aneurysm repair (EV AR); however, there has been a divided opinion regard - ing their significance in EV AR.",Non-OADS,/arxiv_data1/oa_pdf/8d/01/vhrm-12-053.PMC4780400.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/8d/01/vhrm-12-053.PMC4780400.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9c/a7/ppa-10-257.PMC4780401.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 257–264submit your manuscript | www.dovepress.co m Dove press  257 http: //dx.doi.org/10.2147/PPA.S10215 6Patient Preference and Adherence Dove press OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article Influence of structured telephone follow-up on  patient compliance with rehabilitation after total  knee arthroplasty Mochuan chen1 Pihong li2 Feiou lin3 1Department of Orthopaedics,   2Department of general surgery, The  second Affiliated hospital & Yuying  children’s hospital, 3Orthodontic  Department, school and hospital  of stomatology, Wenzhou Medical  University, Wenzhou, Zhejiang,   People’s republic of chinaIntroduction:  To assess the effects of structured telephone follow-up on patient’s home-exercise  compliance after total knee arthroplasty (TKA).",Non-OADS,/arxiv_data1/oa_pdf/9c/a7/ppa-10-257.PMC4780401.pdf
"correspondence: Feiou lin Orthodontic Department, school  and hospital of stomatology,  Wenzhou Medical University,  no 373, West Xueyuan road,  Wenzhou, Zhejiang 325000, People’s  republic of china Tel/fax +86 577 8806 3008 email linfeiousci@163.co mJournal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Chen et al Running head recto: Effects of telephone follow-up on patient home-exercise compliance DOI: http://dx.doi.org/10.2147/PPA.S102156",Non-OADS,/arxiv_data1/oa_pdf/9c/a7/ppa-10-257.PMC4780401.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/9c/a7/ppa-10-257.PMC4780401.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/70/3c/tcrm-12-335.PMC4780402.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 335–338submit your manuscript | www.dovepress.co m Dove press  335 http: //dx.doi.org/10.2147/TCRM.S9569 5Dove press ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article T otalTrack video intubating laryngeal mask in  super-obese patients – series of cases T omasz Gaszynski Department of Emergency and  Disaster Medicine, Medical University  of Lodz, Lodz, PolandBackground:  Super-obese patients are at increased risk of difficult mask ventilation and difficult  intubation.",Non-OADS,/arxiv_data1/oa_pdf/70/3c/tcrm-12-335.PMC4780402.pdf
"Kopcinskiego 22, 90-153 Lodz, Poland Tel +48 42 678 37 48 Email tomasz.gaszynski@umed.lodz.p l Journal name: Therapeutics and Clinical Risk Management Article Designation: ORIGINAL RESEARCH Y ear: 2016 Volume: 12 Running head verso: Gaszynski Running head recto: TotalTrack video intubating laryngeal mask in super-obese patients DOI: http://dx.doi.org/10.2147/TCRM.S95695",Non-OADS,/arxiv_data1/oa_pdf/70/3c/tcrm-12-335.PMC4780402.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/70/3c/tcrm-12-335.PMC4780402.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/70/3c/tcrm-12-335.PMC4780402.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c5/4d/ppa-10-243.PMC4780403.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 243–250Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  243OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S9378 6The interactive web-based program Msmonitor  for self-management and multidisciplinary care  in multiple sclerosis: utilization and valuation  by patients Peter Joseph Jongen,1,2  ludovicus g sinnige,3 Björn M  van geel,4 Freek Verheul,5 Wim  i Verhagen,6 ruud A van der  Kruijk,7 reinoud haverkamp,8  hans M schrijver,9 Jacoba  c Baart,10 leo h Visser,11 edo  P Arnoldus,12 herman Jacobus  gilhuis,13 Paul Pop,14 Monique  Booy,15 Marco heerings,16  Anton Kool,17 esther van  noort17 1Department of community and Occupational  Medicine, University Medical center  groningen, University of groningen,   groningen, 2Ms4 research institute, nijmegen,   3Multiple sclerosis centre leeuwarden,   Medical centre leeuwarden, leeuwarden,   4Department of n eurology, Medical centre  Alkmaar, Alkmaar, 5Department of n eurology,   groene hart hospital, gouda, 6Department  of neurology, canisius Wilhelmina hospital,   nijmegen, 7Department of neurology,   slingeland hospital, Doetinchem, 8Department  of neurology, Zuwe hofpoort hospital,   Woerden, 9Multiple sclerosis centre, Westfries  gasthuis, hoorn, 10Department of n eurology,   Ziekenhuisgroep T wente, Almelo-hengelo,   11Multiple sclerosis centre Midden Brabant, st  elisabeth hospital, Tilburg, 12Multiple sclerosis  centre Midden Brabant, T weesteden hospital,   13Department of neurology, reinier de graaf  gasthuis, Delft, 14Department of n eurology,   Viecuri Medical centre, Venlo-Venray, 15Multiple  sclerosis centre, Amphia hospital, Breda, 16Mh  Advies en organisatiebureau, Assen, 17curavista  bv, geertruidenberg, the netherlandsBackground:  MSmonitor is an interactive web-based program for self-management and  integrated, multidisciplinary care in multiple sclerosis.",Non-OADS,/arxiv_data1/oa_pdf/c5/4d/ppa-10-243.PMC4780403.pdf
"In ~80% of the  persons with MS (PwMS), the first phase of the disease is characterized by recurrent  episodes of symptoms that are typically followed by complete or partial remissions:  relapsing remitting MS (RRMS).1 In spite of the fact that disease-modifying drugs  (DMDs) reduce the frequency and severity of relapses, after about 15 years, most correspondence: Peter Joseph Jongen Department of community and Occupational  Medicine, University Medical center groningen,  University of groningen, Antonius Deusinglaan 1,  9713 AV groningen, the netherlands Tel +31 50 363 2843  email p.j.h.jongen@rug.n l Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Jongen et al Running head recto: Web-based self-management and care in multiple sclerosis DOI: http://dx.doi.org/10.2147/PPA.S93786",Non-OADS,/arxiv_data1/oa_pdf/c5/4d/ppa-10-243.PMC4780403.pdf
"MSmonitor is a care project and has therefore not been  submitted to an ethical committee or the Central Committee  on Research Involving Human Subjects, in accordance with  the Dutch Medical Research Involving Human Subjects Act  of 1999 ( http://wetten.overheid.nl/BWBR000940 8).15 At the  start of participation in MSmonitor, patients were asked to  give their informed consent for analysis of their anonymized  data for research purposes.",Non-OADS,/arxiv_data1/oa_pdf/c5/4d/ppa-10-243.PMC4780403.pdf
"After having received a personal code, respondents  logged on to the study website of the MS4 Research Insti - tute, then http://ms4ri.net/ms4-researc h, to choose a user - name and password.",OADS,/arxiv_data1/oa_pdf/c5/4d/ppa-10-243.PMC4780403.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/c5/4d/ppa-10-243.PMC4780403.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/db/76/nihms-755768.PMC4780405.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/dd/bc/ott-9-1145.PMC4780433.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1145–1149OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1145Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9581 8cytogenetic abnormality in patients with multiple  myeloma analyzed by fluorescent in situ  hybridization Ying hu Wenming chen shilun chen Zhongxia huang Department of hematology, Beijing  chaoyang hospital affiliated to  capital Medical University, Beijing,   People’s republic of chinaObjective:  To analyze the fluorescent in situ hybridization (FISH) data and the association with  clinical characteristics, therapy response, and survival time in patients with multiple myeloma.",Non-OADS,/arxiv_data1/oa_pdf/dd/bc/ott-9-1145.PMC4780433.pdf
"We identified correspondence: Wenming chen Department of hematology, Beijing  Chaoyang Hospital Affiliated to Capital  Medical University, no 5 Jingyuan road,  Beijing 100043, People’s republic of  china email 13910107759@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Hu et al Running head recto: Cytogenetic abnormality in patients with MM DOI: http://dx.doi.org/10.2147/OTT.S95818",Non-OADS,/arxiv_data1/oa_pdf/dd/bc/ott-9-1145.PMC4780433.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/dd/bc/ott-9-1145.PMC4780433.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/bc/ott-9-1145.PMC4780433.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c2/e5/ott-9-1115.PMC4780434.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1115–1122OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1115Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9650 9Dose-escalated intensity-modulated radiotherapy  and irradiation of subventricular zones in relation  to tumor control outcomes of patients with  glioblastoma multiforme grace Kusumawidjaja1 Patricia Zhun hong gan1 Whee sze Ong2 achiraya T eyateeti3 Pittaya Dankulchai3 Daniel Yat harn Tan1 eu Tiong chua1 Kevin lee Min chua1 chee Kian Tham4 Fuh Y ong Wong1 Melvin lee Kiang chua1,5 1Division of radiation Oncology,   national cancer centre, singapore;   2Division of clinical Trials and  epidemiological sciences, national  cancer centre, singapore;   3Department of radiology, Division  of radiation Oncology, Faculty of  Medicine siriraj hospital, Mahidol  University, Thailand; 4Division of  Medical Oncology, n ational cancer  centre, singapore; 5Duke-n Us  graduate Medical school, singaporeBackground:  Glioblastoma multiforme (GBM) is the most aggressive primary brain tumor  with high relapse rate.",Non-OADS,/arxiv_data1/oa_pdf/c2/e5/ott-9-1115.PMC4780434.pdf
"In patients diagnosed  with the disease, few survive beyond 2 years, even with combination temozolomide  (TMZ) and radiotherapy, although stratification based on MGMT promoter methyla - tion status identifies individuals who will benefit most from this manner of treatment  intensification.1,2 Nonetheless, in patients lacking the methylated epigenome, alternative correspondence: Melvin lee Kiang chua Division of radiation Oncology, national  cancer centre, 11 hospital Drive,  singapore 169610 Tel +65 6321 4204 Fax +65 6223 4854 email melvin.chua.l.k@nccs.com.s g Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Kusumawidjaja et al Running head recto: Dose escalation in glioblastoma multiforme DOI: http://dx.doi.org/10.2147/OTT.S96509",Non-OADS,/arxiv_data1/oa_pdf/c2/e5/ott-9-1115.PMC4780434.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/c2/e5/ott-9-1115.PMC4780434.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c2/e5/ott-9-1115.PMC4780434.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1a/ba/ott-9-1123.PMC4780435.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1123–1133OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1123Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9187 9mir-429 functions as a tumor suppressor by  targeting FSCN1  in gastric cancer cells Min Zhang1 Bing-bin Dong2 Min lu1 Mei-juan Zheng1 he chen1 Jing-zhen Ding3 a-Man Xu2 Yuan-hong Xu1 1clinical laboratory, 2Department  of general surgery, The First  affiliated hospital of anhui Medical  University, hefei, People’s republic  of china; 3Department of cellular  and Molecular Medicine, howard  hughes Medical institute, University  of california at san Diego, la Jolla,   ca, UsaAbstract:  It has been previously reported that the deregulation of microRNAs in gastric cancer  (GC) was correlated with the progression and prognosis.",Non-OADS,/arxiv_data1/oa_pdf/1a/ba/ott-9-1123.PMC4780435.pdf
"We also evaluated the biological influence of overexpression of miR-429 in correspondence: Yuan-hong Xu Clinical Laboratory, The First Affiliated  hospital of anhui Medical University,  218 Jixi road, hefei, anhui 230022,  People’s republic of china Tel +86 551 6292 2125 Fax +86 551 6292 2125 email xyhong1964@163.co m a-Man Xu Department of general surgery,  The First Affiliated Hospital of Anhui  Medical University, 218 Jixi road, hefei,  anhui 230022, People’s republic of china  Tel +86 551 6287 6038 Fax +86 551 6287 6038 email xuaman166@sina.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Zhang et al Running head recto: miR-429 inhibits GC cells by targeting FSCN1 DOI: http://dx.doi.org/10.2147/OTT.S91879",Non-OADS,/arxiv_data1/oa_pdf/1a/ba/ott-9-1123.PMC4780435.pdf
Tcga dataming The public TCGA ( http://cancergenome.nih.gov /) data  were used as our primary source of samples.,OADS,/arxiv_data1/oa_pdf/1a/ba/ott-9-1123.PMC4780435.pdf
TargetScan version 6.2  human miRNA target predictions were obtained online  (http://targetscan.or g).,OADS,/arxiv_data1/oa_pdf/1a/ba/ott-9-1123.PMC4780435.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/1a/ba/ott-9-1123.PMC4780435.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/ba/ott-9-1123.PMC4780435.pdf
"In this study (n=705), 68 patients with atrophic gastritis or intestinal metaplasia were initially classified as  H. pylori - negative gastric cancer, but authors determined to recategorize   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.See “Comparison between Resectable Helicobacter pylori -Negative and -Positive Gastric Cancers” by Hee Jin Kim, et al.",Non-OADS,/arxiv_data1/oa_pdf/f2/f4/gnl-10-157.PMC4780443.pdf
"2, 2016  Correspondence to: Dae Young Cheung Department of Internal Medicine, Yeouido St. Mary’s Hospital, The Catholic University of Korea College of Medicine, 222 Banpo-daero, Seocho-gu,  Seoul 06591, Korea Tel: +82-2-3779-1519, Fax: +82-2-3779-1331, E-mail: adagio@catholic.ac.kr pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl16002",Non-OADS,/arxiv_data1/oa_pdf/f2/f4/gnl-10-157.PMC4780443.pdf
"However, considering the fact that  the time interval is a significant factor affecting the quality of  bowel preparation 9 and proximal colon is frequently involved in  poor bowel preparation, we cannot exclude the possibility that the Ottawa bowel preparation scale in this study might have   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.See “Does Polyethylene Glycol (PEG) Plus Ascorbic Acid Induce More Mucosal Injuries than Split-Dose 4-L PEG during Bowel  Preparation?” by Min Sung Kim, et al.",Non-OADS,/arxiv_data1/oa_pdf/78/9c/gnl-10-160.PMC4780444.pdf
"2, 2016 Correspondence to: Ji Won Kim  Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul National University College of Medicine, 20 Boramae-ro  5-gil, Dongjak-gu, Seoul 07061, Korea  Tel: +82-2-870-2221, Fax: +82-2-870-3863, E-mail: kjwjor@snu.ac.kr pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl15659",Non-OADS,/arxiv_data1/oa_pdf/78/9c/gnl-10-160.PMC4780444.pdf
"The authors revealed that adalimumab was more effec-  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.See “Efficacy and Safety of Adalimumab in Moderately to Severely Active Cases of Ulcerative Colitis: A Meta-Analysis of  Published Placebo-Controlled Trials” by Zong Mei Zhang, et al.",Non-OADS,/arxiv_data1/oa_pdf/c0/14/gnl-10-162.PMC4780445.pdf
"2, 2016 Correspondence to: Jae Hee Cheon Department of Internal Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea   Tel: +82-2-2228-1990, Fax: +82-2-393-6884, E-mail: geniushee@yuhs.ac pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl16024",Non-OADS,/arxiv_data1/oa_pdf/c0/14/gnl-10-162.PMC4780445.pdf
Epub 2015 Apr  20. http://dx.doi.org/10.1136/gutjnl-2015-309290.,Non-OADS,/arxiv_data1/oa_pdf/c0/14/gnl-10-162.PMC4780445.pdf
"IMRT is a modality that is sensitive to the motion of the tar- get and the surrounding normal organs because inverse plan - ning optimization of the individual beam intensity is performed   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.See “A Comparison of Gastrointestinal Toxicities between Intensity-Modulated Radiotherapy and Three-Dimensional Con - formal Radiotherapy for Pancreatic Cancer” by Kyong Joo Lee, et al.",Non-OADS,/arxiv_data1/oa_pdf/3b/08/gnl-10-164.PMC4780446.pdf
"2, 2016 Correspondence to: Hee Chul Park Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul  06351, KoreaTel: +82-2-3410-2612, Fax: +82-2-3410-2619, E-mail: rophc@skku.edu pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl16014",Non-OADS,/arxiv_data1/oa_pdf/3b/08/gnl-10-164.PMC4780446.pdf
"6,7 The mesothe- lium acts as a semipermeable barrier for water and solutes, and   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Correspondence to: Kinji Asahina Southern California Research Center for ALPD and Cirrhosis, Department of Pathology, Keck School of Medicine, University of Southern California,  1333 San Pablo St., MMR 402, Los Angeles, CA 90089-9141, USA Tel: +1-323-442-2213, Fax: +1-323-442-3126, E-mail: asahina@usc.edu Received on May 20, 2015.",Non-OADS,/arxiv_data1/oa_pdf/9a/b7/gnl-10-166.PMC4780447.pdf
"Accepted on August 18, 2015.pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl15226",Non-OADS,/arxiv_data1/oa_pdf/9a/b7/gnl-10-166.PMC4780447.pdf
"34,52-60 The goals of this review are to describe the nonclassical clini- cal phenotypes of autoimmune hepatitis, present the diagnostic  criteria that have been formalized for this disease, indicate the  current and evolving serological repertoire, present guidelines  for the administration of conventional treatment regimens, out- line strategies for incorporating nonstandard drugs in the treat- ment of selected patients, and indicate the site-specific molecu-  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Correspondence to: Albert J. Czaja  Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, 200 First Street S.W., Rochester, MN 55905, USA  Tel: +1-507-284-2691, Fax: +1-507-284-0538, E-mail: czaja.albert@mayo.edu Received on July 28, 2015.",Non-OADS,/arxiv_data1/oa_pdf/4b/2e/gnl-10-177.PMC4780448.pdf
"Accepted on November 4, 2015.pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl15352",Non-OADS,/arxiv_data1/oa_pdf/4b/2e/gnl-10-177.PMC4780448.pdf
"Emerging Molecular, Cellular and Pharmacological Interventions for Autoimmune Hepatitis Emerging interventions Putative actions Experience Molecular interventions CTLA-4Ig (abatacept) Disrupts CD28 binding to B7 ligands52 Dampens T lymphocyte activation34,300Approved for rheumatoid arthritis52 Improved murine model of PBC303 Anti-CD20 (rituximab) Inhibits B lymphocyte activation53,300Isolated patients with AIH281-284 Effective in refractory AIH285 Anti-TNF- α (infliximab) Inhibits TNF- α and interferes with   maturation of cytotoxic T cells34,52Effective in refractory AIH55 Frequent side effects (27%)55 Nonmitogenic anti-CD3 Binds to antigen receptor of T cells300 Promotes apoptosis of immune cells34,53Effective in diabetic model307 Increases insulin in diabetic humans308 Anti-lysyl oxidase-like 2 (simtuzumab) Inhibits lysyl oxidase and antifibrotic323 Prevents cross-linkage of collagen322Phase 2 studies to prevent fibrosis in NAFLD  and PSC (https://clinicaltrials.gov) Cellular interventions Adoptive transfer of regulatory T cells Corrects deficiencies in cell population60 Expands immune regulatory population60Effective in models of AIH56,312 Effective in model of PBC313 Adoptive transfer of mesenchymal   stromal cellsAffects innate and adaptive immunity60 Inhibits B and T lymphocytes60Effective in models of RA301 Promising in early human studies319-321 Modulation of natural killer T cells Tailored glycolipid antigens skew dual   immune actions favorably59,314,315Effective in animal models of diabetes, RA,   SLE and AIH300,316,317 Pharmacological prospects Antioxidants (N-acetylcysteine,   S-adenosyl-L methionine)Reduce reactive oxygen species322,323 Decrease hepatocyte apoptosis322,323 Inhibit stellate cell activation322,323Effective in NAFLD, chronic hepatitis C,   and alcoholic cirrhosis324-327 Angiotensin inhibitors (losartan) Reduce profibrotic transformation of hepatic   stellate cells to myofibroblasts322Decreased fibrosis in chronic hepatitis C328 CTLA-4Ig, cytotoxic T lymphocyte antigen-4 fused with human immunoglobulin; PBC, primary biliary cholangitis; AIH, autoimmune hepatitis;  TNF-α, tumor necrosis factor-alpha; NAFLD, nonalcoholic fatty liver disease; PSC, primary sclerosing cholangitis; RA, rheumatoid arthritis; SLE,  systemic lupus erythematosus.",Non-OADS,/arxiv_data1/oa_pdf/4b/2e/gnl-10-177.PMC4780448.pdf
"Simtuzumab has been safe and well-tolerated in Phase 1 studies  involving patients with hepatic fibrosis, and this monoclonal  antibody to lysyl oxidase-like 2 has entered Phase 2 clinical  studies designed to prevent hepatic fibrosis in NAFLD and PSC  (https://clinicaltrials.gov., NCT01672853 and NCT016772879).",Non-OADS,/arxiv_data1/oa_pdf/4b/2e/gnl-10-177.PMC4780448.pdf
"In an attempt to improve CRC  screening and make available additional options without the   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Correspondence to: James R. Bailey Department of Medicine, Indiana University School of Medicine, 1120 West Michigan Street, Gatch Hall Room 626, Indianapolis, IN 46202, USA  Tel: +1-317-988-2522, Fax: +1-317-278-2650, E-mail: jarobail@iupui.edu Received on August 27, 2015.",Non-OADS,/arxiv_data1/oa_pdf/98/c9/gnl-10-204.PMC4780449.pdf
"Accepted on October 29, 2015.pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl15420",Non-OADS,/arxiv_data1/oa_pdf/98/c9/gnl-10-204.PMC4780449.pdf
Available from: http://www.exactsciences.,Non-OADS,/arxiv_data1/oa_pdf/98/c9/gnl-10-204.PMC4780449.pdf
Available from: http://www.theglobeandmail.com/life/health- and-fitness/blood-test-for-colon-cancer-removes-the-ick-factor/article572600/.,Non-OADS,/arxiv_data1/oa_pdf/98/c9/gnl-10-204.PMC4780449.pdf
Avail-able from: http://www.estatlabs.com/products/ColoVantage- %28methylated-Septin-9-biomarker-for-colon-cancer-screen- ing%29.html.81.,Non-OADS,/arxiv_data1/oa_pdf/98/c9/gnl-10-204.PMC4780449.pdf
Available from: https://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NC AId=87&TAId=20&IsPopup=y &bc=AAAAAAAAAgAAAA%3D% 3D&.,OADS,/arxiv_data1/oa_pdf/98/c9/gnl-10-204.PMC4780449.pdf
"Published online June 19, 2015pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl14416Background/Aims: Controversy exists regarding the char - acteristics of Helicobacter pylori  infection-negative gastric  cancer (HPIN-GC).",Non-OADS,/arxiv_data1/oa_pdf/06/ae/gnl-10-212.PMC4780450.pdf
"7,11 In our recent research, clinicopathologic features and   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.See editorial on page 157.",Non-OADS,/arxiv_data1/oa_pdf/06/ae/gnl-10-212.PMC4780450.pdf
"Published online June 19, 2015pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl14310Background/Aims: Microsatellite instability (MSI) plays a  crucial role in gastrointestinal carcinogenesis.",Non-OADS,/arxiv_data1/oa_pdf/32/d8/gnl-10-220.PMC4780451.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/32/d8/gnl-10-220.PMC4780451.pdf
"Published online June 19, 2015pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl14472Background/Aims: To identify the risk factors for meta - chronous gastric neoplasms in patients who underwent an  endoscopic resection of a gastric neoplasm.",Non-OADS,/arxiv_data1/oa_pdf/b4/06/gnl-10-228.PMC4780452.pdf
"H. pylori  infection induces chronic   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b4/06/gnl-10-228.PMC4780452.pdf
"After isolation, the DNA was subjected  to sodium bisulfite modification.20 DNA methylation in the four  selected CpG sites ( HAND1 , THBD , APC, and MOS) were evalu- ated as previously.10,11 The primer sequences for methylation- specific PCR were designed using BLAST (http://www.ncbi.nlm.",Non-OADS,/arxiv_data1/oa_pdf/b4/06/gnl-10-228.PMC4780452.pdf
"Published online August 11, 2015pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl14439Background/Aims: The aims of this study were to compare  the bowel-cleansing efficacy, patient affinity for the prepara-tion solution, and mucosal injury between a split dose of poly - ethylene glycol (SD-PEG) and low-volume PEG plus ascorbic acid (LV-PEG+Asc) in outpatient scheduled colonoscopies.",Non-OADS,/arxiv_data1/oa_pdf/ef/50/gnl-10-237.PMC4780453.pdf
"All  consecutive outpatients or patients visiting the Health Screening  Center between the ages of 20 and 65 years who were scheduled   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.See editorial on page 160.",Non-OADS,/arxiv_data1/oa_pdf/ef/50/gnl-10-237.PMC4780453.pdf
"Published online June 19, 2015pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl14407 Background/Aims: Diverticular bleeding can occasionally  cause massive bleeding that requires urgent colonoscopy (CS) and treatment.",Non-OADS,/arxiv_data1/oa_pdf/17/17/gnl-10-244.PMC4780454.pdf
"7 These changes arise asymmetri-  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/17/17/gnl-10-244.PMC4780454.pdf
Available from: http://www.R-project.org.,Non-OADS,/arxiv_data1/oa_pdf/17/17/gnl-10-244.PMC4780454.pdf
"Published online August 11, 2015pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl14435Background/Aims: To determine the incidence and clinical  characteristics of tuberculosis (TB) medication-associated  Clostridium difficile  infection.",Non-OADS,/arxiv_data1/oa_pdf/b2/56/gnl-10-250.PMC4780455.pdf
"So,  while the incidence of CDI after TB medication could be consid-ered unimportant in Western nations, TB remains prevalent in   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b2/56/gnl-10-250.PMC4780455.pdf
Available from: http://www.who.int/tb/country/data/pro- files/en/.,OADS,/arxiv_data1/oa_pdf/b2/56/gnl-10-250.PMC4780455.pdf
"Published online October 19, 2015pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl15165Background/Aims: Adalimumab is effective for both remis- sion induction and the maintenance of Crohn’s disease (CD) in Western countries.",Non-OADS,/arxiv_data1/oa_pdf/f9/cb/gnl-10-255.PMC4780456.pdf
"Therefore, in the present study,  we aimed to evaluate the efficacy of adalimumab in Korean  patients with CD in a single tertiary academic center and deter-  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f9/cb/gnl-10-255.PMC4780456.pdf
"Published online January 19, 2016pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl15042Background/Aims: To evaluate the efficacy and safety of  adalimumab (ADA) in moderately to severely active ulcerative colitis (UC) patients who are unresponsive to traditional ther - apy.",Non-OADS,/arxiv_data1/oa_pdf/a7/eb/gnl-10-262.PMC4780457.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.See editorial on page 162.",Non-OADS,/arxiv_data1/oa_pdf/a7/eb/gnl-10-262.PMC4780457.pdf
Available from: http://www.fda.gov/ downloads/advisorycommittees/committeesmeetingmaterials/drugs/gastrointestinaldrugsadvisorycommittee/ucm323504.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a7/eb/gnl-10-262.PMC4780457.pdf
"Published online June 19, 2015pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl14391Background/Aims: To determine factors predictive of dis- cordance in staging liver fibrosis using liver biopsy (LB) and acoustic radiation force impulse (ARFI) elastography in pa-tients with chronic hepatitis B (CHB).",Non-OADS,/arxiv_data1/oa_pdf/79/25/gnl-10-275.PMC4780458.pdf
"However, unsatisfactory TE  performance has been reported for patients with ascites, a nar- row intercostal space, or obesity.11,12 In addition, necroinflam- matory activity, as indicated by a high alanine aminotransferase  (ALT) level, is the single most important confounder and has  been known to diminish the accuracy of LS measurement using  TE.13,14  Recently, ARFI elastography, which uses radiation-forced im-  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/79/25/gnl-10-275.PMC4780458.pdf
"Published online November 23, 2015pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl14324Wen-Tao Kong and Zheng-Biao Ji contributed equally to this work as first authors.Background/Aims: To evaluate the enhancement patterns  of liver metastases and their influencing factors using dy - namic contrast-enhanced ultrasound (CEUS).",Non-OADS,/arxiv_data1/oa_pdf/26/31/gnl-10-283.PMC4780459.pdf
"On the   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/26/31/gnl-10-283.PMC4780459.pdf
"Published online September 9, 2015pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl14368Hyosun Cho and Hyojeung Kang contributed equally to this work as first authors.Background/Aims: The immunoregulatory molecules pro - grammed death 1 (PD-1) and cytotoxic T lymphocyte-associ- ated antigen 4 (CTLA-4) are associated with the dysfunction of antiviral effector T-cells, which leads to T-cell exhaustion and persistent viral infection in patients with chronic hepa - titis C and chronic hepatitis B.",Non-OADS,/arxiv_data1/oa_pdf/a3/d0/gnl-10-288.PMC4780460.pdf
"Patients Patients were recruited from the Department of Internal Med-  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a3/d0/gnl-10-288.PMC4780460.pdf
"Published online September 9, 2015pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl15155Background/Aims: The aim of this study was to evaluate  the relationship between controlled attenuation parameter (CAP) and hepatic steatosis, as assessed by ultrasound (US) in patients with alcoholic liver disease (ALD) or non-alcoholic  fatty liver disease (NAFLD).",Non-OADS,/arxiv_data1/oa_pdf/fb/4a/gnl-10-295.PMC4780461.pdf
"In a previous study, US has 92%  sensitivity and 100% specificity for the detection of hepatic ste- atosis compared to the use of biopsy as the standard method.14  Another study also demonstrated that US combined with ultra- sonographic images has both high sensitivity and specificity for  evaluating hepatic steatosis when fat content is over 20%.15  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fb/4a/gnl-10-295.PMC4780461.pdf
"Published online October 19, 2015pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl15186Background/Aims:  Concurrent chemoradiotherapy (CCRT)  is considered the treatment option for locally advanced pan- creatic cancer, but accompanying gastrointestinal toxicities are the most common complication.",Non-OADS,/arxiv_data1/oa_pdf/5c/e3/gnl-10-303.PMC4780462.pdf
"IMRT is therefore superior to 3-D CRT in maximiz-  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.See editorial on page 164.",Non-OADS,/arxiv_data1/oa_pdf/5c/e3/gnl-10-303.PMC4780462.pdf
"Published online October 19, 2015pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl15195Background/Aims: Statins act as antineoplastic agents  through the inhibition of cell proliferation.",Non-OADS,/arxiv_data1/oa_pdf/8e/c2/gnl-10-310.PMC4780463.pdf
"These effects are due to the suppression of the mevalonate pathway, 8-11  and 3-hydroxy-3-methylglutaryl-coenzyme A reductase expres- sion has been demonstrated in cholangiocarcinoma cell lines  and the normal human cholangiocyte cell line.12 Furthermore, in  an epidemiological study, statins were associated with a reduced  risk of hepatocellular carcinoma in a large cohort of patients   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8e/c2/gnl-10-310.PMC4780463.pdf
"Published online October 19, 2015pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl15238Endoscopic ultrasound-guided choledochoduodenostomy  (EUS-CDS) using a covered self-expandable metallic stent  (CSEMS) was developed as an alternative biliary drainage  technique in patients with failed endoscopic retrograde cholan-giopancreatography (ERCP).",Non-OADS,/arxiv_data1/oa_pdf/de/c6/gnl-10-318.PMC4780464.pdf
"3 However, no dislocation was   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/de/c6/gnl-10-318.PMC4780464.pdf
Susceptibility testing was performed by disc diffusion using Oxoid disc  and  interpreted  using  EUCAST  breakpoints  (http://www.eucast.org).,OADS,/arxiv_data1/oa_pdf/a4/26/TOMICROJ-10-1.PMC4780465.pdf
"Finally, the edited consensus sequence was used to query the NCBI bacterial database using BLASTn (http://blast.ncbi.nlm.nih.gov) for the species identification.",OADS,/arxiv_data1/oa_pdf/a4/26/TOMICROJ-10-1.PMC4780465.pdf
"[http://dx.doi.org/10.1128/JCM.01119-08 ] [PMID: 18768650 ] [4] Dahl KM, Barry J, DeBiasi RL.",OADS,/arxiv_data1/oa_pdf/a4/26/TOMICROJ-10-1.PMC4780465.pdf
"[http://dx.doi.org/10.1086/342304 ] [PMID: 12384853 ] [5] Kaewpoowat Q, Permpalung N, Sentochnik DE.",OADS,/arxiv_data1/oa_pdf/a4/26/TOMICROJ-10-1.PMC4780465.pdf
"[http://dx.doi.org/10.1128/JCM.00983-13 ] [PMID: 23740732 ] [6] Tong YQ, Xin B, Sun SQ.",OADS,/arxiv_data1/oa_pdf/a4/26/TOMICROJ-10-1.PMC4780465.pdf
"[http://dx.doi.org/10.5812/jjm.18138 ] [PMID: 25147714 ] [7] Choudhury S, Seet C. Escherichia hermannii  bloodstream infection in a long-term haemodialysis patient.",Non-OADS,/arxiv_data1/oa_pdf/a4/26/TOMICROJ-10-1.PMC4780465.pdf
"[http://dx.doi.org/10.1097/PAT.0b013e3283633fd7 ] [PMID: 23856851 ] [8] Ginsberg HG, Daum RS.",OADS,/arxiv_data1/oa_pdf/a4/26/TOMICROJ-10-1.PMC4780465.pdf
"[http://dx.doi.org/10.1097/00006454-198703000-00025 ] [PMID: 3575017 ] [9] Yamanaka T, Sumita-Sasazaki Y, Sugimori C, et al.",OADS,/arxiv_data1/oa_pdf/a4/26/TOMICROJ-10-1.PMC4780465.pdf
"[http://dx.doi.org/10.1128/AAC.47.8.2669-2673.2003 ] [PMID: 12878539 ] Received: April 22, 2015 Revised: July 23, 2015 Accepted: July 24, 2015 © Rank et al.",OADS,/arxiv_data1/oa_pdf/a4/26/TOMICROJ-10-1.PMC4780465.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/a4/26/TOMICROJ-10-1.PMC4780465.pdf
"First, the Science Citation Index (SCI) Expanded® has coverage  only  since  1991  for  70%  of  the  articles  of  full-length,  English-language,  author,  abstracts, (http://images.webofknowledge.com/WOK45/help/WOS/h_database.html).",Non-OADS,/arxiv_data1/oa_pdf/e9/85/TODENTJ-10-35.PMC4780466.pdf
[http://dx.doi.org/10.1090/S0002-9904-1943-07818-4 ] [2] Clough RW.,Non-OADS,/arxiv_data1/oa_pdf/e9/85/TODENTJ-10-35.PMC4780466.pdf
"[http://dx.doi.org/10.1016/j.jdent.2008.03.010 ] [PMID: 18455859 ] [5] Kelly JR, Benetti P, Rungruanganunt P, Bona AD.",OADS,/arxiv_data1/oa_pdf/e9/85/TODENTJ-10-35.PMC4780466.pdf
"[http://dx.doi.org/10.1016/j.dental.2011.09.001 ] [PMID: 22192250 ] [6] Glanzel W, Schubert A, Braun T. A relational charting approach to the world of basic research in twelve science fields at the end of the second millennium.",OADS,/arxiv_data1/oa_pdf/e9/85/TODENTJ-10-35.PMC4780466.pdf
"[http://dx.doi.org/10.1023/A:1020406627944 ] [7] Shelton RD, Foland P. The race for world leadership of science and technology: Status and forecasts.",Non-OADS,/arxiv_data1/oa_pdf/e9/85/TODENTJ-10-35.PMC4780466.pdf
"[http://dx.doi.org/10.1007/s11192-007-1780-2 ] [9] Vergidis PI, Karavasiou AI, Paraschakis K, Bliziotis IA, Falagas ME.",Non-OADS,/arxiv_data1/oa_pdf/e9/85/TODENTJ-10-35.PMC4780466.pdf
[http://dx.doi.org/10.1007/s10096-005-1306-x ] [PMID: 15834594 ],Non-OADS,/arxiv_data1/oa_pdf/e9/85/TODENTJ-10-35.PMC4780466.pdf
"[http://dx.doi.org/10.1016/j.ijcard.2004.11.005 ] [PMID: 15837089 ] [11] Cimmino MA, Maio T, Ugolini D, Borasi F, Mela GS.",OADS,/arxiv_data1/oa_pdf/e9/85/TODENTJ-10-35.PMC4780466.pdf
"[http://dx.doi.org/10.1016/j.otohns.2004.09.026 ] [PMID: 15692544 ] [12] Albarran P, Crespo JA, Ortuno I, Ruiz-Castillo J.",OADS,/arxiv_data1/oa_pdf/e9/85/TODENTJ-10-35.PMC4780466.pdf
"[http://dx.doi.org/10.1007/s11192-010-0223-7 ] [13] Robert C, Wilson CS, Gaudy JF, Hornebeck W, Arreto CD.",Non-OADS,/arxiv_data1/oa_pdf/e9/85/TODENTJ-10-35.PMC4780466.pdf
"[http://dx.doi.org/10.1139/O10-006 ] [PMID: 20921995 ] [14] Brunski JB, Puleo DA, Nanci A. Biomaterials and biomechanics of oral and maxillofacial implants: current status and future developments.",OADS,/arxiv_data1/oa_pdf/e9/85/TODENTJ-10-35.PMC4780466.pdf
"[http://dx.doi.org/10.1016/j.ijom.2008.09.006 ] [PMID: 18963818 ] [16] Althouse BM, West JD, Bergstrom CT, Bergstrom T. Differences in impact factor across fields and over time.",OADS,/arxiv_data1/oa_pdf/e9/85/TODENTJ-10-35.PMC4780466.pdf
[http://dx.doi.org/10.1177/0022034512437374 ] [PMID: 22302142 ] [18] Opthof T. Sense and nonsense about the impact factor.,Non-OADS,/arxiv_data1/oa_pdf/e9/85/TODENTJ-10-35.PMC4780466.pdf
"[http://dx.doi.org/10.1016/S0008-6363(96)00215-5 ] [PMID: 9059521 ] [19] Nieri M, Saletta D, Guidi L, et al.",OADS,/arxiv_data1/oa_pdf/e9/85/TODENTJ-10-35.PMC4780466.pdf
"[http://dx.doi.org/10.1111/j.1600-051X.2007.01060.x ] [PMID: 17378889 ] [20] Fardi A, Kodonas K, Gogos C, Economides N. Top-cited articles in endodontic journals.",Non-OADS,/arxiv_data1/oa_pdf/e9/85/TODENTJ-10-35.PMC4780466.pdf
"[http://dx.doi.org/10.1016/j.joen.2011.05.037 ] [PMID: 21846531 ] [21] Atieh MA, Ibrahim HM, Atieh AH.",OADS,/arxiv_data1/oa_pdf/e9/85/TODENTJ-10-35.PMC4780466.pdf
"[http://dx.doi.org/10.1902/jop.2010.100232 ] [PMID: 20575657 ] [22] Wennström J, Zurdo J, Karlsson S, Ekestubbe A, Gröndahl K, Lindhe J.",OADS,/arxiv_data1/oa_pdf/e9/85/TODENTJ-10-35.PMC4780466.pdf
"[http://dx.doi.org/10.1111/j.1600-051X.2004.00603.x ] [PMID: 15560808 ] [23] Magne P, Belser UC.",OADS,/arxiv_data1/oa_pdf/e9/85/TODENTJ-10-35.PMC4780466.pdf
"[http://dx.doi.org/10.1097/00004770-200301000-00005 ] [PMID: 12540212 ] [25] Xu  X,  Eng  M,  Zheng  Y,  Eng  D.  Comparative  study  of  torsional  and  bending  properties  for  six  models  of  nickel-titanium  root  canal instruments with different cross-sections.",OADS,/arxiv_data1/oa_pdf/e9/85/TODENTJ-10-35.PMC4780466.pdf
"[http://dx.doi.org/10.1016/j.joen.2005.08.012 ] [PMID: 16554216 ] [26] Tay FR, Pashley DH.",OADS,/arxiv_data1/oa_pdf/e9/85/TODENTJ-10-35.PMC4780466.pdf
"[http://dx.doi.org/10.1016/j.joen.2006.10.009 ] [PMID: 17368325 ] [27] Tanne K, Sakuda M, Burstone CJ.",OADS,/arxiv_data1/oa_pdf/e9/85/TODENTJ-10-35.PMC4780466.pdf
"[http://dx.doi.org/10.1016/0889-5406(87)90232-0 ] [PMID: 3479896 ] [28] Hui J, Han Z, Geng G, Yan W, Shao P. The 100 top-cited articles in orthodontics from 1975 to 2011.",Non-OADS,/arxiv_data1/oa_pdf/e9/85/TODENTJ-10-35.PMC4780466.pdf
"[http://dx.doi.org/10.2319/040512-284.1 ] [PMID: 23050741 ] Received: March 12, 2015 Revised: September 25, 2015 Accepted: November 10, 2015 © Diarra et al.",Non-OADS,/arxiv_data1/oa_pdf/e9/85/TODENTJ-10-35.PMC4780466.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/e9/85/TODENTJ-10-35.PMC4780466.pdf
[http://dx.doi.org/10.1086/322620 ] [PMID: 11595975 ] [2] International Study Team.,OADS,/arxiv_data1/oa_pdf/2b/ef/TOVJ-10-1.PMC4780467.pdf
"[http://dx.doi.org/10.1086/514285 ] [PMID: 9988164 ] [5] Miranda ME, Ksiazek TG, Retuya TJ, et al.",OADS,/arxiv_data1/oa_pdf/2b/ef/TOVJ-10-1.PMC4780467.pdf
"[http://dx.doi.org/10.1086/514314 ] [PMID: 9988174 ] [6] Gear JS, Cassel GA, Gear AJ, et al.",OADS,/arxiv_data1/oa_pdf/2b/ef/TOVJ-10-1.PMC4780467.pdf
"[http://dx.doi.org/10.1016/0035-9203(69)90001-7 ] [PMID: 5815873 ] [8] Teichmann D, Grobusch MP, Wesselmann H, et al.",OADS,/arxiv_data1/oa_pdf/2b/ef/TOVJ-10-1.PMC4780467.pdf
[http://dx.doi.org/10.1016/S0140-6736(99)09233-8 ] [PMID: 10560677 ],OADS,/arxiv_data1/oa_pdf/2b/ef/TOVJ-10-1.PMC4780467.pdf
"[http://dx.doi.org/10.1001/jama.283.17.2230-JWR0503-2-1 ] [PMID: 10807371 ] [10] Gjenero-Margan I, Aleraj B, Krajcar D, et al.",OADS,/arxiv_data1/oa_pdf/2b/ef/TOVJ-10-1.PMC4780467.pdf
"[http://dx.doi.org/10.1111/j.1708-8305.2011.00501.x ] [PMID: 21539658 ] [12] Buckley SM, Casals J. Lassa fever, a new virus disease of man from West Africa.",Non-OADS,/arxiv_data1/oa_pdf/2b/ef/TOVJ-10-1.PMC4780467.pdf
"[http://dx.doi.org/10.1007/978-3-642-71726-0_3 ] [PMID: 3581899 ] [14] Lassa fever, imported case, Netherlands.",Non-OADS,/arxiv_data1/oa_pdf/2b/ef/TOVJ-10-1.PMC4780467.pdf
"[http://dx.doi.org/10.3201/eid1610.100774 ] [PMID: 20875288 ] [16] Gear JH, Thompson PD, Hopp M, et al.",OADS,/arxiv_data1/oa_pdf/2b/ef/TOVJ-10-1.PMC4780467.pdf
"[http://dx.doi.org/10.3201/eid1801.111040 ] [PMID: 22261502 ] [19] An outbreak of Rift Valley Fever, eastern Africa, 1997-1998.",Non-OADS,/arxiv_data1/oa_pdf/2b/ef/TOVJ-10-1.PMC4780467.pdf
"[http://dx.doi.org/10.1086/514319 ] [PMID: 9988163 ] [23] Fisher-Hoch SP, Khan JA, Rehman S, Mirza S, Khurshid M, McCormick JB.",OADS,/arxiv_data1/oa_pdf/2b/ef/TOVJ-10-1.PMC4780467.pdf
"[http://dx.doi.org/10.1016/S0140-6736(95)91323-8 ] [PMID: 7637481 ] [24] McCormick JB, King IJ, Webb PA, et al.",OADS,/arxiv_data1/oa_pdf/2b/ef/TOVJ-10-1.PMC4780467.pdf
"[http://dx.doi.org/10.1056/NEJM198601023140104 ] [PMID: 3940312 ] [25] Huggins J, Zhang ZX, Bray M. Antiviral drug therapy of filovirus infections: S-adenosylhomocysteine hydrolase inhibitors inhibit Ebola virus in vitro  and in a lethal mouse model.",Non-OADS,/arxiv_data1/oa_pdf/2b/ef/TOVJ-10-1.PMC4780467.pdf
"[http://dx.doi.org/10.1086/514316 ] [PMID: 9988190 ] [26] Qiu X, Wong G, Audet J, et al.",OADS,/arxiv_data1/oa_pdf/2b/ef/TOVJ-10-1.PMC4780467.pdf
[http://dx.doi.org/10.1016/S0140-6736(15)61117-5 ] [PMID: 26248676 ] [28] Management of patients with suspected viral hemorrhagic fever.,Non-OADS,/arxiv_data1/oa_pdf/2b/ef/TOVJ-10-1.PMC4780467.pdf
"[http://dx.doi.org/10.1258/0004563001899997 ] [PMID: 11085629 ] Received: November 12, 2014 Revised: November 18, 2015 Accepted: November 27, 2015",Non-OADS,/arxiv_data1/oa_pdf/2b/ef/TOVJ-10-1.PMC4780467.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/2b/ef/TOVJ-10-1.PMC4780467.pdf
"[http://dx.doi.org/10.1007/BF00419356 ] [4] Shields JA, Shields CL, Honavar SG, Demirci H, Cater J.",Non-OADS,/arxiv_data1/oa_pdf/61/7d/TOOPHTJ-10-27.PMC4780468.pdf
"[http://dx.doi.org/10.1016/S0002-9394(01)00896-0 ] [PMID: 11336931 ] [5] Shields JA, Eagle RC Jr, Fammartino J, Shields CL, De Potter P. Coats’ disease as a cause of anterior chamber cholesterolosis.",Non-OADS,/arxiv_data1/oa_pdf/61/7d/TOOPHTJ-10-27.PMC4780468.pdf
"[http://dx.doi.org/10.1001/archopht.1995.01100080025014 ] [PMID: 7639669 ] [6] Gupta N, Beri S, D’souza P. Cholesterolosis bulbi of the anterior chamber in coats disease.",Non-OADS,/arxiv_data1/oa_pdf/61/7d/TOOPHTJ-10-27.PMC4780468.pdf
"[http://dx.doi.org/10.3928/01913913-20090616-04 ] [PMID: 19645389 ] [7] Patel AK, Murphy M, Shields CL.",Non-OADS,/arxiv_data1/oa_pdf/61/7d/TOOPHTJ-10-27.PMC4780468.pdf
"[http://dx.doi.org/10.1001/archpediatrics.2011.190-a ] [PMID: 22147780 ] [8] Shields JA, Shields CL, Honavar SG, Demirci H. Clinical variations and complications of Coats disease in 150 cases: the 2000 Sanford Gifford Memorial Lecture.",Non-OADS,/arxiv_data1/oa_pdf/61/7d/TOOPHTJ-10-27.PMC4780468.pdf
"[http://dx.doi.org/10.1016/S0002-9394(00)00883-7 ] [PMID: 11336930 ] [9] Sanmugasunderam S, Giligson A, Choi SB.",OADS,/arxiv_data1/oa_pdf/61/7d/TOOPHTJ-10-27.PMC4780468.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/61/7d/TOOPHTJ-10-27.PMC4780468.pdf
[http://dx.doi.org/10.1542/peds.108.3.809 ] [PMID: 11533356 ] [2] American Academy of Pediatrics (Section on Ophthalmology); American Academy of Ophthalmology; American Association for Pediatric Ophthalmology and Strabismus.,Non-OADS,/arxiv_data1/oa_pdf/6b/64/TOOPHTJ-10-17.PMC4780469.pdf
[http://dx.doi.org/10.1542/peds.2005-2749 ] [PMID: 16452383 ] [3] Phelps D. Retinopathy of prematurity.,Non-OADS,/arxiv_data1/oa_pdf/6b/64/TOOPHTJ-10-17.PMC4780469.pdf
"[http://dx.doi.org/10.1038/sj.eye.6702924 ] [PMID: 17618242 ] [5] Chen  Y,  Li  XX,  Yin  H,  et  al.",OADS,/arxiv_data1/oa_pdf/6b/64/TOOPHTJ-10-17.PMC4780469.pdf
"[http://dx.doi.org/10.1136/bjo.2007.131813 ] [PMID: 18303154 ] [6] Binkhathlan AA, Almahmoud LA, Saleh MJ, Srungeri S. Retinopathy of prematurity in Saudi Arabia: incidence, risk factors, and the applicability of current screening criteria.",Non-OADS,/arxiv_data1/oa_pdf/6b/64/TOOPHTJ-10-17.PMC4780469.pdf
"[http://dx.doi.org/10.1136/bjo.2007.126508 ] [PMID: 18227198 ] [7] Gilbert C. Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control.",Non-OADS,/arxiv_data1/oa_pdf/6b/64/TOOPHTJ-10-17.PMC4780469.pdf
"[http://dx.doi.org/10.1016/j.earlhumdev.2007.11.009 ] [PMID: 18234457 ] [8] Gergely K, Gerinec A. Retinopathy of prematurity--epidemics, incidence, prevalence, blindness.",Non-OADS,/arxiv_data1/oa_pdf/6b/64/TOOPHTJ-10-17.PMC4780469.pdf
"[http://dx.doi.org/10.1111/ped.12371 ] [PMID: 24803073 ] [10] Good WV, Hardy RJ, Dobson V, et al.",OADS,/arxiv_data1/oa_pdf/6b/64/TOOPHTJ-10-17.PMC4780469.pdf
"[http://dx.doi.org/10.1542/peds.2004-1413 ] [PMID: 15995025 ] [11] Fielder AR, Reynolds JD.",OADS,/arxiv_data1/oa_pdf/6b/64/TOOPHTJ-10-17.PMC4780469.pdf
"[http://dx.doi.org/10.1053/siny.2001.0091 ] [PMID: 12014887 ] [12] Gandhi B, Rich W, Finer N. Time to achieve stable pulse oximetry values in VLBW infants in the delivery room.",Non-OADS,/arxiv_data1/oa_pdf/6b/64/TOOPHTJ-10-17.PMC4780469.pdf
[http://dx.doi.org/10.1016/j.resuscitation.2012.12.007 ] [PMID: 23238422 ],OADS,/arxiv_data1/oa_pdf/6b/64/TOOPHTJ-10-17.PMC4780469.pdf
"[http://dx.doi.org/10.1097/00000658-197801000-00001 ] [PMID: 413500 ] [14] Clemett R, Darlow B.",OADS,/arxiv_data1/oa_pdf/6b/64/TOOPHTJ-10-17.PMC4780469.pdf
"[http://dx.doi.org/10.1097/00055735-199906000-00001 ] [PMID: 10537772 ] [15] Taqui AM, Syed R, Chaudhry TA, Ahmad K, Salat MS. Retinopathy of prematurity: frequency and risk factors in a tertiary care hospital in Karachi, Pakistan.",Non-OADS,/arxiv_data1/oa_pdf/6b/64/TOOPHTJ-10-17.PMC4780469.pdf
"[http://dx.doi.org/10.1136/bjo.2008.145136 ] [PMID: 18728050 ] [17] Lad EM, Nguyen TC, Morton JM, Moshfeghi DM.",OADS,/arxiv_data1/oa_pdf/6b/64/TOOPHTJ-10-17.PMC4780469.pdf
"[http://dx.doi.org/10.1136/bjo.2007.126201 ] [PMID: 18303153 ] [18] Shah VA, Yeo CL, Ling YL, Ho LY.",Non-OADS,/arxiv_data1/oa_pdf/6b/64/TOOPHTJ-10-17.PMC4780469.pdf
"[http://dx.doi.org/10.3928/01913913-20080901-12 ] [PMID: 18825902 ] [23] Blumenfeld LC, Siatkowski RM, Johnson RA, Feuer WJ, Flynn JT.",OADS,/arxiv_data1/oa_pdf/6b/64/TOOPHTJ-10-17.PMC4780469.pdf
"[http://dx.doi.org/10.1016/S0002-9394(99)80092-0 ] [PMID: 9467447 ] [24] Riazi-Esfahani M, Alizadeh Y, Karkhaneh R, et al.",OADS,/arxiv_data1/oa_pdf/6b/64/TOOPHTJ-10-17.PMC4780469.pdf
"[http://dx.doi.org/10.1590/S0004-27492009000400005 ] [PMID: 19820782 ] [28] Hakeem AH, Mohamed GB, Othman MF.",Non-OADS,/arxiv_data1/oa_pdf/6b/64/TOOPHTJ-10-17.PMC4780469.pdf
"[http://dx.doi.org/10.4103/0974-9233.97927 ] [PMID: 22837621 ] Received: March 29, 2015 Revised: June 17, 2015 Accepted: June 17, 2015 © Rasoulinejad and Montazeri; Licensee Bentham Open.",Non-OADS,/arxiv_data1/oa_pdf/6b/64/TOOPHTJ-10-17.PMC4780469.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/6b/64/TOOPHTJ-10-17.PMC4780469.pdf
URL  http://www.R-project.org/.),Non-OADS,/arxiv_data1/oa_pdf/dd/5b/TOMCJ-10-1.PMC4780470.pdf
"[http://dx.doi.org/10.1007/978-3-0348-0364-9_1] [PMID: 22642188] [2] Chaudhary, A.K.",Non-OADS,/arxiv_data1/oa_pdf/dd/5b/TOMCJ-10-1.PMC4780470.pdf
"[http://dx.doi.org/10.1016/j.mrrev.2013.01.002] [PMID: 23370482] [3] Wang,  M.;  Sampson,  E.R.",OADS,/arxiv_data1/oa_pdf/dd/5b/TOMCJ-10-1.PMC4780470.pdf
"[http://dx.doi.org/10.1186/ar4133] [PMID: 23298463] [4] Kalva, S.; Saranyah, K.; Suganya, P.R.",Non-OADS,/arxiv_data1/oa_pdf/dd/5b/TOMCJ-10-1.PMC4780470.pdf
"[http://dx.doi.org/10.1016/j.jmgm.2013.06.005] [PMID: 23938376] [5] Xi, L.; Li, S.; Yao, X.; Wei, Y.; Li, J.; Liu, H.; Wu, X.",OADS,/arxiv_data1/oa_pdf/dd/5b/TOMCJ-10-1.PMC4780470.pdf
"[http://dx.doi.org/10.1002/ardp.201400200] [PMID: 25363411] [6] Jacobsen, J.A.",OADS,/arxiv_data1/oa_pdf/dd/5b/TOMCJ-10-1.PMC4780470.pdf
"[http://dx.doi.org/10.1016/j.bbamcr.2009.08.006] [PMID: 19712708] [7] Cuniasse,  P.;  Devel,  L.;  Makaritis,  A.;  Beau,  F.;  Georgiadis,  D.;  Matziari,  M.;  Yiotakis,  A.;  Dive,  V.  Future  challenges  facing  the development of specific active-site-directed synthetic inhibitors of MMPs.",Non-OADS,/arxiv_data1/oa_pdf/dd/5b/TOMCJ-10-1.PMC4780470.pdf
"[http://dx.doi.org/10.1016/j.biochi.2004.09.025] [PMID: 15781327] [8] Fabre, B.; Ramos, A.; de Pascual-Teresa, B.",OADS,/arxiv_data1/oa_pdf/dd/5b/TOMCJ-10-1.PMC4780470.pdf
"[http://dx.doi.org/10.1021/jm500505f] [PMID: 25265401] [9] Khamis, M.A.",OADS,/arxiv_data1/oa_pdf/dd/5b/TOMCJ-10-1.PMC4780470.pdf
"[http://dx.doi.org/10.1016/j.artmed.2015.02.002] [PMID: 25724101] [10] Wallach, I.; Lilien, R. Virtual decoy sets for molecular docking benchmarks.",OADS,/arxiv_data1/oa_pdf/dd/5b/TOMCJ-10-1.PMC4780470.pdf
"[http://dx.doi.org/10.1021/ci100374f] [PMID: 21207928] [11] Shamsara, J.",OADS,/arxiv_data1/oa_pdf/dd/5b/TOMCJ-10-1.PMC4780470.pdf
"http://www.hindawi.com/journals/ijmc/2014/ 162150/cta/, 2014.",Non-OADS,/arxiv_data1/oa_pdf/dd/5b/TOMCJ-10-1.PMC4780470.pdf
"[http://dx.doi.org/10.1155/2014/162150] [12] Sing,  T.;  Sander,  O.;  Beerenwinkel,  N.;  Lengauer,  T.  ROCR:  visualizing  classifier  performance  in  R.  Bioinformatics,  2005,  21(20), 3940-3941.",OADS,/arxiv_data1/oa_pdf/dd/5b/TOMCJ-10-1.PMC4780470.pdf
"[http://dx.doi.org/10.1093/bioinformatics/bti623] [PMID: 16096348] [13] Hadizadeh, F.; Shamsara, J. Receptor-based 3D-QSAR approach to find selectivity features of flexible similar binding sites: case study on MMP-12/MMP-13.",Non-OADS,/arxiv_data1/oa_pdf/dd/5b/TOMCJ-10-1.PMC4780470.pdf
"[http://dx.doi.org/10.1504/IJBRA.2015.070139] [PMID: 26561318] [14] De Savi, C.; Morley, A.D.; Ting, A.; Nash, I.; Karabelas, K.; Wood, C.M.",OADS,/arxiv_data1/oa_pdf/dd/5b/TOMCJ-10-1.PMC4780470.pdf
"[http://dx.doi.org/10.1016/j.bmcl.2011.05.075] [PMID: 21669521] Received: March 3, 2015 Revised: June 26, 2015 Accepted: July 15, 2015 © Jamal Shamsara; Licensee Bentham Open.",Non-OADS,/arxiv_data1/oa_pdf/dd/5b/TOMCJ-10-1.PMC4780470.pdf
"This  is  an  open  access  article  licensed  under  the  terms  of  the  Creative  Commons  Attribution  Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/ ) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dd/5b/TOMCJ-10-1.PMC4780470.pdf
http://www.pediatricurol ogybook.com/index.htm.,Non-OADS,/arxiv_data1/oa_pdf/3c/f8/CG-17-14.PMC4780472.pdf
"Notes of row 5: (a) the two mutations found are described, in the literature, as oncogenic [56]; (b): NF1 is classified as a tumor suppressor (URL: http://www.omim.org/entry/613113) and, fo r this reason, it should behave as a recessive  trait; however, neurofibromatosis is caused by a heterozygous mutation in the NF1 gene and it is transmitted as an autosomal do minant condition (URL: http://www.omim.org/entry/162200); therefore, this protein activity is considered, for our analyses, und etermined; (c) from the literature it is  known that the mutation (codon Q61) described for these two patients is oncogenic [57]; (d) this case is considered conflicting  because, in the same patient, there is a stop codon (a.a. 136) mutation of one allele but also positive TP53 immunoreactivity.",Non-OADS,/arxiv_data1/oa_pdf/df/1c/CG-17-33.PMC4780474.pdf
"Gene Identification   Considering that multiple gene names are used in the  literature for the same DNA sequence, all genes analyzed in the Results are uniquely identified through the Online Men- delian Inheritance in Man (OMIM; http://www.omim.org)  database identification (ID) number.",OADS,/arxiv_data1/oa_pdf/df/1c/CG-17-33.PMC4780474.pdf
http://www.cancer.,Non-OADS,/arxiv_data1/oa_pdf/df/1c/CG-17-33.PMC4780474.pdf
"http://www.oncotherapynetwork.com/  conference-report/basket-design-novel-approach-cancer-clinical- trials (A ccessed April 30, 2015 ) [48] Hosack, D.A.",Non-OADS,/arxiv_data1/oa_pdf/df/1c/CG-17-33.PMC4780474.pdf
http://www.mathworks.com   [56] Barbacid M. ras genes.,Non-OADS,/arxiv_data1/oa_pdf/df/1c/CG-17-33.PMC4780474.pdf
"http://www.atcc.org/ Prod- ucts/All/CRL- 1472.aspx (Accessed February 25, 2015 ).",Non-OADS,/arxiv_data1/oa_pdf/df/1c/CG-17-33.PMC4780474.pdf
"http://www.ebi.ac.uk/  QuickGO/ (Accessed January 12, 2015 ).",Non-OADS,/arxiv_data1/oa_pdf/df/1c/CG-17-33.PMC4780474.pdf
"http://atlasgeneticsoncology.org/Genes/RBL2ID 443.html (Ac- cessed April 4, 2015 ) [115] Di Fiore, R.; D'Anneo, A.; Tesoriere, G.; Vento, R. RB1 in cancer:  different mechanisms of RB1 inactivation and alterations of pRb  pathway in tumorigenesis.",OADS,/arxiv_data1/oa_pdf/df/1c/CG-17-33.PMC4780474.pdf
http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/df/1c/CG-17-33.PMC4780474.pdf
"The oligonucleotide array showed in- creased sensitivity over the SNP array; however, the major-ity of CNVs that were detected were observed multiple times in the Database of Genome Variants (http://dgv.tcag.ca/",OADS,/arxiv_data1/oa_pdf/29/94/CG-17-4.PMC4780475.pdf
"The  most associated SNP within this region resides 4 kb next to the WNT3  promoter (http://promoter.cdb.riken.jp/), a region  highly conserved among amniotes.",Non-OADS,/arxiv_data1/oa_pdf/29/94/CG-17-4.PMC4780475.pdf
"The kidney development database:  http://golgi.ana..ed.ac.uk/kidhome.htlm (acessed may, 15, 2015)  [18] Qazi, Q.; Masakawa, D.; Milman, D.; Chua, A.; Haller, J. Renal  anomalies in fetal alcohol syndrome.",Non-OADS,/arxiv_data1/oa_pdf/b2/2e/CG-17-62.PMC4780476.pdf
"[http://dx.doi.org/10.1093/ejo/22.6.697 ] [PMID: 11212605 ] [5] Nordquist GG, McNeill RW.",OADS,/arxiv_data1/oa_pdf/68/7c/TODENTJ-10-19.PMC4780478.pdf
"[http://dx.doi.org/10.1902/jop.1975.46.3.139 ] [PMID: 1054757 ] [6] Kinzer GA, Kokich VO Jr.",Non-OADS,/arxiv_data1/oa_pdf/68/7c/TODENTJ-10-19.PMC4780478.pdf
"[http://dx.doi.org/10.1111/j.1708-8240.2005.tb00089.x ] [PMID: 16036123 ] [7] Kinzer GA, Kokich VO Jr.",OADS,/arxiv_data1/oa_pdf/68/7c/TODENTJ-10-19.PMC4780478.pdf
[http://dx.doi.org/10.1111/j.1708-8240.2005.tb00116.x ] [PMID: 16231491 ] [8] Senty EL.,OADS,/arxiv_data1/oa_pdf/68/7c/TODENTJ-10-19.PMC4780478.pdf
"[http://dx.doi.org/10.1016/j.ajodo.2011.02.003 ] [PMID: 21457853 ] [10] Kokich VO Jr, Kinzer GA, Janakievski J. Congenitally missing maxillary lateral incisors: restorative replacement.",OADS,/arxiv_data1/oa_pdf/68/7c/TODENTJ-10-19.PMC4780478.pdf
[http://dx.doi.org/10.1016/j.ajodo.2011.02.004 ] [PMID: 21457854 ] [11] D’Amico A.,OADS,/arxiv_data1/oa_pdf/68/7c/TODENTJ-10-19.PMC4780478.pdf
[http://dx.doi.org/10.1016/j.ajodo.2006.04.026 ] [PMID: 17628256 ],OADS,/arxiv_data1/oa_pdf/68/7c/TODENTJ-10-19.PMC4780478.pdf
[http://dx.doi.org/10.1038/bdj.2007.891 ] [PMID: 17891115 ] [14] Tuverson DL.,OADS,/arxiv_data1/oa_pdf/68/7c/TODENTJ-10-19.PMC4780478.pdf
[http://dx.doi.org/10.1016/0002-9416(70)90065-5 ] [PMID: 5269760 ] [15] Al-Anezi SA.,OADS,/arxiv_data1/oa_pdf/68/7c/TODENTJ-10-19.PMC4780478.pdf
"[http://dx.doi.org/10.1016/j.ajodo.2009.10.042 ] [PMID: 21536213 ] [16] dos Santos-Pinto A, Raveli DB, Chiavini PC, Paulin RF, Jacob HB.",OADS,/arxiv_data1/oa_pdf/68/7c/TODENTJ-10-19.PMC4780478.pdf
"[http://dx.doi.org/10.1016/j.ajodo.2006.07.022 ] [PMID: 17448387 ] [19] Jemt  T,  Ahlberg  G,  Henriksson  K,  Bondevik  O.",OADS,/arxiv_data1/oa_pdf/68/7c/TODENTJ-10-19.PMC4780478.pdf
"[http://dx.doi.org/10.1034/j.1600-0501.1999.100502.x ] [PMID: 10551059 ] [21] Bernard JP, Schatz JP, Christou P, Belser U, Kiliaridis S. Long-term vertical changes of the anterior maxillary teeth adjacent to single implants in young and mature adults.",Non-OADS,/arxiv_data1/oa_pdf/68/7c/TODENTJ-10-19.PMC4780478.pdf
[http://dx.doi.org/10.1111/j.1600-051X.2004.00574.x ] [PMID: 15491321 ] [22] Mucha JN.,OADS,/arxiv_data1/oa_pdf/68/7c/TODENTJ-10-19.PMC4780478.pdf
"[http://dx.doi.org/10.2319/0003-3219(2007)077[0404:OSOIPW]2.0.CO;2 ] [PMID: 17465645 ] [25] Krassnig M, Fickl S. Congenitally missing lateral incisors--a comparison between restorative, implant, and orthodontic approaches.",Non-OADS,/arxiv_data1/oa_pdf/68/7c/TODENTJ-10-19.PMC4780478.pdf
"[http://dx.doi.org/10.1016/j.cden.2011.01.004 ] [PMID: 21473994 ] [26] Chang M, Wennström JL, Odman P, Andersson B. Implant supported single-tooth replacements compared to contralateral natural teeth.",Non-OADS,/arxiv_data1/oa_pdf/68/7c/TODENTJ-10-19.PMC4780478.pdf
"[http://dx.doi.org/10.1034/j.1600-0501.1999.100301.x ] [PMID: 10522178 ] [27] Dueled E, Gotfredsen K, Trab Damsgaard M, Hede B.",OADS,/arxiv_data1/oa_pdf/68/7c/TODENTJ-10-19.PMC4780478.pdf
"[http://dx.doi.org/10.1111/j.1600-0501.2008.01698.x ] [PMID: 19515060 ] [28] Iseri H, Solow B.",OADS,/arxiv_data1/oa_pdf/68/7c/TODENTJ-10-19.PMC4780478.pdf
"[http://dx.doi.org/10.1093/ejo/18.3.245 ] [PMID: 8791889 ] [29] Björk A, Palling M. Adolescent age changes in sagittal jaw relation, alveolar prognathy, and incisal inclination.",Non-OADS,/arxiv_data1/oa_pdf/68/7c/TODENTJ-10-19.PMC4780478.pdf
"[http://dx.doi.org/10.3109/00016355509028164 ] [PMID: 14375891 ] [30] Hobkirk JA, Goodman JR, Jones SP.",Non-OADS,/arxiv_data1/oa_pdf/68/7c/TODENTJ-10-19.PMC4780478.pdf
"[http://dx.doi.org/10.1038/sj.bdj.4808606 ] [PMID: 7980981 ] [31] Ackerman JL, Nguyen T, Proffit WR.",OADS,/arxiv_data1/oa_pdf/68/7c/TODENTJ-10-19.PMC4780478.pdf
"[http://dx.doi.org/10.1016/0002-9416(60)90145-7 ] [34] Hier LA, Evans CA, BeGole EA, Giddon DB.",Non-OADS,/arxiv_data1/oa_pdf/68/7c/TODENTJ-10-19.PMC4780478.pdf
"[http://dx.doi.org/10.1093/ejo/cjq095 ] [PMID: 20966067 ] [36] Kokich VO Jr, Kinzer GA.",OADS,/arxiv_data1/oa_pdf/68/7c/TODENTJ-10-19.PMC4780478.pdf
"[http://dx.doi.org/10.1111/j.1708-8240.2005.tb00076.x ] [PMID: 15934680 ] [37] Hans MG, Groisser G, Damon C, Amberman D, Nelson S, Palomo JM.",OADS,/arxiv_data1/oa_pdf/68/7c/TODENTJ-10-19.PMC4780478.pdf
"[http://dx.doi.org/10.1016/j.ajodo.2005.01.021 ] [PMID: 16905062 ] [38] Travess H, Roberts-Harry D, Sandy J. Orthodontics.",Non-OADS,/arxiv_data1/oa_pdf/68/7c/TODENTJ-10-19.PMC4780478.pdf
[http://dx.doi.org/10.1038/sj.bdj.4810979 ] [PMID: 15039723 ] [39] MacMillan HW.,Non-OADS,/arxiv_data1/oa_pdf/68/7c/TODENTJ-10-19.PMC4780478.pdf
"[http://dx.doi.org/10.1016/j.ajodo.2006.04.026 ] [PMID: 17628256 ] [41] Ash MM, Ramjford S. Occlusion.",OADS,/arxiv_data1/oa_pdf/68/7c/TODENTJ-10-19.PMC4780478.pdf
[http://dx.doi.org/10.1590/S2176-94512013000300024 ] [PMID: 24094026 ] [44] Henry RG.,Non-OADS,/arxiv_data1/oa_pdf/68/7c/TODENTJ-10-19.PMC4780478.pdf
"[http://dx.doi.org/10.2319/081706-336 ] [PMID: 17685775 ] [46] Beyer A, Tausche E, Boening K, Harzer W. Orthodontic space opening in patients with congenitally missing lateral incisors.",Non-OADS,/arxiv_data1/oa_pdf/68/7c/TODENTJ-10-19.PMC4780478.pdf
"[http://dx.doi.org/10.2319/0003-3219(2007)077[0404:OSOIPW]2.0.CO;2 ] [PMID: 17465645 ] [47] Al-Buraiki H, Sadowsky C, Schneider B.",OADS,/arxiv_data1/oa_pdf/68/7c/TODENTJ-10-19.PMC4780478.pdf
"[http://dx.doi.org/10.1016/j.ajodo.2003.10.034 ] [PMID: 15643414 ] [48] Thilander B, Ödman J, Lekholm U.",OADS,/arxiv_data1/oa_pdf/68/7c/TODENTJ-10-19.PMC4780478.pdf
[http://dx.doi.org/10.1093/ejo/23.6.715 ] [PMID: 11890067 ] [49] D’Amico A.,OADS,/arxiv_data1/oa_pdf/68/7c/TODENTJ-10-19.PMC4780478.pdf
[http://dx.doi.org/10.1016/0022-3913(87)90150-8 ] [PMID: 3470513 ] [54] Storey AT.,Non-OADS,/arxiv_data1/oa_pdf/68/7c/TODENTJ-10-19.PMC4780478.pdf
"[http://dx.doi.org/10.2174/1874210601206010248 ] [PMID: 23346262 ] Received: January 27, 2015 Revised: October 31, 2015 Accepted: November 6, 2015 © Silveira and Mucha; Licensee Bentham Open.",Non-OADS,/arxiv_data1/oa_pdf/68/7c/TODENTJ-10-19.PMC4780478.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/68/7c/TODENTJ-10-19.PMC4780478.pdf
"Trial Registration: Open-Label  Study  Comparing  Etanercept  to  Conventional  Disease  Modifying  Antirheumatic  Drug  (DMARD)  Therapy; ClinicalTrials.gov,  number  NCT00848354;  https://clinicaltrials.gov/ct2/show/NCT00848354 Keywords: Disease-modifying antirheumatic drugs, etanercept, Latin America, methotrexate, rheumatoid arthritis.",Non-OADS,/arxiv_data1/oa_pdf/5e/c3/TORJ-10-13.PMC4780479.pdf
"[http://dx.doi.org/10.1007/s10067-015-3012-0] [PMID: 26219487] [2] Massardo L, Suárez-Almazor ME, Cardiel MH, et al.",Non-OADS,/arxiv_data1/oa_pdf/5e/c3/TORJ-10-13.PMC4780479.pdf
"[http://dx.doi.org/10.1097/RHU.0b013e3181a90cd8] [PMID: 19502907] [3] Spindler A, Bellomio V, Berman A, et al.",OADS,/arxiv_data1/oa_pdf/5e/c3/TORJ-10-13.PMC4780479.pdf
"[http://dx.doi.org/10.1136/ard.2010.138461] [PMID: 20699241] [7] Smolen JS, Landewé R, Breedveld FC, et al.",OADS,/arxiv_data1/oa_pdf/5e/c3/TORJ-10-13.PMC4780479.pdf
"[http://dx.doi.org/10.1136/ard.2009.126532] [PMID: 20444750] [8] Felson DT, Smolen JS, Wells G, et al.",OADS,/arxiv_data1/oa_pdf/5e/c3/TORJ-10-13.PMC4780479.pdf
[http://dx.doi.org/10.1136/ard.2011.149765] [PMID: 21292833] [9] Cardiel MH.,OADS,/arxiv_data1/oa_pdf/5e/c3/TORJ-10-13.PMC4780479.pdf
"[http://dx.doi.org/10.1016/S0140-6736(08)61000-4] [PMID: 18635256] [11] Klareskog L, van der Heijde D, de Jager JP, et al.",OADS,/arxiv_data1/oa_pdf/5e/c3/TORJ-10-13.PMC4780479.pdf
"[http://dx.doi.org/10.1016/S0140-6736(04)15640-7] [PMID: 15001324] [12] Machado DA, Guzman RM, Xavier RM, et al.",OADS,/arxiv_data1/oa_pdf/5e/c3/TORJ-10-13.PMC4780479.pdf
"[http://dx.doi.org/10.1097/RHU.0000000000000055] [PMID: 24356474] [13] Moreland LW, O’Dell JR, Paulus HE, et al.",OADS,/arxiv_data1/oa_pdf/5e/c3/TORJ-10-13.PMC4780479.pdf
"[http://dx.doi.org/10.1002/art.34498] [PMID: 22508468] [14] O’Dell JR, Mikuls TR, Taylor TH, et al.",OADS,/arxiv_data1/oa_pdf/5e/c3/TORJ-10-13.PMC4780479.pdf
"[http://dx.doi.org/10.1056/NEJMoa1303006] [PMID: 23755969] [15] van Vollenhoven RF, Ernestam S, Geborek P, et al.",OADS,/arxiv_data1/oa_pdf/5e/c3/TORJ-10-13.PMC4780479.pdf
"[http://dx.doi.org/10.1016/S0140-6736(09)60944-2] [PMID: 19665644] [16] Kremer JM, Weinblatt ME, Bankhurst AD, et al.",OADS,/arxiv_data1/oa_pdf/5e/c3/TORJ-10-13.PMC4780479.pdf
"[http://dx.doi.org/10.1002/art.11142] [PMID: 12794815] [17] Klareskog L, Gaubitz M, Rodríguez-Valverde V, Malaise M, Dougados M, Wajdula J.",OADS,/arxiv_data1/oa_pdf/5e/c3/TORJ-10-13.PMC4780479.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/5e/c3/TORJ-10-13.PMC4780479.pdf
Randomisation was by online ran- dom number generator software (https://www.sealeden- velope.com/simple-randomiser/v1/lists) into either a Macintosh or a McGRATH group using blocks of random sizes of 4.,OADS,/arxiv_data1/oa_pdf/d8/26/ejanet-33-263.PMC4780480.pdf
"[http://dx.doi.org/10.1089/jop.2009.0026 ] [PMID: 19857105 ] [2] Bell SC, Senini SL, McCormack JG.",OADS,/arxiv_data1/oa_pdf/e2/40/TOOPHTJ-10-12.PMC4780483.pdf
"[http://dx.doi.org/10.1191/1479972305cd066rs ] [PMID: 16279156 ] [3] Wyrick  PB,  Davis  CH,  Knight  ST,  Choong  J.  In-vitro  activity  of  azithromycin  on  Chlamydia  trachomatis  infected,  polarized  human endometrial epithelial cells.",OADS,/arxiv_data1/oa_pdf/e2/40/TOOPHTJ-10-12.PMC4780483.pdf
"[http://dx.doi.org/10.1093/jac/31.1.139 ] [PMID: 8383102 ] [4] Chiu CH, Lin TY, Ou JT.",OADS,/arxiv_data1/oa_pdf/e2/40/TOOPHTJ-10-12.PMC4780483.pdf
"[http://dx.doi.org/10.1016/S0924-8579(99)00038-2 ] [PMID: 10389647 ] [5] Blais J, Beauchamp D, Chamberland S. Azithromycin uptake and intracellular accumulation by Toxoplasma gondii-infected macrophages.",OADS,/arxiv_data1/oa_pdf/e2/40/TOOPHTJ-10-12.PMC4780483.pdf
"[http://dx.doi.org/10.1093/jac/34.3.371 ] [PMID: 7829411 ] [6] Chia JK, Nakata MM, Lami JL, Park SS, Ding JC.",OADS,/arxiv_data1/oa_pdf/e2/40/TOOPHTJ-10-12.PMC4780483.pdf
[http://dx.doi.org/10.1086/517061 ] [PMID: 9455538 ] [7] Spectrum  Thea  Pharmaceuticals  Ltd.  Azyter® (azithromycin  dihydrate  1.5%  ophthalmic  solution):  summary  of  product  characteristics [online].,OADS,/arxiv_data1/oa_pdf/e2/40/TOOPHTJ-10-12.PMC4780483.pdf
"Available at: https://www.medicines.org.uk/emcmobile/medicine/24743 [8] Cochereau I, Meddeb-Ouertani A, Khairallah M, et al.",Non-OADS,/arxiv_data1/oa_pdf/e2/40/TOOPHTJ-10-12.PMC4780483.pdf
"[http://dx.doi.org/10.1136/bjo.2006.103556 ] [PMID: 17050578 ] [9] Ozdemir D, Cilaker S, Tugyan K, et al.",OADS,/arxiv_data1/oa_pdf/e2/40/TOOPHTJ-10-12.PMC4780483.pdf
"[http://dx.doi.org/10.1016/j.ajo.2005.04.015 ] [PMID: 16083841 ] [10] Kowalski RP, Romanowski EG, Mah FS, Yates KA, Gordon YJ.",OADS,/arxiv_data1/oa_pdf/e2/40/TOOPHTJ-10-12.PMC4780483.pdf
"[http://dx.doi.org/10.1016/j.ajo.2005.04.015 ] [PMID: 16083841 ] [11] Espiritu CR, Caparas VL, Bolinao JG.",OADS,/arxiv_data1/oa_pdf/e2/40/TOOPHTJ-10-12.PMC4780483.pdf
"[http://dx.doi.org/10.1016/j.jcrs.2006.09.019 ] [PMID: 17189795 ] [12] Gao H, Pennesi ME, Qiao X, et al.",OADS,/arxiv_data1/oa_pdf/e2/40/TOOPHTJ-10-12.PMC4780483.pdf
"[http://dx.doi.org/10.1167/iovs.05-0702 ] [PMID: 16565399 ] [13] Kernt M, Neubauer AS, Ulbig MW, Kampik A, Welge-Lüssen U.",OADS,/arxiv_data1/oa_pdf/e2/40/TOOPHTJ-10-12.PMC4780483.pdf
"[http://dx.doi.org/10.1016/j.jcrs.2007.10.046 ] [PMID: 18299076 ] [14] Rothova A, Bosch-Driessen LE, van Loon NH, Treffers WF.",OADS,/arxiv_data1/oa_pdf/e2/40/TOOPHTJ-10-12.PMC4780483.pdf
"[http://dx.doi.org/10.1136/bjo.82.11.1306 ] [PMID: 9924338 ] [15] Raihan AR, Zunaina E, Wan-Hazabbah WH, Adil H, Lakana-Kumar T. Neuroretinitis in ocular bartonellosis: a case series.",Non-OADS,/arxiv_data1/oa_pdf/e2/40/TOOPHTJ-10-12.PMC4780483.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/e2/40/TOOPHTJ-10-12.PMC4780483.pdf
"The coal ﬁlter prototype designed by Maquet Critical Care’s research department was obtained by modifying a heat and moisture exchanger (Servo Filter Humidiﬁer 172; Maquet Critical Care, Solna, Sweden) by replacing the existing ﬁlter with 1.2 g of KF-1700FL, a nonwoven activated carbon ﬁlter from Toyobo Co Ltd, Tokyo, Japan (Picture 1 inSupplemental Digital Content, http://links.lww.com/ EJA/A82).",Non-OADS,/arxiv_data1/oa_pdf/c0/49/ejanet-33-283.PMC4780484.pdf
"With propofol, CV Vtwas higher than with sevoﬂurane during sedation [34 (26 to 35)% vs. 13 (7 to 27)%, P¼0.03] and during anaesthesia [27 (19 to 29)% vs. 11(10 to 20)%, P¼0.01] (Supplemental Digital Content Table 2, http://links.lww.com/EJA/A82).",Non-OADS,/arxiv_data1/oa_pdf/c0/49/ejanet-33-283.PMC4780484.pdf
"During anaesthesia, this difference in sighs did not reach statistical signiﬁcance ( P¼0.12) (Supplemental Digital Content Table 3, http://links.lww.com/EJA/A82).",Non-OADS,/arxiv_data1/oa_pdf/c0/49/ejanet-33-283.PMC4780484.pdf
"4 and Supplemental Digital Content Table 4, http://links.lww.com/EJA/A82).",Non-OADS,/arxiv_data1/oa_pdf/c0/49/ejanet-33-283.PMC4780484.pdf
"Without remifentanil, Vt variability was greater with propofol than with sevoﬂurane (Supplemental Digital Content Table 2, http://links.lww.com/EJA/A82).",Non-OADS,/arxiv_data1/oa_pdf/c0/49/ejanet-33-283.PMC4780484.pdf
"5 and Supplemental Digital Content Table 3, http://links.lww.com/EJA/ A82).",Non-OADS,/arxiv_data1/oa_pdf/c0/49/ejanet-33-283.PMC4780484.pdf
"4 and Supplemental Digital Content Table 4, http://links.lww.com/EJA/A82).",Non-OADS,/arxiv_data1/oa_pdf/c0/49/ejanet-33-283.PMC4780484.pdf
"Available  from:  http://www12.statcan.gc.ca/  nhs-enm/2011/as- sa/99-010-x/99-010-x2011001-eng.pdf  , 2013 [cited 4th December 2013]; [2] Leininger MM, McFarland MR. Culture care diversity and universality: a worldwide nursing theory.",Non-OADS,/arxiv_data1/oa_pdf/97/4c/TONURSJ-10-1.PMC4780485.pdf
"[http://dx.doi.org/10.1186/1475-9276-11-47 ] [4] Divi C, Koss R, Schmaltz S, Loeb J.",OADS,/arxiv_data1/oa_pdf/97/4c/TONURSJ-10-1.PMC4780485.pdf
"[http://dx.doi.org/10.1093/intqhc/mzl069 ] [5] Boateng L, Nicolaou M, Dijkshoorn H, Stronks K, Agyemang C. An exploration of the enablers and barriers in access to the Dutch healthcare system among Ghanaians in Amsterdam.",Non-OADS,/arxiv_data1/oa_pdf/97/4c/TONURSJ-10-1.PMC4780485.pdf
"[http://dx.doi.org/10.1186/1472-6963-12-75 ] [6] Higginbottom GM, Richter S, Ortiz L, et al.",OADS,/arxiv_data1/oa_pdf/97/4c/TONURSJ-10-1.PMC4780485.pdf
", 2010 [cited: 4th December 2013]; [http://dx.doi.org/10.1186/1756-0500-7-71 ] [7] Hadziabdic E, Albin B, Hjelm K. Arabic-speaking migrants' attitudes, opinions, preferences and past experiences concerning the use of interpreters in healthcare: a postal cross-sectional survey.",Non-OADS,/arxiv_data1/oa_pdf/97/4c/TONURSJ-10-1.PMC4780485.pdf
"BMC Res Notes 2014; 7(71) [http://dx.doi.org/10.1186/1756-0500-7-71 ] [8] Ramsey  KW,  Davis  J,  French  G.  Perspectives  of  Chuukese  patients  and  their  health  care  providers  on  the  use  of  different  sources  of interpreters.",Non-OADS,/arxiv_data1/oa_pdf/97/4c/TONURSJ-10-1.PMC4780485.pdf
"[http://dx.doi.org/10.1111/j.1466-7657.2009.00738.x ] [10] Hadziabdic E, Hjelm K. Arabic-speaking migrants' experiences of the use of interpreters in healthcare: a qualitative explorative study.",Non-OADS,/arxiv_data1/oa_pdf/97/4c/TONURSJ-10-1.PMC4780485.pdf
"[http://dx.doi.org/10.1186/1475-9276-13-49 ] [11] MacFarlane A, Dzebisova Z, Karapish D, Kovacevic B, Ogbebor F, Okonkwo E. Arranging and negotiating the use of informal interpreters in general practice consultations: Experiences of refugees and asylum seekers in the west of Ireland.",Non-OADS,/arxiv_data1/oa_pdf/97/4c/TONURSJ-10-1.PMC4780485.pdf
"[http://dx.doi.org/10.1016/j.socscimed.2009.04.022 ] [12] Rhodes P, Nocon A.",OADS,/arxiv_data1/oa_pdf/97/4c/TONURSJ-10-1.PMC4780485.pdf
"Ukrainian-Speaking Migrants’ The Open Nursing Journal, 2016, Volume 10    7 [http://dx.doi.org/10.1046/j.1365-2524.2003.00398.x ] [13] Edwards R, Temple B, Alexander C. Users' experiences of interpreters: the critical role of trust.",Non-OADS,/arxiv_data1/oa_pdf/97/4c/TONURSJ-10-1.PMC4780485.pdf
"[http://dx.doi.org/10.1075/intp.7.1.05edw ] [14] Svensk  författningssamling  1986:223  Available  from:  http://www.riksdagen.se/sv/Dokument-Lagar/Lagar/Svenskforfattningssamling/ _sfs-1986-223/  ,  2013  [cited:  17th December  2013]; [15] Department of Health.",OADS,/arxiv_data1/oa_pdf/97/4c/TONURSJ-10-1.PMC4780485.pdf
The Equality and Human Rights Grou Guidance on Developing Local Communication Support Services and Strategies Available from: http://www.dh.gov.uk/prod_consum_dh/ groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4082350.pdf .,Non-OADS,/arxiv_data1/oa_pdf/97/4c/TONURSJ-10-1.PMC4780485.pdf
"Available from: http://www.hc-sc.gc.ca/hcs-sss/pubs/ acces/2001- lang-acces/gen-eng.php  , 2006 [cited: 17th December 2013]; [17] Bowling A.",Non-OADS,/arxiv_data1/oa_pdf/97/4c/TONURSJ-10-1.PMC4780485.pdf
"[http://dx.doi.org/10.1111/j.1440-1800.2011.00542.x ] [20] Hadziabdic E, Albin B, Heikkila K, Hjelm K. Family members' experiences of the use of interpreters in healthcare.",Non-OADS,/arxiv_data1/oa_pdf/97/4c/TONURSJ-10-1.PMC4780485.pdf
"[http://dx.doi.org/10.1017/S1463423612000680 ] [21] Mallinckrodt B, Wang C-C. Quantitative methods for verifying semantic equivalence of translated research instruments: a chinese version of the experiences in close relationships scale.",Non-OADS,/arxiv_data1/oa_pdf/97/4c/TONURSJ-10-1.PMC4780485.pdf
"[http://dx.doi.org/10.1037/0022-0167.51.3.368 ] [22] Streiner DL, Norman GR.",Non-OADS,/arxiv_data1/oa_pdf/97/4c/TONURSJ-10-1.PMC4780485.pdf
"[http://dx.doi.org/10.1093/acprof:oso/9780199231881.001.0001 ] [23] Polit  DF,  Beck  CT.  Essentials  of  nursing  research:  appraising  evidence  for  nursing  practice.",Non-OADS,/arxiv_data1/oa_pdf/97/4c/TONURSJ-10-1.PMC4780485.pdf
[http://dx.doi.org/10.1111/j.1365-2648.2004.03185.x ] [25] World Health Organization.,Non-OADS,/arxiv_data1/oa_pdf/97/4c/TONURSJ-10-1.PMC4780485.pdf
Available from: http://www.wma.net/en/30publications/ 10policies/b3/index.html.pdf?print-media-type&footer-right=[page]/[toPage]  2008.,Non-OADS,/arxiv_data1/oa_pdf/97/4c/TONURSJ-10-1.PMC4780485.pdf
"[http://dx.doi.org/10.1016/j.annemergmed.2012.01.025 ] [27] Jimenez N, Moreno G, Leng M, Buchwald D, Morales LS.",OADS,/arxiv_data1/oa_pdf/97/4c/TONURSJ-10-1.PMC4780485.pdf
"[http://dx.doi.org/10.1007/s11606-012-2154-x ] [28] Fatahi N, Nordholm L, Mattsson B, Hellström M. Experiences of Kurdish war-wounded refugees in communication with Swedish authorities through interpreter.",Non-OADS,/arxiv_data1/oa_pdf/97/4c/TONURSJ-10-1.PMC4780485.pdf
"[http://dx.doi.org/10.1016/j.pec.2009.03.010 ] [29] Greenhalgh T, Robb N, Scambler G. Communicative and strategic action in interpreted consultations in primary health care: a Habermasian perspective.",Non-OADS,/arxiv_data1/oa_pdf/97/4c/TONURSJ-10-1.PMC4780485.pdf
"[http://dx.doi.org/10.1016/j.socscimed.2006.03.033 ] [30] Robb N, Greenhalgh T. “You have to cover up the words of the doctor”: the mediation of trust in interpreted consultations in primary care.",Non-OADS,/arxiv_data1/oa_pdf/97/4c/TONURSJ-10-1.PMC4780485.pdf
[http://dx.doi.org/10.1108/14777260610701803 ] [31] Kammarkollegiet.,Non-OADS,/arxiv_data1/oa_pdf/97/4c/TONURSJ-10-1.PMC4780485.pdf
"Available  from:  http://www.kammarkollegiet.se/ sites/default/files/god_tolksed.pdf  ,  2010  [cited:  17th December  2013]; Received: March 20, 2015 Revised: June 02, 2015 Accepted: June 15, 2015 © Emina Hadziabdic; Licensee Bentham Open.",Non-OADS,/arxiv_data1/oa_pdf/97/4c/TONURSJ-10-1.PMC4780485.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/97/4c/TONURSJ-10-1.PMC4780485.pdf
"[http://dx.doi.org/10.1016/S1473-3099(06)70382-6 ] [PMID: 16439329 ] [2] Roushan MR, Ahmadi SA, Gangi SM, Janmohammadi N, Amiri MJ.",OADS,/arxiv_data1/oa_pdf/51/23/TOORTHJ-10-7.PMC4780486.pdf
"[http://dx.doi.org/10.1258/004947505774938693 ] [PMID: 16354479 ] [3] Matyas Z, Fujikura T. Brucellosis as a world problem.",Non-OADS,/arxiv_data1/oa_pdf/51/23/TOORTHJ-10-7.PMC4780486.pdf
"[http://dx.doi.org/10.1111/j.1442-200X.2008.02661.x ] [PMID: 19371290 ] [5] Godfroid J, Cloeckaert A, Liautard JP, et al.",OADS,/arxiv_data1/oa_pdf/51/23/TOORTHJ-10-7.PMC4780486.pdf
"[http://dx.doi.org/10.1051/vetres:2005003 ] [PMID: 15845228 ] [6] Pappas G, Akritidis N, Bosilkovski M, Tsianos E. Brucellosis.",Non-OADS,/arxiv_data1/oa_pdf/51/23/TOORTHJ-10-7.PMC4780486.pdf
[http://dx.doi.org/10.1056/NEJMra050570 ] [PMID: 15930423 ],Non-OADS,/arxiv_data1/oa_pdf/51/23/TOORTHJ-10-7.PMC4780486.pdf
"[http://dx.doi.org/10.2174/1574891X11308010008 ] [PMID: 22812616 ] [8] Tsolia M, Drakonaki S, Messaritaki A, et al.",OADS,/arxiv_data1/oa_pdf/51/23/TOORTHJ-10-7.PMC4780486.pdf
"[http://dx.doi.org/10.1053/jinf.2002.1000 ] [PMID: 12099734 ] [9] Bosilkovski M, Kirova-Urosevic V, Cekovska Z, et al.",OADS,/arxiv_data1/oa_pdf/51/23/TOORTHJ-10-7.PMC4780486.pdf
"[http://dx.doi.org/10.3329/jhpn.v31i2.16386 ] [PMID: 23930340 ] [11] Palanduz A, Telhan L, Kadıoğlu LE, Erdem E, Öztürk AO.",Non-OADS,/arxiv_data1/oa_pdf/51/23/TOORTHJ-10-7.PMC4780486.pdf
"[http://dx.doi.org/10.1017/S0950268803001857 ] [PMID: 15188722 ] [13] Sasan MS, Nateghi M, Bonyadi B, Aelami MH.",Non-OADS,/arxiv_data1/oa_pdf/51/23/TOORTHJ-10-7.PMC4780486.pdf
[http://dx.doi.org/10.3201/eid1312.070527 ] [PMID: 18258041 ] [15] Shen MW.,OADS,/arxiv_data1/oa_pdf/51/23/TOORTHJ-10-7.PMC4780486.pdf
"[http://dx.doi.org/10.1542/peds.2007-1874 ] [PMID: 18450861 ] [16] Buzgan T, Karahocagil MK, Irmak H, et al.",OADS,/arxiv_data1/oa_pdf/51/23/TOORTHJ-10-7.PMC4780486.pdf
"[http://dx.doi.org/10.1016/j.ijid.2009.06.031 ] [PMID: 19910232 ] [17] Lubani M, Sharda D, Helin I. Brucella arthritis in children.",Non-OADS,/arxiv_data1/oa_pdf/51/23/TOORTHJ-10-7.PMC4780486.pdf
"[http://dx.doi.org/10.1007/BF01644269 ] [PMID: 3793238 ] [18] Gómez-Reino  FJ,  Mateo  I,  Fuertes  A,  Gómez-Reino  JJ.",Non-OADS,/arxiv_data1/oa_pdf/51/23/TOORTHJ-10-7.PMC4780486.pdf
"[http://dx.doi.org/10.1136/ard.45.3.256 ] [PMID: 3485409 ] [19] Mousa AR, Muhtaseb SA, Almudallal DS, Khodeir SM, Marafie AA.",OADS,/arxiv_data1/oa_pdf/51/23/TOORTHJ-10-7.PMC4780486.pdf
"[http://dx.doi.org/10.1093/clinids/9.3.531 ] [PMID: 3496650 ] [20] El-Koumi MA, Afify M, Al-Zahrani SH.",Non-OADS,/arxiv_data1/oa_pdf/51/23/TOORTHJ-10-7.PMC4780486.pdf
"[http://dx.doi.org/10.4084/mjhid.2013.011 ] [PMID: 23505599 ] [21] Benjamin B, Annobil SH, Khan MR. Osteoarticular complications of childhood brucellosis: a study of 57 cases in Saudi Arabia.",Non-OADS,/arxiv_data1/oa_pdf/51/23/TOORTHJ-10-7.PMC4780486.pdf
"[http://dx.doi.org/10.1097/01241398-199211000-00019 ] [PMID: 1452754 ] [22] al-Eissa YA, Kambal AM, Alrabeeah AA, Abdullah AM, al-Jurayyan NA, al-Jishi NM.",Non-OADS,/arxiv_data1/oa_pdf/51/23/TOORTHJ-10-7.PMC4780486.pdf
"[http://dx.doi.org/10.1136/ard.49.11.896 ] [PMID: 2256735 ] Received: June 16, 2015 Revised: September 3, 2015 Accepted: September 11, 2015 © Yilmaz et al.",Non-OADS,/arxiv_data1/oa_pdf/51/23/TOORTHJ-10-7.PMC4780486.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/51/23/TOORTHJ-10-7.PMC4780486.pdf
"[http://dx.doi.org/10.1097/00003086-200211000-00042 ] [PMID: 12439270 ] [2] Schneider A, Bennett JM, O’Connor DP, Mehlhoff T, Bennett JB.",OADS,/arxiv_data1/oa_pdf/c8/9f/TOORTHJ-10-1.PMC4780487.pdf
"[http://dx.doi.org/10.1016/j.jse.2009.01.029 ] [PMID: 19362860 ] [3] Savvidou C, Moreno R. Spontaneous distal biceps tendon ruptures: are they related to statin administration?",Non-OADS,/arxiv_data1/oa_pdf/c8/9f/TOORTHJ-10-1.PMC4780487.pdf
"[http://dx.doi.org/10.1142/S0218810412500153 ] [PMID: 22745079 ] [4] D’Alessandro DF, Shields CL Jr, Tibone JE, Chandler RW.",OADS,/arxiv_data1/oa_pdf/c8/9f/TOORTHJ-10-1.PMC4780487.pdf
"[http://dx.doi.org/10.1177/036354659302100119 ] [PMID: 8427351 ] [5] Stucken C, Ciccotti MG. Distal biceps and triceps injuries in athletes.",Non-OADS,/arxiv_data1/oa_pdf/c8/9f/TOORTHJ-10-1.PMC4780487.pdf
"[http://dx.doi.org/10.1097/JSA.0000000000000030 ] [PMID: 25077745 ] [6] Davis WM, Yassine Z.",Non-OADS,/arxiv_data1/oa_pdf/c8/9f/TOORTHJ-10-1.PMC4780487.pdf
"[http://dx.doi.org/10.1016/S1058-2746(05)80044-8 ] [PMID: 7552670 ] [8] Mazzocca AD, Cohen M, Berkson E, et al.",OADS,/arxiv_data1/oa_pdf/c8/9f/TOORTHJ-10-1.PMC4780487.pdf
"[http://dx.doi.org/10.1016/j.jse.2006.04.012 ] [PMID: 17055747 ] [9] Athwal GS, Steinmann SP, Rispoli DM.",OADS,/arxiv_data1/oa_pdf/c8/9f/TOORTHJ-10-1.PMC4780487.pdf
"[http://dx.doi.org/10.1016/j.jhsa.2007.05.027 ] [PMID: 17923307 ] [10] Forthman CL, Zimmerman RM, Sullivan MJ, Gabel GT.",OADS,/arxiv_data1/oa_pdf/c8/9f/TOORTHJ-10-1.PMC4780487.pdf
"[http://dx.doi.org/10.1016/j.jse.2007.11.002 ] [PMID: 18325797 ] [11] Hutchinson HL, Gloystein D, Gillespie M. Distal biceps tendon insertion: an anatomic study.",OADS,/arxiv_data1/oa_pdf/c8/9f/TOORTHJ-10-1.PMC4780487.pdf
"[http://dx.doi.org/10.1016/j.jse.2007.05.005 ] [PMID: 17931901 ] [12] Jarrett CD, Weir DM, Stuffmann ES, Jain S, Miller MC, Schmidt CC.",OADS,/arxiv_data1/oa_pdf/c8/9f/TOORTHJ-10-1.PMC4780487.pdf
"[http://dx.doi.org/10.1016/j.jse.2011.04.030 ] [PMID: 21813298 ] [13] Eames MH, Bain GI, Fogg QA, van Riet RP.",OADS,/arxiv_data1/oa_pdf/c8/9f/TOORTHJ-10-1.PMC4780487.pdf
[http://dx.doi.org/10.2106/JBJS.D.02992 ] [PMID: 17473142 ],Non-OADS,/arxiv_data1/oa_pdf/c8/9f/TOORTHJ-10-1.PMC4780487.pdf
"[http://dx.doi.org/10.1097/BLO.0b013e31802f78aa ] [PMID: 17179788 ] [15] Krueger CA, Aden JK, Broughton K, Rispoli DM.",OADS,/arxiv_data1/oa_pdf/c8/9f/TOORTHJ-10-1.PMC4780487.pdf
[http://dx.doi.org/10.1016/j.jse.2014.02.023 ] [PMID: 24862250 ] [16] Wolff J.,OADS,/arxiv_data1/oa_pdf/c8/9f/TOORTHJ-10-1.PMC4780487.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/c8/9f/TOORTHJ-10-1.PMC4780487.pdf
"[http://dx.doi.org/10.1016/j.prosdent.2014.01.018 ] [PMID: 24721500 ] [2] Coachman C, Calamita M. Digital smile design: A tool for treatment planning and communication in esthetic dentistry quintessence of dental technology.",Non-OADS,/arxiv_data1/oa_pdf/01/87/TODENTJ-10-28.PMC4780488.pdf
"[http://dx.doi.org/10.11607/prd.0381 ] [PMID: 23820713 ] [5] Davarpanah M, Jansen CE, Vidjak FM, Etienne D, Kebir M, Martinez H. Restorative and periodontal considerations of short clinical crowns.",Non-OADS,/arxiv_data1/oa_pdf/01/87/TODENTJ-10-28.PMC4780488.pdf
"[http://dx.doi.org/10.1111/j.1708-8240.2012.00515.x ] [PMID: 23374405 ] [7] Figueiredo FE, Martins-Filho PR.",OADS,/arxiv_data1/oa_pdf/01/87/TODENTJ-10-28.PMC4780488.pdf
"[http://dx.doi.org/10.14219/jada.archive.2008.0358 ] [PMID: 18768905 ] [9] Tang X, Tang C, Su H, Luo H, Nakamura T, Yatani H. The effects of repeated heat-pressing on the mechanical properties and microstructure of IPS e.max Press.",OADS,/arxiv_data1/oa_pdf/01/87/TODENTJ-10-28.PMC4780488.pdf
"[http://dx.doi.org/10.1016/j.jmbbm.2014.09.016 ] [PMID: 25300063 ] [10] Cho SH, Nagy WW, Goodman JT, Solomon E, Koike M. The effect of multiple firings on the marginal integrity of pressable ceramic single crowns.",OADS,/arxiv_data1/oa_pdf/01/87/TODENTJ-10-28.PMC4780488.pdf
"[http://dx.doi.org/10.1016/S0022-3913(12)60011-0 ] [PMID: 22230912 ] [11] Balkaya MC, Cinar A, Pamuk S. Influence of firing cycles on the margin distortion of 3 all-ceramic crown systems.",OADS,/arxiv_data1/oa_pdf/01/87/TODENTJ-10-28.PMC4780488.pdf
[http://dx.doi.org/10.1016/j.prosdent.2005.02.003 ] [PMID: 15798685 ] [12] Simonsen RJ.,OADS,/arxiv_data1/oa_pdf/01/87/TODENTJ-10-28.PMC4780488.pdf
[http://dx.doi.org/10.1016/j.cden.2007.03.002 ] [PMID: 17532912 ] [13] Beall AE.,OADS,/arxiv_data1/oa_pdf/01/87/TODENTJ-10-28.PMC4780488.pdf
[http://dx.doi.org/10.1016/j.cden.2007.02.002 ] [PMID: 17532913 ] [14] Goodlin R. Photographic-assisted diagnosis and treatment planning.,OADS,/arxiv_data1/oa_pdf/01/87/TODENTJ-10-28.PMC4780488.pdf
[http://dx.doi.org/10.1016/j.cden.2011.02.001 ] [PMID: 21473989 ],OADS,/arxiv_data1/oa_pdf/01/87/TODENTJ-10-28.PMC4780488.pdf
[http://dx.doi.org/10.1016/j.cden.2011.01.012 ] [PMID: 21473988 ] [16] Ward DH.,OADS,/arxiv_data1/oa_pdf/01/87/TODENTJ-10-28.PMC4780488.pdf
"[http://dx.doi.org/10.1155/2012/479241 ] [18] Schmidt JC, Sahrmann P, Weiger R, Schmidlin PR, Walter C. Biologic width dimensions-a systematic review.",OADS,/arxiv_data1/oa_pdf/01/87/TODENTJ-10-28.PMC4780488.pdf
"[http://dx.doi.org/10.1111/jcpe.12078 ] [PMID: 23461747 ] [19] Herrero  F,  Scott  JB,  Maropis  PS,  Yukna  RA.",OADS,/arxiv_data1/oa_pdf/01/87/TODENTJ-10-28.PMC4780488.pdf
[http://dx.doi.org/10.1902/jop.1995.66.7.568 ] [PMID: 7562348 ] [20] Chu SJ.,OADS,/arxiv_data1/oa_pdf/01/87/TODENTJ-10-28.PMC4780488.pdf
"[http://dx.doi.org/10.1016/j.cden.2006.12.006 ] [PMID: 17532914 ] Received: December 31, 2014 Revised: October 28, 2015 Accepted: November 15, 2015 © Zanardi et al.",OADS,/arxiv_data1/oa_pdf/01/87/TODENTJ-10-28.PMC4780488.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/01/87/TODENTJ-10-28.PMC4780488.pdf
"Available from: http://www.sbpt.org.br/downloads/arquivos/ COM_DPOC/Relatorio_final_DPOC_Saude_Publica_2012_SBPT.pdf [3] Celli BR, Macnee W, Agusti A, et al.",Non-OADS,/arxiv_data1/oa_pdf/3f/43/TORMJ-10-12.PMC4780503.pdf
"[http://dx.doi.org/10.1016/j.physio.2009.06.008 ] [PMID: 20113757 ] [5] Basoglu OK, Atasever A, Bacakoglu F. The efficacy of incentive spirometry in patients with COPD.",OADS,/arxiv_data1/oa_pdf/3f/43/TORMJ-10-12.PMC4780503.pdf
"[http://dx.doi.org/10.1111/j.1440-1843.2005.00716.x ] [PMID: 15955148 ] [6] Langer D, Probst VS, Pitta F, et al.",OADS,/arxiv_data1/oa_pdf/3f/43/TORMJ-10-12.PMC4780503.pdf
"[http://dx.doi.org/10.1590/S1413-35552009005000034 ] [7] Pitta F, Troosters T, Probst VS, Spruit MA, Decramer M, Gosselink R. Physical activity and hospitalization for exacerbation of COPD.",OADS,/arxiv_data1/oa_pdf/3f/43/TORMJ-10-12.PMC4780503.pdf
[http://dx.doi.org/10.1378/chest.129.3.536 ] [PMID: 16537849 ] [8] PEDro – Physiotherapy Evidence Database [homepage da internet].,OADS,/arxiv_data1/oa_pdf/3f/43/TORMJ-10-12.PMC4780503.pdf
"[http://dx.doi.org/10.1016/S0895-4356(98)00131-0 ] [PMID: 10086815 ] [10] Mahajan AK, Diette GB, Hatipoğlu U, et al.",OADS,/arxiv_data1/oa_pdf/3f/43/TORMJ-10-12.PMC4780503.pdf
"[http://dx.doi.org/10.1186/1465-9921-12-120 ] [PMID: 21906390 ] [11] Paschoal IA, Villalba WO, Pereira MC.",Non-OADS,/arxiv_data1/oa_pdf/3f/43/TORMJ-10-12.PMC4780503.pdf
[http://dx.doi.org/10.1590/S1806-37132007000100016 ] [PMID: 17568873 ] [12] High-Frequency chest wall oscillation for airway clearance in neuromuscular dysfunction [homepage da internet].,Non-OADS,/arxiv_data1/oa_pdf/3f/43/TORMJ-10-12.PMC4780503.pdf
"Disponível em: http://www.dartin.cz/files/files/ soubory_download/the_ vest/LaRusso%20-%20HFCWO%20in%20NMD%20Whitepaper%20r ev6.pdf [13] Fink JB, Mahlmeister MJ.",Non-OADS,/arxiv_data1/oa_pdf/3f/43/TORMJ-10-12.PMC4780503.pdf
"[http://dx.doi.org/10.1164/rccm.200908-1203OC ] [PMID: 20133927 ] [22] Trevisan ME, Porto AS, Pinheiro TM.",OADS,/arxiv_data1/oa_pdf/3f/43/TORMJ-10-12.PMC4780503.pdf
"[http://dx.doi.org/10.1164/ajrccm.153.3.8630582 ] [PMID: 8630582 ] [24] Dourado VZ, Godoy I. Recondicionamento muscular na DPOC: principais intervenções e novas tendências.",OADS,/arxiv_data1/oa_pdf/3f/43/TORMJ-10-12.PMC4780503.pdf
"[http://dx.doi.org/10.1590/S1517-86922004000400010 ] [25] Silva EG, Dourado VZ.",Non-OADS,/arxiv_data1/oa_pdf/3f/43/TORMJ-10-12.PMC4780503.pdf
"[http://dx.doi.org/10.1590/S1517-86922008000300014 ] [26] Trevisan ME, Porto AS, Pinheiro TM.",Non-OADS,/arxiv_data1/oa_pdf/3f/43/TORMJ-10-12.PMC4780503.pdf
"[http://dx.doi.org/10.1111/j.1440-1843.2008.01466.x ] [PMID: 19192230 ] [29] Guimarães FS, Moço VJ, Menezes SL, et al.",OADS,/arxiv_data1/oa_pdf/3f/43/TORMJ-10-12.PMC4780503.pdf
"[http://dx.doi.org/10.1183/09059180.00010120 ] [31] Pascotini FS, Ramos MC, Silva AM, Trevisan ME.",Non-OADS,/arxiv_data1/oa_pdf/3f/43/TORMJ-10-12.PMC4780503.pdf
[http://dx.doi.org/10.1590/S1809-29502013000400009 ] [32] Guimarães MM.,Non-OADS,/arxiv_data1/oa_pdf/3f/43/TORMJ-10-12.PMC4780503.pdf
"[http://dx.doi.org/10.1016/0197-2456(95)00134-4 ] [PMID: 8721797 ] [34] Guyatt GH, Cook DJ, Sackett DL, Eckman M, Pauker S. Grades of recommendation for antithrombotic agents.",OADS,/arxiv_data1/oa_pdf/3f/43/TORMJ-10-12.PMC4780503.pdf
"[http://dx.doi.org/10.1378/chest.114.5_Supplement.441S ] [PMID: 9822056 ] [35] Verhagen AP, de Vet HC, de Bie RA, Boers M, van den Brandt PA.",OADS,/arxiv_data1/oa_pdf/3f/43/TORMJ-10-12.PMC4780503.pdf
"[http://dx.doi.org/10.1016/S0895-4356(00)00360-7 ] [PMID: 11438404 ] Received: December 15, 2014 Revised: April 8, 2015 Accepted: April 9, 2015 © de Alvarenga et al.",OADS,/arxiv_data1/oa_pdf/3f/43/TORMJ-10-12.PMC4780503.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/3f/43/TORMJ-10-12.PMC4780503.pdf
"[http://dx.doi.org/10.1016/S0002-9394(00)00883-7 ] [PMID: 11336930 ] [2] Spitznas M, Joussen F, Wessing A, Meyer-Schwickerath G. Coat’s disease.",OADS,/arxiv_data1/oa_pdf/0d/d7/TOOPHTJ-10-22.PMC4780504.pdf
"[http://dx.doi.org/10.1007/BF00414937 ] [PMID: 1080374 ] [3] Silodor SW, Augsburger JJ, Shields JA, Tasman W. Natural history and management of advanced Coats’ disease.",Non-OADS,/arxiv_data1/oa_pdf/0d/d7/TOOPHTJ-10-22.PMC4780504.pdf
"[http://dx.doi.org/10.1136/bjo.84.1.37 ] [PMID: 10611097 ] [5] Shields JA, Shields CL, Honavar SG, Demirci H, Cater J.",OADS,/arxiv_data1/oa_pdf/0d/d7/TOOPHTJ-10-22.PMC4780504.pdf
"[http://dx.doi.org/10.1016/S0002-9394(01)00896-0 ] [PMID: 11336931 ] [6] Morris B, Foot B, Mulvihill A.",OADS,/arxiv_data1/oa_pdf/0d/d7/TOOPHTJ-10-22.PMC4780504.pdf
"[http://dx.doi.org/10.1038/eye.2010.126 ] [PMID: 20865031 ] [7] Rishi P, Rishi E, Uparkar M, et al.",OADS,/arxiv_data1/oa_pdf/0d/d7/TOOPHTJ-10-22.PMC4780504.pdf
[http://dx.doi.org/10.4103/0301-4738.60081 ] [PMID: 20195034 ],Non-OADS,/arxiv_data1/oa_pdf/0d/d7/TOOPHTJ-10-22.PMC4780504.pdf
"[http://dx.doi.org/10.1136/bjo.2006.103382 ] [PMID: 17020897 ] [9] Smithen LM, Brown GC, Brucker AJ, Yannuzzi LA, Klais CM, Spaide RF.",OADS,/arxiv_data1/oa_pdf/0d/d7/TOOPHTJ-10-22.PMC4780504.pdf
"[http://dx.doi.org/10.1016/j.ophtha.2004.12.038 ] [PMID: 15882905 ] [10] Schefler AC, Berrocal AM, Murray TG.",OADS,/arxiv_data1/oa_pdf/0d/d7/TOOPHTJ-10-22.PMC4780504.pdf
"[http://dx.doi.org/10.1097/IAE.0b013e318163cd7c ] [PMID: 18317343 ] [11] Budning AS, Heon E, Gallie BL.",OADS,/arxiv_data1/oa_pdf/0d/d7/TOOPHTJ-10-22.PMC4780504.pdf
"[http://dx.doi.org/10.1016/S1091-8531(98)90034-9 ] [PMID: 10532724 ] [12] Nucci P, Bandello F, Serafino M, Wilson ME.",OADS,/arxiv_data1/oa_pdf/0d/d7/TOOPHTJ-10-22.PMC4780504.pdf
"[http://dx.doi.org/10.1097/IAE.0b013e31816b3158 ] [PMID: 18317340 ] [14] Othman IS, Moussa M, Bouhaimed M. Management of lipid exudates in Coats disease by adjuvant intravitreal triamcinolone: effects and complications.",Non-OADS,/arxiv_data1/oa_pdf/0d/d7/TOOPHTJ-10-22.PMC4780504.pdf
"[http://dx.doi.org/10.1136/bjo.2009.168013 ] [PMID: 19955197 ] [15] Ray R, Barañano DE, Hubbard GB.",Non-OADS,/arxiv_data1/oa_pdf/0d/d7/TOOPHTJ-10-22.PMC4780504.pdf
"[http://dx.doi.org/10.1136/bjophthalmol-2012-302250 ] [PMID: 23269680 ] [16] Zheng XX, Jiang YR.",OADS,/arxiv_data1/oa_pdf/0d/d7/TOOPHTJ-10-22.PMC4780504.pdf
"[http://dx.doi.org/10.1007/s00417-013-2409-1 ] [PMID: 23873253 ] [17] Ramasubramanian A, Shields CL.",Non-OADS,/arxiv_data1/oa_pdf/0d/d7/TOOPHTJ-10-22.PMC4780504.pdf
"[http://dx.doi.org/10.1136/bjophthalmol-2011-300141 ] [PMID: 21653215 ] [18] Zhao Q, Peng XY, Chen FH, et al.",OADS,/arxiv_data1/oa_pdf/0d/d7/TOOPHTJ-10-22.PMC4780504.pdf
"[http://dx.doi.org/10.1111/aos.12158 ] [PMID: 23764089 ] [19] Sigler EJ, Randolph JC, Calzada JI, Wilson MW, Haik BG.",OADS,/arxiv_data1/oa_pdf/0d/d7/TOOPHTJ-10-22.PMC4780504.pdf
[http://dx.doi.org/10.1016/j.survophthal.2013.03.007 ] [PMID: 24138893 ] [20] Coats G. Forms of retinal disease with massive exudation.,Non-OADS,/arxiv_data1/oa_pdf/0d/d7/TOOPHTJ-10-22.PMC4780504.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/0d/d7/TOOPHTJ-10-22.PMC4780504.pdf
"[http://dx.doi.org/10.3921/joptom.2008.43 ] [3] Goldmann H, Schmidt T. [Applanation tonometry].",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
[http://dx.doi.org/10.1159/000303213 ] [PMID: 13484216 ] [4] Stamper RL.,OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1097/OPX.0b013e318205a4e7 ] [PMID: 21150677 ] [5] Whitacre MM, Stein RA, Hassanein K. The effect of corneal thickness on applanation tonometry.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1016/S0002-9394(14)71455-2 ] [PMID: 8488910 ] [6] Herndon LW, Choudhri SA, Cox T, Damji KF, Shields MB, Allingham RR.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1001/archopht.1997.01100160307007 ] [PMID: 9298054 ] [7] Brandt JD, Beiser JA, Kass MA, Gordon MO.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1016/S0161-6420(01)00760-6 ] [PMID: 11581049 ] [8] Böhm  A,  Kohlhaas  M,  Lerche  RC,  Bischoff  B,  Richard  G.  [Measuring  intraocular  pressure  in  keratoconus.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1007/s003470050201 ] [PMID: 9465707 ] [9] Papastergiou GI, Kozobolis V, Siganos DS.",Non-OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1097/IJG.0b013e3181622502 ] [PMID: 18794685 ] [10] Ismail AR, Lamont M, Perera S, et al.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
[http://dx.doi.org/10.1136/bjo.2006.099564 ] [PMID: 17576716 ],OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1097/01.ijg.0000176940.81799.33 ] [PMID: 16148580 ] [12] Wozniak K, Köller AU, Spörl E, Böhm AG, Pillunat LE.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1007/s00347-006-1407-7 ] [PMID: 17048019 ] [13] Baskett JS, Goen TM, Terry JE.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1016/j.ophtha.2012.02.030 ] [15] Jorge J, Díaz-Rey JA, González-Méijome JM, Almeida JB, Parafita MA.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1046/j.1475-1313.2002.00077.x ] [PMID: 12477021 ] [16] Parker VA, Herrtage J, Sarkies NJ.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1136/bjo.85.11.1303 ] [PMID: 11673293 ] [17] Moseley MJ, Evans NM, Fielder AR.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1038/eye.1989.48 ] [PMID: 2612679 ] [18] Gupta V, Sony P, Agarwal HC, Sihota R, Sharma A. Inter-instrument agreement and influence of central corneal thickness on measurements with Goldmann, pneumotonometer and noncontact tonometer in glaucomatous eyes.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.4103/0301-4738.27952 ] [PMID: 17090879 ] [19] Domke N, Hager A, Wiegand W. [Intraocular pressure and corneal thickness.",Non-OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1007/s00347-006-1364-1 ] [PMID: 16786183 ] [20] Broman  AT,  Congdon  NG,  Bandeen-Roche  K,  Quigley  HA.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1097/01.ijg.0000212268.42606.97 ] [PMID: 16988597 ] [22] Wells AP, Garway-Heath DF, Poostchi A, Wong T, Chan KC, Sachdev N. Corneal hysteresis but not corneal thickness correlates with optic nerve surface compliance in glaucoma patients.",Non-OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1167/iovs.07-1556 ] [PMID: 18316697 ] [23] Congdon NG, Broman AT, Bandeen-Roche K, Grover D, Quigley HA.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1016/j.ajo.2005.12.007 ] [PMID: 16527231 ] [24] Sullivan-Mee M, Billingsley SC, Patel AD, Halverson KD, Alldredge BR, Qualls C. Ocular Response Analyzer in subjects with and without glaucoma.",Non-OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1097/OPX.0b013e3181784673 ] [PMID: 18521025 ] [25] Laiquzzaman M, Bhojwani R, Cunliffe I, Shah S. Diurnal variation of ocular hysteresis in normal subjects: relevance in clinical context.",Non-OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1111/j.1442-9071.2006.01185.x ] [PMID: 16626423 ] [26] Touboul D, Roberts C, Kérautret J, et al.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1016/j.jcrs.2007.11.051 ] [PMID: 18361984 ] [27] Hager A, Schroeder B, Sadeghi M, Grossherr M, Wiegand W. [The influence of corneal hysteresis and corneal resistance factor on the measurement of intraocular pressure].",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1007/s00347-007-1532-y ] [PMID: 17587093 ] [28] Hager A, Loge K, Schroeder B, Füllhas M-O, Wiegand W. Effect of central corneal thickness and corneal hysteresis on tonometry as measured by dynamic contour tonometry, ocular response analyzer, and Goldmann tonometry in glaucomatous eyes.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1097/IJG.0b013e31815c3ad3 ] [PMID: 18703945 ] [29] Sullivan-Mee M, Lewis SE, Pensyl D, Gerhardt G, Halverson KD, Qualls C. Factors influencing intermethod agreement between goldmann applanation, pascal dynamic contour, and ocular response analyzer tonometry.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1097/IJG.0b013e31824cd08d ] [PMID: 22407388 ] [30] Moreno-Montañés J, Maldonado MJ, García N, Mendiluce L, García-Gómez PJ, Seguí-Gómez M. Reproducibility and clinical relevance of",Non-OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1167/iovs.07-0280 ] [PMID: 18326720 ] [31] González-Méijome JM, Queirós A, Jorge J, Díaz-Rey A, Parafita MA.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1097/OPX.0b013e3181783a5f ] [PMID: 18521024 ] [32] Hon Y, Lam AK.",Non-OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1097/OPX.0b013e318279eb87 ] [PMID: 23238261 ] [33] Ali NQ, Patel DV, McGhee CN.",Non-OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1167/iovs.13-13715 ] [PMID: 24833745 ] [34] Bañeros-Rojas P, Martinez-de-la-Casa JM, Arribas-Pardo P, Berrozpe-Villabona C, Toro-Utrera P, García-Feijoó J.",Non-OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1016/j.oftal.2014.02.001 ] [PMID: 24814401 ] [35] Augsburger A, Terry JE.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
[http://dx.doi.org/10.1097/00006324-197701000-00004 ] [PMID: 871146 ] [36] Stepanik J. Das mackay-marg-tonometer.,OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1016/0002-9394(70)91047-0 ] [PMID: 5423765 ] [38] Currie BD, Bagga H, Rademaker AW, Tanna AP.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1097/IJG.0b013e3181f46324 ] [PMID: 20852435 ] [39] Mark LK, Asbell PA, Torres MA, Failla SJ.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1097/00003226-199207000-00001 ] [PMID: 1424645 ] [40] Azuara-Blanco  A,  Bhojani  TK,  Sarhan  AR,  Pillai  CT,  Dua  HS.",Non-OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1136/bjo.82.6.634 ] [PMID: 9797663 ] [41] Minckler DS, Baerveldt G, Heuer DK, Quillen-Thomas B, Walonker AF, Weiner J.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1016/0002-9394(87)90010-9 ] [PMID: 3618714 ] [42] Kao  SF,  Lichter  PR,  Bergstrom  TJ,  Rowe  S,  Musch  DC.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1016/S0161-6420(87)33249-X ] [PMID: 3431824 ] [43] Boothe WA, Lee DA, Panek WC, Pettit TH.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1001/archopht.1988.01060140374035 ] [PMID: 3415545 ] [44] Kooner  KS,  Cooksey  JC,  Barron  JB,  Zimmerman  TJ,  Gupte  RK,  Wall  JL.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1016/0002-9394(89)90666-1 ] [PMID: 2929709 ] [46] Horowitz GS, Byles J, Lee J, D’Este C. Comparison of the Tono-Pen and Goldmann tonometer for measuring intraocular pressure in patients with glaucoma.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1111/j.1442-9071.2004.00907.x ] [PMID: 15575828 ] [47] Salvetat ML, Zeppieri M, Tosoni C, Brusini P. Comparisons between Pascal dynamic contour tonometry, the TonoPen, and Goldmann applanation tonometry in patients with glaucoma.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1111/j.1600-0420.2006.00834.x ] [48] Moses RA, Grodzki WJ Jr.",Non-OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1001/archopht.1979.01020010291023 ] [PMID: 420643 ] [49] Scibilia GD, Ehlers WH, Donshik PC.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1136/bjo.2004.056622 ] [PMID: 15965165 ] [52] Saleh TA, Adams M, McDermott B, Claridge KG, Ewings P. Effects of central corneal thickness and corneal curvature on the intraocular pressure measurement by Goldmann applanation tonometer and ocular blood flow pneumatonometer.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1111/j.1442-9071.2006.01266.x ] [PMID: 16925697 ] [53] Morgan AJ, Harper J, Hosking SL, Gilmartin B.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1076/ceyr.25.2.107.10162 ] [PMID: 12525964 ] [54] Dekking HM, Coster HD.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1159/000305149 ] [PMID: 6059593 ] [55] ElMallah MK, Asrani SG.",Non-OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1097/ICU.0b013e3282f391ae ] [PMID: 18301285 ] [56] Chui WS, Lam A, Chen D, Chiu R. The influence of corneal properties on rebound tonometry.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1016/j.ophtha.2007.03.061 ] [PMID: 17573114 ] [57] González-Méijome JM, Jorge J, Queirós A, et al.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1136/bjo.2006.103044 ] [PMID: 16885185 ] [58] Moreno-Montañés J, García N, Fernández-Hortelano A, García-Layana A.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
[http://dx.doi.org/10.1097/ICO.0b013e318030df6e ] [PMID: 17457191 ] [59] Cervino A.,Non-OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1136/bjo.2006.102970 ] [PMID: 17114589 ] [60] Vincent SJ, Vincent RA, Shields D, Lee GA.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1111/j.1442-9071.2011.02670.x ] [61] Van der Jagt LH, Jansonius NM.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1016/j.ajo.2006.02.035 ] [PMID: 16876523 ] [63] Martinez-de-la-Casa JM, Garcia-Feijoo J, Castillo A, Garcia-Sanchez J. Reproducibility and clinical evaluation of rebound tonometry.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1167/iovs.05-0586 ] [PMID: 16303951 ] [64] Jóhannesson G, Hallberg P, Eklund A, Lindén C. ICare and Goldmann applanation tonometry-a comparative study.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1111/j.1600-0420.2005.00610.x ] [PMID: 16637838 ] [66] Kanngiesser HE, Kniestedt C, Robert YC.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1097/01.ijg.0000176936.16015.4e ] [PMID: 16148581 ] [67] Kniestedt C, Lin S, Choe J, Bostrom A, Nee M, Stamper RL.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1001/archopht.123.11.1532 ] [PMID: 16286615 ] [68] Kotecha A, White ET, Shewry JM, Garway-Heath DF.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1136/bjo.2005.075580 ] [PMID: 16299132 ] [69] Weizer JS, Asrani S, Stinnett SS, Herndon LW.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1097/IJG.0b013e31806ab2fe ] [PMID: 18091458 ] [70] Francis BA, Hsieh A, Lai M-Y, et al.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1016/j.ophtha.2006.06.047 ] [71] Sullivan-Mee M, Gerhardt G, Halverson KD, Qualls C. Repeatability and reproducibility for intraocular pressure measurement by dynamic contour, ocular response analyzer, and goldmann applanation tonometry.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"54   The Open Ophthalmology Journal, 2016, Volume 10 Nuyen and Mansouri [http://dx.doi.org/10.1097/IJG.0b013e31819c487d ] [PMID: 20010245 ] [72] Milla E, Duch S, Buchacra O, Masuet C. Poor agreement between Goldmann and Pascal tonometry in eyes with extreme pachymetry.",Non-OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1038/eye.2008.90 ] [PMID: 18369376 ] [73] Mansouri K, Weinreb RN, Medeiros FA.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.3109/08820538.2013.771201 ] [PMID: 23697618 ] [74] Liu JH, Kripke DF, Twa MD, et al.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1167/iovs.02-0666 ] [PMID: 12657596 ] [76] Barkana Y, Anis S, Liebmann J, Tello C, Ritch R. Clinical utility of intraocular pressure monitoring outside of normal office hours in patients with glaucoma.",Non-OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1001/archopht.124.6.793 ] [PMID: 16769832 ] [77] Caprioli J, Coleman AL.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1016/j.ophtha.2007.10.031 ] [PMID: 18082889 ] [78] Quaranta L, Katsanos A, Russo A, Riva I.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1034/j.1600-0420.2001.790317.x ] [PMID: 11401642 ] [80] Todani A, Behlau I, Fava MA, et al.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1167/iovs.11-7878 ] [PMID: 22039243 ] [81] Downs JC, Burgoyne CF, Seigfreid WP, Reynaud JF, Strouthidis NG, Sallee V. 24-hour IOP telemetry in the nonhuman primate: implant system performance and initial characterization of IOP at multiple timescales.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1167/iovs.11-7955 ] [PMID: 21791586 ] [82] Leonardi M, Leuenberger P, Bertrand D, Bertsch A, Renaud P. First steps toward noninvasive intraocular pressure monitoring with a sensing contact lens.",Non-OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1167/iovs.04-0015 ] [PMID: 15326128 ] [83] Yung E, Trubnik V, Katz LJ.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1007/s00417-014-2668-5 ] [84] Chitnis  G,  Maleki  T,  Samuels  B,  Cantor  LB,  Ziaie  B.",Non-OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1109/TBME.2012.2205248 ] [PMID: 22736631 ] [85] Hjortdal JO, Jensen PK.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1111/j.1600-0420.1995.tb00004.x ] [PMID: 7627759 ] [86] Lam AKC, Douthwaite WA.",Non-OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1167/iovs.10-7064 ] [PMID: 21948548 ] [88] Leonardi M, Pitchon EM, Bertsch A, Renaud P, Mermoud A. Wireless contact lens sensor for intraocular pressure monitoring: assessment on enucleated pig eyes.",Non-OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1111/j.1755-3768.2008.01404.x ] [PMID: 19016660 ] [89] Mottet B, Aptel F, Romanet J-P, Hubanova R, Pépin J-L, Chiquet C. 24-hour intraocular pressure rhythm in young healthy subjects evaluated with continuous monitoring using a contact lens sensor.",Non-OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1111/aos.12408 ] [PMID: 24720477 ] [91] Lorenz K, Korb C, Herzog N, et al.",OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1097/IJG.0b013e31821dac43 ] [PMID: 21602707 ] [93] Mansouri K, Shaarawy T. Continuous intraocular pressure monitoring with a wireless ocular telemetry sensor: initial clinical experience in patients with open angle glaucoma.",Non-OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1136/bjo.2010.192922 ] [PMID: 21216796 ] [94] Mansouri K, Medeiros FA, Tafreshi A, Weinreb RN.",Non-OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1001/archophthalmol.2012.2280 ] [95] Chen G-Z, Chan I-S, Leung LK, Lam DC.",Non-OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1016/j.medengphy.2014.06.005 ] [PMID: 25034639 ] Received: July 26, 2015 Revised: August 18, 2015 Accepted: August 18, 2015 © Nuyen and Mansouri; Licensee Bentham Open.",Non-OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/78/3d/TOOPHTJ-10-44.PMC4780505.pdf
"[http://dx.doi.org/10.1016/j.ijantimicag.2011.09.009 ] [PMID: 22018988 ] [3] Wullt B, Sunden F. Asymptomatic bacteriuria with the model strain Escherichia coli 83972 protects against symptomatic urinary tract infections.",Non-OADS,/arxiv_data1/oa_pdf/e4/e9/TOMICROJ-10-23.PMC4780506.pdf
[http://dx.doi.org/10.1016/S0022-5347(05)68562-X ] [PMID: 10411041 ],OADS,/arxiv_data1/oa_pdf/e4/e9/TOMICROJ-10-23.PMC4780506.pdf
"[http://dx.doi.org/10.1001/archinte.1960.00270140016003 ] [PMID: 14404662 ] [7] Hooton TM, Roberts PL, Cox ME, Stapleton AE.",OADS,/arxiv_data1/oa_pdf/e4/e9/TOMICROJ-10-23.PMC4780506.pdf
"[http://dx.doi.org/10.1056/NEJMoa1302186 ] [PMID: 24224622 ] [8] Wagenlehner FM, Naber KG.",OADS,/arxiv_data1/oa_pdf/e4/e9/TOMICROJ-10-23.PMC4780506.pdf
"[http://dx.doi.org/10.1093/cid/cis541 ] [PMID: 22677709 ] [9] Kogan MI, Naboka YL, Ibishev KS, Gudima IA, Naber KG.",OADS,/arxiv_data1/oa_pdf/e4/e9/TOMICROJ-10-23.PMC4780506.pdf
"[http://dx.doi.org/10.1159/000369631 ] [PMID: 25766599 ] [10] Cai T, Mazzoli S, Mondaini N, et al.",OADS,/arxiv_data1/oa_pdf/e4/e9/TOMICROJ-10-23.PMC4780506.pdf
"[http://dx.doi.org/10.1093/cid/cis534 ] [PMID: 22677710 ] [11] Wullt B, Ragnarsdottir B, Fischer H, Gronberg-Hernandez J, Lutay N, Svanborg C. Urogenital Infections In: Kurt G. Naber, Anthony J. Scaeffer, Chris F. Heyns, Tetsuro Matsumoto, Daniel A. Shoskes, Truls E. Bjerklund Johansen, Eds.",Non-OADS,/arxiv_data1/oa_pdf/e4/e9/TOMICROJ-10-23.PMC4780506.pdf
"[http://dx.doi.org/10.1186/1471-2180-11-244 ] [PMID: 22047020 ] [13] Hilt EE, McKinley K, Pearce MM, et al.",OADS,/arxiv_data1/oa_pdf/e4/e9/TOMICROJ-10-23.PMC4780506.pdf
"[http://dx.doi.org/10.1128/JCM.02876-13 ] [PMID: 24371246 ] [14] Fouts DE, Pieper R, Szpakowski S, et al.",OADS,/arxiv_data1/oa_pdf/e4/e9/TOMICROJ-10-23.PMC4780506.pdf
"[http://dx.doi.org/10.1186/1479-5876-10-174 ] [PMID: 22929533 ] [15] Wolfe AJ, Brubaker L. “Sterile Urine” and the Presence of Bacteria.",Non-OADS,/arxiv_data1/oa_pdf/e4/e9/TOMICROJ-10-23.PMC4780506.pdf
"[http://dx.doi.org/10.1016/j.eururo.2015.02.041 ] [PMID: 25774008 ] [16] Lewis DA, Brown R, Williams J, et al.",OADS,/arxiv_data1/oa_pdf/e4/e9/TOMICROJ-10-23.PMC4780506.pdf
"[http://dx.doi.org/10.3389/fcimb.2013.00041 ] [PMID: 23967406 ] [17] Pearce MM, Hilt EE, Rosenfeld AB, et al.",OADS,/arxiv_data1/oa_pdf/e4/e9/TOMICROJ-10-23.PMC4780506.pdf
"[http://dx.doi.org/10.1128/mBio.01283-14 ] [PMID: 25006228 ] [18] Khasriya R, Sathiananthamoorthy S, Ismail S, et al.",Non-OADS,/arxiv_data1/oa_pdf/e4/e9/TOMICROJ-10-23.PMC4780506.pdf
"[http://dx.doi.org/10.1128/JCM.03314-12 ] [PMID: 23596238 ] [19] Brubaker L, Nager CW, Richter HE, et al.",OADS,/arxiv_data1/oa_pdf/e4/e9/TOMICROJ-10-23.PMC4780506.pdf
"[http://dx.doi.org/10.1007/s00192-013-2325-2 ] [PMID: 24515544 ] [20] Nienhouse V, Gao X, Dong Q, et al.",OADS,/arxiv_data1/oa_pdf/e4/e9/TOMICROJ-10-23.PMC4780506.pdf
"[http://dx.doi.org/10.1371/journal.pone.0114185 ] [PMID: 25486068 ] [21] Smelov V, Arroyo Mühr LS, Bzhalava D, Brown LJ, Komyakov B, Dillner J. Metagenomic sequencing of expressed prostate secretions.",OADS,/arxiv_data1/oa_pdf/e4/e9/TOMICROJ-10-23.PMC4780506.pdf
"[http://dx.doi.org/10.1002/jmv.23900 ] [PMID: 24532541 ] [22] Beal MA, Glenn TC, Somers CM.",OADS,/arxiv_data1/oa_pdf/e4/e9/TOMICROJ-10-23.PMC4780506.pdf
"[http://dx.doi.org/10.1016/j.mrrev.2011.11.002 ] [PMID: 22178956 ] Received: July 10, 2015 Revised: August 10, 2015 Accepted: August 13, 2015 © Smelov et al.",OADS,/arxiv_data1/oa_pdf/e4/e9/TOMICROJ-10-23.PMC4780506.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/e4/e9/TOMICROJ-10-23.PMC4780506.pdf
"[http://dx.doi.org/10.1161/01.CIR.64.2.360 ] [PMID: 7249303 ] [2] Amin AP, Nathan S, Prodduturi P, et al.",OADS,/arxiv_data1/oa_pdf/60/02/TOCMJ-10-11.PMC4780507.pdf
[http://dx.doi.org/10.1016/S0195-668X(02)00844-8 ] [PMID: 12727150 ] [4] Trial of invasive versus  medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): a randomised trial.,Non-OADS,/arxiv_data1/oa_pdf/60/02/TOCMJ-10-11.PMC4780507.pdf
"[http://dx.doi.org/10.1016/S0140-6736(01)06100-1 ] [PMID: 11583747 ] [5] Sheridan BC, Stearns SC, Rossi JS, D’Arcy LP, Federspiel JJ, Carey TS.",OADS,/arxiv_data1/oa_pdf/60/02/TOCMJ-10-11.PMC4780507.pdf
"[http://dx.doi.org/10.1161/CIRCULATIONAHA.108.840041 ] [PMID: 19752390 ] [7] Hoff SJ, Ball SK, Leacche M, et al.",OADS,/arxiv_data1/oa_pdf/60/02/TOCMJ-10-11.PMC4780507.pdf
"[http://dx.doi.org/10.1053/j.semtcvs.2011.12.010 ] [PMID: 22643668 ] [9] Mack  M,  Acuff  T,  Yong  P,  Jett  GK,  Carter  D.  Minimally  invasive  thoracoscopically  assisted  coronary  artery  bypass  surgery.",Non-OADS,/arxiv_data1/oa_pdf/60/02/TOCMJ-10-11.PMC4780507.pdf
"[http://dx.doi.org/10.1016/S1010-7940(97)00141-3 ] [PMID: 9262076 ] [10] Ruel M, Shariff MA, Lapierre H, et al.",OADS,/arxiv_data1/oa_pdf/60/02/TOCMJ-10-11.PMC4780507.pdf
"[http://dx.doi.org/10.1016/j.jtcvs.2013.09.016 ] [PMID: 24183338 ] [11] Lapierre H, Chan V, Sohmer B, Mesana TG, Ruel M. Minimally invasive coronary artery bypass grafting via a small thoracotomy versus  off- pump: a case-matched study.",Non-OADS,/arxiv_data1/oa_pdf/60/02/TOCMJ-10-11.PMC4780507.pdf
"[http://dx.doi.org/10.1093/eurheartj/ehr213 ] [PMID: 21697170 ] [13] Hannan EL, Wu C, Walford G, et al.",OADS,/arxiv_data1/oa_pdf/60/02/TOCMJ-10-11.PMC4780507.pdf
"[http://dx.doi.org/10.1056/NEJMoa071804 ] [PMID: 18216353 ] [14] Malenka DJ, Leavitt BJ, Hearne MJ, et al.",OADS,/arxiv_data1/oa_pdf/60/02/TOCMJ-10-11.PMC4780507.pdf
"[http://dx.doi.org/10.1161/01.CIR.0000126826.58526.14 ] [PMID: 15117846 ] [16] van Domburg RT, Takkenberg JJ, Noordzij LJ, et al.",OADS,/arxiv_data1/oa_pdf/60/02/TOCMJ-10-11.PMC4780507.pdf
"[http://dx.doi.org/10.1056/NEJMoa1110717 ] [PMID: 22452338 ] [18] Hlatky MA, Boothroyd DB, Bravata DM, et al.",OADS,/arxiv_data1/oa_pdf/60/02/TOCMJ-10-11.PMC4780507.pdf
"[http://dx.doi.org/10.1016/S0140-6736(09)60552-3 ] [PMID: 19303634 ] [19] Alam M, Virani SS, Shahzad SA, et al.",OADS,/arxiv_data1/oa_pdf/60/02/TOCMJ-10-11.PMC4780507.pdf
"[http://dx.doi.org/10.1016/j.amjcard.2013.04.034 ] [PMID: 23726179 ] [20] Benedetto U, Melina G, Angeloni E, et al.",OADS,/arxiv_data1/oa_pdf/60/02/TOCMJ-10-11.PMC4780507.pdf
"[http://dx.doi.org/10.1016/j.ejcts.2009.03.012 ] [PMID: 19394857 ] [21] Bravata DM, Gienger AL, McDonald KM, et al.",OADS,/arxiv_data1/oa_pdf/60/02/TOCMJ-10-11.PMC4780507.pdf
"[http://dx.doi.org/10.7326/0003-4819-147-10-200711200-00185 ] [PMID: 17938385 ] [22] Fosbøl EL, Zhao Y, Shahian DM, Grover FL, Edwards FH, Peterson ED.",OADS,/arxiv_data1/oa_pdf/60/02/TOCMJ-10-11.PMC4780507.pdf
"[http://dx.doi.org/10.1161/CIRCULATIONAHA.113.001882 ] [PMID: 23532630 ] [23] Harskamp RE, Williams JB, Halkos ME, et al.",OADS,/arxiv_data1/oa_pdf/60/02/TOCMJ-10-11.PMC4780507.pdf
"[http://dx.doi.org/10.1016/j.jtcvs.2014.03.028 ] [PMID: 24755335 ] [24] Alexander KP, Anstrom KJ, Muhlbaier LH, et al.",OADS,/arxiv_data1/oa_pdf/60/02/TOCMJ-10-11.PMC4780507.pdf
